ontology,GO.ID,Term,Annotated,Significant,Expected,classicFisher,bonferroni,bh,foldEnrichment
BP,GO:0007275,multicellular organism development,5627,21,8.09,1.1e-06,0.0056166,0.0028083,2.6
BP,GO:0022603,regulation of anatomical structure morph...,1045,10,1.5,1.1e-06,0.0056166,0.0028083,6.67
BP,GO:0048856,anatomical structure development,6261,21,9,7.2e-06,0.036763199999999996,0.0097014,2.33
BP,GO:0000904,cell morphogenesis involved in different...,748,8,1.08,7.6e-06,0.0388056,0.0097014,7.41
BP,GO:0048731,system development,5225,19,7.51,1.0e-05,0.05106,0.010212,2.53
BP,GO:0000902,cell morphogenesis,1065,9,1.53,1.2e-05,0.061272,0.010212,5.88
BP,GO:0051179,localization,6784,21,9.75,2.9e-05,0.148074,0.018154666666666666,2.15
BP,GO:0007399,nervous system development,2630,13,3.78,2.9e-05,0.148074,0.018154666666666666,3.44
BP,GO:2001222,regulation of neuron migration,43,3,0.06,3.2e-05,0.16339199999999998,0.018154666666666666,50
BP,GO:0032502,developmental process,7006,21,10.07,4.9e-05,0.25019399999999997,0.0250194,2.09
BP,GO:0061001,regulation of dendritic spine morphogene...,52,3,0.07,5.6e-05,0.28593599999999997,0.02599418181818182,42.86
BP,GO:0048813,dendrite morphogenesis,157,4,0.23,7.3e-05,0.372738,0.0310615,17.39
BP,GO:0031122,cytoplasmic microtubule organization,61,3,0.09,9.1e-05,0.464646,0.03391842857142857,33.33
BP,GO:0009653,anatomical structure morphogenesis,2932,13,4.21,9.3e-05,0.474858,0.03391842857142857,3.09
BP,GO:0022604,regulation of cell morphogenesis,332,5,0.48,0.00010,0.5106,0.03404,10.42
BP,GO:0060997,dendritic spine morphogenesis,66,3,0.09,0.00012,0.61272,0.03604235294117648,33.33
BP,GO:0060998,regulation of dendritic spine developmen...,67,3,0.1,0.00012,0.61272,0.03604235294117648,30
BP,GO:0099173,postsynapse organization,184,4,0.26,0.00013,0.6637799999999999,0.036471428571428564,15.38
BP,GO:0032879,regulation of localization,3069,13,4.41,0.00015,0.7658999999999999,0.036471428571428564,2.95
BP,GO:0035418,protein localization to synapse,72,3,0.1,0.00015,0.7658999999999999,0.036471428571428564,30
BP,GO:0048814,regulation of dendrite morphogenesis,72,3,0.1,0.00015,0.7658999999999999,0.036471428571428564,30
BP,GO:0048667,cell morphogenesis involved in neuron di...,583,6,0.84,0.00016,0.81696,0.037134545454545455,7.14
BP,GO:0099518,vesicle cytoskeletal trafficking,78,3,0.11,0.00019,0.97014,0.0387351724137931,27.27
BP,GO:0006928,movement of cell or subcellular componen...,2297,11,3.3,0.00021,1,0.0387351724137931,3.33
BP,GO:2000026,regulation of multicellular organismal d...,1531,9,2.2,0.00021,1,0.0387351724137931,4.09
BP,GO:0065008,regulation of biological quality,4153,15,5.97,0.00022,1,0.0387351724137931,2.51
BP,GO:0009791,post-embryonic development,82,3,0.12,0.00022,1,0.0387351724137931,25
BP,GO:0051270,regulation of cellular component movemen...,1201,8,1.73,0.00022,1,0.0387351724137931,4.62
BP,GO:0030705,cytoskeleton-dependent intracellular tra...,210,4,0.3,0.00022,1,0.0387351724137931,13.33
BP,GO:0010770,positive regulation of cell morphogenesi...,83,3,0.12,0.00023,1,0.039146,25
BP,GO:0007051,spindle organization,216,4,0.31,0.00025,1,0.041177419354838714,12.9
BP,GO:0006305,DNA alkylation,88,3,0.13,0.00027,1,0.04177636363636363,23.08
BP,GO:0006306,DNA methylation,88,3,0.13,0.00027,1,0.04177636363636363,23.08
BP,GO:0032501,multicellular organismal process,8498,22,12.22,0.00030,1,0.043765714285714276,1.8
BP,GO:0048812,neuron projection morphogenesis,659,6,0.95,0.00030,1,0.043765714285714276,6.32
BP,GO:0097061,dendritic spine organization,92,3,0.13,0.00031,1,0.04396833333333334,23.08
BP,GO:0120039,plasma membrane bounded cell projection ...,674,6,0.97,0.00034,1,0.04692,6.19
BP,GO:0048858,cell projection morphogenesis,678,6,0.97,0.00035,1,0.04702894736842106,6.19
BP,GO:0099175,regulation of postsynapse organization,100,3,0.14,0.00039,1,0.04984428571428571,21.43
BP,GO:0106027,neuron projection organization,101,3,0.15,0.00041,1,0.04984428571428571,20
BP,GO:0032990,cell part morphogenesis,697,6,1,0.00041,1,0.04984428571428571,6
BP,GO:0008090,retrograde axonal transport,21,2,0.03,0.00041,1,0.04984428571428571,66.67
BP,GO:0010769,regulation of cell morphogenesis involve...,102,3,0.15,0.00042,1,0.04987255813953489,20
BP,GO:1902414,protein localization to cell junction,103,3,0.15,0.00043,1,0.04989954545454545,20
BP,GO:0060996,dendritic spine development,106,3,0.15,0.00047,1,0.05210204081632653,20
BP,GO:0010975,regulation of neuron projection developm...,467,5,0.67,0.00049,1,0.05210204081632653,7.46
BP,GO:0051240,positive regulation of multicellular org...,1718,9,2.47,0.00049,1,0.05210204081632653,3.64
BP,GO:0061003,positive regulation of dendritic spine m...,23,2,0.03,0.00050,1,0.05210204081632653,66.67
BP,GO:0006816,calcium ion transport,469,5,0.67,0.00050,1,0.05210204081632653,7.46
BP,GO:0050773,regulation of dendrite development,110,3,0.16,0.00052,1,0.0531024,18.75
BP,GO:0016358,dendrite development,268,4,0.39,0.00056,1,0.054913584905660374,10.26
BP,GO:0044728,DNA methylation or demethylation,113,3,0.16,0.00056,1,0.054913584905660374,18.75
BP,GO:0051960,regulation of nervous system development,482,5,0.69,0.00057,1,0.054913584905660374,7.25
BP,GO:0030334,regulation of cell migration,1066,7,1.53,0.00064,1,0.06051555555555556,4.58
BP,GO:0034330,cell junction organization,765,6,1.1,0.00066,1,0.06127200000000001,5.45
BP,GO:0035235,ionotropic glutamate receptor signaling ...,28,2,0.04,0.00074,1,0.06628842105263158,50
BP,GO:0060074,synapse maturation,28,2,0.04,0.00074,1,0.06628842105263158,50
BP,GO:0007268,chemical synaptic transmission,787,6,1.13,0.00077,1,0.06663762711864406,5.31
BP,GO:0098916,anterograde trans-synaptic signaling,787,6,1.13,0.00077,1,0.06663762711864406,5.31
BP,GO:0032989,cellular component morphogenesis,793,6,1.14,0.00080,1,0.06780098360655737,5.26
BP,GO:0099537,trans-synaptic signaling,795,6,1.14,0.00081,1,0.06780098360655737,5.26
BP,GO:0048468,cell development,2259,10,3.25,0.00084,1,0.06917806451612904,3.08
BP,GO:0034968,histone lysine methylation,131,3,0.19,0.00087,1,0.06935014925373134,15.79
BP,GO:0051094,positive regulation of developmental pro...,1476,8,2.12,0.00088,1,0.06935014925373134,3.77
BP,GO:2000145,regulation of cell motility,1125,7,1.62,0.00089,1,0.06935014925373134,4.32
BP,GO:2001032,regulation of double-strand break repair...,31,2,0.04,0.00091,1,0.06935014925373134,50
BP,GO:0006304,DNA modification,133,3,0.19,0.00091,1,0.06935014925373134,15.79
BP,GO:0007420,brain development,816,6,1.17,0.00093,1,0.06983205882352941,5.13
BP,GO:0060284,regulation of cell development,542,5,0.78,0.00097,1,0.07091666666666667,6.41
BP,GO:0050793,regulation of developmental process,2749,11,3.95,0.00100,1,0.07091666666666667,2.78
BP,GO:0099536,synaptic signaling,827,6,1.19,0.00100,1,0.07091666666666667,5.04
BP,GO:0051130,positive regulation of cellular componen...,1149,7,1.65,0.00100,1,0.07091666666666667,4.24
BP,GO:0040012,regulation of locomotion,1168,7,1.68,0.00110,1,0.07693972602739726,4.17
BP,GO:0016043,cellular component organization,6554,18,9.42,0.00114,1,0.078292,1.91
BP,GO:0010720,positive regulation of cell development,325,4,0.47,0.00115,1,0.078292,8.51
BP,GO:0018022,peptidyl-lysine methylation,147,3,0.21,0.00121,1,0.07885215189873418,14.29
BP,GO:0001666,response to hypoxia,330,4,0.47,0.00122,1,0.07885215189873418,8.51
BP,GO:0006336,DNA replication-independent nucleosome a...,36,2,0.05,0.00122,1,0.07885215189873418,40
BP,GO:0060322,head development,860,6,1.24,0.00122,1,0.07885215189873418,4.84
BP,GO:0060078,regulation of postsynaptic membrane pote...,149,3,0.21,0.00126,1,0.08005703703703704,14.29
BP,GO:0070588,calcium ion transmembrane transport,334,4,0.48,0.00127,1,0.08005703703703704,8.33
BP,GO:0034724,DNA replication-independent nucleosome o...,37,2,0.05,0.00129,1,0.0803260975609756,40
BP,GO:1903539,protein localization to postsynaptic mem...,38,2,0.05,0.00136,1,0.08327642857142857,40
BP,GO:0043414,macromolecule methylation,341,4,0.49,0.00137,1,0.08327642857142857,8.16
BP,GO:0062237,protein localization to postsynapse,39,2,0.06,0.00143,1,0.08471318181818181,33.33
BP,GO:0097106,postsynaptic density organization,39,2,0.06,0.00143,1,0.08471318181818181,33.33
BP,GO:0036293,response to decreased oxygen levels,346,4,0.5,0.00145,1,0.08471318181818181,8
BP,GO:0034220,ion transmembrane transport,1226,7,1.76,0.00146,1,0.08471318181818181,3.98
BP,GO:0016571,histone methylation,159,3,0.23,0.00151,1,0.08662988764044945,13.04
BP,GO:0050905,neuromuscular process,160,3,0.23,0.00154,1,0.08674709677419355,13.04
BP,GO:0001764,neuron migration,161,3,0.23,0.00157,1,0.08674709677419355,13.04
BP,GO:0050775,positive regulation of dendrite morphoge...,41,2,0.06,0.00158,1,0.08674709677419355,33.33
BP,GO:0099084,postsynaptic specialization organization,41,2,0.06,0.00158,1,0.08674709677419355,33.33
BP,GO:0040011,locomotion,2032,9,2.92,0.00166,1,0.09016978723404256,3.08
BP,GO:0071840,cellular component organization or bioge...,6774,18,9.74,0.00174,1,0.09352042105263159,1.85
BP,GO:0051650,establishment of vesicle localization,170,3,0.24,0.00183,1,0.097333125,12.5
BP,GO:0070482,response to oxygen levels,371,4,0.53,0.00187,1,0.09843525773195876,7.55
BP,GO:0006812,cation transport,1285,7,1.85,0.00192,1,0.10003591836734693,3.78
BP,GO:0006811,ion transport,1681,8,2.42,0.00204,1,0.10521454545454546,3.31
BP,GO:0060999,positive regulation of dendritic spine d...,47,2,0.07,0.00207,1,0.10569419999999999,28.57
BP,GO:0030001,metal ion transport,960,6,1.38,0.00214,1,0.10818653465346535,4.35
BP,GO:0032259,methylation,391,4,0.56,0.00226,1,0.11313294117647059,7.14
BP,GO:0048522,positive regulation of cellular process,6314,17,9.08,0.00233,1,0.1142994495412844,1.87
BP,GO:0120035,regulation of plasma membrane bounded ce...,663,5,0.95,0.00235,1,0.1142994495412844,5.26
BP,GO:0000226,microtubule cytoskeleton organization,664,5,0.95,0.00236,1,0.1142994495412844,5.26
BP,GO:0098655,cation transmembrane transport,981,6,1.41,0.00239,1,0.1142994495412844,4.26
BP,GO:0050767,regulation of neurogenesis,398,4,0.57,0.00241,1,0.1142994495412844,7.02
BP,GO:0018023,peptidyl-lysine trimethylation,51,2,0.07,0.00244,1,0.1142994495412844,28.57
BP,GO:0051648,vesicle localization,188,3,0.27,0.00244,1,0.1142994495412844,11.11
BP,GO:0000122,negative regulation of transcription by ...,996,6,1.43,0.00258,1,0.1197589090909091,4.2
BP,GO:0031344,regulation of cell projection organizati...,681,5,0.98,0.00264,1,0.12081160714285714,5.1
BP,GO:0018193,peptidyl-amino acid modification,1360,7,1.95,0.00265,1,0.12081160714285714,3.59
BP,GO:0009893,positive regulation of metabolic process,4110,13,5.91,0.00268,1,0.12109805309734513,2.2
BP,GO:0030900,forebrain development,412,4,0.59,0.00273,1,0.1214733870967742,6.78
BP,GO:0051656,establishment of organelle localization,413,4,0.59,0.00276,1,0.1214733870967742,6.78
BP,GO:0007155,cell adhesion,1772,8,2.55,0.00285,1,0.1214733870967742,3.14
BP,GO:0006333,chromatin assembly or disassembly,199,3,0.29,0.00287,1,0.1214733870967742,10.34
BP,GO:0006479,protein methylation,199,3,0.29,0.00287,1,0.1214733870967742,10.34
BP,GO:0008213,protein alkylation,199,3,0.29,0.00287,1,0.1214733870967742,10.34
BP,GO:0022008,neurogenesis,1779,8,2.56,0.00292,1,0.1214733870967742,3.12
BP,GO:0022610,biological adhesion,1779,8,2.56,0.00292,1,0.1214733870967742,3.12
BP,GO:0007215,glutamate receptor signaling pathway,56,2,0.08,0.00293,1,0.1214733870967742,25
BP,GO:0043113,receptor clustering,56,2,0.08,0.00293,1,0.1214733870967742,25
BP,GO:0051239,regulation of multicellular organismal p...,3134,11,4.51,0.00295,1,0.1214733870967742,2.44
BP,GO:0051172,negative regulation of nitrogen compound...,2668,10,3.84,0.00303,1,0.12376944000000001,2.6
BP,GO:0031175,neuron projection development,1031,6,1.48,0.00307,1,0.12440809523809523,4.05
BP,GO:0016447,somatic recombination of immunoglobulin ...,59,2,0.08,0.00325,1,0.13066535433070867,25
BP,GO:0097120,receptor localization to synapse,60,2,0.09,0.00336,1,0.1340325,22.22
BP,GO:0006357,regulation of transcription by RNA polym...,2710,10,3.9,0.00340,1,0.1345767441860465,2.56
BP,GO:0010564,regulation of cell cycle process,731,5,1.05,0.00358,1,0.1403175572519084,4.76
BP,GO:0006325,chromatin organization,445,4,0.64,0.00360,1,0.1403175572519084,6.25
BP,GO:0060348,bone development,219,3,0.31,0.00375,1,0.1432728358208955,9.68
BP,GO:0048870,cell motility,1853,8,2.66,0.00376,1,0.1432728358208955,3.01
BP,GO:0051674,localization of cell,1853,8,2.66,0.00376,1,0.1432728358208955,3.01
BP,GO:0048513,animal organ development,3743,12,5.38,0.00381,1,0.14410266666666666,2.23
BP,GO:0048167,regulation of synaptic plasticity,222,3,0.32,0.00390,1,0.1464220588235294,9.38
BP,GO:0051054,positive regulation of DNA metabolic pro...,223,3,0.32,0.00395,1,0.1472167883211679,9.38
BP,GO:0051173,positive regulation of nitrogen compound...,3256,11,4.68,0.00400,1,0.148,2.35
BP,GO:0016445,somatic diversification of immunoglobuli...,67,2,0.1,0.00417,1,0.1490118367346939,20
BP,GO:0042391,regulation of membrane potential,464,4,0.67,0.00418,1,0.1490118367346939,5.97
BP,GO:0007163,establishment or maintenance of cell pol...,228,3,0.33,0.00420,1,0.1490118367346939,9.09
BP,GO:0043269,regulation of ion transport,759,5,1.09,0.00420,1,0.1490118367346939,4.59
BP,GO:0010604,positive regulation of macromolecule met...,3786,12,5.44,0.00420,1,0.1490118367346939,2.21
BP,GO:0030182,neuron differentiation,1478,7,2.12,0.00423,1,0.1490118367346939,3.3
BP,GO:0002562,somatic diversification of immune recept...,68,2,0.1,0.00429,1,0.1490118367346939,20
BP,GO:0016444,somatic cell DNA recombination,68,2,0.1,0.00429,1,0.1490118367346939,20
BP,GO:0098930,axonal transport,68,2,0.1,0.00429,1,0.1490118367346939,20
BP,GO:0006303,double-strand break repair via nonhomolo...,69,2,0.1,0.00441,1,0.15180926174496642,20
BP,GO:0006366,transcription by RNA polymerase II,2809,10,4.04,0.00443,1,0.15180926174496642,2.48
BP,GO:0007417,central nervous system development,1118,6,1.61,0.00457,1,0.1555628,3.73
BP,GO:0050808,synapse organization,477,4,0.69,0.00461,1,0.1558851655629139,5.8
BP,GO:0007411,axon guidance,239,3,0.34,0.00479,1,0.16090618421052633,8.82
BP,GO:0097485,neuron projection guidance,240,3,0.34,0.00485,1,0.16185686274509806,8.82
BP,GO:0032270,positive regulation of cellular protein ...,1520,7,2.18,0.00493,1,0.1634583116883117,3.21
BP,GO:0050807,regulation of synapse organization,245,3,0.35,0.00513,1,0.1673992405063291,8.57
BP,GO:0050804,modulation of chemical synaptic transmis...,492,4,0.71,0.00514,1,0.1673992405063291,5.63
BP,GO:0009790,embryo development,1147,6,1.65,0.00518,1,0.1673992405063291,3.64
BP,GO:0099177,regulation of trans-synaptic signaling,493,4,0.71,0.00518,1,0.1673992405063291,5.63
BP,GO:0006996,organelle organization,3891,12,5.59,0.00530,1,0.16913625000000002,2.15
BP,GO:0007010,cytoskeleton organization,1540,7,2.21,0.00530,1,0.16913625000000002,3.17
BP,GO:0002200,somatic diversification of immune recept...,77,2,0.11,0.00547,1,0.17303666666666667,18.18
BP,GO:0050769,positive regulation of neurogenesis,251,3,0.36,0.00549,1,0.17303666666666667,8.33
BP,GO:0050803,regulation of synapse structure or activ...,253,3,0.36,0.00561,1,0.17573411042944787,8.33
BP,GO:0051495,positive regulation of cytoskeleton orga...,254,3,0.37,0.00567,1,0.17653060975609755,8.11
BP,GO:0051966,"regulation of synaptic transmission, glu...",79,2,0.11,0.00575,1,0.17793636363636364,18.18
BP,GO:0008088,axo-dendritic transport,80,2,0.11,0.00589,1,0.18117072289156627,18.18
BP,GO:0008306,associative learning,83,2,0.12,0.00632,1,0.19323305389221557,16.67
BP,GO:0051128,regulation of cellular component organiz...,2475,9,3.56,0.00638,1,0.19390642857142856,2.53
BP,GO:0034765,regulation of ion transmembrane transpor...,525,4,0.75,0.00646,1,0.19431977142857143,5.33
BP,GO:0051234,establishment of localization,5094,14,7.32,0.00650,1,0.19431977142857143,1.91
BP,GO:0048666,neuron development,1204,6,1.73,0.00655,1,0.19431977142857143,3.47
BP,GO:0048518,positive regulation of biological proces...,6900,17,9.92,0.00655,1,0.19431977142857143,1.71
BP,GO:2000134,negative regulation of G1/S transition o...,85,2,0.12,0.00662,1,0.19431977142857143,16.67
BP,GO:0031325,positive regulation of cellular metaboli...,3473,11,4.99,0.00663,1,0.19431977142857143,2.2
BP,GO:0050794,regulation of cellular process,12637,25,18.17,0.00666,1,0.19431977142857143,1.38
BP,GO:0001501,skeletal system development,533,4,0.77,0.00681,1,0.19702813559322033,5.19
BP,GO:0098662,inorganic cation transmembrane transport,852,5,1.22,0.00683,1,0.19702813559322033,4.1
BP,GO:0051247,positive regulation of protein metabolic...,1616,7,2.32,0.00688,1,0.19735550561797752,3.02
BP,GO:0032508,DNA duplex unwinding,87,2,0.13,0.00693,1,0.197679217877095,15.38
BP,GO:0022414,reproductive process,1623,7,2.33,0.00704,1,0.19893868852459018,3
BP,GO:2000779,regulation of double-strand break repair,88,2,0.13,0.00708,1,0.19893868852459018,15.38
BP,GO:0000003,reproduction,1626,7,2.34,0.00711,1,0.19893868852459018,2.99
BP,GO:0021537,telencephalon development,276,3,0.4,0.00713,1,0.19893868852459018,7.5
BP,GO:0002637,regulation of immunoglobulin production,89,2,0.13,0.00724,1,0.20091,15.38
BP,GO:0006338,chromatin remodeling,280,3,0.4,0.00742,1,0.20451451612903226,7.5
BP,GO:1901698,response to nitrogen compound,1237,6,1.78,0.00745,1,0.20451451612903226,3.37
BP,GO:0014068,positive regulation of phosphatidylinosi...,91,2,0.13,0.00756,1,0.20640126984126983,15.38
BP,GO:0048699,generation of neurons,1647,7,2.37,0.00762,1,0.20640126984126983,2.95
BP,GO:0051640,organelle localization,551,4,0.79,0.00764,1,0.20640126984126983,5.06
BP,GO:0032392,DNA geometric change,93,2,0.13,0.00788,1,0.21176463157894737,15.38
BP,GO:0032412,regulation of ion transmembrane transpor...,288,3,0.41,0.00802,1,0.21187268041237112,7.32
BP,GO:0009628,response to abiotic stimulus,1257,6,1.81,0.00804,1,0.21187268041237112,3.31
BP,GO:1902807,negative regulation of cell cycle G1/S p...,94,2,0.14,0.00804,1,0.21187268041237112,14.29
BP,GO:0016477,cell migration,1664,7,2.39,0.00805,1,0.21187268041237112,2.93
BP,GO:0010638,positive regulation of organelle organiz...,562,4,0.81,0.00818,1,0.21419015384615384,4.94
BP,GO:0055085,transmembrane transport,1673,7,2.4,0.00829,1,0.21596295918367348,2.92
BP,GO:0033554,cellular response to stress,2118,8,3.04,0.00844,1,0.2186812121212121,2.63
BP,GO:0043270,positive regulation of ion transport,294,3,0.42,0.00848,1,0.2186812121212121,7.14
BP,GO:0006915,apoptotic process,2123,8,3.05,0.00856,1,0.21963497487437184,2.62
BP,GO:0022898,regulation of transmembrane transporter ...,299,3,0.43,0.00888,1,0.22670640000000003,6.98
BP,GO:0006468,protein phosphorylation,1706,7,2.45,0.00919,1,0.23280326732673265,2.86
BP,GO:0051962,positive regulation of nervous system de...,303,3,0.44,0.00921,1,0.23280326732673265,6.82
BP,GO:0022402,cell cycle process,1297,6,1.86,0.00932,1,0.2335244117647059,3.23
BP,GO:0051276,chromosome organization,919,5,1.32,0.00933,1,0.2335244117647059,3.79
BP,GO:0007044,cell-substrate junction assembly,102,2,0.15,0.00941,1,0.23437785365853658,13.33
BP,GO:0098660,inorganic ion transmembrane transport,922,5,1.33,0.00946,1,0.23447941747572815,3.76
BP,GO:0035249,"synaptic transmission, glutamatergic",103,2,0.15,0.00959,1,0.23639798076923077,13.33
BP,GO:2000113,negative regulation of cellular macromol...,1721,7,2.47,0.00963,1,0.23639798076923077,2.83
BP,GO:0051716,cellular response to stimulus,8455,19,12.15,0.00968,1,0.23648842105263157,1.56
BP,GO:0031323,regulation of cellular metabolic process,6531,16,9.39,0.00988,1,0.2398856603773585,1.7
BP,GO:0060079,excitatory postsynaptic potential,105,2,0.15,0.00995,1,0.2398856603773585,13.33
BP,GO:0010558,negative regulation of macromolecule bio...,1732,7,2.49,0.00996,1,0.2398856603773585,2.81
BP,GO:0007017,microtubule-based process,937,5,1.35,0.01010,1,0.24211549295774645,3.7
BP,GO:0012501,programmed cell death,2187,8,3.14,0.01019,1,0.2431314953271028,2.55
BP,GO:0071103,DNA conformation change,316,3,0.45,0.01032,1,0.2446625,6.67
BP,GO:0032268,regulation of cellular protein metabolic...,2667,9,3.83,0.01035,1,0.2446625,2.35
BP,GO:0150115,cell-substrate junction organization,108,2,0.16,0.01050,1,0.24620712328767125,12.5
BP,GO:0006355,"regulation of transcription, DNA-templat...",3692,11,5.31,0.01054,1,0.24620712328767125,2.07
BP,GO:1903506,regulation of nucleic acid-templated tra...,3693,11,5.31,0.01056,1,0.24620712328767125,2.07
BP,GO:0030335,positive regulation of cell migration,607,4,0.87,0.01065,1,0.24652045248868779,4.6
BP,GO:2001141,regulation of RNA biosynthetic process,3698,11,5.32,0.01067,1,0.24652045248868779,2.07
BP,GO:0045597,positive regulation of cell differentiat...,957,5,1.38,0.01100,1,0.253,3.62
BP,GO:0032414,positive regulation of ion transmembrane...,112,2,0.16,0.01126,1,0.2555269333333333,12.5
BP,GO:0042982,amyloid precursor protein metabolic proc...,112,2,0.16,0.01126,1,0.2555269333333333,12.5
BP,GO:0099565,"chemical synaptic transmission, postsyna...",112,2,0.16,0.01126,1,0.2555269333333333,12.5
BP,GO:0072657,protein localization to membrane,624,4,0.9,0.01170,1,0.26403394736842106,4.44
BP,GO:0007204,positive regulation of cytosolic calcium...,332,3,0.48,0.01179,1,0.26403394736842106,6.25
BP,GO:0032409,regulation of transporter activity,332,3,0.48,0.01179,1,0.26403394736842106,6.25
BP,GO:0000278,mitotic cell cycle,975,5,1.4,0.01186,1,0.26444174672489085,3.57
BP,GO:0006259,DNA metabolic process,981,5,1.41,0.01216,1,0.26910592274678113,3.55
BP,GO:0060291,long-term synaptic potentiation,117,2,0.17,0.01224,1,0.26910592274678113,11.76
BP,GO:0010948,negative regulation of cell cycle proces...,337,3,0.48,0.01227,1,0.26910592274678113,6.25
BP,GO:2000147,positive regulation of cell motility,633,4,0.91,0.01228,1,0.26910592274678113,4.4
BP,GO:0034762,regulation of transmembrane transport,634,4,0.91,0.01235,1,0.26942297872340426,4.4
BP,GO:0031327,negative regulation of cellular biosynth...,1806,7,2.6,0.01240,1,0.26942297872340426,2.69
BP,GO:0007267,cell-cell signaling,1808,7,2.6,0.01247,1,0.26979584745762714,2.69
BP,GO:0045892,"negative regulation of transcription, DN...",1386,6,1.99,0.01270,1,0.2736126582278481,3.02
BP,GO:1903507,negative regulation of nucleic acid-temp...,1388,6,2,0.01279,1,0.2743938655462185,3
BP,GO:1902679,negative regulation of RNA biosynthetic ...,1390,6,2,0.01287,1,0.2749548953974895,3
BP,GO:0051272,positive regulation of cellular componen...,646,4,0.93,0.01316,1,0.279979,4.3
BP,GO:0051171,regulation of nitrogen compound metaboli...,6108,15,8.78,0.01335,1,0.28051738775510204,1.71
BP,GO:0006810,transport,4925,13,7.08,0.01336,1,0.28051738775510204,1.84
BP,GO:0040017,positive regulation of locomotion,649,4,0.93,0.01336,1,0.28051738775510204,4.3
BP,GO:0003206,cardiac chamber morphogenesis,123,2,0.18,0.01346,1,0.28051738775510204,11.11
BP,GO:0032411,positive regulation of transporter activ...,123,2,0.18,0.01346,1,0.28051738775510204,11.11
BP,GO:0009890,negative regulation of biosynthetic proc...,1838,7,2.64,0.01358,1,0.2818678048780488,2.65
BP,GO:0014066,regulation of phosphatidylinositol 3-kin...,124,2,0.18,0.01366,1,0.2823804048582996,11.11
BP,GO:0043009,chordate embryonic development,657,4,0.94,0.01392,1,0.28659483870967745,4.26
BP,GO:0006351,"transcription, DNA-templated",3841,11,5.52,0.01412,1,0.28940808,1.99
BP,GO:0097659,nucleic acid-templated transcription,3843,11,5.52,0.01417,1,0.28940808,1.99
BP,GO:0018107,peptidyl-threonine phosphorylation,127,2,0.18,0.01430,1,0.29089960159362555,11.11
BP,GO:0048523,negative regulation of cellular process,5562,14,8,0.01458,1,0.2942985826771654,1.75
BP,GO:0032774,RNA biosynthetic process,3859,11,5.55,0.01461,1,0.2942985826771654,1.98
BP,GO:1990778,protein localization to cell periphery,360,3,0.52,0.01464,1,0.2942985826771654,5.77
BP,GO:1901700,response to oxygen-containing compound,1871,7,2.69,0.01488,1,0.29795011764705887,2.6
BP,GO:0021987,cerebral cortex development,131,2,0.19,0.01516,1,0.3023709375,10.53
BP,GO:0030048,actin filament-based movement,132,2,0.19,0.01538,1,0.3037971428571429,10.53
BP,GO:0009792,embryo development ending in birth or eg...,677,4,0.97,0.01539,1,0.3037971428571429,4.12
BP,GO:0031324,negative regulation of cellular metaboli...,2841,9,4.08,0.01541,1,0.3037971428571429,2.21
BP,GO:0006282,regulation of DNA repair,133,2,0.19,0.01560,1,0.30577310344827585,10.53
BP,GO:0051480,regulation of cytosolic calcium ion conc...,369,3,0.53,0.01563,1,0.30577310344827585,5.66
BP,GO:0007613,memory,134,2,0.19,0.01583,1,0.30850374045801526,10.53
BP,GO:0018210,peptidyl-threonine modification,136,2,0.2,0.01628,1,0.31557383458646615,10
BP,GO:0007049,cell cycle,1906,7,2.74,0.01636,1,0.31557383458646615,2.55
BP,GO:0031346,positive regulation of cell projection o...,376,3,0.54,0.01643,1,0.31557383458646615,5.56
BP,GO:0051246,regulation of protein metabolic process,2871,9,4.13,0.01644,1,0.31557383458646615,2.18
BP,GO:0003006,developmental process involved in reprod...,1065,5,1.53,0.01686,1,0.3224238202247191,3.27
BP,GO:1904019,epithelial cell apoptotic process,139,2,0.2,0.01696,1,0.3231259701492537,10
BP,GO:0008219,cell death,2393,8,3.44,0.01706,1,0.3238228996282527,2.33
BP,GO:0010595,positive regulation of endothelial cell ...,140,2,0.2,0.01719,1,0.32508200000000004,10
BP,GO:0080090,regulation of primary metabolic process,6287,15,9.04,0.01754,1,0.3304769003690037,1.66
BP,GO:0030154,cell differentiation,4528,12,6.51,0.01795,1,0.33695845588235296,1.84
BP,GO:0051668,localization within membrane,711,4,1.02,0.01811,1,0.33766686131386864,3.92
BP,GO:0000723,telomere maintenance,144,2,0.21,0.01812,1,0.33766686131386864,9.52
BP,GO:0051052,regulation of DNA metabolic process,391,3,0.56,0.01822,1,0.33829570909090906,5.36
BP,GO:0051253,negative regulation of RNA metabolic pro...,1502,6,2.16,0.01831,1,0.338735,2.78
BP,GO:0051252,regulation of RNA metabolic process,3996,11,5.74,0.01879,1,0.3460325179856115,1.92
BP,GO:0006334,nucleosome assembly,147,2,0.21,0.01884,1,0.3460325179856115,9.52
BP,GO:0008284,positive regulation of cell population p...,1099,5,1.58,0.01908,1,0.34918451612903223,3.16
BP,GO:0045471,response to ethanol,149,2,0.21,0.01932,1,0.35231399999999996,9.52
BP,GO:2000045,regulation of G1/S transition of mitotic...,150,2,0.22,0.01957,1,0.3556029181494662,9.09
BP,GO:0072006,nephron development,151,2,0.22,0.01981,1,0.3568806338028169,9.09
BP,GO:0097553,calcium ion transmembrane import into cy...,151,2,0.22,0.01981,1,0.3568806338028169,9.09
BP,GO:0050678,regulation of epithelial cell proliferat...,404,3,0.58,0.01985,1,0.3568806338028169,5.17
BP,GO:0007612,learning,153,2,0.22,0.02031,1,0.3627759440559441,9.09
BP,GO:0006950,response to stress,4602,12,6.62,0.02032,1,0.3627759440559441,1.81
BP,GO:0007568,aging,409,3,0.59,0.02050,1,0.36471428571428577,5.08
BP,GO:0016310,phosphorylation,1995,7,2.87,0.02059,1,0.3650435416666667,2.44
BP,GO:0010212,response to ionizing radiation,155,2,0.22,0.02081,1,0.36766733564013837,9.09
BP,GO:0071456,cellular response to hypoxia,156,2,0.22,0.02106,1,0.3708012413793103,9.09
BP,GO:0010243,response to organonitrogen compound,1129,5,1.62,0.02118,1,0.37163257731958765,3.09
BP,GO:0014065,phosphatidylinositol 3-kinase signaling,158,2,0.23,0.02157,1,0.3758922184300341,8.7
BP,GO:0018205,peptidyl-lysine modification,417,3,0.6,0.02157,1,0.3758922184300341,5
BP,GO:0065007,biological regulation,14349,26,20.63,0.02169,1,0.37669775510204084,1.26
BP,GO:0048869,cellular developmental process,4656,12,6.69,0.02219,1,0.3834640268456376,1.79
BP,GO:0010970,transport along microtubule,161,2,0.23,0.02234,1,0.3834640268456376,8.7
BP,GO:0050789,regulation of biological process,13537,25,19.46,0.02237,1,0.3834640268456376,1.28
BP,GO:0048519,negative regulation of biological proces...,6455,15,9.28,0.02238,1,0.3834640268456376,1.62
BP,GO:0045727,positive regulation of translation,162,2,0.23,0.02259,1,0.3857676923076923,8.7
BP,GO:0051726,regulation of cell cycle,1149,5,1.65,0.02267,1,0.3858434,3.03
BP,GO:0120036,plasma membrane bounded cell projection ...,1577,6,2.27,0.02275,1,0.3859186046511628,2.64
BP,GO:1901699,cellular response to nitrogen compound,763,4,1.1,0.02283,1,0.3859933112582781,3.64
BP,GO:0003205,cardiac chamber development,166,2,0.24,0.02364,1,0.3983691089108911,8.33
BP,GO:0036294,cellular response to decreased oxygen le...,167,2,0.24,0.02391,1,0.4015936184210527,8.33
BP,GO:0043434,response to peptide hormone,435,3,0.63,0.02407,1,0.40163862745098045,4.76
BP,GO:0048608,reproductive structure development,435,3,0.63,0.02407,1,0.40163862745098045,4.76
BP,GO:0061458,reproductive system development,438,3,0.63,0.02450,1,0.4056889389067524,4.76
BP,GO:0051641,cellular localization,3069,9,4.41,0.02462,1,0.4056889389067524,2.04
BP,GO:0010605,negative regulation of macromolecule met...,3603,10,5.18,0.02469,1,0.4056889389067524,1.93
BP,GO:0008360,regulation of cell shape,170,2,0.24,0.02471,1,0.4056889389067524,8.33
BP,GO:0060402,calcium ion transport into cytosol,170,2,0.24,0.02471,1,0.4056889389067524,8.33
BP,GO:0010976,positive regulation of neuron projection...,171,2,0.25,0.02498,1,0.4062034394904458,8
BP,GO:0031497,chromatin assembly,171,2,0.25,0.02498,1,0.4062034394904458,8
BP,GO:0034767,positive regulation of ion transmembrane...,171,2,0.25,0.02498,1,0.4062034394904458,8
BP,GO:0032200,telomere organization,172,2,0.25,0.02526,1,0.40945257142857144,8
BP,GO:0045786,negative regulation of cell cycle,444,3,0.64,0.02538,1,0.4100958227848101,4.69
BP,GO:0007409,axonogenesis,445,3,0.64,0.02553,1,0.4105608150470219,4.69
BP,GO:0045934,negative regulation of nucleobase-contai...,1620,6,2.33,0.02560,1,0.4105608150470219,2.58
BP,GO:1903047,mitotic cell cycle process,791,4,1.14,0.02565,1,0.4105608150470219,3.51
BP,GO:0043412,macromolecule modification,4179,11,6.01,0.02574,1,0.410713875,1.83
BP,GO:0030030,cell projection organization,1624,6,2.33,0.02588,1,0.41166130841121495,2.58
BP,GO:0010959,regulation of metal ion transport,449,3,0.65,0.02612,1,0.4138547368421052,4.62
BP,GO:0001934,positive regulation of protein phosphory...,796,4,1.14,0.02618,1,0.4138547368421052,3.51
BP,GO:0019222,regulation of metabolic process,7856,17,11.29,0.02641,1,0.41523563076923076,1.51
BP,GO:0007166,cell surface receptor signaling pathway,3106,9,4.46,0.02643,1,0.41523563076923076,2.02
BP,GO:0001932,regulation of protein phosphorylation,1205,5,1.73,0.02719,1,0.42109656976744186,2.89
BP,GO:0010646,regulation of cell communication,3658,10,5.26,0.02722,1,0.42109656976744186,1.9
BP,GO:0035295,tube development,1206,5,1.73,0.02728,1,0.42109656976744186,2.89
BP,GO:0034329,cell junction assembly,457,3,0.66,0.02734,1,0.42109656976744186,4.55
BP,GO:0050673,epithelial cell proliferation,461,3,0.66,0.02796,1,0.42109656976744186,4.55
BP,GO:1902806,regulation of cell cycle G1/S phase tran...,182,2,0.26,0.02804,1,0.42109656976744186,7.69
BP,GO:0023051,regulation of signaling,3677,10,5.29,0.02813,1,0.42109656976744186,1.89
BP,GO:0031399,regulation of protein modification proce...,1656,6,2.38,0.02817,1,0.42109656976744186,2.52
BP,GO:0071453,cellular response to oxygen levels,183,2,0.26,0.02832,1,0.42109656976744186,7.69
BP,GO:0006346,DNA methylation-dependent heterochromati...,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0007097,nuclear migration,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0030011,maintenance of cell polarity,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0032793,positive regulation of CREB transcriptio...,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0043046,DNA methylation involved in gamete gener...,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0060216,definitive hemopoiesis,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0097623,potassium ion export across plasma membr...,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0099558,maintenance of synapse structure,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:1900151,regulation of nuclear-transcribed mRNA c...,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:2000251,positive regulation of actin cytoskeleto...,20,1,0.03,0.02837,1,0.42109656976744186,33.33
BP,GO:0010634,positive regulation of epithelial cell m...,184,2,0.26,0.02861,1,0.42323722543352604,7.69
BP,GO:0097435,supramolecular fiber organization,819,4,1.18,0.02868,1,0.42323722543352604,3.39
BP,GO:0034654,nucleobase-containing compound biosynthe...,4259,11,6.12,0.02933,1,0.4269820786516854,1.8
BP,GO:0019219,regulation of nucleobase-containing comp...,4264,11,6.13,0.02956,1,0.4269820786516854,1.79
BP,GO:0034728,nucleosome organization,188,2,0.27,0.02976,1,0.4269820786516854,7.41
BP,GO:0002902,regulation of B cell apoptotic process,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:0030050,vesicle transport along actin filament,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:0036035,osteoclast development,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:0042985,negative regulation of amyloid precursor...,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:0048485,sympathetic nervous system development,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:0050849,negative regulation of calcium-mediated ...,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:1900424,regulation of defense response to bacter...,21,1,0.03,0.02977,1,0.4269820786516854,33.33
BP,GO:2000112,regulation of cellular macromolecule bio...,4280,11,6.15,0.03033,1,0.42927174515235456,1.79
BP,GO:0006874,cellular calcium ion homeostasis,476,3,0.68,0.03034,1,0.42927174515235456,4.41
BP,GO:0034250,positive regulation of cellular amide me...,190,2,0.27,0.03035,1,0.42927174515235456,7.41
BP,GO:0045766,positive regulation of angiogenesis,190,2,0.27,0.03035,1,0.42927174515235456,7.41
BP,GO:1904018,positive regulation of vasculature devel...,190,2,0.27,0.03035,1,0.42927174515235456,7.41
BP,GO:1901991,negative regulation of mitotic cell cycl...,191,2,0.27,0.03064,1,0.43217635359116024,7.41
BP,GO:0007063,regulation of sister chromatid cohesion,22,1,0.03,0.03117,1,0.4336621798365123,33.33
BP,GO:0014821,phasic smooth muscle contraction,22,1,0.03,0.03117,1,0.4336621798365123,33.33
BP,GO:0032402,melanosome transport,22,1,0.03,0.03117,1,0.4336621798365123,33.33
BP,GO:0048745,smooth muscle tissue development,22,1,0.03,0.03117,1,0.4336621798365123,33.33
BP,GO:0097164,ammonium ion metabolic process,22,1,0.03,0.03117,1,0.4336621798365123,33.33
BP,GO:0045944,positive regulation of transcription by ...,1252,5,1.8,0.03141,1,0.43407631168831173,2.78
BP,GO:0021543,pallium development,194,2,0.28,0.03153,1,0.43407631168831173,7.14
BP,GO:0010556,regulation of macromolecule biosynthetic...,4310,11,6.2,0.03181,1,0.43407631168831173,1.77
BP,GO:0048015,phosphatidylinositol-mediated signaling,195,2,0.28,0.03183,1,0.43407631168831173,7.14
BP,GO:0060401,cytosolic calcium ion transport,196,2,0.28,0.03213,1,0.43407631168831173,7.14
BP,GO:0099111,microtubule-based transport,196,2,0.28,0.03213,1,0.43407631168831173,7.14
BP,GO:0023052,signaling,7363,16,10.58,0.03233,1,0.43407631168831173,1.51
BP,GO:0055074,calcium ion homeostasis,488,3,0.7,0.03233,1,0.43407631168831173,4.29
BP,GO:0002320,lymphoid progenitor cell differentiation,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0021819,layer formation in cerebral cortex,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0032401,establishment of melanosome localization,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0033962,P-body assembly,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0042430,indole-containing compound metabolic pro...,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0051904,pigment granule transport,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0099515,actin filament-based transport,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:2000773,negative regulation of cellular senescen...,23,1,0.03,0.03256,1,0.43407631168831173,33.33
BP,GO:0009314,response to radiation,490,3,0.7,0.03267,1,0.43407631168831173,4.29
BP,GO:0050806,positive regulation of synaptic transmis...,198,2,0.28,0.03273,1,0.43407631168831173,7.14
BP,GO:0018130,heterocycle biosynthetic process,4332,11,6.23,0.03292,1,0.43546507772020726,1.77
BP,GO:0048017,inositol lipid-mediated signaling,199,2,0.29,0.03304,1,0.4359231007751938,6.9
BP,GO:0019438,aromatic compound biosynthetic process,4347,11,6.25,0.03370,1,0.4366465994962217,1.76
BP,GO:0003283,atrial septum development,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0006349,regulation of gene expression by genetic...,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0034629,cellular protein-containing complex loca...,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0048169,regulation of long-term neuronal synapti...,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0051647,nucleus localization,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0051905,establishment of pigment granule localiz...,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0060343,trabecula formation,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:0070989,oxidative demethylation,24,1,0.03,0.03395,1,0.4366465994962217,33.33
BP,GO:2001257,regulation of cation channel activity,202,2,0.29,0.03395,1,0.4366465994962217,6.9
BP,GO:0042770,signal transduction in response to DNA d...,203,2,0.29,0.03426,1,0.43924365000000004,6.9
BP,GO:0061564,axon development,500,3,0.72,0.03438,1,0.43924365000000004,4.17
BP,GO:0045595,regulation of cell differentiation,1735,6,2.49,0.03441,1,0.43924365000000004,2.41
BP,GO:0016570,histone modification,502,3,0.72,0.03473,1,0.44011229268292684,4.17
BP,GO:0001935,endothelial cell proliferation,205,2,0.29,0.03488,1,0.44011229268292684,6.9
BP,GO:0048660,regulation of smooth muscle cell prolife...,205,2,0.29,0.03488,1,0.44011229268292684,6.9
BP,GO:0007154,cell communication,7424,16,10.67,0.03491,1,0.44011229268292684,1.5
BP,GO:0030220,platelet formation,25,1,0.04,0.03534,1,0.44011229268292684,25
BP,GO:0032400,melanosome localization,25,1,0.04,0.03534,1,0.44011229268292684,25
BP,GO:0032469,endoplasmic reticulum calcium ion homeos...,25,1,0.04,0.03534,1,0.44011229268292684,25
BP,GO:0036344,platelet morphogenesis,25,1,0.04,0.03534,1,0.44011229268292684,25
BP,GO:0072012,glomerulus vasculature development,25,1,0.04,0.03534,1,0.44011229268292684,25
BP,GO:2000310,regulation of NMDA receptor activity,25,1,0.04,0.03534,1,0.44011229268292684,25
BP,GO:0001667,ameboidal-type cell migration,506,3,0.73,0.03543,1,0.44015956204379564,4.11
BP,GO:0051896,regulation of protein kinase B signaling,208,2,0.3,0.03582,1,0.4423652727272728,6.67
BP,GO:0034622,cellular protein-containing complex asse...,1298,5,1.87,0.03593,1,0.4423652727272728,2.67
BP,GO:0048659,smooth muscle cell proliferation,209,2,0.3,0.03613,1,0.4423652727272728,6.67
BP,GO:0009892,negative regulation of metabolic process,3834,10,5.51,0.03658,1,0.4423652727272728,1.81
BP,GO:0001783,B cell apoptotic process,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:0006541,glutamine metabolic process,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:0010288,response to lead ion,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:0032878,regulation of establishment or maintenan...,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:0043501,skeletal muscle adaptation,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:0051875,pigment granule localization,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:1900273,positive regulation of long-term synapti...,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:1902473,regulation of protein localization to sy...,26,1,0.04,0.03673,1,0.4423652727272728,25
BP,GO:0051649,establishment of localization in cell,2249,7,3.23,0.03688,1,0.4423652727272728,2.17
BP,GO:0042327,positive regulation of phosphorylation,888,4,1.28,0.03705,1,0.4423652727272728,3.12
BP,GO:0032869,cellular response to insulin stimulus,214,2,0.31,0.03772,1,0.4423652727272728,6.45
BP,GO:0033674,positive regulation of kinase activity,519,3,0.75,0.03777,1,0.4423652727272728,4
BP,GO:0072503,cellular divalent inorganic cation homeo...,519,3,0.75,0.03777,1,0.4423652727272728,4
BP,GO:0007165,signal transduction,6848,15,9.84,0.03788,1,0.4423652727272728,1.52
BP,GO:0001958,endochondral ossification,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0001964,startle response,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0003159,morphogenesis of an endothelium,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0021952,central nervous system projection neuron...,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0036075,replacement ossification,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0050857,positive regulation of antigen receptor-...,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0061154,endothelial tube morphogenesis,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0061437,renal system vasculature development,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0061440,kidney vasculature development,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0072567,chemokine (C-X-C motif) ligand 2 product...,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:2000341,regulation of chemokine (C-X-C motif) li...,27,1,0.04,0.03812,1,0.4423652727272728,25
BP,GO:0010561,negative regulation of glycoprotein bios...,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0045655,regulation of monocyte differentiation,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0045830,positive regulation of isotype switching,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0050855,regulation of B cell receptor signaling ...,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0051894,positive regulation of focal adhesion as...,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0060765,regulation of androgen receptor signalin...,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0098901,regulation of cardiac muscle cell action...,28,1,0.04,0.03950,1,0.4512013422818792,25
BP,GO:0006974,cellular response to DNA damage stimulus,909,4,1.31,0.03985,1,0.4527983116883117,3.05
BP,GO:0006323,DNA packaging,221,2,0.32,0.03998,1,0.4527983116883117,6.25
BP,GO:0000082,G1/S transition of mitotic cell cycle,222,2,0.32,0.04031,1,0.4527983116883117,6.25
BP,GO:0019722,calcium-mediated signaling,222,2,0.32,0.04031,1,0.4527983116883117,6.25
BP,GO:1901652,response to peptide,535,3,0.77,0.04075,1,0.4527983116883117,3.9
BP,GO:0002360,T cell lineage commitment,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0010586,miRNA metabolic process,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0021602,cranial nerve morphogenesis,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0034063,stress granule assembly,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0042983,amyloid precursor protein biosynthetic p...,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0042984,regulation of amyloid precursor protein ...,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0048265,response to pain,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0080111,DNA demethylation,29,1,0.04,0.04089,1,0.4527983116883117,25
BP,GO:0048583,regulation of response to stimulus,4475,11,6.43,0.04089,1,0.4527983116883117,1.71
BP,GO:0048705,skeletal system morphogenesis,224,2,0.32,0.04097,1,0.4527983116883117,6.25
BP,GO:0034764,positive regulation of transmembrane tra...,226,2,0.32,0.04164,1,0.4551634285714285,6.25
BP,GO:0065004,protein-DNA complex assembly,226,2,0.32,0.04164,1,0.4551634285714285,6.25
BP,GO:0072507,divalent inorganic cation homeostasis,540,3,0.78,0.04171,1,0.4551634285714285,3.85
BP,GO:0031326,regulation of cellular biosynthetic proc...,4492,11,6.46,0.04192,1,0.4551634285714285,1.7
BP,GO:0002285,lymphocyte activation involved in immune...,227,2,0.33,0.04197,1,0.4551634285714285,6.06
BP,GO:0009725,response to hormone,925,4,1.33,0.04206,1,0.4551634285714285,3.01
BP,GO:0003209,cardiac atrium morphogenesis,30,1,0.04,0.04227,1,0.4551634285714285,25
BP,GO:0007064,mitotic sister chromatid cohesion,30,1,0.04,0.04227,1,0.4551634285714285,25
BP,GO:0031571,mitotic G1 DNA damage checkpoint signali...,30,1,0.04,0.04227,1,0.4551634285714285,25
BP,GO:0060218,hematopoietic stem cell differentiation,30,1,0.04,0.04227,1,0.4551634285714285,25
BP,GO:0061384,heart trabecula morphogenesis,30,1,0.04,0.04227,1,0.4551634285714285,25
BP,GO:2000637,positive regulation of gene silencing by...,30,1,0.04,0.04227,1,0.4551634285714285,25
BP,GO:0006464,cellular protein modification process,3939,10,5.66,0.04318,1,0.4551634285714285,1.77
BP,GO:0036211,protein modification process,3939,10,5.66,0.04318,1,0.4551634285714285,1.77
BP,GO:1901362,organic cyclic compound biosynthetic pro...,4517,11,6.49,0.04348,1,0.4551634285714285,1.69
BP,GO:0006379,mRNA cleavage,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0010800,positive regulation of peptidyl-threonin...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0042044,fluid transport,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0044819,mitotic G1/S transition checkpoint signa...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0051570,regulation of histone H3-K9 methylation,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0051968,positive regulation of synaptic transmis...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0060148,positive regulation of posttranscription...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0062009,secondary palate development,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0070229,negative regulation of lymphocyte apopto...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0090344,negative regulation of cell aging,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:1903019,negative regulation of glycoprotein meta...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:2000463,positive regulation of excitatory postsy...,31,1,0.04,0.04364,1,0.4551634285714285,25
BP,GO:0042325,regulation of phosphorylation,1369,5,1.97,0.04368,1,0.4551634285714285,2.54
BP,GO:0031503,protein-containing complex localization,235,2,0.34,0.04467,1,0.4645316089613035,5.88
BP,GO:0030431,sleep,32,1,0.05,0.04502,1,0.4653281781376518,20
BP,GO:0035510,DNA dealkylation,32,1,0.05,0.04502,1,0.4653281781376518,20
BP,GO:0070633,transepithelial transport,32,1,0.05,0.04502,1,0.4653281781376518,20
BP,GO:0043491,protein kinase B signaling,237,2,0.34,0.04536,1,0.46789527272727266,5.88
BP,GO:0009889,regulation of biosynthetic process,4561,11,6.56,0.04632,1,0.4710107355864811,1.68
BP,GO:0008045,motor neuron axon guidance,33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:0043552,positive regulation of phosphatidylinosi...,33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:0051642,centrosome localization,33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:0070198,"protein localization to chromosome, telo...",33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:0071514,genetic imprinting,33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:0150117,positive regulation of cell-substrate ju...,33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:2000311,regulation of AMPA receptor activity,33,1,0.05,0.04640,1,0.4710107355864811,20
BP,GO:0006281,DNA repair,565,3,0.81,0.04666,1,0.4727102380952381,3.7
BP,GO:0001975,response to amphetamine,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:0021801,cerebral cortex radial glia-guided migra...,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:0022030,telencephalon glial cell migration,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:0031579,membrane raft organization,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:0061842,microtubule organizing center localizati...,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:1901532,regulation of hematopoietic progenitor c...,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:2000352,negative regulation of endothelial cell ...,34,1,0.05,0.04777,1,0.4765932421875,20
BP,GO:2001020,regulation of response to DNA damage sti...,244,2,0.35,0.04779,1,0.4765932421875,5.71
BP,GO:0051493,regulation of cytoskeleton organization,574,3,0.83,0.04851,1,0.48218918287937745,3.61
BP,GO:0035556,intracellular signal transduction,2910,8,4.18,0.04854,1,0.48218918287937745,1.91
BP,GO:0010941,regulation of cell death,1888,6,2.71,0.04896,1,0.48296291746641073,2.21
BP,GO:0048536,spleen development,35,1,0.05,0.04914,1,0.48296291746641073,20
BP,GO:0048841,regulation of axon extension involved in...,35,1,0.05,0.04914,1,0.48296291746641073,20
BP,GO:0090169,regulation of spindle assembly,35,1,0.05,0.04914,1,0.48296291746641073,20
BP,GO:0046777,protein autophosphorylation,248,2,0.36,0.04920,1,0.48296291746641073,5.56
BP,GO:0010562,positive regulation of phosphorus metabo...,974,4,1.4,0.04928,1,0.48296291746641073,2.86
BP,GO:0045937,positive regulation of phosphate metabol...,974,4,1.4,0.04928,1,0.48296291746641073,2.86
BP,GO:0048585,negative regulation of response to stimu...,1896,6,2.73,0.04981,1,0.48722195402298846,2.2
BP,GO:0044089,positive regulation of cellular componen...,582,3,0.84,0.05019,1,0.4888144,3.57
BP,GO:0003007,heart morphogenesis,251,2,0.36,0.05026,1,0.4888144,5.56
BP,GO:0045637,regulation of myeloid cell differentiati...,251,2,0.36,0.05026,1,0.4888144,5.56
BP,GO:0046649,lymphocyte activation,981,4,1.41,0.05036,1,0.4888558174904943,2.84
BP,GO:0086004,regulation of cardiac muscle cell contra...,36,1,0.05,0.05051,1,0.4893815180265655,20
BP,GO:0002700,regulation of production of molecular me...,252,2,0.36,0.05062,1,0.48951840909090905,5.56
BP,GO:0010594,regulation of endothelial cell migration,253,2,0.36,0.05098,1,0.49113939622641506,5.56
BP,GO:0022618,ribonucleoprotein complex assembly,253,2,0.36,0.05098,1,0.49113939622641506,5.56
BP,GO:0044843,cell cycle G1/S phase transition,255,2,0.37,0.05170,1,0.49329474860335193,5.41
BP,GO:0000460,maturation of 5.8S rRNA,37,1,0.05,0.05188,1,0.49329474860335193,20
BP,GO:0003230,cardiac atrium development,37,1,0.05,0.05188,1,0.49329474860335193,20
BP,GO:0021955,central nervous system neuron axonogenes...,37,1,0.05,0.05188,1,0.49329474860335193,20
BP,GO:0033260,nuclear DNA replication,37,1,0.05,0.05188,1,0.49329474860335193,20
BP,GO:0086005,ventricular cardiac muscle cell action p...,37,1,0.05,0.05188,1,0.49329474860335193,20
BP,GO:0090218,positive regulation of lipid kinase acti...,37,1,0.05,0.05188,1,0.49329474860335193,20
BP,GO:0035239,tube morphogenesis,994,4,1.43,0.05241,1,0.4974079182156133,2.8
BP,GO:0051050,positive regulation of transport,995,4,1.43,0.05257,1,0.49800077922077923,2.8
BP,GO:0043066,negative regulation of apoptotic process,999,4,1.44,0.05321,1,0.5005002197802197,2.78
BP,GO:0009065,glutamine family amino acid catabolic pr...,38,1,0.05,0.05324,1,0.5005002197802197,20
BP,GO:0045191,regulation of isotype switching,38,1,0.05,0.05324,1,0.5005002197802197,20
BP,GO:0072529,pyrimidine-containing compound catabolic...,38,1,0.05,0.05324,1,0.5005002197802197,20
BP,GO:0006302,double-strand break repair,260,2,0.37,0.05352,1,0.5005002197802197,5.41
BP,GO:0071826,ribonucleoprotein complex subunit organi...,260,2,0.37,0.05352,1,0.5005002197802197,5.41
BP,GO:0090068,positive regulation of cell cycle proces...,260,2,0.37,0.05352,1,0.5005002197802197,5.41
BP,GO:0051049,regulation of transport,1934,6,2.78,0.05400,1,0.5040658135283363,2.16
BP,GO:0010035,response to inorganic substance,602,3,0.87,0.05450,1,0.5069793818181818,3.45
BP,GO:0031507,heterochromatin assembly,39,1,0.06,0.05461,1,0.5069793818181818,16.67
BP,GO:0033144,negative regulation of intracellular ste...,39,1,0.06,0.05461,1,0.5069793818181818,16.67
BP,GO:0044267,cellular protein metabolic process,5279,12,7.59,0.05476,1,0.5074492921960073,1.58
BP,GO:0042592,homeostatic process,1945,6,2.8,0.05525,1,0.5110625,2.14
BP,GO:0051347,positive regulation of transferase activ...,608,3,0.87,0.05583,1,0.5112393917710196,3.45
BP,GO:0000289,nuclear-transcribed mRNA poly(A) tail sh...,40,1,0.06,0.05597,1,0.5112393917710196,16.67
BP,GO:0031297,replication fork processing,40,1,0.06,0.05597,1,0.5112393917710196,16.67
BP,GO:0034331,cell junction maintenance,40,1,0.06,0.05597,1,0.5112393917710196,16.67
BP,GO:0048846,axon extension involved in axon guidance,40,1,0.06,0.05597,1,0.5112393917710196,16.67
BP,GO:0060412,ventricular septum morphogenesis,40,1,0.06,0.05597,1,0.5112393917710196,16.67
BP,GO:1902284,neuron projection extension involved in ...,40,1,0.06,0.05597,1,0.5112393917710196,16.67
BP,GO:0071824,protein-DNA complex subunit organization,268,2,0.39,0.05647,1,0.5148853928571429,5.13
BP,GO:0006875,cellular metal ion homeostasis,613,3,0.88,0.05695,1,0.5153644014084507,3.41
BP,GO:0045930,negative regulation of mitotic cell cycl...,270,2,0.39,0.05722,1,0.5153644014084507,5.13
BP,GO:0035136,forelimb morphogenesis,41,1,0.06,0.05733,1,0.5153644014084507,16.67
BP,GO:0044786,cell cycle DNA replication,41,1,0.06,0.05733,1,0.5153644014084507,16.67
BP,GO:0071526,semaphorin-plexin signaling pathway,41,1,0.06,0.05733,1,0.5153644014084507,16.67
BP,GO:1903115,regulation of actin filament-based movem...,41,1,0.06,0.05733,1,0.5153644014084507,16.67
BP,GO:2000249,regulation of actin cytoskeleton reorgan...,41,1,0.06,0.05733,1,0.5153644014084507,16.67
BP,GO:2000781,positive regulation of double-strand bre...,41,1,0.06,0.05733,1,0.5153644014084507,16.67
BP,GO:0043069,negative regulation of programmed cell d...,1027,4,1.48,0.05782,1,0.5169384827586206,2.7
BP,GO:0007507,heart development,617,3,0.89,0.05786,1,0.5169384827586206,3.37
BP,GO:0090257,regulation of muscle system process,273,2,0.39,0.05834,1,0.5169384827586206,5.13
BP,GO:0001941,postsynaptic membrane organization,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0007616,long-term memory,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0016233,telomere capping,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0021799,cerebral cortex radially oriented cell m...,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0042417,dopamine metabolic process,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0045648,positive regulation of erythrocyte diffe...,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0045740,positive regulation of DNA replication,42,1,0.06,0.05868,1,0.5169384827586206,16.67
BP,GO:0033002,muscle cell proliferation,274,2,0.39,0.05872,1,0.5169384827586206,5.13
BP,GO:0097305,response to alcohol,274,2,0.39,0.05872,1,0.5169384827586206,5.13
BP,GO:0044057,regulation of system process,625,3,0.9,0.05969,1,0.5245733907056799,3.33
BP,GO:0032868,response to insulin,277,2,0.4,0.05986,1,0.5249387671232877,5
BP,GO:0009167,purine ribonucleoside monophosphate meta...,43,1,0.06,0.06004,1,0.5249387671232877,16.67
BP,GO:0030224,monocyte differentiation,43,1,0.06,0.06004,1,0.5249387671232877,16.67
BP,GO:0045494,photoreceptor cell maintenance,44,1,0.06,0.06139,1,0.5330907142857143,16.67
BP,GO:0051567,histone H3-K9 methylation,44,1,0.06,0.06139,1,0.5330907142857143,16.67
BP,GO:0060236,regulation of mitotic spindle organizati...,44,1,0.06,0.06139,1,0.5330907142857143,16.67
BP,GO:0098751,bone cell development,44,1,0.06,0.06139,1,0.5330907142857143,16.67
BP,GO:1901988,negative regulation of cell cycle phase ...,282,2,0.41,0.06177,1,0.5354798302207131,4.88
BP,GO:0032870,cellular response to hormone stimulus,636,3,0.91,0.06224,1,0.5386397288135594,3.3
BP,GO:0098742,cell-cell adhesion via plasma-membrane a...,284,2,0.41,0.06254,1,0.5403060708263069,4.88
BP,GO:0008542,visual learning,45,1,0.06,0.06275,1,0.5403060708263069,16.67
BP,GO:0060711,labyrinthine layer development,45,1,0.06,0.06275,1,0.5403060708263069,16.67
BP,GO:0031401,positive regulation of protein modificat...,1059,4,1.52,0.06335,1,0.5445540404040404,2.63
BP,GO:0010648,negative regulation of cell communicatio...,1522,5,2.19,0.06365,1,0.5445833610648918,2.28
BP,GO:0009126,purine nucleoside monophosphate metaboli...,46,1,0.07,0.06410,1,0.5445833610648918,14.29
BP,GO:0021517,ventral spinal cord development,46,1,0.07,0.06410,1,0.5445833610648918,14.29
BP,GO:0045197,establishment or maintenance of epitheli...,46,1,0.07,0.06410,1,0.5445833610648918,14.29
BP,GO:0048538,thymus development,46,1,0.07,0.06410,1,0.5445833610648918,14.29
BP,GO:0061383,trabecula morphogenesis,46,1,0.07,0.06410,1,0.5445833610648918,14.29
BP,GO:0070828,heterochromatin organization,46,1,0.07,0.06410,1,0.5445833610648918,14.29
BP,GO:0023057,negative regulation of signaling,1526,5,2.19,0.06423,1,0.5447813621262458,2.28
BP,GO:0060255,regulation of macromolecule metabolic pr...,7301,15,10.49,0.06480,1,0.5473698854337152,1.43
BP,GO:0051924,regulation of calcium ion transport,290,2,0.42,0.06488,1,0.5473698854337152,4.76
BP,GO:0042110,T cell activation,648,3,0.93,0.06509,1,0.5473698854337152,3.23
BP,GO:0019220,regulation of phosphate metabolic proces...,1532,5,2.2,0.06511,1,0.5473698854337152,2.27
BP,GO:0051174,regulation of phosphorus metabolic proce...,1532,5,2.2,0.06511,1,0.5473698854337152,2.27
BP,GO:0048483,autonomic nervous system development,47,1,0.07,0.06544,1,0.5473698854337152,14.29
BP,GO:0090329,regulation of DNA-dependent DNA replicat...,47,1,0.07,0.06544,1,0.5473698854337152,14.29
BP,GO:0098815,modulation of excitatory postsynaptic po...,47,1,0.07,0.06544,1,0.5473698854337152,14.29
BP,GO:0002520,immune system development,1071,4,1.54,0.06550,1,0.5473698854337152,2.6
BP,GO:0030866,cortical actin cytoskeleton organization,48,1,0.07,0.06679,1,0.5535499837925446,14.29
BP,GO:0045005,DNA-dependent DNA replication maintenanc...,48,1,0.07,0.06679,1,0.5535499837925446,14.29
BP,GO:0050919,negative chemotaxis,48,1,0.07,0.06679,1,0.5535499837925446,14.29
BP,GO:2000273,positive regulation of signaling recepto...,48,1,0.07,0.06679,1,0.5535499837925446,14.29
BP,GO:0021700,developmental maturation,295,2,0.42,0.06685,1,0.5535499837925446,4.76
BP,GO:0080134,regulation of response to stress,1544,5,2.22,0.06689,1,0.5535499837925446,2.25
BP,GO:0045935,positive regulation of nucleobase-contai...,2044,6,2.94,0.06734,1,0.555787284345048,2.04
BP,GO:0097190,apoptotic signaling pathway,658,3,0.95,0.06751,1,0.555787284345048,3.16
BP,GO:0030217,T cell differentiation,297,2,0.43,0.06764,1,0.555787284345048,4.65
BP,GO:0010799,regulation of peptidyl-threonine phospho...,49,1,0.07,0.06814,1,0.555787284345048,14.29
BP,GO:0030521,androgen receptor signaling pathway,49,1,0.07,0.06814,1,0.555787284345048,14.29
BP,GO:0032008,positive regulation of TOR signaling,49,1,0.07,0.06814,1,0.555787284345048,14.29
BP,GO:0045911,positive regulation of DNA recombination,49,1,0.07,0.06814,1,0.555787284345048,14.29
BP,GO:0048146,positive regulation of fibroblast prolif...,49,1,0.07,0.06814,1,0.555787284345048,14.29
BP,GO:0090224,regulation of spindle organization,49,1,0.07,0.06814,1,0.555787284345048,14.29
BP,GO:0007611,learning or memory,299,2,0.43,0.06844,1,0.5573439234449761,4.65
BP,GO:0047496,vesicle transport along microtubule,50,1,0.07,0.06948,1,0.563377614678899,14.29
BP,GO:1904036,negative regulation of epithelial cell a...,50,1,0.07,0.06948,1,0.563377614678899,14.29
BP,GO:0098813,nuclear chromosome segregation,302,2,0.43,0.06964,1,0.563377614678899,4.65
BP,GO:0048589,developmental growth,668,3,0.96,0.06998,1,0.563377614678899,3.12
BP,GO:0043542,endothelial cell migration,303,2,0.44,0.07004,1,0.563377614678899,4.55
BP,GO:0051249,regulation of lymphocyte activation,670,3,0.96,0.07048,1,0.563377614678899,3.12
BP,GO:0002204,somatic recombination of immunoglobulin ...,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0002208,somatic diversification of immunoglobuli...,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0007632,visual behavior,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0035088,establishment or maintenance of apical/b...,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0043268,positive regulation of potassium ion tra...,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0045190,isotype switching,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0050885,neuromuscular process controlling balanc...,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0061245,establishment or maintenance of bipolar ...,51,1,0.07,0.07082,1,0.563377614678899,14.29
BP,GO:0003008,system process,2597,7,3.73,0.07098,1,0.563377614678899,1.88
BP,GO:0002377,immunoglobulin production,308,2,0.44,0.07206,1,0.563377614678899,4.55
BP,GO:0071375,cellular response to peptide hormone sti...,308,2,0.44,0.07206,1,0.563377614678899,4.55
BP,GO:0014075,response to amine,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0021545,cranial nerve development,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0021795,cerebral cortex cell migration,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0031641,regulation of myelination,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0032873,negative regulation of stress-activated ...,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0043114,regulation of vascular permeability,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0048168,regulation of neuronal synaptic plastici...,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0070303,negative regulation of stress-activated ...,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:1990573,potassium ion import across plasma membr...,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:2000107,negative regulation of leukocyte apoptot...,52,1,0.07,0.07216,1,0.563377614678899,14.29
BP,GO:0072659,protein localization to plasma membrane,310,2,0.45,0.07287,1,0.5680522442748092,4.44
BP,GO:0006935,chemotaxis,680,3,0.98,0.07299,1,0.5681203353658536,3.06
BP,GO:0033059,cellular pigmentation,53,1,0.08,0.07350,1,0.5712191780821917,12.5
BP,GO:0030003,cellular cation homeostasis,683,3,0.98,0.07375,1,0.5714226100151745,3.06
BP,GO:0042330,taxis,683,3,0.98,0.07375,1,0.5714226100151745,3.06
BP,GO:0071417,cellular response to organonitrogen comp...,684,3,0.98,0.07400,1,0.5723200302571861,3.06
BP,GO:0001822,kidney development,313,2,0.45,0.07409,1,0.5723200302571861,4.44
BP,GO:0014888,striated muscle adaptation,54,1,0.08,0.07483,1,0.5752504060150376,12.5
BP,GO:0051293,establishment of spindle localization,54,1,0.08,0.07483,1,0.5752504060150376,12.5
BP,GO:0060350,endochondral bone morphogenesis,54,1,0.08,0.07483,1,0.5752504060150376,12.5
BP,GO:0010632,regulation of epithelial cell migration,315,2,0.45,0.07492,1,0.5752504060150376,4.44
BP,GO:0002366,leukocyte activation involved in immune ...,316,2,0.45,0.07533,1,0.57753,4.44
BP,GO:0031648,protein destabilization,55,1,0.08,0.07616,1,0.5804074029850746,12.5
BP,GO:0045104,intermediate filament cytoskeleton organ...,55,1,0.08,0.07616,1,0.5804074029850746,12.5
BP,GO:0061647,histone H3-K9 modification,55,1,0.08,0.07616,1,0.5804074029850746,12.5
BP,GO:1900744,regulation of p38MAPK cascade,55,1,0.08,0.07616,1,0.5804074029850746,12.5
BP,GO:0055065,metal ion homeostasis,694,3,1,0.07657,1,0.5826623248882266,3
BP,GO:0002263,cell activation involved in immune respo...,320,2,0.46,0.07698,1,0.5840082195845697,4.35
BP,GO:0097193,intrinsic apoptotic signaling pathway,320,2,0.46,0.07698,1,0.5840082195845697,4.35
BP,GO:0010942,positive regulation of cell death,696,3,1,0.07709,1,0.5840082195845697,3
BP,GO:0045103,intermediate filament-based process,56,1,0.08,0.07750,1,0.5845125553914328,12.5
BP,GO:0045814,"negative regulation of gene expression, ...",56,1,0.08,0.07750,1,0.5845125553914328,12.5
BP,GO:0086002,cardiac muscle cell action potential inv...,56,1,0.08,0.07750,1,0.5845125553914328,12.5
BP,GO:0072001,renal system development,322,2,0.46,0.07781,1,0.5859850442477876,4.35
BP,GO:0006873,cellular ion homeostasis,702,3,1.01,0.07866,1,0.5909763876651982,2.97
BP,GO:0070839,metal ion export,57,1,0.08,0.07882,1,0.5909763876651982,12.5
BP,GO:0098900,regulation of action potential,57,1,0.08,0.07882,1,0.5909763876651982,12.5
BP,GO:0006310,DNA recombination,325,2,0.47,0.07906,1,0.5919066862170088,4.26
BP,GO:1901990,regulation of mitotic cell cycle phase t...,326,2,0.47,0.07948,1,0.5941799121522693,4.26
BP,GO:0002639,positive regulation of immunoglobulin pr...,58,1,0.08,0.08015,1,0.5965683673469387,12.5
BP,GO:0006584,catecholamine metabolic process,58,1,0.08,0.08015,1,0.5965683673469387,12.5
BP,GO:0009712,catechol-containing compound metabolic p...,58,1,0.08,0.08015,1,0.5965683673469387,12.5
BP,GO:0044703,multi-organism reproductive process,1153,4,1.66,0.08118,1,0.5992213793103448,2.41
BP,GO:0007062,sister chromatid cohesion,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0007566,embryo implantation,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0010332,response to gamma radiation,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0010559,regulation of glycoprotein biosynthetic ...,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0045646,regulation of erythrocyte differentiatio...,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0051653,spindle localization,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0070228,regulation of lymphocyte apoptotic proce...,59,1,0.08,0.08148,1,0.5992213793103448,12.5
BP,GO:0042113,B cell activation,331,2,0.48,0.08159,1,0.5992213793103448,4.17
BP,GO:0022607,cellular component assembly,3237,8,4.65,0.08168,1,0.5992213793103448,1.72
BP,GO:0008104,protein localization,2687,7,3.86,0.08222,1,0.5996834042553191,1.81
BP,GO:0001658,branching involved in ureteric bud morph...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0001954,positive regulation of cell-matrix adhes...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0002701,negative regulation of production of mol...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0002714,positive regulation of B cell mediated i...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0002891,positive regulation of immunoglobulin me...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0009161,ribonucleoside monophosphate metabolic p...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0035196,production of miRNAs involved in gene si...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:1900271,regulation of long-term synaptic potenti...,60,1,0.09,0.08280,1,0.5996834042553191,11.11
BP,GO:0042221,response to chemical,5012,11,7.2,0.08343,1,0.6024077419354839,1.53
BP,GO:0045321,leukocyte activation,1165,4,1.67,0.08362,1,0.6024077419354839,2.4
BP,GO:0009101,glycoprotein biosynthetic process,336,2,0.48,0.08371,1,0.6024077419354839,4.17
BP,GO:0043551,regulation of phosphatidylinositol 3-kin...,61,1,0.09,0.08412,1,0.6024077419354839,11.11
BP,GO:0050879,multicellular organismal movement,61,1,0.09,0.08412,1,0.6024077419354839,11.11
BP,GO:0050881,musculoskeletal movement,61,1,0.09,0.08412,1,0.6024077419354839,11.11
BP,GO:0060964,regulation of gene silencing by miRNA,61,1,0.09,0.08412,1,0.6024077419354839,11.11
BP,GO:2000736,regulation of stem cell differentiation,61,1,0.09,0.08412,1,0.6024077419354839,11.11
BP,GO:0042981,regulation of apoptotic process,1656,5,2.38,0.08487,1,0.6060144459644323,2.1
BP,GO:0032101,regulation of response to external stimu...,1172,4,1.68,0.08506,1,0.6060144459644323,2.38
BP,GO:0060548,negative regulation of cell death,1173,4,1.69,0.08527,1,0.6060144459644323,2.37
BP,GO:0031050,dsRNA processing,62,1,0.09,0.08545,1,0.6060144459644323,11.11
BP,GO:0032206,positive regulation of telomere maintena...,62,1,0.09,0.08545,1,0.6060144459644323,11.11
BP,GO:0070918,production of small RNA involved in gene...,62,1,0.09,0.08545,1,0.6060144459644323,11.11
BP,GO:0019932,second-messenger-mediated signaling,341,2,0.49,0.08585,1,0.6060144459644323,4.08
BP,GO:0045787,positive regulation of cell cycle,341,2,0.49,0.08585,1,0.6060144459644323,4.08
BP,GO:0051056,regulation of small GTPase mediated sign...,342,2,0.49,0.08628,1,0.6060144459644323,4.08
BP,GO:0044093,positive regulation of molecular functio...,1665,5,2.39,0.08642,1,0.6060144459644323,2.09
BP,GO:1902105,regulation of leukocyte differentiation,343,2,0.49,0.08671,1,0.6060144459644323,4.08
BP,GO:0032835,glomerulus development,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0038066,p38MAPK cascade,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0042220,response to cocaine,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0042255,ribosome assembly,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0048016,inositol phosphate-mediated signaling,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0051898,negative regulation of protein kinase B ...,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0061098,positive regulation of protein tyrosine ...,63,1,0.09,0.08676,1,0.6060144459644323,11.11
BP,GO:0051704,multi-organism process,1185,4,1.7,0.08778,1,0.612301475409836,2.35
BP,GO:0060147,regulation of posttranscriptional gene s...,64,1,0.09,0.08808,1,0.6135559072305594,11.11
BP,GO:0009605,response to external stimulus,3300,8,4.74,0.08938,1,0.6190160162601626,1.69
BP,GO:0031638,zymogen activation,65,1,0.09,0.08940,1,0.6190160162601626,11.11
BP,GO:0060966,regulation of gene silencing by RNA,65,1,0.09,0.08940,1,0.6190160162601626,11.11
BP,GO:1903018,regulation of glycoprotein metabolic pro...,65,1,0.09,0.08940,1,0.6190160162601626,11.11
BP,GO:0060429,epithelium development,1193,4,1.71,0.08947,1,0.6190160162601626,2.34
BP,GO:0048638,regulation of developmental growth,351,2,0.5,0.09018,1,0.6230840054127198,4
BP,GO:0003002,regionalization,352,2,0.51,0.09061,1,0.6233718169582773,3.92
BP,GO:0001756,somitogenesis,66,1,0.09,0.09071,1,0.6233718169582773,11.11
BP,GO:0022029,telencephalon cell migration,66,1,0.09,0.09071,1,0.6233718169582773,11.11
BP,GO:0099072,regulation of postsynaptic membrane neur...,66,1,0.09,0.09071,1,0.6233718169582773,11.11
BP,GO:0043067,regulation of programmed cell death,1694,5,2.44,0.09151,1,0.6280242741935483,2.05
BP,GO:0043954,cellular component maintenance,67,1,0.1,0.09202,1,0.6298312600536193,10
BP,GO:0060675,ureteric bud morphogenesis,67,1,0.1,0.09202,1,0.6298312600536193,10
BP,GO:0050890,cognition,357,2,0.51,0.09281,1,0.634388032128514,3.92
BP,GO:0009719,response to endogenous stimulus,1704,5,2.45,0.09331,1,0.6345445805592543,2.04
BP,GO:0002218,activation of innate immune response,68,1,0.1,0.09333,1,0.6345445805592543,10
BP,GO:0008347,glial cell migration,68,1,0.1,0.09333,1,0.6345445805592543,10
BP,GO:0072171,mesonephric tubule morphogenesis,68,1,0.1,0.09333,1,0.6345445805592543,10
BP,GO:0001655,urogenital system development,359,2,0.52,0.09369,1,0.6358427888446215,3.85
BP,GO:0033043,regulation of organelle organization,1213,4,1.74,0.09377,1,0.6358427888446215,2.3
BP,GO:0070372,regulation of ERK1 and ERK2 cascade,361,2,0.52,0.09457,1,0.6383511756935271,3.85
BP,GO:0021885,forebrain cell migration,69,1,0.1,0.09464,1,0.6383511756935271,10
BP,GO:0030865,cortical cytoskeleton organization,69,1,0.1,0.09464,1,0.6383511756935271,10
BP,GO:0060411,cardiac septum morphogenesis,69,1,0.1,0.09464,1,0.6383511756935271,10
BP,GO:0045893,"positive regulation of transcription, DN...",1713,5,2.46,0.09494,1,0.6386872727272728,2.03
BP,GO:1903508,positive regulation of nucleic acid-temp...,1713,5,2.46,0.09494,1,0.6386872727272728,2.03
BP,GO:1902680,positive regulation of RNA biosynthetic ...,1715,5,2.47,0.09530,1,0.6402655263157895,2.02
BP,GO:0002694,regulation of leukocyte activation,765,3,1.1,0.09594,1,0.6411906282722513,2.73
BP,GO:0030036,actin cytoskeleton organization,765,3,1.1,0.09594,1,0.6411906282722513,2.73
BP,GO:0051568,histone H3-K4 methylation,70,1,0.1,0.09594,1,0.6411906282722513,10
BP,GO:1901016,regulation of potassium ion transmembran...,70,1,0.1,0.09594,1,0.6411906282722513,10
BP,GO:0055080,cation homeostasis,768,3,1.1,0.09680,1,0.645719765929779,2.73
BP,GO:0044271,cellular nitrogen compound biosynthetic ...,5141,11,7.39,0.09693,1,0.645719765929779,1.49
BP,GO:0000288,nuclear-transcribed mRNA catabolic proce...,71,1,0.1,0.09725,1,0.645719765929779,10
BP,GO:0051893,regulation of focal adhesion assembly,71,1,0.1,0.09725,1,0.645719765929779,10
BP,GO:0090109,regulation of cell-substrate junction as...,71,1,0.1,0.09725,1,0.645719765929779,10
BP,GO:0080135,regulation of cellular response to stres...,774,3,1.11,0.09853,1,0.6503223255813954,2.7
BP,GO:0050854,regulation of antigen receptor-mediated ...,72,1,0.1,0.09855,1,0.6503223255813954,10
BP,GO:1902305,regulation of sodium ion transmembrane t...,72,1,0.1,0.09855,1,0.6503223255813954,10
BP,GO:1903078,positive regulation of protein localizat...,72,1,0.1,0.09855,1,0.6503223255813954,10
BP,GO:0007059,chromosome segregation,370,2,0.53,0.09858,1,0.6503223255813954,3.77
BP,GO:0007162,negative regulation of cell adhesion,371,2,0.53,0.09903,1,0.6524479741935485,3.77
BP,GO:0050896,response to stimulus,10430,19,14.99,0.09962,1,0.6553137532133676,1.27
BP,GO:0033555,multicellular organismal response to str...,73,1,0.1,0.09985,1,0.6553137532133676,10
BP,GO:0051310,metaphase plate congression,73,1,0.1,0.09985,1,0.6553137532133676,10
BP,GO:0050778,positive regulation of immune response,779,3,1.12,0.09998,1,0.655324621309371,2.68
BP,GO:0045765,regulation of angiogenesis,374,2,0.54,0.10038,1,0.6554211928934011,3.7
BP,GO:0060562,epithelial tube morphogenesis,374,2,0.54,0.10038,1,0.6554211928934011,3.7
BP,GO:0072359,circulatory system development,1246,4,1.79,0.10107,1,0.6554211928934011,2.23
BP,GO:0003281,ventricular septum development,74,1,0.11,0.10115,1,0.6554211928934011,9.09
BP,GO:0030330,"DNA damage response, signal transduction...",74,1,0.11,0.10115,1,0.6554211928934011,9.09
BP,GO:0043550,regulation of lipid kinase activity,74,1,0.11,0.10115,1,0.6554211928934011,9.09
BP,GO:0045739,positive regulation of DNA repair,74,1,0.11,0.10115,1,0.6554211928934011,9.09
BP,GO:0070059,intrinsic apoptotic signaling pathway in...,74,1,0.11,0.10115,1,0.6554211928934011,9.09
BP,GO:2000351,regulation of endothelial cell apoptotic...,74,1,0.11,0.10115,1,0.6554211928934011,9.09
BP,GO:0098771,inorganic ion homeostasis,784,3,1.13,0.10144,1,0.6564672243346008,2.65
BP,GO:0033143,regulation of intracellular steroid horm...,75,1,0.11,0.10244,1,0.6620995443037975,9.09
BP,GO:0043085,positive regulation of catalytic activit...,1254,4,1.8,0.10289,1,0.66378,2.22
BP,GO:1901342,regulation of vasculature development,380,2,0.55,0.10309,1,0.66378,3.64
BP,GO:0032956,regulation of actin cytoskeleton organiz...,381,2,0.55,0.10354,1,0.66378,3.64
BP,GO:0050795,regulation of behavior,76,1,0.11,0.10374,1,0.66378,9.09
BP,GO:0086003,cardiac muscle cell contraction,76,1,0.11,0.10374,1,0.66378,9.09
BP,GO:0099601,regulation of neurotransmitter receptor ...,76,1,0.11,0.10374,1,0.66378,9.09
BP,GO:0150116,regulation of cell-substrate junction or...,76,1,0.11,0.10374,1,0.66378,9.09
BP,GO:2001259,positive regulation of cation channel ac...,76,1,0.11,0.10374,1,0.66378,9.09
BP,GO:0070371,ERK1 and ERK2 cascade,382,2,0.55,0.10400,1,0.66378,3.64
BP,GO:1904062,regulation of cation transmembrane trans...,382,2,0.55,0.10400,1,0.66378,3.64
BP,GO:0010631,epithelial cell migration,383,2,0.55,0.10445,1,0.6645392565055762,3.64
BP,GO:1901653,cellular response to peptide,384,2,0.55,0.10491,1,0.6645392565055762,3.64
BP,GO:0021675,nerve development,77,1,0.11,0.10503,1,0.6645392565055762,9.09
BP,GO:0043627,response to estrogen,77,1,0.11,0.10503,1,0.6645392565055762,9.09
BP,GO:0046902,regulation of mitochondrial membrane per...,77,1,0.11,0.10503,1,0.6645392565055762,9.09
BP,GO:0072078,nephron tubule morphogenesis,77,1,0.11,0.10503,1,0.6645392565055762,9.09
BP,GO:1902117,positive regulation of organelle assembl...,77,1,0.11,0.10503,1,0.6645392565055762,9.09
BP,GO:0034645,cellular macromolecule biosynthetic proc...,5219,11,7.5,0.10574,1,0.6678824721878862,1.47
BP,GO:0090132,epithelium migration,386,2,0.55,0.10582,1,0.6678824721878862,3.64
BP,GO:0042093,T-helper cell differentiation,78,1,0.11,0.10632,1,0.6693833785450062,9.09
BP,GO:0070227,lymphocyte apoptotic process,78,1,0.11,0.10632,1,0.6693833785450062,9.09
BP,GO:0051248,negative regulation of protein metabolic...,1270,4,1.83,0.10656,1,0.6700681773399014,2.19
BP,GO:0009123,nucleoside monophosphate metabolic proce...,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:0014823,response to activity,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:0051057,positive regulation of small GTPase medi...,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:0070988,demethylation,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:0072088,nephron epithelium morphogenesis,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:0086001,cardiac muscle cell action potential,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:1904377,positive regulation of protein localizat...,79,1,0.11,0.10761,1,0.6708872527472527,9.09
BP,GO:0090130,tissue migration,391,2,0.56,0.10812,1,0.6732447804878048,3.57
BP,GO:0002294,"CD4-positive, alpha-beta T cell differen...",80,1,0.11,0.10890,1,0.6738085508982036,9.09
BP,GO:0009988,cell-cell recognition,80,1,0.11,0.10890,1,0.6738085508982036,9.09
BP,GO:0033077,T cell differentiation in thymus,80,1,0.11,0.10890,1,0.6738085508982036,9.09
BP,GO:0072577,endothelial cell apoptotic process,80,1,0.11,0.10890,1,0.6738085508982036,9.09
BP,GO:1905330,regulation of morphogenesis of an epithe...,80,1,0.11,0.10890,1,0.6738085508982036,9.09
BP,GO:0031347,regulation of defense response,810,3,1.16,0.10917,1,0.6738085508982036,2.59
BP,GO:0002287,alpha-beta T cell activation involved in...,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0002293,alpha-beta T cell differentiation involv...,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0002712,regulation of B cell mediated immunity,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0002889,regulation of immunoglobulin mediated im...,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0061333,renal tubule morphogenesis,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0061515,myeloid cell development,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0070373,negative regulation of ERK1 and ERK2 cas...,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0071230,cellular response to amino acid stimulus,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0140115,export across plasma membrane,81,1,0.12,0.11019,1,0.6738085508982036,8.33
BP,GO:0001701,in utero embryonic development,398,2,0.57,0.11135,1,0.6767726753864447,3.51
BP,GO:0009059,macromolecule biosynthetic process,5267,11,7.57,0.11141,1,0.6767726753864447,1.45
BP,GO:0007422,peripheral nervous system development,82,1,0.12,0.11147,1,0.6767726753864447,8.33
BP,GO:0055117,regulation of cardiac muscle contraction,82,1,0.12,0.11147,1,0.6767726753864447,8.33
BP,GO:0072028,nephron morphogenesis,82,1,0.12,0.11147,1,0.6767726753864447,8.33
BP,GO:0072527,pyrimidine-containing compound metabolic...,82,1,0.12,0.11147,1,0.6767726753864447,8.33
BP,GO:0007018,microtubule-based movement,400,2,0.57,0.11228,1,0.6808808551068883,3.51
BP,GO:0042274,ribosomal small subunit biogenesis,83,1,0.12,0.11275,1,0.6813035502958581,8.33
BP,GO:0070192,chromosome organization involved in meio...,83,1,0.12,0.11275,1,0.6813035502958581,8.33
BP,GO:0070830,bicellular tight junction assembly,83,1,0.12,0.11275,1,0.6813035502958581,8.33
BP,GO:0001892,embryonic placenta development,84,1,0.12,0.11403,1,0.6867208726415095,8.33
BP,GO:0001895,retina homeostasis,84,1,0.12,0.11403,1,0.6867208726415095,8.33
BP,GO:0050865,regulation of cell activation,826,3,1.19,0.11405,1,0.6867208726415095,2.52
BP,GO:0021954,central nervous system neuron developmen...,85,1,0.12,0.11531,1,0.6934898233215547,8.33
BP,GO:0050801,ion homeostasis,832,3,1.2,0.11590,1,0.6946424037339557,2.5
BP,GO:0002088,lens development in camera-type eye,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:0002312,B cell activation involved in immune res...,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:0007193,adenylate cyclase-inhibiting G protein-c...,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:0031060,regulation of histone methylation,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:0050848,regulation of calcium-mediated signaling,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:0061053,somite development,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:2000243,positive regulation of reproductive proc...,86,1,0.12,0.11659,1,0.6946424037339557,8.33
BP,GO:0048646,anatomical structure formation involved ...,1314,4,1.89,0.11697,1,0.6960941958041958,2.12
BP,GO:0019538,protein metabolic process,5942,12,8.54,0.11727,1,0.6965198611111112,1.41
BP,GO:0032535,regulation of cellular component size,411,2,0.59,0.11742,1,0.6965198611111112,3.39
BP,GO:0002292,T cell differentiation involved in immun...,87,1,0.13,0.11786,1,0.6965198611111112,7.69
BP,GO:0048145,regulation of fibroblast proliferation,87,1,0.13,0.11786,1,0.6965198611111112,7.69
BP,GO:0050772,positive regulation of axonogenesis,87,1,0.13,0.11786,1,0.6965198611111112,7.69
BP,GO:0120192,tight junction assembly,87,1,0.13,0.11786,1,0.6965198611111112,7.69
BP,GO:0043549,regulation of kinase activity,839,3,1.21,0.11807,1,0.696798013856813,2.48
BP,GO:0044085,cellular component biogenesis,3510,8,5.05,0.11818,1,0.696798013856813,1.58
BP,GO:0065003,protein-containing complex assembly,1834,5,2.64,0.11833,1,0.6968777162629758,1.89
BP,GO:0021766,hippocampus development,88,1,0.13,0.11914,1,0.6994223421354765,7.69
BP,GO:0048144,fibroblast proliferation,88,1,0.13,0.11914,1,0.6994223421354765,7.69
BP,GO:0009100,glycoprotein metabolic process,415,2,0.6,0.11931,1,0.6994223421354765,3.33
BP,GO:0018108,peptidyl-tyrosine phosphorylation,415,2,0.6,0.11931,1,0.6994223421354765,3.33
BP,GO:0140694,non-membrane-bounded organelle assembly,416,2,0.6,0.11978,1,0.7002431207289295,3.33
BP,GO:0001775,cell activation,1326,4,1.91,0.11988,1,0.7002431207289295,2.09
BP,GO:0006446,regulation of translational initiation,89,1,0.13,0.12041,1,0.7002431207289295,7.69
BP,GO:0006493,protein O-linked glycosylation,89,1,0.13,0.12041,1,0.7002431207289295,7.69
BP,GO:0050805,negative regulation of synaptic transmis...,89,1,0.13,0.12041,1,0.7002431207289295,7.69
BP,GO:0051303,establishment of chromosome localization,89,1,0.13,0.12041,1,0.7002431207289295,7.69
BP,GO:0072384,organelle transport along microtubule,89,1,0.13,0.12041,1,0.7002431207289295,7.69
BP,GO:0018212,peptidyl-tyrosine modification,418,2,0.6,0.12073,1,0.7005083863636364,3.33
BP,GO:0030098,lymphocyte differentiation,418,2,0.6,0.12073,1,0.7005083863636364,3.33
BP,GO:0071229,cellular response to acid chemical,90,1,0.13,0.12168,1,0.7044195918367346,7.69
BP,GO:2001251,negative regulation of chromosome organi...,90,1,0.13,0.12168,1,0.7044195918367346,7.69
BP,GO:1901701,cellular response to oxygen-containing c...,1335,4,1.92,0.12209,1,0.7059926840317101,2.08
BP,GO:0032970,regulation of actin filament-based proce...,422,2,0.61,0.12263,1,0.7077595264937994,3.28
BP,GO:0030029,actin filament-based process,854,3,1.23,0.12278,1,0.7077595264937994,2.44
BP,GO:0050000,chromosome localization,91,1,0.13,0.12295,1,0.7077595264937994,7.69
BP,GO:2000106,regulation of leukocyte apoptotic proces...,91,1,0.13,0.12295,1,0.7077595264937994,7.69
BP,GO:0045860,positive regulation of protein kinase ac...,423,2,0.61,0.12311,1,0.7078825,3.28
BP,GO:0009064,glutamine family amino acid metabolic pr...,92,1,0.13,0.12421,1,0.711802760942761,7.69
BP,GO:0043297,apical junction assembly,92,1,0.13,0.12421,1,0.711802760942761,7.69
BP,GO:0060349,bone morphogenesis,92,1,0.13,0.12421,1,0.711802760942761,7.69
BP,GO:0032204,regulation of telomere maintenance,93,1,0.13,0.12548,1,0.7150679464285715,7.69
BP,GO:0060021,roof of mouth development,93,1,0.13,0.12548,1,0.7150679464285715,7.69
BP,GO:0060968,regulation of gene silencing,93,1,0.13,0.12548,1,0.7150679464285715,7.69
BP,GO:0090559,regulation of membrane permeability,93,1,0.13,0.12548,1,0.7150679464285715,7.69
BP,GO:0120193,tight junction organization,93,1,0.13,0.12548,1,0.7150679464285715,7.69
BP,GO:0051254,positive regulation of RNA metabolic pro...,1870,5,2.69,0.12579,1,0.7160353846153847,1.86
BP,GO:0044260,cellular macromolecule metabolic process,8634,16,12.41,0.12637,1,0.71785021134594,1.29
BP,GO:0006796,phosphate-containing compound metabolic ...,2983,7,4.29,0.12639,1,0.71785021134594,1.63
BP,GO:0033273,response to vitamin,94,1,0.14,0.12674,1,0.7182402219755826,7.14
BP,GO:0048041,focal adhesion assembly,94,1,0.14,0.12674,1,0.7182402219755826,7.14
BP,GO:0034613,cellular protein localization,1877,5,2.7,0.12727,1,0.718996699669967,1.85
BP,GO:0002028,regulation of sodium ion transport,95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:0032615,interleukin-12 production,95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:0032655,regulation of interleukin-12 production,95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:0035278,miRNA mediated inhibition of translation,95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:0040033,"negative regulation of translation, ncRN...",95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:0043367,"CD4-positive, alpha-beta T cell differen...",95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:2001252,positive regulation of chromosome organi...,95,1,0.14,0.12800,1,0.718996699669967,7.14
BP,GO:0034470,ncRNA processing,435,2,0.63,0.12886,1,0.721313180327869,3.17
BP,GO:0016070,RNA metabolic process,5406,11,7.77,0.12890,1,0.721313180327869,1.42
BP,GO:0001657,ureteric bud development,96,1,0.14,0.12926,1,0.721313180327869,7.14
BP,GO:0045666,positive regulation of neuron differenti...,96,1,0.14,0.12926,1,0.721313180327869,7.14
BP,GO:0045974,"regulation of translation, ncRNA-mediate...",96,1,0.14,0.12926,1,0.721313180327869,7.14
BP,GO:0090502,"RNA phosphodiester bond hydrolysis, endo...",96,1,0.14,0.12926,1,0.721313180327869,7.14
BP,GO:0061024,membrane organization,875,3,1.26,0.12949,1,0.7218077947598253,2.38
BP,GO:0006793,phosphorus metabolic process,3005,7,4.32,0.13011,1,0.7220315492957746,1.62
BP,GO:0070727,cellular macromolecule localization,1891,5,2.72,0.13025,1,0.7220315492957746,1.84
BP,GO:0032465,regulation of cytokinesis,97,1,0.14,0.13052,1,0.7220315492957746,7.14
BP,GO:0048704,embryonic skeletal system morphogenesis,97,1,0.14,0.13052,1,0.7220315492957746,7.14
BP,GO:0051591,response to cAMP,97,1,0.14,0.13052,1,0.7220315492957746,7.14
BP,GO:0072163,mesonephric epithelium development,97,1,0.14,0.13052,1,0.7220315492957746,7.14
BP,GO:0072164,mesonephric tubule development,97,1,0.14,0.13052,1,0.7220315492957746,7.14
BP,GO:1902531,regulation of intracellular signal trans...,1894,5,2.72,0.13090,1,0.7233499999999999,1.84
BP,GO:0055082,cellular chemical homeostasis,880,3,1.26,0.13111,1,0.7237272,2.38
BP,GO:1901987,regulation of cell cycle phase transitio...,440,2,0.63,0.13127,1,0.7238278833693305,3.17
BP,GO:0034502,protein localization to chromosome,99,1,0.14,0.13303,1,0.7311638105489774,7.14
BP,GO:0042130,negative regulation of T cell proliferat...,99,1,0.14,0.13303,1,0.7311638105489774,7.14
BP,GO:0072080,nephron tubule development,99,1,0.14,0.13303,1,0.7311638105489774,7.14
BP,GO:1903706,regulation of hemopoiesis,444,2,0.64,0.13321,1,0.7313658709677419,3.12
BP,GO:0010628,positive regulation of gene expression,1380,4,1.98,0.13341,1,0.7316771858216972,2.02
BP,GO:0035282,segmentation,100,1,0.14,0.13428,1,0.7325146153846155,7.14
BP,GO:0060993,kidney morphogenesis,100,1,0.14,0.13428,1,0.7325146153846155,7.14
BP,GO:0061157,mRNA destabilization,100,1,0.14,0.13428,1,0.7325146153846155,7.14
BP,GO:0070252,actin-mediated cell contraction,100,1,0.14,0.13428,1,0.7325146153846155,7.14
BP,GO:1901379,regulation of potassium ion transmembran...,100,1,0.14,0.13428,1,0.7325146153846155,7.14
BP,GO:0001823,mesonephros development,101,1,0.15,0.13553,1,0.7346243949044587,6.67
BP,GO:0006942,regulation of striated muscle contractio...,101,1,0.15,0.13553,1,0.7346243949044587,6.67
BP,GO:0043473,pigmentation,101,1,0.15,0.13553,1,0.7346243949044587,6.67
BP,GO:0070301,cellular response to hydrogen peroxide,101,1,0.15,0.13553,1,0.7346243949044587,6.67
BP,GO:0097306,cellular response to alcohol,101,1,0.15,0.13553,1,0.7346243949044587,6.67
BP,GO:1901606,alpha-amino acid catabolic process,101,1,0.15,0.13553,1,0.7346243949044587,6.67
BP,GO:0050727,regulation of inflammatory response,451,2,0.65,0.13663,1,0.7374854065469905,3.08
BP,GO:0021510,spinal cord development,102,1,0.15,0.13678,1,0.7374854065469905,6.67
BP,GO:0044773,mitotic DNA damage checkpoint signaling,102,1,0.15,0.13678,1,0.7374854065469905,6.67
BP,GO:0061326,renal tubule development,102,1,0.15,0.13678,1,0.7374854065469905,6.67
BP,GO:2000772,regulation of cellular senescence,102,1,0.15,0.13678,1,0.7374854065469905,6.67
BP,GO:0044772,mitotic cell cycle phase transition,452,2,0.65,0.13711,1,0.7384848734177216,3.08
BP,GO:0061014,positive regulation of mRNA catabolic pr...,103,1,0.15,0.13803,1,0.742656670179136,6.67
BP,GO:0009968,negative regulation of signal transducti...,1400,4,2.01,0.13859,1,0.7448847789473684,1.99
BP,GO:0030099,myeloid cell differentiation,456,2,0.66,0.13908,1,0.7467323659305994,3.03
BP,GO:0030516,regulation of axon extension,104,1,0.15,0.13927,1,0.746967037815126,6.67
BP,GO:0007389,pattern specification process,458,2,0.66,0.14006,1,0.750415907660021,3.03
BP,GO:0061097,regulation of protein tyrosine kinase ac...,105,1,0.15,0.14051,1,0.7520377987421384,6.67
BP,GO:0044774,mitotic DNA integrity checkpoint signali...,106,1,0.15,0.14176,1,0.7563495924764889,6.67
BP,GO:0070509,calcium ion import,106,1,0.15,0.14176,1,0.7563495924764889,6.67
BP,GO:2001022,positive regulation of response to DNA d...,106,1,0.15,0.14176,1,0.7563495924764889,6.67
BP,GO:0003279,cardiac septum development,107,1,0.15,0.14300,1,0.7589999999999999,6.67
BP,GO:0006576,cellular biogenic amine metabolic proces...,107,1,0.15,0.14300,1,0.7589999999999999,6.67
BP,GO:0009135,purine nucleoside diphosphate metabolic ...,107,1,0.15,0.14300,1,0.7589999999999999,6.67
BP,GO:0009179,purine ribonucleoside diphosphate metabo...,107,1,0.15,0.14300,1,0.7589999999999999,6.67
BP,GO:0032006,regulation of TOR signaling,107,1,0.15,0.14300,1,0.7589999999999999,6.67
BP,GO:0019233,sensory perception of pain,108,1,0.16,0.14423,1,0.7647335202492211,6.25
BP,GO:0048568,embryonic organ development,467,2,0.67,0.14450,1,0.7653703319502074,2.99
BP,GO:0042127,regulation of cell population proliferat...,1958,5,2.81,0.14498,1,0.7671169740932642,1.78
BP,GO:0000018,regulation of DNA recombination,109,1,0.16,0.14547,1,0.767324194214876,6.25
BP,GO:0050779,RNA destabilization,109,1,0.16,0.14547,1,0.767324194214876,6.25
BP,GO:0120162,positive regulation of cold-induced ther...,109,1,0.16,0.14547,1,0.767324194214876,6.25
BP,GO:0010557,positive regulation of macromolecule bio...,1962,5,2.82,0.14588,1,0.7686927554179567,1.77
BP,GO:0009185,ribonucleoside diphosphate metabolic pro...,110,1,0.16,0.14671,1,0.7714740061791968,6.25
BP,GO:0030838,positive regulation of actin filament po...,110,1,0.16,0.14671,1,0.7714740061791968,6.25
BP,GO:0002440,production of molecular mediator of immu...,472,2,0.68,0.14698,1,0.7720986419753086,2.94
BP,GO:0007015,actin filament organization,473,2,0.68,0.14748,1,0.7739289619732785,2.94
BP,GO:0043502,regulation of muscle adaptation,111,1,0.16,0.14794,1,0.7755458316221766,6.25
BP,GO:0002253,activation of immune response,476,2,0.68,0.14897,1,0.7780000204290092,2.94
BP,GO:0006939,smooth muscle contraction,112,1,0.16,0.14917,1,0.7780000204290092,6.25
BP,GO:0031532,actin cytoskeleton reorganization,112,1,0.16,0.14917,1,0.7780000204290092,6.25
BP,GO:0034446,substrate adhesion-dependent cell spread...,112,1,0.16,0.14917,1,0.7780000204290092,6.25
BP,GO:0090342,regulation of cell aging,112,1,0.16,0.14917,1,0.7780000204290092,6.25
BP,GO:0071495,cellular response to endogenous stimulus,1442,4,2.07,0.14972,1,0.7800717551020407,1.93
BP,GO:0003012,muscle system process,478,2,0.69,0.14997,1,0.7803028716904278,2.9
BP,GO:0002252,immune effector process,937,3,1.35,0.15007,1,0.7803028716904278,2.22
BP,GO:1904035,regulation of epithelial cell apoptotic ...,113,1,0.16,0.15040,1,0.780429268292683,6.25
BP,GO:2001237,negative regulation of extrinsic apoptot...,113,1,0.16,0.15040,1,0.780429268292683,6.25
BP,GO:0002831,regulation of response to biotic stimulu...,480,2,0.69,0.15097,1,0.782591695431472,2.9
BP,GO:0001938,positive regulation of endothelial cell ...,114,1,0.16,0.15163,1,0.7844202431610942,6.25
BP,GO:0043266,regulation of potassium ion transport,114,1,0.16,0.15163,1,0.7844202431610942,6.25
BP,GO:0000041,transition metal ion transport,115,1,0.17,0.15285,1,0.789132558139535,5.88
BP,GO:1903076,regulation of protein localization to pl...,115,1,0.17,0.15285,1,0.789132558139535,5.88
BP,GO:0006892,post-Golgi vesicle-mediated transport,116,1,0.17,0.15408,1,0.792278429003021,5.88
BP,GO:0021761,limbic system development,116,1,0.17,0.15408,1,0.792278429003021,5.88
BP,GO:0098659,inorganic cation import across plasma me...,116,1,0.17,0.15408,1,0.792278429003021,5.88
BP,GO:0099587,inorganic ion import across plasma membr...,116,1,0.17,0.15408,1,0.792278429003021,5.88
BP,GO:0051251,positive regulation of lymphocyte activa...,487,2,0.7,0.15448,1,0.7935360965794769,2.86
BP,GO:0006275,regulation of DNA replication,117,1,0.17,0.15530,1,0.7953478435305917,5.88
BP,GO:0071887,leukocyte apoptotic process,117,1,0.17,0.15530,1,0.7953478435305917,5.88
BP,GO:0072009,nephron epithelium development,117,1,0.17,0.15530,1,0.7953478435305917,5.88
BP,GO:0002244,hematopoietic progenitor cell differenti...,118,1,0.17,0.15652,1,0.7991911199999999,5.88
BP,GO:0008630,intrinsic apoptotic signaling pathway in...,118,1,0.17,0.15652,1,0.7991911199999999,5.88
BP,GO:1905477,positive regulation of protein localizat...,118,1,0.17,0.15652,1,0.7991911199999999,5.88
BP,GO:0030097,hemopoiesis,957,3,1.38,0.15693,1,0.8004840959040957,2.17
BP,GO:0051338,regulation of transferase activity,958,3,1.38,0.15728,1,0.8014133731343283,2.17
BP,GO:0009410,response to xenobiotic stimulus,493,2,0.71,0.15750,1,0.8014133731343283,2.82
BP,GO:0007229,integrin-mediated signaling pathway,119,1,0.17,0.15774,1,0.8014133731343283,5.88
BP,GO:0061387,regulation of extent of cell growth,119,1,0.17,0.15774,1,0.8014133731343283,5.88
BP,GO:1903131,mononuclear cell differentiation,494,2,0.71,0.15800,1,0.8014857453109576,2.82
BP,GO:1901565,organonitrogen compound catabolic proces...,1474,4,2.12,0.15844,1,0.8014857453109576,1.89
BP,GO:0002697,regulation of immune effector process,495,2,0.71,0.15851,1,0.8014857453109576,2.82
BP,GO:0018958,phenol-containing compound metabolic pro...,120,1,0.17,0.15896,1,0.8014857453109576,5.88
BP,GO:0040029,"regulation of gene expression, epigeneti...",120,1,0.17,0.15896,1,0.8014857453109576,5.88
BP,GO:0044106,cellular amine metabolic process,120,1,0.17,0.15896,1,0.8014857453109576,5.88
BP,GO:1901890,positive regulation of cell junction ass...,120,1,0.17,0.15896,1,0.8014857453109576,5.88
BP,GO:0046700,heterocycle catabolic process,496,2,0.71,0.15901,1,0.8014857453109576,2.82
BP,GO:0030155,regulation of cell adhesion,965,3,1.39,0.15971,1,0.8042201775147928,2.16
BP,GO:0019725,cellular homeostasis,969,3,1.39,0.16110,1,0.8102825368731563,2.16
BP,GO:0032642,regulation of chemokine production,122,1,0.18,0.16139,1,0.8102825368731563,5.56
BP,GO:0051209,release of sequestered calcium ion into ...,122,1,0.18,0.16139,1,0.8102825368731563,5.56
BP,GO:0019953,sexual reproduction,972,3,1.4,0.16215,1,0.8123636007827788,2.14
BP,GO:0043933,protein-containing complex subunit organ...,2033,5,2.92,0.16233,1,0.8123636007827788,1.71
BP,GO:0052548,regulation of endopeptidase activity,503,2,0.72,0.16256,1,0.8123636007827788,2.78
BP,GO:0032602,chemokine production,123,1,0.18,0.16260,1,0.8123636007827788,5.56
BP,GO:0051283,negative regulation of sequestering of c...,123,1,0.18,0.16260,1,0.8123636007827788,5.56
BP,GO:0050672,negative regulation of lymphocyte prolif...,124,1,0.18,0.16381,1,0.8164652325581396,5.56
BP,GO:0033036,macromolecule localization,3192,7,4.59,0.16403,1,0.8164652325581396,1.53
BP,GO:0044270,cellular nitrogen compound catabolic pro...,507,2,0.73,0.16459,1,0.8164652325581396,2.74
BP,GO:0009308,amine metabolic process,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0010811,positive regulation of cell-substrate ad...,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0030316,osteoclast differentiation,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0032945,negative regulation of mononuclear cell ...,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0042752,regulation of circadian rhythm,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0045639,positive regulation of myeloid cell diff...,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0051282,regulation of sequestering of calcium io...,125,1,0.18,0.16502,1,0.8164652325581396,5.56
BP,GO:0030518,intracellular steroid hormone receptor s...,126,1,0.18,0.16623,1,0.8192764285714286,5.56
BP,GO:0043200,response to amino acid,126,1,0.18,0.16623,1,0.8192764285714286,5.56
BP,GO:0048706,embryonic skeletal system development,126,1,0.18,0.16623,1,0.8192764285714286,5.56
BP,GO:0050853,B cell receptor signaling pathway,126,1,0.18,0.16623,1,0.8192764285714286,5.56
BP,GO:0007346,regulation of mitotic cell cycle,511,2,0.73,0.16663,1,0.8204559112825459,2.74
BP,GO:0003231,cardiac ventricle development,127,1,0.18,0.16744,1,0.822066,5.56
BP,GO:0009063,cellular amino acid catabolic process,127,1,0.18,0.16744,1,0.822066,5.56
BP,GO:0009132,nucleoside diphosphate metabolic process,127,1,0.18,0.16744,1,0.822066,5.56
BP,GO:1901564,organonitrogen compound metabolic proces...,6970,13,10.02,0.16775,1,0.8227968299711816,1.3
BP,GO:0046632,alpha-beta T cell differentiation,128,1,0.18,0.16864,1,0.8255760690316396,5.56
BP,GO:0048661,positive regulation of smooth muscle cel...,128,1,0.18,0.16864,1,0.8255760690316396,5.56
BP,GO:0022613,ribonucleoprotein complex biogenesis,517,2,0.74,0.16970,1,0.8282741547277935,2.7
BP,GO:0031929,TOR signaling,129,1,0.19,0.16984,1,0.8282741547277935,5.26
BP,GO:0043279,response to alkaloid,129,1,0.19,0.16984,1,0.8282741547277935,5.26
BP,GO:0051208,sequestering of calcium ion,129,1,0.19,0.16984,1,0.8282741547277935,5.26
BP,GO:0006413,translational initiation,130,1,0.19,0.17104,1,0.8325359771210676,5.26
BP,GO:0048675,axon extension,130,1,0.19,0.17104,1,0.8325359771210676,5.26
BP,GO:0019439,aromatic compound catabolic process,521,2,0.75,0.17175,1,0.8351957142857144,2.67
BP,GO:0006417,regulation of translation,523,2,0.75,0.17278,1,0.8394050237868697,2.67
BP,GO:0031328,positive regulation of cellular biosynth...,2084,5,3,0.17462,1,0.8459779696394688,1.67
BP,GO:0045621,positive regulation of lymphocyte differ...,133,1,0.19,0.17463,1,0.8459779696394688,5.26
BP,GO:0070664,negative regulation of leukocyte prolife...,133,1,0.19,0.17463,1,0.8459779696394688,5.26
BP,GO:0048534,hematopoietic or lymphoid organ developm...,1008,3,1.45,0.17488,1,0.8463860473933649,2.07
BP,GO:0007006,mitochondrial membrane organization,134,1,0.19,0.17583,1,0.8469697924528301,5.26
BP,GO:0035264,multicellular organism growth,134,1,0.19,0.17583,1,0.8469697924528301,5.26
BP,GO:0043500,muscle adaptation,134,1,0.19,0.17583,1,0.8469697924528301,5.26
BP,GO:0051897,positive regulation of protein kinase B ...,134,1,0.19,0.17583,1,0.8469697924528301,5.26
BP,GO:0051928,positive regulation of calcium ion trans...,134,1,0.19,0.17583,1,0.8469697924528301,5.26
BP,GO:0040007,growth,1012,3,1.45,0.17631,1,0.8484814891611687,2.07
BP,GO:0035710,"CD4-positive, alpha-beta T cell activati...",135,1,0.19,0.17702,1,0.8510961581920905,5.26
BP,GO:0009966,regulation of signal transduction,3260,7,4.69,0.17735,1,0.8518806208842898,1.49
BP,GO:0052547,regulation of peptidase activity,533,2,0.77,0.17793,1,0.8536024953095686,2.6
BP,GO:0042116,macrophage activation,136,1,0.2,0.17821,1,0.8536024953095686,5
BP,GO:0046683,response to organophosphorus,136,1,0.2,0.17821,1,0.8536024953095686,5
BP,GO:0008015,blood circulation,535,2,0.77,0.17896,1,0.8556721568627451,2.6
BP,GO:0002286,T cell activation involved in immune res...,137,1,0.2,0.17940,1,0.8556721568627451,5
BP,GO:1903313,positive regulation of mRNA metabolic pr...,137,1,0.2,0.17940,1,0.8556721568627451,5
BP,GO:1904375,regulation of protein localization to ce...,137,1,0.2,0.17940,1,0.8556721568627451,5
BP,GO:0002696,positive regulation of leukocyte activat...,536,2,0.77,0.17948,1,0.8556721568627451,2.6
BP,GO:0050790,regulation of catalytic activity,2683,6,3.86,0.18032,1,0.8587493296089386,1.55
BP,GO:0000956,nuclear-transcribed mRNA catabolic proce...,138,1,0.2,0.18059,1,0.8587493296089386,5
BP,GO:0014070,response to organic cyclic compound,1024,3,1.47,0.18063,1,0.8587493296089386,2.04
BP,GO:0001508,action potential,139,1,0.2,0.18177,1,0.8625628438661709,5
BP,GO:0007052,mitotic spindle organization,139,1,0.2,0.18177,1,0.8625628438661709,5
BP,GO:0034660,ncRNA metabolic process,542,2,0.78,0.18258,1,0.8656021169916435,2.56
BP,GO:0007098,centrosome cycle,140,1,0.2,0.18296,1,0.8665990352504639,5
BP,GO:0042552,myelination,141,1,0.2,0.18414,1,0.8713798331788694,5
BP,GO:0009891,positive regulation of biosynthetic proc...,2125,5,3.05,0.18478,1,0.8735987777777778,1.64
BP,GO:0001952,regulation of cell-matrix adhesion,142,1,0.2,0.18532,1,0.8752472426470589,5
BP,GO:0090066,regulation of anatomical structure size,549,2,0.79,0.18622,1,0.8752472426470589,2.53
BP,GO:0007272,ensheathment of neurons,143,1,0.21,0.18650,1,0.8752472426470589,4.76
BP,GO:0008366,axon ensheathment,143,1,0.21,0.18650,1,0.8752472426470589,4.76
BP,GO:0008584,male gonad development,143,1,0.21,0.18650,1,0.8752472426470589,4.76
BP,GO:0032147,activation of protein kinase activity,143,1,0.21,0.18650,1,0.8752472426470589,4.76
BP,GO:0060048,cardiac muscle contraction,143,1,0.21,0.18650,1,0.8752472426470589,4.76
BP,GO:0090398,cellular senescence,143,1,0.21,0.18650,1,0.8752472426470589,4.76
BP,GO:1901361,organic cyclic compound catabolic proces...,550,2,0.79,0.18674,1,0.8755688154269972,2.53
BP,GO:0000077,DNA damage checkpoint signaling,144,1,0.21,0.18768,1,0.8759543692870202,4.76
BP,GO:0042177,negative regulation of protein catabolic...,144,1,0.21,0.18768,1,0.8759543692870202,4.76
BP,GO:0046546,development of primary male sexual chara...,144,1,0.21,0.18768,1,0.8759543692870202,4.76
BP,GO:0050871,positive regulation of B cell activation,144,1,0.21,0.18768,1,0.8759543692870202,4.76
BP,GO:0072073,kidney epithelium development,144,1,0.21,0.18768,1,0.8759543692870202,4.76
BP,GO:0044087,regulation of cellular component biogene...,1046,3,1.5,0.18863,1,0.8782040983606556,2
BP,GO:0002009,morphogenesis of an epithelium,554,2,0.8,0.18882,1,0.8782040983606556,2.5
BP,GO:0001101,response to acid chemical,145,1,0.21,0.18885,1,0.8782040983606556,4.76
BP,GO:0051225,spindle assembly,145,1,0.21,0.18885,1,0.8782040983606556,4.76
BP,GO:0050867,positive regulation of cell activation,555,2,0.8,0.18934,1,0.8796815650591447,2.5
BP,GO:0007264,small GTPase mediated signal transductio...,556,2,0.8,0.18986,1,0.8800096101541252,2.5
BP,GO:0030183,B cell differentiation,146,1,0.21,0.19003,1,0.8800096101541252,4.76
BP,GO:0032355,response to estradiol,146,1,0.21,0.19003,1,0.8800096101541252,4.76
BP,GO:0051093,negative regulation of developmental pro...,1050,3,1.51,0.19010,1,0.8800096101541252,1.99
BP,GO:0001890,placenta development,147,1,0.21,0.19120,1,0.8843000000000001,4.76
BP,GO:0002761,regulation of myeloid leukocyte differen...,148,1,0.21,0.19237,1,0.888102368896926,4.76
BP,GO:0030218,erythrocyte differentiation,148,1,0.21,0.19237,1,0.888102368896926,4.76
BP,GO:0048871,multicellular organismal homeostasis,563,2,0.81,0.19352,1,0.891086780883679,2.47
BP,GO:0035107,appendage morphogenesis,149,1,0.21,0.19354,1,0.891086780883679,4.76
BP,GO:0035108,limb morphogenesis,149,1,0.21,0.19354,1,0.891086780883679,4.76
BP,GO:0007093,mitotic cell cycle checkpoint signaling,151,1,0.22,0.19587,1,0.8993814928057554,4.55
BP,GO:0042542,response to hydrogen peroxide,151,1,0.22,0.19587,1,0.8993814928057554,4.55
BP,GO:0043401,steroid hormone mediated signaling pathw...,151,1,0.22,0.19587,1,0.8993814928057554,4.55
BP,GO:0010468,regulation of gene expression,5858,11,8.42,0.19653,1,0.9016012398921833,1.31
BP,GO:0031570,DNA integrity checkpoint signaling,152,1,0.22,0.19704,1,0.903006403587444,4.55
BP,GO:0044770,cell cycle phase transition,570,2,0.82,0.19719,1,0.903006403587444,2.44
BP,GO:0009056,catabolic process,2760,6,3.97,0.19765,1,0.90430188172043,1.51
BP,GO:0002381,immunoglobulin production involved in im...,153,1,0.22,0.19820,1,0.9043871313672922,4.55
BP,GO:0014074,response to purine-containing compound,153,1,0.22,0.19820,1,0.9043871313672922,4.55
BP,GO:0031023,microtubule organizing center organizati...,153,1,0.22,0.19820,1,0.9043871313672922,4.55
BP,GO:0006261,DNA-dependent DNA replication,154,1,0.22,0.19936,1,0.908868,4.55
BP,GO:0009894,regulation of catabolic process,1076,3,1.55,0.19970,1,0.9096058876003568,1.94
BP,GO:1904064,positive regulation of cation transmembr...,155,1,0.22,0.20052,1,0.9125268449197861,4.55
BP,GO:1905114,cell surface receptor signaling pathway ...,577,2,0.83,0.20087,1,0.9133056277827247,2.41
BP,GO:0009887,animal organ morphogenesis,1081,3,1.55,0.20156,1,0.9144134693877551,1.94
BP,GO:0031644,regulation of nervous system process,156,1,0.22,0.20168,1,0.9144134693877551,4.55
BP,GO:0046907,intracellular transport,1624,4,2.33,0.20180,1,0.9144134693877551,1.72
BP,GO:0070887,cellular response to chemical stimulus,3379,7,4.86,0.20183,1,0.9144134693877551,1.44
BP,GO:0032611,interleukin-1 beta production,157,1,0.23,0.20284,1,0.9149302473498233,4.35
BP,GO:0032651,regulation of interleukin-1 beta product...,157,1,0.23,0.20284,1,0.9149302473498233,4.35
BP,GO:0050768,negative regulation of neurogenesis,157,1,0.23,0.20284,1,0.9149302473498233,4.35
BP,GO:0106106,cold-induced thermogenesis,157,1,0.23,0.20284,1,0.9149302473498233,4.35
BP,GO:0120161,regulation of cold-induced thermogenesis,157,1,0.23,0.20284,1,0.9149302473498233,4.35
BP,GO:0045834,positive regulation of lipid metabolic p...,158,1,0.23,0.20399,1,0.9193053309797,4.35
BP,GO:0010033,response to organic substance,3391,7,4.87,0.20438,1,0.9202506878306878,1.44
BP,GO:0034101,erythrocyte homeostasis,159,1,0.23,0.20514,1,0.9228588898678415,4.35
BP,GO:0003158,endothelium development,160,1,0.23,0.20629,1,0.9261691739894551,4.35
BP,GO:0032273,positive regulation of protein polymeriz...,160,1,0.23,0.20629,1,0.9261691739894551,4.35
BP,GO:1901135,carbohydrate derivative metabolic proces...,1094,3,1.57,0.20642,1,0.9261691739894551,1.91
BP,GO:0034248,regulation of cellular amide metabolic p...,588,2,0.85,0.20666,1,0.926431922739245,2.35
BP,GO:0007043,cell-cell junction assembly,161,1,0.23,0.20744,1,0.9291128421052632,4.35
BP,GO:0051961,negative regulation of nervous system de...,162,1,0.23,0.20859,1,0.9334448203330412,4.35
BP,GO:0007605,sensory perception of sound,163,1,0.23,0.20974,1,0.9369487664041996,4.35
BP,GO:0034614,cellular response to reactive oxygen spe...,163,1,0.23,0.20974,1,0.9369487664041996,4.35
BP,GO:0010629,negative regulation of gene expression,1651,4,2.37,0.20999,1,0.937245576923077,1.69
BP,GO:0050868,negative regulation of T cell activation,164,1,0.24,0.21088,1,0.9403958777292576,4.17
BP,GO:0050770,regulation of axonogenesis,165,1,0.24,0.21203,1,0.944699109947644,4.17
BP,GO:0002683,negative regulation of immune system pro...,599,2,0.86,0.21248,1,0.9458787096774193,2.33
BP,GO:1902532,negative regulation of intracellular sig...,600,2,0.86,0.21301,1,0.9474120731707317,2.33
BP,GO:0098609,cell-cell adhesion,1112,3,1.6,0.21320,1,0.9474318537859008,1.88
BP,GO:0008283,cell population proliferation,2239,5,3.22,0.21419,1,0.9510036000000001,1.55
BP,GO:0016525,negative regulation of angiogenesis,168,1,0.24,0.21545,1,0.9541090199479619,4.17
BP,GO:0046661,male sex differentiation,168,1,0.24,0.21545,1,0.9541090199479619,4.17
BP,GO:1902850,microtubule cytoskeleton organization in...,168,1,0.24,0.21545,1,0.9541090199479619,4.17
BP,GO:0007423,sensory organ development,605,2,0.87,0.21566,1,0.954211403812825,2.3
BP,GO:0002824,positive regulation of adaptive immune r...,169,1,0.24,0.21658,1,0.9574523636363637,4.17
BP,GO:0090304,nucleic acid metabolic process,5978,11,8.59,0.21711,1,0.9575390745501284,1.28
BP,GO:0021953,central nervous system neuron differenti...,170,1,0.24,0.21772,1,0.9575390745501284,4.17
BP,GO:2000181,negative regulation of blood vessel morp...,170,1,0.24,0.21772,1,0.9575390745501284,4.17
BP,GO:2001236,regulation of extrinsic apoptotic signal...,170,1,0.24,0.21772,1,0.9575390745501284,4.17
BP,GO:0043065,positive regulation of apoptotic process,609,2,0.88,0.21779,1,0.9575390745501284,2.27
BP,GO:0046483,heterocycle metabolic process,6636,12,9.54,0.21811,1,0.9575390745501284,1.26
BP,GO:0007156,homophilic cell adhesion via plasma memb...,171,1,0.25,0.21885,1,0.9575390745501284,4
BP,GO:0007338,single fertilization,171,1,0.25,0.21885,1,0.9575390745501284,4
BP,GO:0070507,regulation of microtubule cytoskeleton o...,171,1,0.25,0.21885,1,0.9575390745501284,4
BP,GO:1901343,negative regulation of vasculature devel...,171,1,0.25,0.21885,1,0.9575390745501284,4
BP,GO:1990845,adaptive thermogenesis,171,1,0.25,0.21885,1,0.9575390745501284,4
BP,GO:2001056,positive regulation of cysteine-type end...,171,1,0.25,0.21885,1,0.9575390745501284,4
BP,GO:1901575,organic substance catabolic process,2258,5,3.25,0.21925,1,0.9584678938356165,1.54
BP,GO:0031056,regulation of histone modification,172,1,0.25,0.21999,1,0.9608801881950385,4
BP,GO:0002821,positive regulation of adaptive immune r...,174,1,0.25,0.22224,1,0.9698781538461537,4
BP,GO:0065009,regulation of molecular function,3475,7,5,0.22260,1,0.9706196413321947,1.4
BP,GO:0043488,regulation of mRNA stability,175,1,0.25,0.22337,1,0.9731460921501707,4
BP,GO:0000070,mitotic sister chromatid segregation,176,1,0.25,0.22450,1,0.9764028960817718,4
BP,GO:0090501,RNA phosphodiester bond hydrolysis,176,1,0.25,0.22450,1,0.9764028960817718,4
BP,GO:0003013,circulatory system process,623,2,0.9,0.22524,1,0.9787876085106383,2.22
BP,GO:0006937,regulation of muscle contraction,177,1,0.25,0.22562,1,0.9796052040816327,4
BP,GO:0009611,response to wounding,625,2,0.9,0.22630,1,0.9803433530906013,2.22
BP,GO:0043068,positive regulation of programmed cell d...,625,2,0.9,0.22630,1,0.9803433530906013,2.22
BP,GO:0048754,branching morphogenesis of an epithelial...,178,1,0.26,0.22675,1,0.9803433530906013,3.85
BP,GO:0072331,signal transduction by p53 class mediato...,178,1,0.26,0.22675,1,0.9803433530906013,3.85
BP,GO:2000241,regulation of reproductive process,178,1,0.26,0.22675,1,0.9803433530906013,3.85
BP,GO:0032612,interleukin-1 production,179,1,0.26,0.22787,1,0.982689375,3.85
BP,GO:0032652,regulation of interleukin-1 production,179,1,0.26,0.22787,1,0.982689375,3.85
BP,GO:0050680,negative regulation of epithelial cell p...,179,1,0.26,0.22787,1,0.982689375,3.85
BP,GO:0007283,spermatogenesis,630,2,0.91,0.22897,1,0.9850235383319293,2.2
BP,GO:0006725,cellular aromatic compound metabolic pro...,6699,12,9.63,0.22898,1,0.9850235383319293,1.25
BP,GO:0000910,cytokinesis,180,1,0.26,0.22899,1,0.9850235383319293,3.85
BP,GO:0002521,leukocyte differentiation,633,2,0.91,0.23057,1,0.9909852020202019,2.2
BP,GO:0001525,angiogenesis,636,2,0.91,0.23218,1,0.9935318090452263,2.2
BP,GO:0007610,behavior,636,2,0.91,0.23218,1,0.9935318090452263,2.2
BP,GO:0048736,appendage development,183,1,0.26,0.23233,1,0.9935318090452263,3.85
BP,GO:0060173,limb development,183,1,0.26,0.23233,1,0.9935318090452263,3.85
BP,GO:0061013,regulation of mRNA catabolic process,183,1,0.26,0.23233,1,0.9935318090452263,3.85
BP,GO:1903038,negative regulation of leukocyte cell-ce...,183,1,0.26,0.23233,1,0.9935318090452263,3.85
BP,GO:0050954,sensory perception of mechanical stimulu...,184,1,0.26,0.23345,1,0.9974859414225942,3.85
BP,GO:0007569,cell aging,185,1,0.27,0.23456,1,1,3.7
BP,GO:0030833,regulation of actin filament polymerizat...,185,1,0.27,0.23456,1,1,3.7
BP,GO:0007626,locomotory behavior,186,1,0.27,0.23567,1,1,3.7
BP,GO:0002262,myeloid cell homeostasis,187,1,0.27,0.23678,1,1,3.7
BP,GO:0006941,striated muscle contraction,187,1,0.27,0.23678,1,1,3.7
BP,GO:0098739,import across plasma membrane,187,1,0.27,0.23678,1,1,3.7
BP,GO:0016482,cytosolic transport,188,1,0.27,0.23789,1,1,3.7
BP,GO:0035725,sodium ion transmembrane transport,188,1,0.27,0.23789,1,1,3.7
BP,GO:0051336,regulation of hydrolase activity,1178,3,1.69,0.23848,1,1,1.78
BP,GO:1905475,regulation of protein localization to me...,189,1,0.27,0.23899,1,1,3.7
BP,GO:1990138,neuron projection extension,189,1,0.27,0.23899,1,1,3.7
BP,GO:0048232,male gamete generation,649,2,0.93,0.23913,1,1,2.15
BP,GO:0032269,negative regulation of cellular protein ...,1181,3,1.7,0.23964,1,1,1.76
BP,GO:1901137,carbohydrate derivative biosynthetic pro...,651,2,0.94,0.24020,1,1,2.13
BP,GO:0002684,positive regulation of immune system pro...,1183,3,1.7,0.24042,1,1,1.76
BP,GO:0051301,cell division,652,2,0.94,0.24074,1,1,2.13
BP,GO:0001936,regulation of endothelial cell prolifera...,191,1,0.27,0.24120,1,1,3.7
BP,GO:0050728,negative regulation of inflammatory resp...,191,1,0.27,0.24120,1,1,3.7
BP,GO:0051302,regulation of cell division,191,1,0.27,0.24120,1,1,3.7
BP,GO:0050877,nervous system process,1753,4,2.52,0.24181,1,1,1.59
BP,GO:0043409,negative regulation of MAPK cascade,192,1,0.28,0.24230,1,1,3.57
BP,GO:0043487,regulation of RNA stability,192,1,0.28,0.24230,1,1,3.57
BP,GO:0048639,positive regulation of developmental gro...,192,1,0.28,0.24230,1,1,3.57
BP,GO:0050864,regulation of B cell activation,192,1,0.28,0.24230,1,1,3.57
BP,GO:0002702,positive regulation of production of mol...,193,1,0.28,0.24340,1,1,3.57
BP,GO:0031345,negative regulation of cell projection o...,193,1,0.28,0.24340,1,1,3.57
BP,GO:0002040,sprouting angiogenesis,194,1,0.28,0.24450,1,1,3.57
BP,GO:0001659,temperature homeostasis,195,1,0.28,0.24559,1,1,3.57
BP,GO:0007584,response to nutrient,195,1,0.28,0.24559,1,1,3.57
BP,GO:0050776,regulation of immune response,1201,3,1.73,0.24742,1,1,1.73
BP,GO:0008361,regulation of cell size,197,1,0.28,0.24778,1,1,3.57
BP,GO:0000075,cell cycle checkpoint signaling,199,1,0.29,0.24996,1,1,3.45
BP,GO:1902107,positive regulation of leukocyte differe...,200,1,0.29,0.25105,1,1,3.45
BP,GO:1903708,positive regulation of hemopoiesis,200,1,0.29,0.25105,1,1,3.45
BP,GO:0002698,negative regulation of immune effector p...,201,1,0.29,0.25214,1,1,3.45
BP,GO:0008064,regulation of actin polymerization or de...,201,1,0.29,0.25214,1,1,3.45
BP,GO:0045664,regulation of neuron differentiation,201,1,0.29,0.25214,1,1,3.45
BP,GO:0048839,inner ear development,201,1,0.29,0.25214,1,1,3.45
BP,GO:0030832,regulation of actin filament length,202,1,0.29,0.25322,1,1,3.45
BP,GO:0010721,negative regulation of cell development,204,1,0.29,0.25539,1,1,3.45
BP,GO:0048729,tissue morphogenesis,680,2,0.98,0.25577,1,1,2.04
BP,GO:0007565,female pregnancy,205,1,0.29,0.25647,1,1,3.45
BP,GO:0044248,cellular catabolic process,2396,5,3.44,0.25716,1,1,1.45
BP,GO:0000819,sister chromatid segregation,206,1,0.3,0.25755,1,1,3.33
BP,GO:0033044,regulation of chromosome organization,207,1,0.3,0.25863,1,1,3.33
BP,GO:0045619,regulation of lymphocyte differentiation,209,1,0.3,0.26078,1,1,3.33
BP,GO:0010950,positive regulation of endopeptidase act...,210,1,0.3,0.26185,1,1,3.33
BP,GO:0030041,actin filament polymerization,210,1,0.3,0.26185,1,1,3.33
BP,GO:0032872,regulation of stress-activated MAPK casc...,210,1,0.3,0.26185,1,1,3.33
BP,GO:0061138,morphogenesis of a branching epithelium,210,1,0.3,0.26185,1,1,3.33
BP,GO:0008016,regulation of heart contraction,212,1,0.3,0.26399,1,1,3.33
BP,GO:0032388,positive regulation of intracellular tra...,213,1,0.31,0.26506,1,1,3.23
BP,GO:0046631,alpha-beta T cell activation,213,1,0.31,0.26506,1,1,3.23
BP,GO:0050679,positive regulation of epithelial cell p...,213,1,0.31,0.26506,1,1,3.23
BP,GO:0050731,positive regulation of peptidyl-tyrosine...,213,1,0.31,0.26506,1,1,3.23
BP,GO:0070302,regulation of stress-activated protein k...,213,1,0.31,0.26506,1,1,3.23
BP,GO:0009952,anterior/posterior pattern specification,214,1,0.31,0.26613,1,1,3.23
BP,GO:0045859,regulation of protein kinase activity,700,2,1.01,0.26653,1,1,1.98
BP,GO:0010469,regulation of signaling receptor activit...,215,1,0.31,0.26720,1,1,3.23
BP,GO:1901605,alpha-amino acid metabolic process,215,1,0.31,0.26720,1,1,3.23
BP,GO:0045089,positive regulation of innate immune res...,216,1,0.31,0.26826,1,1,3.23
BP,GO:0009566,fertilization,217,1,0.31,0.26932,1,1,3.23
BP,GO:0045216,cell-cell junction organization,217,1,0.31,0.26932,1,1,3.23
BP,GO:0048863,stem cell differentiation,217,1,0.31,0.26932,1,1,3.23
BP,GO:0002682,regulation of immune system process,1839,4,2.64,0.26956,1,1,1.52
BP,GO:0007623,circadian rhythm,218,1,0.31,0.27038,1,1,3.23
BP,GO:0009755,hormone-mediated signaling pathway,218,1,0.31,0.27038,1,1,3.23
BP,GO:0051250,negative regulation of lymphocyte activa...,218,1,0.31,0.27038,1,1,3.23
BP,GO:0002708,positive regulation of lymphocyte mediat...,219,1,0.31,0.27144,1,1,3.23
BP,GO:0051651,maintenance of location in cell,221,1,0.32,0.27356,1,1,3.12
BP,GO:0071383,cellular response to steroid hormone sti...,221,1,0.32,0.27356,1,1,3.12
BP,GO:0044249,cellular biosynthetic process,6284,11,9.03,0.27398,1,1,1.22
BP,GO:0010647,positive regulation of cell communicatio...,1856,4,2.67,0.27513,1,1,1.5
BP,GO:1902115,regulation of organelle assembly,223,1,0.32,0.27567,1,1,3.12
BP,GO:0001763,morphogenesis of a branching structure,224,1,0.32,0.27672,1,1,3.12
BP,GO:0008406,gonad development,224,1,0.32,0.27672,1,1,3.12
BP,GO:1901360,organic cyclic compound metabolic proces...,6965,12,10.01,0.27759,1,1,1.2
BP,GO:0023056,positive regulation of signaling,1865,4,2.68,0.27809,1,1,1.49
BP,GO:0048878,chemical homeostasis,1283,3,1.84,0.27977,1,1,1.63
BP,GO:0040008,regulation of growth,725,2,1.04,0.27999,1,1,1.92
BP,GO:0010952,positive regulation of peptidase activit...,229,1,0.33,0.28196,1,1,3.03
BP,GO:1903046,meiotic cell cycle process,229,1,0.33,0.28196,1,1,3.03
BP,GO:0045137,development of primary sexual characteri...,230,1,0.33,0.28300,1,1,3.03
BP,GO:0071805,potassium ion transmembrane transport,230,1,0.33,0.28300,1,1,3.03
BP,GO:0048514,blood vessel morphogenesis,731,2,1.05,0.28322,1,1,1.9
BP,GO:0048584,positive regulation of response to stimu...,2488,5,3.58,0.28340,1,1,1.4
BP,GO:0032640,tumor necrosis factor production,231,1,0.33,0.28405,1,1,3.03
BP,GO:0032680,regulation of tumor necrosis factor prod...,231,1,0.33,0.28405,1,1,3.03
BP,GO:0000302,response to reactive oxygen species,233,1,0.33,0.28613,1,1,3.03
BP,GO:0043583,ear development,233,1,0.33,0.28613,1,1,3.03
BP,GO:0044706,multi-multicellular organism process,233,1,0.33,0.28613,1,1,3.03
BP,GO:1901576,organic substance biosynthetic process,6348,11,9.13,0.28659,1,1,1.2
BP,GO:0050953,sensory perception of light stimulus,234,1,0.34,0.28716,1,1,2.94
BP,GO:1901888,regulation of cell junction assembly,234,1,0.34,0.28716,1,1,2.94
BP,GO:1902905,positive regulation of supramolecular fi...,235,1,0.34,0.28820,1,1,2.94
BP,GO:0071706,tumor necrosis factor superfamily cytoki...,236,1,0.34,0.28924,1,1,2.94
BP,GO:1903555,regulation of tumor necrosis factor supe...,236,1,0.34,0.28924,1,1,2.94
BP,GO:0008154,actin polymerization or depolymerization,238,1,0.34,0.29130,1,1,2.94
BP,GO:0010810,regulation of cell-substrate adhesion,238,1,0.34,0.29130,1,1,2.94
BP,GO:0071241,cellular response to inorganic substance,238,1,0.34,0.29130,1,1,2.94
BP,GO:0043408,regulation of MAPK cascade,747,2,1.07,0.29183,1,1,1.87
BP,GO:0008037,cell recognition,239,1,0.34,0.29233,1,1,2.94
BP,GO:0006486,protein glycosylation,240,1,0.34,0.29336,1,1,2.94
BP,GO:0043413,macromolecule glycosylation,240,1,0.34,0.29336,1,1,2.94
BP,GO:0002705,positive regulation of leukocyte mediate...,241,1,0.35,0.29439,1,1,2.86
BP,GO:0051129,negative regulation of cellular componen...,757,2,1.09,0.29721,1,1,1.83
BP,GO:0002822,regulation of adaptive immune response b...,245,1,0.35,0.29848,1,1,2.86
BP,GO:0006364,rRNA processing,245,1,0.35,0.29848,1,1,2.86
BP,GO:0002064,epithelial cell development,246,1,0.35,0.29950,1,1,2.86
BP,GO:0016458,gene silencing,763,2,1.1,0.30044,1,1,1.82
BP,GO:0010001,glial cell differentiation,247,1,0.36,0.30052,1,1,2.78
BP,GO:0097191,extrinsic apoptotic signaling pathway,247,1,0.36,0.30052,1,1,2.78
BP,GO:0060047,heart contraction,248,1,0.36,0.30154,1,1,2.78
BP,GO:0098657,import into cell,248,1,0.36,0.30154,1,1,2.78
BP,GO:0002695,negative regulation of leukocyte activat...,249,1,0.36,0.30256,1,1,2.78
BP,GO:0007188,adenylate cyclase-modulating G protein-c...,249,1,0.36,0.30256,1,1,2.78
BP,GO:0016485,protein processing,250,1,0.36,0.30357,1,1,2.78
BP,GO:0042129,regulation of T cell proliferation,253,1,0.36,0.30661,1,1,2.78
BP,GO:0060560,developmental growth involved in morphog...,253,1,0.36,0.30661,1,1,2.78
BP,GO:2001234,negative regulation of apoptotic signali...,253,1,0.36,0.30661,1,1,2.78
BP,GO:0002573,myeloid leukocyte differentiation,254,1,0.37,0.30762,1,1,2.7
BP,GO:0009058,biosynthetic process,6454,11,9.28,0.30794,1,1,1.19
BP,GO:0006813,potassium ion transport,255,1,0.37,0.30862,1,1,2.7
BP,GO:0022408,negative regulation of cell-cell adhesio...,255,1,0.37,0.30862,1,1,2.7
BP,GO:0050920,regulation of chemotaxis,255,1,0.37,0.30862,1,1,2.7
BP,GO:0070085,glycosylation,255,1,0.37,0.30862,1,1,2.7
BP,GO:0006139,nucleobase-containing compound metabolic...,6470,11,9.3,0.31121,1,1,1.18
BP,GO:0003015,heart process,258,1,0.37,0.31164,1,1,2.7
BP,GO:0006814,sodium ion transport,258,1,0.37,0.31164,1,1,2.7
BP,GO:0016072,rRNA metabolic process,258,1,0.37,0.31164,1,1,2.7
BP,GO:0032271,regulation of protein polymerization,258,1,0.37,0.31164,1,1,2.7
BP,GO:0046395,carboxylic acid catabolic process,258,1,0.37,0.31164,1,1,2.7
BP,GO:0048588,developmental cell growth,261,1,0.38,0.31464,1,1,2.63
BP,GO:0051403,stress-activated MAPK cascade,261,1,0.38,0.31464,1,1,2.63
BP,GO:0007276,gamete generation,791,2,1.14,0.31547,1,1,1.75
BP,GO:0016054,organic acid catabolic process,262,1,0.38,0.31564,1,1,2.63
BP,GO:0009987,cellular process,19262,29,27.69,0.31601,1,1,1.05
BP,GO:0002819,regulation of adaptive immune response,268,1,0.39,0.32159,1,1,2.56
BP,GO:0007160,cell-matrix adhesion,268,1,0.39,0.32159,1,1,2.56
BP,GO:0017148,negative regulation of translation,268,1,0.39,0.32159,1,1,2.56
BP,GO:0070374,positive regulation of ERK1 and ERK2 cas...,268,1,0.39,0.32159,1,1,2.56
BP,GO:1903522,regulation of blood circulation,268,1,0.39,0.32159,1,1,2.56
BP,GO:0031098,stress-activated protein kinase signalin...,269,1,0.39,0.32258,1,1,2.56
BP,GO:0032886,regulation of microtubule-based process,269,1,0.39,0.32258,1,1,2.56
BP,GO:0002274,myeloid leukocyte activation,270,1,0.39,0.32357,1,1,2.56
BP,GO:0002833,positive regulation of response to bioti...,270,1,0.39,0.32357,1,1,2.56
BP,GO:2000116,regulation of cysteine-type endopeptidas...,270,1,0.39,0.32357,1,1,2.56
BP,GO:0006260,DNA replication,272,1,0.39,0.32554,1,1,2.56
BP,GO:0031334,positive regulation of protein-containin...,272,1,0.39,0.32554,1,1,2.56
BP,GO:0050866,negative regulation of cell activation,272,1,0.39,0.32554,1,1,2.56
BP,GO:0001568,blood vessel development,810,2,1.16,0.32564,1,1,1.72
BP,GO:0006402,mRNA catabolic process,274,1,0.39,0.32750,1,1,2.56
BP,GO:0003018,vascular process in circulatory system,279,1,0.4,0.33238,1,1,2.5
BP,GO:0006412,translation,826,2,1.19,0.33418,1,1,1.68
BP,GO:0009888,tissue development,2033,4,2.92,0.33424,1,1,1.37
BP,GO:0042098,T cell proliferation,281,1,0.4,0.33433,1,1,2.5
BP,GO:0006839,mitochondrial transport,282,1,0.41,0.33530,1,1,2.44
BP,GO:0007548,sex differentiation,282,1,0.41,0.33530,1,1,2.44
BP,GO:0050851,antigen receptor-mediated signaling path...,284,1,0.41,0.33723,1,1,2.44
BP,GO:0010951,negative regulation of endopeptidase act...,285,1,0.41,0.33820,1,1,2.44
BP,GO:0045927,positive regulation of growth,286,1,0.41,0.33916,1,1,2.44
BP,GO:0009636,response to toxic substance,290,1,0.42,0.34301,1,1,2.38
BP,GO:0034976,response to endoplasmic reticulum stress,290,1,0.42,0.34301,1,1,2.38
BP,GO:0045165,cell fate commitment,291,1,0.42,0.34397,1,1,2.38
BP,GO:0050730,regulation of peptidyl-tyrosine phosphor...,291,1,0.42,0.34397,1,1,2.38
BP,GO:0001944,vasculature development,846,2,1.22,0.34481,1,1,1.64
BP,GO:0051321,meiotic cell cycle,293,1,0.42,0.34588,1,1,2.38
BP,GO:0001894,tissue homeostasis,294,1,0.42,0.34683,1,1,2.38
BP,GO:0010466,negative regulation of peptidase activit...,295,1,0.42,0.34778,1,1,2.38
BP,GO:0090305,nucleic acid phosphodiester bond hydroly...,295,1,0.42,0.34778,1,1,2.38
BP,GO:0043043,peptide biosynthetic process,852,2,1.22,0.34800,1,1,1.64
BP,GO:0000165,MAPK cascade,856,2,1.23,0.35012,1,1,1.63
BP,GO:0034249,negative regulation of cellular amide me...,298,1,0.43,0.35063,1,1,2.33
BP,GO:0030162,regulation of proteolysis,857,2,1.23,0.35065,1,1,1.63
BP,GO:0110053,regulation of actin filament organizatio...,299,1,0.43,0.35158,1,1,2.33
BP,GO:0048562,embryonic organ morphogenesis,301,1,0.43,0.35347,1,1,2.33
BP,GO:0030522,intracellular receptor signaling pathway,302,1,0.43,0.35441,1,1,2.33
BP,GO:0009057,macromolecule catabolic process,1470,3,2.11,0.35493,1,1,1.42
BP,GO:1903829,positive regulation of cellular protein ...,303,1,0.44,0.35535,1,1,2.27
BP,GO:0060341,regulation of cellular localization,870,2,1.25,0.35752,1,1,1.6
BP,GO:0048511,rhythmic process,308,1,0.44,0.36004,1,1,2.27
BP,GO:0048872,homeostasis of number of cells,308,1,0.44,0.36004,1,1,2.27
BP,GO:0002706,regulation of lymphocyte mediated immuni...,311,1,0.45,0.36284,1,1,2.22
BP,GO:0140014,mitotic nuclear division,311,1,0.45,0.36284,1,1,2.22
BP,GO:0016064,immunoglobulin mediated immune response,315,1,0.45,0.36655,1,1,2.22
BP,GO:0034641,cellular nitrogen compound metabolic pro...,7415,12,10.66,0.36808,1,1,1.13
BP,GO:0034599,cellular response to oxidative stress,317,1,0.46,0.36840,1,1,2.17
BP,GO:0050670,regulation of lymphocyte proliferation,317,1,0.46,0.36840,1,1,2.17
BP,GO:1903311,regulation of mRNA metabolic process,318,1,0.46,0.36932,1,1,2.17
BP,GO:0006520,cellular amino acid metabolic process,319,1,0.46,0.37024,1,1,2.17
BP,GO:0032944,regulation of mononuclear cell prolifera...,319,1,0.46,0.37024,1,1,2.17
BP,GO:0006401,RNA catabolic process,320,1,0.46,0.37116,1,1,2.17
BP,GO:0051604,protein maturation,320,1,0.46,0.37116,1,1,2.17
BP,GO:0006470,protein dephosphorylation,323,1,0.46,0.37391,1,1,2.17
BP,GO:0042254,ribosome biogenesis,323,1,0.46,0.37391,1,1,2.17
BP,GO:0019724,B cell mediated immunity,325,1,0.47,0.37574,1,1,2.13
BP,GO:0051091,positive regulation of DNA-binding trans...,325,1,0.47,0.37574,1,1,2.13
BP,GO:0048193,Golgi vesicle transport,326,1,0.47,0.37665,1,1,2.13
BP,GO:0018105,peptidyl-serine phosphorylation,333,1,0.48,0.38299,1,1,2.08
BP,GO:0051258,protein polymerization,334,1,0.48,0.38389,1,1,2.08
BP,GO:0031329,regulation of cellular catabolic process,923,2,1.33,0.38529,1,1,1.5
BP,GO:0032880,regulation of protein localization,924,2,1.33,0.38581,1,1,1.5
BP,GO:0033365,protein localization to organelle,924,2,1.33,0.38581,1,1,1.5
BP,GO:0048609,multicellular organismal reproductive pr...,928,2,1.33,0.38789,1,1,1.5
BP,GO:0070663,regulation of leukocyte proliferation,339,1,0.49,0.38838,1,1,2.04
BP,GO:0045088,regulation of innate immune response,340,1,0.49,0.38928,1,1,2.04
BP,GO:0006954,inflammatory response,932,2,1.34,0.38996,1,1,1.49
BP,GO:0031647,regulation of protein stability,341,1,0.49,0.39017,1,1,2.04
BP,GO:0060249,anatomical structure homeostasis,341,1,0.49,0.39017,1,1,2.04
BP,GO:0009416,response to light stimulus,344,1,0.49,0.39284,1,1,2.04
BP,GO:0042063,gliogenesis,344,1,0.49,0.39284,1,1,2.04
BP,GO:0051235,maintenance of location,347,1,0.5,0.39550,1,1,2
BP,GO:0070925,organelle assembly,948,2,1.36,0.39824,1,1,1.47
BP,GO:0043010,camera-type eye development,351,1,0.5,0.39902,1,1,2
BP,GO:0032504,multicellular organism reproduction,952,2,1.37,0.40030,1,1,1.46
BP,GO:0032386,regulation of intracellular transport,353,1,0.51,0.40078,1,1,1.96
BP,GO:0019216,regulation of lipid metabolic process,355,1,0.51,0.40253,1,1,1.96
BP,GO:0018209,peptidyl-serine modification,356,1,0.51,0.40340,1,1,1.96
BP,GO:0002699,positive regulation of immune effector p...,358,1,0.51,0.40515,1,1,1.96
BP,GO:0006936,muscle contraction,359,1,0.52,0.40602,1,1,1.92
BP,GO:0010506,regulation of autophagy,359,1,0.52,0.40602,1,1,1.92
BP,GO:0031348,negative regulation of defense response,360,1,0.52,0.40689,1,1,1.92
BP,GO:0006807,nitrogen compound metabolic process,11028,17,15.85,0.40786,1,1,1.07
BP,GO:0062197,cellular response to chemical stress,368,1,0.53,0.41379,1,1,1.89
BP,GO:0001933,negative regulation of protein phosphory...,369,1,0.53,0.41465,1,1,1.89
BP,GO:0002429,immune response-activating cell surface ...,369,1,0.53,0.41465,1,1,1.89
BP,GO:0002757,immune response-activating signal transd...,369,1,0.53,0.41465,1,1,1.89
BP,GO:0002703,regulation of leukocyte mediated immunit...,371,1,0.53,0.41636,1,1,1.89
BP,GO:0009895,negative regulation of catabolic process,371,1,0.53,0.41636,1,1,1.89
BP,GO:0048545,response to steroid hormone,372,1,0.53,0.41722,1,1,1.89
BP,GO:0043604,amide biosynthetic process,994,2,1.43,0.42175,1,1,1.4
BP,GO:0010639,negative regulation of organelle organiz...,381,1,0.55,0.42485,1,1,1.82
BP,GO:0046651,lymphocyte proliferation,381,1,0.55,0.42485,1,1,1.82
BP,GO:0009967,positive regulation of signal transducti...,1648,3,2.37,0.42615,1,1,1.27
BP,GO:0010467,gene expression,7688,12,11.05,0.42630,1,1,1.09
BP,GO:0032943,mononuclear cell proliferation,384,1,0.55,0.42737,1,1,1.82
BP,GO:0033993,response to lipid,1012,2,1.45,0.43084,1,1,1.38
BP,GO:0044237,cellular metabolic process,11830,18,17.01,0.43099,1,1,1.06
BP,GO:0009150,purine ribonucleotide metabolic process,391,1,0.56,0.43322,1,1,1.79
BP,GO:0043087,regulation of GTPase activity,391,1,0.56,0.43322,1,1,1.79
BP,GO:0031349,positive regulation of defense response,393,1,0.56,0.43488,1,1,1.79
BP,GO:0010038,response to metal ion,394,1,0.57,0.43571,1,1,1.75
BP,GO:0006518,peptide metabolic process,1028,2,1.48,0.43885,1,1,1.35
BP,GO:2001233,regulation of apoptotic signaling pathwa...,398,1,0.57,0.43901,1,1,1.75
BP,GO:0044282,small molecule catabolic process,401,1,0.58,0.44147,1,1,1.72
BP,GO:0045861,negative regulation of proteolysis,401,1,0.58,0.44147,1,1,1.72
BP,GO:0031589,cell-substrate adhesion,402,1,0.58,0.44229,1,1,1.72
BP,GO:0001654,eye development,405,1,0.58,0.44474,1,1,1.72
BP,GO:0032496,response to lipopolysaccharide,405,1,0.58,0.44474,1,1,1.72
BP,GO:0009259,ribonucleotide metabolic process,408,1,0.59,0.44717,1,1,1.69
BP,GO:0150063,visual system development,409,1,0.59,0.44798,1,1,1.69
BP,GO:0022412,cellular process involved in reproductio...,412,1,0.59,0.45041,1,1,1.69
BP,GO:0070661,leukocyte proliferation,414,1,0.6,0.45202,1,1,1.67
BP,GO:0042326,negative regulation of phosphorylation,415,1,0.6,0.45282,1,1,1.67
BP,GO:0006163,purine nucleotide metabolic process,418,1,0.6,0.45523,1,1,1.67
BP,GO:0019693,ribose phosphate metabolic process,419,1,0.6,0.45603,1,1,1.67
BP,GO:0048880,sensory system development,422,1,0.61,0.45842,1,1,1.64
BP,GO:0042742,defense response to bacterium,423,1,0.61,0.45921,1,1,1.64
BP,GO:1902903,regulation of supramolecular fiber organ...,423,1,0.61,0.45921,1,1,1.64
BP,GO:0051346,negative regulation of hydrolase activit...,425,1,0.61,0.46080,1,1,1.64
BP,GO:0045862,positive regulation of proteolysis,428,1,0.62,0.46317,1,1,1.61
BP,GO:0030163,protein catabolic process,1079,2,1.55,0.46403,1,1,1.29
BP,GO:0002237,response to molecule of bacterial origin,431,1,0.62,0.46553,1,1,1.61
BP,GO:0060537,muscle tissue development,432,1,0.62,0.46631,1,1,1.61
BP,GO:1902533,positive regulation of intracellular sig...,1086,2,1.56,0.46744,1,1,1.28
BP,GO:0072521,purine-containing compound metabolic pro...,439,1,0.63,0.47177,1,1,1.59
BP,GO:0001503,ossification,440,1,0.63,0.47255,1,1,1.59
BP,GO:0002768,immune response-regulating cell surface ...,444,1,0.64,0.47564,1,1,1.56
BP,GO:0042176,regulation of protein catabolic process,447,1,0.64,0.47795,1,1,1.56
BP,GO:0034655,nucleobase-containing compound catabolic...,455,1,0.65,0.48405,1,1,1.54
BP,GO:0016311,dephosphorylation,469,1,0.67,0.49457,1,1,1.49
BP,GO:0001558,regulation of cell growth,470,1,0.68,0.49531,1,1,1.47
BP,GO:0043254,regulation of protein-containing complex...,470,1,0.68,0.49531,1,1,1.47
BP,GO:0010608,posttranscriptional regulation of gene e...,1146,2,1.65,0.49616,1,1,1.21
BP,GO:0050863,regulation of T cell activation,475,1,0.68,0.49901,1,1,1.47
BP,GO:0042060,wound healing,480,1,0.69,0.50269,1,1,1.45
BP,GO:1901566,organonitrogen compound biosynthetic pro...,1854,3,2.67,0.50554,1,1,1.12
BP,GO:0048732,gland development,486,1,0.7,0.50706,1,1,1.43
BP,GO:0000280,nuclear division,487,1,0.7,0.50779,1,1,1.43
BP,GO:1903037,regulation of leukocyte cell-cell adhesi...,490,1,0.7,0.50996,1,1,1.43
BP,GO:0007600,sensory perception,1177,2,1.69,0.51064,1,1,1.18
BP,GO:0045936,negative regulation of phosphate metabol...,491,1,0.71,0.51068,1,1,1.41
BP,GO:0010563,negative regulation of phosphorus metabo...,492,1,0.71,0.51140,1,1,1.41
BP,GO:0031331,positive regulation of cellular cataboli...,492,1,0.71,0.51140,1,1,1.41
BP,GO:0006979,response to oxidative stress,493,1,0.71,0.51212,1,1,1.41
BP,GO:0044238,primary metabolic process,11576,17,16.64,0.52318,1,1,1.02
BP,GO:0031667,response to nutrient levels,511,1,0.73,0.52489,1,1,1.37
BP,GO:0009117,nucleotide metabolic process,514,1,0.74,0.52699,1,1,1.35
BP,GO:0002460,adaptive immune response based on somati...,515,1,0.74,0.52769,1,1,1.35
BP,GO:0006753,nucleoside phosphate metabolic process,522,1,0.75,0.53254,1,1,1.33
BP,GO:0007159,leukocyte cell-cell adhesion,526,1,0.76,0.53529,1,1,1.32
BP,GO:0006508,proteolysis,1949,3,2.8,0.54045,1,1,1.07
BP,GO:0051090,regulation of DNA-binding transcription ...,534,1,0.77,0.54074,1,1,1.3
BP,GO:0051241,negative regulation of multicellular org...,1251,2,1.8,0.54416,1,1,1.11
BP,GO:0043410,positive regulation of MAPK cascade,540,1,0.78,0.54479,1,1,1.28
BP,GO:0048285,organelle fission,540,1,0.78,0.54479,1,1,1.28
BP,GO:0044265,cellular macromolecule catabolic process,1253,2,1.8,0.54505,1,1,1.11
BP,GO:0016049,cell growth,541,1,0.78,0.54547,1,1,1.28
BP,GO:0071310,cellular response to organic substance,2669,4,3.84,0.54576,1,1,1.04
BP,GO:0009991,response to extracellular stimulus,549,1,0.79,0.55081,1,1,1.27
BP,GO:0032102,negative regulation of response to exter...,552,1,0.79,0.55279,1,1,1.27
BP,GO:0009896,positive regulation of catabolic process,563,1,0.81,0.56000,1,1,1.23
BP,GO:0007005,mitochondrion organization,565,1,0.81,0.56130,1,1,1.23
BP,GO:0032103,positive regulation of response to exter...,568,1,0.82,0.56325,1,1,1.22
BP,GO:1903827,regulation of cellular protein localizat...,573,1,0.82,0.56646,1,1,1.22
BP,GO:0006914,autophagy,574,1,0.83,0.56710,1,1,1.2
BP,GO:0061919,process utilizing autophagic mechanism,574,1,0.83,0.56710,1,1,1.2
BP,GO:0031400,negative regulation of protein modificat...,584,1,0.84,0.57346,1,1,1.19
BP,GO:0070201,regulation of establishment of protein l...,588,1,0.85,0.57598,1,1,1.18
BP,GO:1901615,organic hydroxy compound metabolic proce...,589,1,0.85,0.57661,1,1,1.18
BP,GO:0043603,cellular amide metabolic process,1328,2,1.91,0.57743,1,1,1.05
BP,GO:0055086,nucleobase-containing small molecule met...,593,1,0.85,0.57911,1,1,1.18
BP,GO:0045785,positive regulation of cell adhesion,602,1,0.87,0.58468,1,1,1.15
BP,GO:0002449,lymphocyte mediated immunity,608,1,0.87,0.58835,1,1,1.15
BP,GO:0002764,immune response-regulating signaling pat...,629,1,0.9,0.60097,1,1,1.11
BP,GO:0002376,immune system process,3577,5,5.14,0.60264,1,1,0.97
BP,GO:0022407,regulation of cell-cell adhesion,641,1,0.92,0.60801,1,1,1.09
BP,GO:0048598,embryonic morphogenesis,643,1,0.92,0.60917,1,1,1.09
BP,GO:0071407,cellular response to organic cyclic comp...,644,1,0.93,0.60975,1,1,1.08
BP,GO:0071396,cellular response to lipid,651,1,0.94,0.61379,1,1,1.06
BP,GO:0035195,gene silencing by miRNA,658,1,0.95,0.61778,1,1,1.05
BP,GO:0007169,transmembrane receptor protein tyrosine ...,660,1,0.95,0.61892,1,1,1.05
BP,GO:0035194,post-transcriptional gene silencing by R...,665,1,0.96,0.62174,1,1,1.04
BP,GO:0001819,positive regulation of cytokine producti...,668,1,0.96,0.62342,1,1,1.04
BP,GO:0051345,positive regulation of hydrolase activit...,669,1,0.96,0.62398,1,1,1.04
BP,GO:0016441,posttranscriptional gene silencing,670,1,0.96,0.62454,1,1,1.04
BP,GO:0043170,macromolecule metabolic process,11390,16,16.37,0.62723,1,1,0.98
BP,GO:0030855,epithelial cell differentiation,691,1,0.99,0.63608,1,1,1.01
BP,GO:0006952,defense response,2234,3,3.21,0.63690,1,1,0.93
BP,GO:0098542,defense response to other organism,1484,2,2.13,0.63960,1,1,0.94
BP,GO:0031047,gene silencing by RNA,702,1,1.01,0.64199,1,1,0.99
BP,GO:0002443,leukocyte mediated immunity,705,1,1.01,0.64358,1,1,0.99
BP,GO:0006511,ubiquitin-dependent protein catabolic pr...,708,1,1.02,0.64517,1,1,0.98
BP,GO:0008152,metabolic process,13535,19,19.46,0.64861,1,1,0.98
BP,GO:0019941,modification-dependent protein catabolic...,718,1,1.03,0.65042,1,1,0.97
BP,GO:0006396,RNA processing,1518,2,2.18,0.65221,1,1,0.92
BP,GO:0043632,modification-dependent macromolecule cat...,729,1,1.05,0.65610,1,1,0.95
BP,GO:0045596,negative regulation of cell differentiat...,767,1,1.1,0.67506,1,1,0.91
BP,GO:0016071,mRNA metabolic process,812,1,1.17,0.69620,1,1,0.85
BP,GO:0051603,proteolysis involved in cellular protein...,845,1,1.21,0.71085,1,1,0.83
BP,GO:0009617,response to bacterium,882,1,1.27,0.72647,1,1,0.79
BP,GO:0043086,negative regulation of catalytic activit...,882,1,1.27,0.72647,1,1,0.79
BP,GO:0008285,negative regulation of cell population p...,887,1,1.28,0.72852,1,1,0.78
BP,GO:0044257,cellular protein catabolic process,903,1,1.3,0.73497,1,1,0.77
BP,GO:0016567,protein ubiquitination,933,1,1.34,0.74666,1,1,0.75
BP,GO:0140352,export from cell,937,1,1.35,0.74819,1,1,0.74
BP,GO:0002250,adaptive immune response,946,1,1.36,0.75158,1,1,0.74
BP,GO:0006955,immune response,2679,3,3.85,0.75931,1,1,0.78
BP,GO:0045184,establishment of protein localization,1854,2,2.67,0.75937,1,1,0.75
BP,GO:0044281,small molecule metabolic process,1870,2,2.69,0.76372,1,1,0.74
BP,GO:0019752,carboxylic acid metabolic process,987,1,1.42,0.76647,1,1,0.7
BP,GO:0032446,protein modification by small protein co...,989,1,1.42,0.76718,1,1,0.7
BP,GO:0019637,organophosphate metabolic process,1011,1,1.45,0.77479,1,1,0.69
BP,GO:0051707,response to other organism,1913,2,2.75,0.77508,1,1,0.73
BP,GO:0043436,oxoacid metabolic process,1012,1,1.45,0.77513,1,1,0.69
BP,GO:0043207,response to external biotic stimulus,1914,2,2.75,0.77534,1,1,0.73
BP,GO:0007167,enzyme linked receptor protein signaling...,1027,1,1.48,0.78017,1,1,0.68
BP,GO:0006082,organic acid metabolic process,1034,1,1.49,0.78249,1,1,0.67
BP,GO:0009607,response to biotic stimulus,1956,2,2.81,0.78599,1,1,0.71
BP,GO:0001817,regulation of cytokine production,1065,1,1.53,0.79247,1,1,0.65
BP,GO:0071704,organic substance metabolic process,12997,17,18.68,0.79595,1,1,0.91
BP,GO:0001816,cytokine production,1078,1,1.55,0.79652,1,1,0.65
BP,GO:0070647,protein modification by small protein co...,1128,1,1.62,0.81140,1,1,0.62
BP,GO:0044419,biological process involved in interspec...,2096,2,3.01,0.81847,1,1,0.66
BP,GO:0045087,innate immune response,1198,1,1.72,0.83048,1,1,0.58
BP,GO:0044092,negative regulation of molecular functio...,1311,1,1.88,0.85740,1,1,0.53
BP,GO:0006629,lipid metabolic process,1474,1,2.12,0.88908,1,1,0.47
BP,GO:0007186,G protein-coupled receptor signaling pat...,1491,1,2.14,0.89196,1,1,0.47
BP,GO:0016192,vesicle-mediated transport,1727,1,2.48,0.92522,1,1,0.4
BP,GO:0015031,protein transport,1735,1,2.49,0.92615,1,1,0.4
BP,GO:0071705,nitrogen compound transport,2231,1,3.21,0.96643,1,1,0.31
BP,GO:0071702,organic substance transport,2687,1,3.86,0.98404,1,1,0.26
BP,GO:0008150,biological_process,20870,30,30,1.00000,1,1,1
BP,GO:0000002,mitochondrial genome maintenance,24,0,0.03,1.00000,1,1,0
BP,GO:0000027,ribosomal large subunit assembly,29,0,0.04,1.00000,1,1,0
BP,GO:0000038,very long-chain fatty acid metabolic pro...,34,0,0.05,1.00000,1,1,0
BP,GO:0000045,autophagosome assembly,116,0,0.17,1.00000,1,1,0
BP,GO:0000079,regulation of cyclin-dependent protein s...,99,0,0.14,1.00000,1,1,0
BP,GO:0000083,regulation of transcription involved in ...,20,0,0.03,1.00000,1,1,0
BP,GO:0000086,G2/M transition of mitotic cell cycle,149,0,0.21,1.00000,1,1,0
BP,GO:0000096,sulfur amino acid metabolic process,37,0,0.05,1.00000,1,1,0
BP,GO:0000132,establishment of mitotic spindle orienta...,32,0,0.05,1.00000,1,1,0
BP,GO:0000154,rRNA modification,38,0,0.05,1.00000,1,1,0
BP,GO:0000184,nuclear-transcribed mRNA catabolic proce...,45,0,0.06,1.00000,1,1,0
BP,GO:0000209,protein polyubiquitination,260,0,0.37,1.00000,1,1,0
BP,GO:0000244,spliceosomal tri-snRNP complex assembly,40,0,0.06,1.00000,1,1,0
BP,GO:0000245,spliceosomal complex assembly,91,0,0.13,1.00000,1,1,0
BP,GO:0000266,mitochondrial fission,46,0,0.07,1.00000,1,1,0
BP,GO:0000271,polysaccharide biosynthetic process,74,0,0.11,1.00000,1,1,0
BP,GO:0000272,polysaccharide catabolic process,22,0,0.03,1.00000,1,1,0
BP,GO:0000281,mitotic cytokinesis,72,0,0.1,1.00000,1,1,0
BP,GO:0000291,nuclear-transcribed mRNA catabolic proce...,24,0,0.03,1.00000,1,1,0
BP,GO:0000303,response to superoxide,29,0,0.04,1.00000,1,1,0
BP,GO:0000305,response to oxygen radical,30,0,0.04,1.00000,1,1,0
BP,GO:0000375,"RNA splicing, via transesterification re...",367,0,0.53,1.00000,1,1,0
BP,GO:0000377,"RNA splicing, via transesterification re...",363,0,0.52,1.00000,1,1,0
BP,GO:0000380,"alternative mRNA splicing, via spliceoso...",81,0,0.12,1.00000,1,1,0
BP,GO:0000381,"regulation of alternative mRNA splicing,...",64,0,0.09,1.00000,1,1,0
BP,GO:0000387,spliceosomal snRNP assembly,67,0,0.1,1.00000,1,1,0
BP,GO:0000394,"RNA splicing, via endonucleolytic cleava...",20,0,0.03,1.00000,1,1,0
BP,GO:0000395,mRNA 5'-splice site recognition,25,0,0.04,1.00000,1,1,0
BP,GO:0000398,"mRNA splicing, via spliceosome",363,0,0.52,1.00000,1,1,0
BP,GO:0000413,protein peptidyl-prolyl isomerization,43,0,0.06,1.00000,1,1,0
BP,GO:0000422,autophagy of mitochondrion,85,0,0.12,1.00000,1,1,0
BP,GO:0000423,mitophagy,29,0,0.04,1.00000,1,1,0
BP,GO:0000462,maturation of SSU-rRNA from tricistronic...,43,0,0.06,1.00000,1,1,0
BP,GO:0000466,maturation of 5.8S rRNA from tricistroni...,26,0,0.04,1.00000,1,1,0
BP,GO:0000469,cleavage involved in rRNA processing,29,0,0.04,1.00000,1,1,0
BP,GO:0000470,maturation of LSU-rRNA,31,0,0.04,1.00000,1,1,0
BP,GO:0000578,embryonic axis specification,39,0,0.06,1.00000,1,1,0
BP,GO:0000724,double-strand break repair via homologou...,142,0,0.2,1.00000,1,1,0
BP,GO:0000725,recombinational repair,144,0,0.21,1.00000,1,1,0
BP,GO:0000731,DNA synthesis involved in DNA repair,35,0,0.05,1.00000,1,1,0
BP,GO:0000737,"DNA catabolic process, endonucleolytic",30,0,0.04,1.00000,1,1,0
BP,GO:0000768,syncytium formation by plasma membrane f...,65,0,0.09,1.00000,1,1,0
BP,GO:0000959,mitochondrial RNA metabolic process,52,0,0.07,1.00000,1,1,0
BP,GO:0000963,mitochondrial RNA processing,21,0,0.03,1.00000,1,1,0
BP,GO:0000966,RNA 5'-end processing,31,0,0.04,1.00000,1,1,0
BP,GO:0001502,cartilage condensation,21,0,0.03,1.00000,1,1,0
BP,GO:0001504,neurotransmitter uptake,53,0,0.08,1.00000,1,1,0
BP,GO:0001505,regulation of neurotransmitter levels,237,0,0.34,1.00000,1,1,0
BP,GO:0001510,RNA methylation,85,0,0.12,1.00000,1,1,0
BP,GO:0001516,prostaglandin biosynthetic process,33,0,0.05,1.00000,1,1,0
BP,GO:0001523,retinoid metabolic process,98,0,0.14,1.00000,1,1,0
BP,GO:0001539,cilium or flagellum-dependent cell motil...,143,0,0.21,1.00000,1,1,0
BP,GO:0001541,ovarian follicle development,54,0,0.08,1.00000,1,1,0
BP,GO:0001556,oocyte maturation,29,0,0.04,1.00000,1,1,0
BP,GO:0001562,response to protozoan,29,0,0.04,1.00000,1,1,0
BP,GO:0001569,branching involved in blood vessel morph...,45,0,0.06,1.00000,1,1,0
BP,GO:0001570,vasculogenesis,80,0,0.11,1.00000,1,1,0
BP,GO:0001573,ganglioside metabolic process,39,0,0.06,1.00000,1,1,0
BP,GO:0001574,ganglioside biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0001578,microtubule bundle formation,114,0,0.16,1.00000,1,1,0
BP,GO:0001580,detection of chemical stimulus involved ...,61,0,0.09,1.00000,1,1,0
BP,GO:0001649,osteoblast differentiation,255,0,0.37,1.00000,1,1,0
BP,GO:0001656,metanephros development,93,0,0.13,1.00000,1,1,0
BP,GO:0001662,behavioral fear response,35,0,0.05,1.00000,1,1,0
BP,GO:0001676,long-chain fatty acid metabolic process,120,0,0.17,1.00000,1,1,0
BP,GO:0001678,cellular glucose homeostasis,183,0,0.26,1.00000,1,1,0
BP,GO:0001682,tRNA 5'-leader removal,20,0,0.03,1.00000,1,1,0
BP,GO:0001696,gastric acid secretion,22,0,0.03,1.00000,1,1,0
BP,GO:0001702,gastrulation with mouth forming second,24,0,0.03,1.00000,1,1,0
BP,GO:0001704,formation of primary germ layer,140,0,0.2,1.00000,1,1,0
BP,GO:0001706,endoderm formation,62,0,0.09,1.00000,1,1,0
BP,GO:0001707,mesoderm formation,83,0,0.12,1.00000,1,1,0
BP,GO:0001708,cell fate specification,106,0,0.15,1.00000,1,1,0
BP,GO:0001709,cell fate determination,57,0,0.08,1.00000,1,1,0
BP,GO:0001710,mesodermal cell fate commitment,24,0,0.03,1.00000,1,1,0
BP,GO:0001711,endodermal cell fate commitment,20,0,0.03,1.00000,1,1,0
BP,GO:0001736,establishment of planar polarity,74,0,0.11,1.00000,1,1,0
BP,GO:0001738,morphogenesis of a polarized epithelium,98,0,0.14,1.00000,1,1,0
BP,GO:0001754,eye photoreceptor cell differentiation,57,0,0.08,1.00000,1,1,0
BP,GO:0001755,neural crest cell migration,56,0,0.08,1.00000,1,1,0
BP,GO:0001759,organ induction,23,0,0.03,1.00000,1,1,0
BP,GO:0001773,myeloid dendritic cell activation,35,0,0.05,1.00000,1,1,0
BP,GO:0001774,microglial cell activation,73,0,0.1,1.00000,1,1,0
BP,GO:0001776,leukocyte homeostasis,89,0,0.13,1.00000,1,1,0
BP,GO:0001779,natural killer cell differentiation,25,0,0.04,1.00000,1,1,0
BP,GO:0001782,B cell homeostasis,31,0,0.04,1.00000,1,1,0
BP,GO:0001818,negative regulation of cytokine producti...,439,0,0.63,1.00000,1,1,0
BP,GO:0001824,blastocyst development,127,0,0.18,1.00000,1,1,0
BP,GO:0001825,blastocyst formation,47,0,0.07,1.00000,1,1,0
BP,GO:0001829,trophectodermal cell differentiation,26,0,0.04,1.00000,1,1,0
BP,GO:0001832,blastocyst growth,20,0,0.03,1.00000,1,1,0
BP,GO:0001835,blastocyst hatching,31,0,0.04,1.00000,1,1,0
BP,GO:0001836,release of cytochrome c from mitochondri...,63,0,0.09,1.00000,1,1,0
BP,GO:0001837,epithelial to mesenchymal transition,172,0,0.25,1.00000,1,1,0
BP,GO:0001838,embryonic epithelial tube formation,135,0,0.19,1.00000,1,1,0
BP,GO:0001841,neural tube formation,112,0,0.16,1.00000,1,1,0
BP,GO:0001843,neural tube closure,98,0,0.14,1.00000,1,1,0
BP,GO:0001881,receptor recycling,36,0,0.05,1.00000,1,1,0
BP,GO:0001885,endothelial cell development,80,0,0.11,1.00000,1,1,0
BP,GO:0001886,endothelial cell morphogenesis,20,0,0.03,1.00000,1,1,0
BP,GO:0001889,liver development,165,0,0.24,1.00000,1,1,0
BP,GO:0001893,maternal placenta development,36,0,0.05,1.00000,1,1,0
BP,GO:0001906,cell killing,365,0,0.52,1.00000,1,1,0
BP,GO:0001909,leukocyte mediated cytotoxicity,285,0,0.41,1.00000,1,1,0
BP,GO:0001910,regulation of leukocyte mediated cytotox...,205,0,0.29,1.00000,1,1,0
BP,GO:0001911,negative regulation of leukocyte mediate...,104,0,0.15,1.00000,1,1,0
BP,GO:0001912,positive regulation of leukocyte mediate...,107,0,0.15,1.00000,1,1,0
BP,GO:0001913,T cell mediated cytotoxicity,106,0,0.15,1.00000,1,1,0
BP,GO:0001914,regulation of T cell mediated cytotoxici...,94,0,0.14,1.00000,1,1,0
BP,GO:0001915,negative regulation of T cell mediated c...,22,0,0.03,1.00000,1,1,0
BP,GO:0001916,positive regulation of T cell mediated c...,73,0,0.1,1.00000,1,1,0
BP,GO:0001919,regulation of receptor recycling,26,0,0.04,1.00000,1,1,0
BP,GO:0001937,negative regulation of endothelial cell ...,85,0,0.12,1.00000,1,1,0
BP,GO:0001942,hair follicle development,88,0,0.13,1.00000,1,1,0
BP,GO:0001945,lymph vessel development,28,0,0.04,1.00000,1,1,0
BP,GO:0001947,heart looping,66,0,0.09,1.00000,1,1,0
BP,GO:0001953,negative regulation of cell-matrix adhes...,45,0,0.06,1.00000,1,1,0
BP,GO:0001959,regulation of cytokine-mediated signalin...,172,0,0.25,1.00000,1,1,0
BP,GO:0001960,negative regulation of cytokine-mediated...,86,0,0.12,1.00000,1,1,0
BP,GO:0001961,positive regulation of cytokine-mediated...,67,0,0.1,1.00000,1,1,0
BP,GO:0001963,"synaptic transmission, dopaminergic",35,0,0.05,1.00000,1,1,0
BP,GO:0001974,blood vessel remodeling,46,0,0.07,1.00000,1,1,0
BP,GO:0001990,regulation of systemic arterial blood pr...,38,0,0.05,1.00000,1,1,0
BP,GO:0002011,morphogenesis of an epithelial sheet,64,0,0.09,1.00000,1,1,0
BP,GO:0002021,response to dietary excess,25,0,0.04,1.00000,1,1,0
BP,GO:0002026,regulation of the force of heart contrac...,27,0,0.04,1.00000,1,1,0
BP,GO:0002027,regulation of heart rate,107,0,0.15,1.00000,1,1,0
BP,GO:0002029,desensitization of G protein-coupled rec...,25,0,0.04,1.00000,1,1,0
BP,GO:0002031,G protein-coupled receptor internalizati...,20,0,0.03,1.00000,1,1,0
BP,GO:0002042,cell migration involved in sprouting ang...,99,0,0.14,1.00000,1,1,0
BP,GO:0002043,blood vessel endothelial cell proliferat...,56,0,0.08,1.00000,1,1,0
BP,GO:0002052,positive regulation of neuroblast prolif...,23,0,0.03,1.00000,1,1,0
BP,GO:0002053,positive regulation of mesenchymal cell ...,22,0,0.03,1.00000,1,1,0
BP,GO:0002062,chondrocyte differentiation,109,0,0.16,1.00000,1,1,0
BP,GO:0002063,chondrocyte development,31,0,0.04,1.00000,1,1,0
BP,GO:0002065,columnar/cuboidal epithelial cell differ...,96,0,0.14,1.00000,1,1,0
BP,GO:0002066,columnar/cuboidal epithelial cell develo...,45,0,0.06,1.00000,1,1,0
BP,GO:0002067,glandular epithelial cell differentiatio...,56,0,0.08,1.00000,1,1,0
BP,GO:0002068,glandular epithelial cell development,30,0,0.04,1.00000,1,1,0
BP,GO:0002082,regulation of oxidative phosphorylation,22,0,0.03,1.00000,1,1,0
BP,GO:0002089,lens morphogenesis in camera-type eye,22,0,0.03,1.00000,1,1,0
BP,GO:0002090,regulation of receptor internalization,68,0,0.1,1.00000,1,1,0
BP,GO:0002092,positive regulation of receptor internal...,29,0,0.04,1.00000,1,1,0
BP,GO:0002097,tRNA wobble base modification,22,0,0.03,1.00000,1,1,0
BP,GO:0002115,store-operated calcium entry,20,0,0.03,1.00000,1,1,0
BP,GO:0002181,cytoplasmic translation,168,0,0.24,1.00000,1,1,0
BP,GO:0002183,cytoplasmic translational initiation,36,0,0.05,1.00000,1,1,0
BP,GO:0002209,behavioral defense response,36,0,0.05,1.00000,1,1,0
BP,GO:0002220,innate immune response activating cell s...,37,0,0.05,1.00000,1,1,0
BP,GO:0002221,pattern recognition receptor signaling p...,211,0,0.3,1.00000,1,1,0
BP,GO:0002224,toll-like receptor signaling pathway,143,0,0.21,1.00000,1,1,0
BP,GO:0002227,innate immune response in mucosa,34,0,0.05,1.00000,1,1,0
BP,GO:0002228,natural killer cell mediated immunity,212,0,0.3,1.00000,1,1,0
BP,GO:0002230,positive regulation of defense response ...,36,0,0.05,1.00000,1,1,0
BP,GO:0002251,organ or tissue specific immune response,48,0,0.07,1.00000,1,1,0
BP,GO:0002260,lymphocyte homeostasis,64,0,0.09,1.00000,1,1,0
BP,GO:0002275,myeloid cell activation involved in immu...,99,0,0.14,1.00000,1,1,0
BP,GO:0002279,mast cell activation involved in immune ...,51,0,0.07,1.00000,1,1,0
BP,GO:0002281,macrophage activation involved in immune...,20,0,0.03,1.00000,1,1,0
BP,GO:0002283,neutrophil activation involved in immune...,21,0,0.03,1.00000,1,1,0
BP,GO:0002291,T cell activation via T cell receptor co...,21,0,0.03,1.00000,1,1,0
BP,GO:0002313,mature B cell differentiation involved i...,29,0,0.04,1.00000,1,1,0
BP,GO:0002323,natural killer cell activation involved ...,37,0,0.05,1.00000,1,1,0
BP,GO:0002335,mature B cell differentiation,35,0,0.05,1.00000,1,1,0
BP,GO:0002347,response to tumor cell,55,0,0.08,1.00000,1,1,0
BP,GO:0002361,"CD4-positive, CD25-positive, alpha-beta ...",20,0,0.03,1.00000,1,1,0
BP,GO:0002363,alpha-beta T cell lineage commitment,23,0,0.03,1.00000,1,1,0
BP,GO:0002367,cytokine production involved in immune r...,183,0,0.26,1.00000,1,1,0
BP,GO:0002369,T cell cytokine production,55,0,0.08,1.00000,1,1,0
BP,GO:0002370,natural killer cell cytokine production,68,0,0.1,1.00000,1,1,0
BP,GO:0002385,mucosal immune response,45,0,0.06,1.00000,1,1,0
BP,GO:0002396,MHC protein complex assembly,104,0,0.15,1.00000,1,1,0
BP,GO:0002399,MHC class II protein complex assembly,97,0,0.14,1.00000,1,1,0
BP,GO:0002407,dendritic cell chemotaxis,27,0,0.04,1.00000,1,1,0
BP,GO:0002418,immune response to tumor cell,42,0,0.06,1.00000,1,1,0
BP,GO:0002424,T cell mediated immune response to tumor...,24,0,0.03,1.00000,1,1,0
BP,GO:0002428,antigen processing and presentation of p...,33,0,0.05,1.00000,1,1,0
BP,GO:0002431,Fc receptor mediated stimulatory signali...,35,0,0.05,1.00000,1,1,0
BP,GO:0002433,immune response-regulating cell surface ...,28,0,0.04,1.00000,1,1,0
BP,GO:0002437,inflammatory response to antigenic stimu...,99,0,0.14,1.00000,1,1,0
BP,GO:0002438,acute inflammatory response to antigenic...,31,0,0.04,1.00000,1,1,0
BP,GO:0002444,myeloid leukocyte mediated immunity,112,0,0.16,1.00000,1,1,0
BP,GO:0002446,neutrophil mediated immunity,36,0,0.05,1.00000,1,1,0
BP,GO:0002448,mast cell mediated immunity,52,0,0.07,1.00000,1,1,0
BP,GO:0002455,humoral immune response mediated by circ...,139,0,0.2,1.00000,1,1,0
BP,GO:0002456,T cell mediated immunity,179,0,0.26,1.00000,1,1,0
BP,GO:0002468,dendritic cell antigen processing and pr...,30,0,0.04,1.00000,1,1,0
BP,GO:0002474,antigen processing and presentation of p...,84,0,0.12,1.00000,1,1,0
BP,GO:0002475,antigen processing and presentation via ...,40,0,0.06,1.00000,1,1,0
BP,GO:0002476,antigen processing and presentation of e...,31,0,0.04,1.00000,1,1,0
BP,GO:0002478,antigen processing and presentation of e...,146,0,0.21,1.00000,1,1,0
BP,GO:0002483,antigen processing and presentation of e...,86,0,0.12,1.00000,1,1,0
BP,GO:0002484,antigen processing and presentation of e...,44,0,0.06,1.00000,1,1,0
BP,GO:0002486,antigen processing and presentation of e...,44,0,0.06,1.00000,1,1,0
BP,GO:0002495,antigen processing and presentation of p...,116,0,0.17,1.00000,1,1,0
BP,GO:0002501,peptide antigen assembly with MHC protei...,99,0,0.14,1.00000,1,1,0
BP,GO:0002503,peptide antigen assembly with MHC class ...,97,0,0.14,1.00000,1,1,0
BP,GO:0002504,antigen processing and presentation of p...,118,0,0.17,1.00000,1,1,0
BP,GO:0002507,tolerance induction,55,0,0.08,1.00000,1,1,0
BP,GO:0002517,T cell tolerance induction,34,0,0.05,1.00000,1,1,0
BP,GO:0002523,leukocyte migration involved in inflamma...,21,0,0.03,1.00000,1,1,0
BP,GO:0002526,acute inflammatory response,129,0,0.19,1.00000,1,1,0
BP,GO:0002532,production of molecular mediator involve...,124,0,0.18,1.00000,1,1,0
BP,GO:0002534,cytokine production involved in inflamma...,101,0,0.15,1.00000,1,1,0
BP,GO:0002544,chronic inflammatory response,32,0,0.05,1.00000,1,1,0
BP,GO:0002548,monocyte chemotaxis,93,0,0.13,1.00000,1,1,0
BP,GO:0002577,regulation of antigen processing and pre...,35,0,0.05,1.00000,1,1,0
BP,GO:0002578,negative regulation of antigen processin...,24,0,0.03,1.00000,1,1,0
BP,GO:0002643,regulation of tolerance induction,38,0,0.05,1.00000,1,1,0
BP,GO:0002645,positive regulation of tolerance inducti...,26,0,0.04,1.00000,1,1,0
BP,GO:0002664,regulation of T cell tolerance induction,32,0,0.05,1.00000,1,1,0
BP,GO:0002666,positive regulation of T cell tolerance ...,23,0,0.03,1.00000,1,1,0
BP,GO:0002673,regulation of acute inflammatory respons...,61,0,0.09,1.00000,1,1,0
BP,GO:0002675,positive regulation of acute inflammator...,41,0,0.06,1.00000,1,1,0
BP,GO:0002676,regulation of chronic inflammatory respo...,21,0,0.03,1.00000,1,1,0
BP,GO:0002685,regulation of leukocyte migration,248,0,0.36,1.00000,1,1,0
BP,GO:0002686,negative regulation of leukocyte migrati...,53,0,0.08,1.00000,1,1,0
BP,GO:0002687,positive regulation of leukocyte migrati...,166,0,0.24,1.00000,1,1,0
BP,GO:0002688,regulation of leukocyte chemotaxis,142,0,0.2,1.00000,1,1,0
BP,GO:0002689,negative regulation of leukocyte chemota...,24,0,0.03,1.00000,1,1,0
BP,GO:0002690,positive regulation of leukocyte chemota...,111,0,0.16,1.00000,1,1,0
BP,GO:0002691,regulation of cellular extravasation,45,0,0.06,1.00000,1,1,0
BP,GO:0002693,positive regulation of cellular extravas...,22,0,0.03,1.00000,1,1,0
BP,GO:0002704,negative regulation of leukocyte mediate...,147,0,0.21,1.00000,1,1,0
BP,GO:0002707,negative regulation of lymphocyte mediat...,137,0,0.2,1.00000,1,1,0
BP,GO:0002709,regulation of T cell mediated immunity,146,0,0.21,1.00000,1,1,0
BP,GO:0002710,negative regulation of T cell mediated i...,48,0,0.07,1.00000,1,1,0
BP,GO:0002711,positive regulation of T cell mediated i...,102,0,0.15,1.00000,1,1,0
BP,GO:0002715,regulation of natural killer cell mediat...,151,0,0.22,1.00000,1,1,0
BP,GO:0002716,negative regulation of natural killer ce...,98,0,0.14,1.00000,1,1,0
BP,GO:0002717,positive regulation of natural killer ce...,97,0,0.14,1.00000,1,1,0
BP,GO:0002718,regulation of cytokine production involv...,181,0,0.26,1.00000,1,1,0
BP,GO:0002719,negative regulation of cytokine producti...,48,0,0.07,1.00000,1,1,0
BP,GO:0002720,positive regulation of cytokine producti...,139,0,0.2,1.00000,1,1,0
BP,GO:0002724,regulation of T cell cytokine production,55,0,0.08,1.00000,1,1,0
BP,GO:0002725,negative regulation of T cell cytokine p...,21,0,0.03,1.00000,1,1,0
BP,GO:0002726,positive regulation of T cell cytokine p...,32,0,0.05,1.00000,1,1,0
BP,GO:0002727,regulation of natural killer cell cytoki...,68,0,0.1,1.00000,1,1,0
BP,GO:0002729,positive regulation of natural killer ce...,67,0,0.1,1.00000,1,1,0
BP,GO:0002753,cytoplasmic pattern recognition receptor...,78,0,0.11,1.00000,1,1,0
BP,GO:0002755,MyD88-dependent toll-like receptor signa...,25,0,0.04,1.00000,1,1,0
BP,GO:0002758,innate immune response-activating signal...,38,0,0.05,1.00000,1,1,0
BP,GO:0002762,negative regulation of myeloid leukocyte...,63,0,0.09,1.00000,1,1,0
BP,GO:0002763,positive regulation of myeloid leukocyte...,71,0,0.1,1.00000,1,1,0
BP,GO:0002765,immune response-inhibiting signal transd...,62,0,0.09,1.00000,1,1,0
BP,GO:0002767,immune response-inhibiting cell surface ...,60,0,0.09,1.00000,1,1,0
BP,GO:0002769,natural killer cell inhibitory signaling...,36,0,0.05,1.00000,1,1,0
BP,GO:0002790,peptide secretion,269,0,0.39,1.00000,1,1,0
BP,GO:0002791,regulation of peptide secretion,221,0,0.32,1.00000,1,1,0
BP,GO:0002792,negative regulation of peptide secretion,45,0,0.06,1.00000,1,1,0
BP,GO:0002793,positive regulation of peptide secretion,116,0,0.17,1.00000,1,1,0
BP,GO:0002820,negative regulation of adaptive immune r...,89,0,0.13,1.00000,1,1,0
BP,GO:0002823,negative regulation of adaptive immune r...,77,0,0.11,1.00000,1,1,0
BP,GO:0002825,regulation of T-helper 1 type immune res...,30,0,0.04,1.00000,1,1,0
BP,GO:0002828,regulation of type 2 immune response,32,0,0.05,1.00000,1,1,0
BP,GO:0002832,negative regulation of response to bioti...,204,0,0.29,1.00000,1,1,0
BP,GO:0002834,regulation of response to tumor cell,27,0,0.04,1.00000,1,1,0
BP,GO:0002836,positive regulation of response to tumor...,22,0,0.03,1.00000,1,1,0
BP,GO:0002837,regulation of immune response to tumor c...,27,0,0.04,1.00000,1,1,0
BP,GO:0002839,positive regulation of immune response t...,22,0,0.03,1.00000,1,1,0
BP,GO:0002861,regulation of inflammatory response to a...,67,0,0.1,1.00000,1,1,0
BP,GO:0002862,negative regulation of inflammatory resp...,34,0,0.05,1.00000,1,1,0
BP,GO:0002863,positive regulation of inflammatory resp...,31,0,0.04,1.00000,1,1,0
BP,GO:0002864,regulation of acute inflammatory respons...,20,0,0.03,1.00000,1,1,0
BP,GO:0002886,regulation of myeloid leukocyte mediated...,64,0,0.09,1.00000,1,1,0
BP,GO:0002888,positive regulation of myeloid leukocyte...,26,0,0.04,1.00000,1,1,0
BP,GO:0002920,regulation of humoral immune response,59,0,0.08,1.00000,1,1,0
BP,GO:0002922,positive regulation of humoral immune re...,38,0,0.05,1.00000,1,1,0
BP,GO:0002923,regulation of humoral immune response me...,32,0,0.05,1.00000,1,1,0
BP,GO:0002925,positive regulation of humoral immune re...,21,0,0.03,1.00000,1,1,0
BP,GO:0002931,response to ischemia,61,0,0.09,1.00000,1,1,0
BP,GO:0003009,skeletal muscle contraction,48,0,0.07,1.00000,1,1,0
BP,GO:0003014,renal system process,117,0,0.17,1.00000,1,1,0
BP,GO:0003016,respiratory system process,39,0,0.06,1.00000,1,1,0
BP,GO:0003044,regulation of systemic arterial blood pr...,48,0,0.07,1.00000,1,1,0
BP,GO:0003071,renal system process involved in regulat...,26,0,0.04,1.00000,1,1,0
BP,GO:0003073,regulation of systemic arterial blood pr...,97,0,0.14,1.00000,1,1,0
BP,GO:0003081,regulation of systemic arterial blood pr...,24,0,0.03,1.00000,1,1,0
BP,GO:0003091,renal water homeostasis,22,0,0.03,1.00000,1,1,0
BP,GO:0003094,glomerular filtration,25,0,0.04,1.00000,1,1,0
BP,GO:0003143,embryonic heart tube morphogenesis,72,0,0.1,1.00000,1,1,0
BP,GO:0003148,outflow tract septum morphogenesis,24,0,0.03,1.00000,1,1,0
BP,GO:0003151,outflow tract morphogenesis,74,0,0.11,1.00000,1,1,0
BP,GO:0003156,regulation of animal organ formation,28,0,0.04,1.00000,1,1,0
BP,GO:0003161,cardiac conduction system development,39,0,0.06,1.00000,1,1,0
BP,GO:0003170,heart valve development,68,0,0.1,1.00000,1,1,0
BP,GO:0003171,atrioventricular valve development,28,0,0.04,1.00000,1,1,0
BP,GO:0003176,aortic valve development,38,0,0.05,1.00000,1,1,0
BP,GO:0003177,pulmonary valve development,22,0,0.03,1.00000,1,1,0
BP,GO:0003179,heart valve morphogenesis,57,0,0.08,1.00000,1,1,0
BP,GO:0003180,aortic valve morphogenesis,33,0,0.05,1.00000,1,1,0
BP,GO:0003181,atrioventricular valve morphogenesis,25,0,0.04,1.00000,1,1,0
BP,GO:0003197,endocardial cushion development,46,0,0.07,1.00000,1,1,0
BP,GO:0003203,endocardial cushion morphogenesis,36,0,0.05,1.00000,1,1,0
BP,GO:0003208,cardiac ventricle morphogenesis,73,0,0.1,1.00000,1,1,0
BP,GO:0003215,cardiac right ventricle morphogenesis,21,0,0.03,1.00000,1,1,0
BP,GO:0003229,ventricular cardiac muscle tissue develo...,56,0,0.08,1.00000,1,1,0
BP,GO:0003254,regulation of membrane depolarization,45,0,0.06,1.00000,1,1,0
BP,GO:0003272,endocardial cushion formation,27,0,0.04,1.00000,1,1,0
BP,GO:0003298,physiological muscle hypertrophy,45,0,0.06,1.00000,1,1,0
BP,GO:0003299,muscle hypertrophy in response to stress,30,0,0.04,1.00000,1,1,0
BP,GO:0003300,cardiac muscle hypertrophy,109,0,0.16,1.00000,1,1,0
BP,GO:0003301,physiological cardiac muscle hypertrophy,45,0,0.06,1.00000,1,1,0
BP,GO:0003309,type B pancreatic cell differentiation,30,0,0.04,1.00000,1,1,0
BP,GO:0003323,type B pancreatic cell development,24,0,0.03,1.00000,1,1,0
BP,GO:0003333,amino acid transmembrane transport,99,0,0.14,1.00000,1,1,0
BP,GO:0003338,metanephros morphogenesis,38,0,0.05,1.00000,1,1,0
BP,GO:0003341,cilium movement,181,0,0.26,1.00000,1,1,0
BP,GO:0003351,epithelial cilium movement involved in e...,35,0,0.05,1.00000,1,1,0
BP,GO:0003352,regulation of cilium movement,37,0,0.05,1.00000,1,1,0
BP,GO:0003382,epithelial cell morphogenesis,40,0,0.06,1.00000,1,1,0
BP,GO:0003401,axis elongation,27,0,0.04,1.00000,1,1,0
BP,GO:0003407,neural retina development,82,0,0.12,1.00000,1,1,0
BP,GO:0003416,endochondral bone growth,26,0,0.04,1.00000,1,1,0
BP,GO:0005975,carbohydrate metabolic process,629,0,0.9,1.00000,1,1,0
BP,GO:0005976,polysaccharide metabolic process,111,0,0.16,1.00000,1,1,0
BP,GO:0005977,glycogen metabolic process,74,0,0.11,1.00000,1,1,0
BP,GO:0005978,glycogen biosynthetic process,45,0,0.06,1.00000,1,1,0
BP,GO:0005979,regulation of glycogen biosynthetic proc...,30,0,0.04,1.00000,1,1,0
BP,GO:0005996,monosaccharide metabolic process,274,0,0.39,1.00000,1,1,0
BP,GO:0006006,glucose metabolic process,213,0,0.31,1.00000,1,1,0
BP,GO:0006022,aminoglycan metabolic process,135,0,0.19,1.00000,1,1,0
BP,GO:0006023,aminoglycan biosynthetic process,85,0,0.12,1.00000,1,1,0
BP,GO:0006024,glycosaminoglycan biosynthetic process,81,0,0.12,1.00000,1,1,0
BP,GO:0006026,aminoglycan catabolic process,32,0,0.05,1.00000,1,1,0
BP,GO:0006027,glycosaminoglycan catabolic process,26,0,0.04,1.00000,1,1,0
BP,GO:0006029,proteoglycan metabolic process,83,0,0.12,1.00000,1,1,0
BP,GO:0006040,amino sugar metabolic process,43,0,0.06,1.00000,1,1,0
BP,GO:0006063,uronic acid metabolic process,24,0,0.03,1.00000,1,1,0
BP,GO:0006066,alcohol metabolic process,380,0,0.55,1.00000,1,1,0
BP,GO:0006067,ethanol metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0006071,glycerol metabolic process,20,0,0.03,1.00000,1,1,0
BP,GO:0006073,cellular glucan metabolic process,76,0,0.11,1.00000,1,1,0
BP,GO:0006081,cellular aldehyde metabolic process,69,0,0.1,1.00000,1,1,0
BP,GO:0006084,acetyl-CoA metabolic process,37,0,0.05,1.00000,1,1,0
BP,GO:0006090,pyruvate metabolic process,111,0,0.16,1.00000,1,1,0
BP,GO:0006091,generation of precursor metabolites and ...,516,0,0.74,1.00000,1,1,0
BP,GO:0006094,gluconeogenesis,81,0,0.12,1.00000,1,1,0
BP,GO:0006096,glycolytic process,85,0,0.12,1.00000,1,1,0
BP,GO:0006099,tricarboxylic acid cycle,30,0,0.04,1.00000,1,1,0
BP,GO:0006109,regulation of carbohydrate metabolic pro...,184,0,0.26,1.00000,1,1,0
BP,GO:0006110,regulation of glycolytic process,46,0,0.07,1.00000,1,1,0
BP,GO:0006111,regulation of gluconeogenesis,50,0,0.07,1.00000,1,1,0
BP,GO:0006112,energy reserve metabolic process,86,0,0.12,1.00000,1,1,0
BP,GO:0006119,oxidative phosphorylation,156,0,0.22,1.00000,1,1,0
BP,GO:0006120,"mitochondrial electron transport, NADH t...",66,0,0.09,1.00000,1,1,0
BP,GO:0006123,"mitochondrial electron transport, cytoch...",21,0,0.03,1.00000,1,1,0
BP,GO:0006140,regulation of nucleotide metabolic proce...,88,0,0.13,1.00000,1,1,0
BP,GO:0006144,purine nucleobase metabolic process,22,0,0.03,1.00000,1,1,0
BP,GO:0006164,purine nucleotide biosynthetic process,202,0,0.29,1.00000,1,1,0
BP,GO:0006165,nucleoside diphosphate phosphorylation,102,0,0.15,1.00000,1,1,0
BP,GO:0006195,purine nucleotide catabolic process,48,0,0.07,1.00000,1,1,0
BP,GO:0006213,pyrimidine nucleoside metabolic process,25,0,0.04,1.00000,1,1,0
BP,GO:0006220,pyrimidine nucleotide metabolic process,49,0,0.07,1.00000,1,1,0
BP,GO:0006221,pyrimidine nucleotide biosynthetic proce...,29,0,0.04,1.00000,1,1,0
BP,GO:0006244,pyrimidine nucleotide catabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0006270,DNA replication initiation,35,0,0.05,1.00000,1,1,0
BP,GO:0006278,RNA-dependent DNA biosynthetic process,76,0,0.11,1.00000,1,1,0
BP,GO:0006284,base-excision repair,43,0,0.06,1.00000,1,1,0
BP,GO:0006289,nucleotide-excision repair,69,0,0.1,1.00000,1,1,0
BP,GO:0006298,mismatch repair,39,0,0.06,1.00000,1,1,0
BP,GO:0006301,postreplication repair,31,0,0.04,1.00000,1,1,0
BP,GO:0006308,DNA catabolic process,35,0,0.05,1.00000,1,1,0
BP,GO:0006309,apoptotic DNA fragmentation,21,0,0.03,1.00000,1,1,0
BP,GO:0006312,mitotic recombination,25,0,0.04,1.00000,1,1,0
BP,GO:0006335,DNA replication-dependent nucleosome ass...,34,0,0.05,1.00000,1,1,0
BP,GO:0006337,nucleosome disassembly,20,0,0.03,1.00000,1,1,0
BP,GO:0006352,"DNA-templated transcription, initiation",142,0,0.2,1.00000,1,1,0
BP,GO:0006353,"DNA-templated transcription, termination",33,0,0.05,1.00000,1,1,0
BP,GO:0006354,"DNA-templated transcription, elongation",103,0,0.15,1.00000,1,1,0
BP,GO:0006356,regulation of transcription by RNA polym...,35,0,0.05,1.00000,1,1,0
BP,GO:0006359,regulation of transcription by RNA polym...,23,0,0.03,1.00000,1,1,0
BP,GO:0006360,transcription by RNA polymerase I,64,0,0.09,1.00000,1,1,0
BP,GO:0006367,transcription initiation from RNA polyme...,86,0,0.12,1.00000,1,1,0
BP,GO:0006368,transcription elongation from RNA polyme...,74,0,0.11,1.00000,1,1,0
BP,GO:0006376,mRNA splice site selection,52,0,0.07,1.00000,1,1,0
BP,GO:0006378,mRNA polyadenylation,55,0,0.08,1.00000,1,1,0
BP,GO:0006383,transcription by RNA polymerase III,49,0,0.07,1.00000,1,1,0
BP,GO:0006397,mRNA processing,567,0,0.82,1.00000,1,1,0
BP,GO:0006399,tRNA metabolic process,210,0,0.3,1.00000,1,1,0
BP,GO:0006400,tRNA modification,92,0,0.13,1.00000,1,1,0
BP,GO:0006403,RNA localization,226,0,0.32,1.00000,1,1,0
BP,GO:0006405,RNA export from nucleus,91,0,0.13,1.00000,1,1,0
BP,GO:0006406,mRNA export from nucleus,67,0,0.1,1.00000,1,1,0
BP,GO:0006414,translational elongation,58,0,0.08,1.00000,1,1,0
BP,GO:0006418,tRNA aminoacylation for protein translat...,54,0,0.08,1.00000,1,1,0
BP,GO:0006448,regulation of translational elongation,20,0,0.03,1.00000,1,1,0
BP,GO:0006450,regulation of translational fidelity,41,0,0.06,1.00000,1,1,0
BP,GO:0006457,protein folding,229,0,0.33,1.00000,1,1,0
BP,GO:0006458,'de novo' protein folding,53,0,0.08,1.00000,1,1,0
BP,GO:0006469,negative regulation of protein kinase ac...,235,0,0.34,1.00000,1,1,0
BP,GO:0006471,protein ADP-ribosylation,38,0,0.05,1.00000,1,1,0
BP,GO:0006473,protein acetylation,223,0,0.32,1.00000,1,1,0
BP,GO:0006475,internal protein amino acid acetylation,182,0,0.26,1.00000,1,1,0
BP,GO:0006476,protein deacetylation,106,0,0.15,1.00000,1,1,0
BP,GO:0006482,protein demethylation,33,0,0.05,1.00000,1,1,0
BP,GO:0006487,protein N-linked glycosylation,69,0,0.1,1.00000,1,1,0
BP,GO:0006491,N-glycan processing,20,0,0.03,1.00000,1,1,0
BP,GO:0006497,protein lipidation,96,0,0.14,1.00000,1,1,0
BP,GO:0006505,GPI anchor metabolic process,34,0,0.05,1.00000,1,1,0
BP,GO:0006506,GPI anchor biosynthetic process,33,0,0.05,1.00000,1,1,0
BP,GO:0006509,membrane protein ectodomain proteolysis,52,0,0.07,1.00000,1,1,0
BP,GO:0006513,protein monoubiquitination,74,0,0.11,1.00000,1,1,0
BP,GO:0006515,protein quality control for misfolded or...,40,0,0.06,1.00000,1,1,0
BP,GO:0006516,glycoprotein catabolic process,30,0,0.04,1.00000,1,1,0
BP,GO:0006517,protein deglycosylation,31,0,0.04,1.00000,1,1,0
BP,GO:0006525,arginine metabolic process,27,0,0.04,1.00000,1,1,0
BP,GO:0006536,glutamate metabolic process,36,0,0.05,1.00000,1,1,0
BP,GO:0006575,cellular modified amino acid metabolic p...,211,0,0.3,1.00000,1,1,0
BP,GO:0006582,melanin metabolic process,28,0,0.04,1.00000,1,1,0
BP,GO:0006590,thyroid hormone generation,22,0,0.03,1.00000,1,1,0
BP,GO:0006605,protein targeting,330,0,0.47,1.00000,1,1,0
BP,GO:0006606,protein import into nucleus,163,0,0.23,1.00000,1,1,0
BP,GO:0006607,NLS-bearing protein import into nucleus,21,0,0.03,1.00000,1,1,0
BP,GO:0006611,protein export from nucleus,67,0,0.1,1.00000,1,1,0
BP,GO:0006612,protein targeting to membrane,135,0,0.19,1.00000,1,1,0
BP,GO:0006613,cotranslational protein targeting to mem...,29,0,0.04,1.00000,1,1,0
BP,GO:0006614,SRP-dependent cotranslational protein ta...,24,0,0.03,1.00000,1,1,0
BP,GO:0006622,protein targeting to lysosome,22,0,0.03,1.00000,1,1,0
BP,GO:0006623,protein targeting to vacuole,37,0,0.05,1.00000,1,1,0
BP,GO:0006626,protein targeting to mitochondrion,112,0,0.16,1.00000,1,1,0
BP,GO:0006631,fatty acid metabolic process,423,0,0.61,1.00000,1,1,0
BP,GO:0006633,fatty acid biosynthetic process,178,0,0.26,1.00000,1,1,0
BP,GO:0006635,fatty acid beta-oxidation,78,0,0.11,1.00000,1,1,0
BP,GO:0006636,unsaturated fatty acid biosynthetic proc...,53,0,0.08,1.00000,1,1,0
BP,GO:0006637,acyl-CoA metabolic process,107,0,0.15,1.00000,1,1,0
BP,GO:0006638,neutral lipid metabolic process,156,0,0.22,1.00000,1,1,0
BP,GO:0006639,acylglycerol metabolic process,155,0,0.22,1.00000,1,1,0
BP,GO:0006641,triglyceride metabolic process,119,0,0.17,1.00000,1,1,0
BP,GO:0006643,membrane lipid metabolic process,222,0,0.32,1.00000,1,1,0
BP,GO:0006644,phospholipid metabolic process,435,0,0.63,1.00000,1,1,0
BP,GO:0006650,glycerophospholipid metabolic process,352,0,0.51,1.00000,1,1,0
BP,GO:0006654,phosphatidic acid biosynthetic process,42,0,0.06,1.00000,1,1,0
BP,GO:0006656,phosphatidylcholine biosynthetic process,37,0,0.05,1.00000,1,1,0
BP,GO:0006658,phosphatidylserine metabolic process,33,0,0.05,1.00000,1,1,0
BP,GO:0006661,phosphatidylinositol biosynthetic proces...,145,0,0.21,1.00000,1,1,0
BP,GO:0006662,glycerol ether metabolic process,23,0,0.03,1.00000,1,1,0
BP,GO:0006664,glycolipid metabolic process,116,0,0.17,1.00000,1,1,0
BP,GO:0006665,sphingolipid metabolic process,172,0,0.25,1.00000,1,1,0
BP,GO:0006670,sphingosine metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0006672,ceramide metabolic process,118,0,0.17,1.00000,1,1,0
BP,GO:0006687,glycosphingolipid metabolic process,70,0,0.1,1.00000,1,1,0
BP,GO:0006688,glycosphingolipid biosynthetic process,34,0,0.05,1.00000,1,1,0
BP,GO:0006690,icosanoid metabolic process,135,0,0.19,1.00000,1,1,0
BP,GO:0006691,leukotriene metabolic process,39,0,0.06,1.00000,1,1,0
BP,GO:0006692,prostanoid metabolic process,52,0,0.07,1.00000,1,1,0
BP,GO:0006693,prostaglandin metabolic process,52,0,0.07,1.00000,1,1,0
BP,GO:0006694,steroid biosynthetic process,197,0,0.28,1.00000,1,1,0
BP,GO:0006695,cholesterol biosynthetic process,60,0,0.09,1.00000,1,1,0
BP,GO:0006699,bile acid biosynthetic process,39,0,0.06,1.00000,1,1,0
BP,GO:0006700,C21-steroid hormone biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0006704,glucocorticoid biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0006706,steroid catabolic process,27,0,0.04,1.00000,1,1,0
BP,GO:0006720,isoprenoid metabolic process,135,0,0.19,1.00000,1,1,0
BP,GO:0006721,terpenoid metabolic process,116,0,0.17,1.00000,1,1,0
BP,GO:0006730,one-carbon metabolic process,41,0,0.06,1.00000,1,1,0
BP,GO:0006734,"NADH metabolic process",30,0,0.04,1.00000,1,1,0
BP,GO:0006739,"NADP metabolic process",35,0,0.05,1.00000,1,1,0
BP,GO:0006749,glutathione metabolic process,74,0,0.11,1.00000,1,1,0
BP,GO:0006754,ATP biosynthetic process,59,0,0.08,1.00000,1,1,0
BP,GO:0006757,ATP generation from ADP,86,0,0.12,1.00000,1,1,0
BP,GO:0006760,folic acid-containing compound metabolic...,28,0,0.04,1.00000,1,1,0
BP,GO:0006766,vitamin metabolic process,116,0,0.17,1.00000,1,1,0
BP,GO:0006767,water-soluble vitamin metabolic process,61,0,0.09,1.00000,1,1,0
BP,GO:0006775,fat-soluble vitamin metabolic process,52,0,0.07,1.00000,1,1,0
BP,GO:0006778,porphyrin-containing compound metabolic ...,53,0,0.08,1.00000,1,1,0
BP,GO:0006779,porphyrin-containing compound biosynthet...,33,0,0.05,1.00000,1,1,0
BP,GO:0006783,heme biosynthetic process,29,0,0.04,1.00000,1,1,0
BP,GO:0006790,sulfur compound metabolic process,366,0,0.53,1.00000,1,1,0
BP,GO:0006801,superoxide metabolic process,79,0,0.11,1.00000,1,1,0
BP,GO:0006805,xenobiotic metabolic process,117,0,0.17,1.00000,1,1,0
BP,GO:0006809,nitric oxide biosynthetic process,94,0,0.14,1.00000,1,1,0
BP,GO:0006817,phosphate ion transport,25,0,0.04,1.00000,1,1,0
BP,GO:0006820,anion transport,544,0,0.78,1.00000,1,1,0
BP,GO:0006821,chloride transport,121,0,0.17,1.00000,1,1,0
BP,GO:0006826,iron ion transport,61,0,0.09,1.00000,1,1,0
BP,GO:0006829,zinc ion transport,35,0,0.05,1.00000,1,1,0
BP,GO:0006833,water transport,22,0,0.03,1.00000,1,1,0
BP,GO:0006835,dicarboxylic acid transport,86,0,0.12,1.00000,1,1,0
BP,GO:0006836,neurotransmitter transport,222,0,0.32,1.00000,1,1,0
BP,GO:0006837,serotonin transport,24,0,0.03,1.00000,1,1,0
BP,GO:0006851,mitochondrial calcium ion transmembrane ...,23,0,0.03,1.00000,1,1,0
BP,GO:0006858,extracellular transport,38,0,0.05,1.00000,1,1,0
BP,GO:0006862,nucleotide transport,39,0,0.06,1.00000,1,1,0
BP,GO:0006865,amino acid transport,147,0,0.21,1.00000,1,1,0
BP,GO:0006869,lipid transport,430,0,0.62,1.00000,1,1,0
BP,GO:0006879,cellular iron ion homeostasis,66,0,0.09,1.00000,1,1,0
BP,GO:0006882,cellular zinc ion homeostasis,43,0,0.06,1.00000,1,1,0
BP,GO:0006883,cellular sodium ion homeostasis,21,0,0.03,1.00000,1,1,0
BP,GO:0006884,cell volume homeostasis,33,0,0.05,1.00000,1,1,0
BP,GO:0006885,regulation of pH,95,0,0.14,1.00000,1,1,0
BP,GO:0006886,intracellular protein transport,949,0,1.36,1.00000,1,1,0
BP,GO:0006887,exocytosis,376,0,0.54,1.00000,1,1,0
BP,GO:0006888,endoplasmic reticulum to Golgi vesicle-m...,139,0,0.2,1.00000,1,1,0
BP,GO:0006890,"retrograde vesicle-mediated transport, G...",59,0,0.08,1.00000,1,1,0
BP,GO:0006891,intra-Golgi vesicle-mediated transport,36,0,0.05,1.00000,1,1,0
BP,GO:0006893,Golgi to plasma membrane transport,64,0,0.09,1.00000,1,1,0
BP,GO:0006896,Golgi to vacuole transport,27,0,0.04,1.00000,1,1,0
BP,GO:0006897,endocytosis,688,0,0.99,1.00000,1,1,0
BP,GO:0006898,receptor-mediated endocytosis,280,0,0.4,1.00000,1,1,0
BP,GO:0006900,vesicle budding from membrane,64,0,0.09,1.00000,1,1,0
BP,GO:0006903,vesicle targeting,47,0,0.07,1.00000,1,1,0
BP,GO:0006904,vesicle docking involved in exocytosis,38,0,0.05,1.00000,1,1,0
BP,GO:0006906,vesicle fusion,113,0,0.16,1.00000,1,1,0
BP,GO:0006907,pinocytosis,23,0,0.03,1.00000,1,1,0
BP,GO:0006909,phagocytosis,331,0,0.48,1.00000,1,1,0
BP,GO:0006910,"phagocytosis, recognition",93,0,0.13,1.00000,1,1,0
BP,GO:0006911,"phagocytosis, engulfment",122,0,0.18,1.00000,1,1,0
BP,GO:0006913,nucleocytoplasmic transport,328,0,0.47,1.00000,1,1,0
BP,GO:0006919,activation of cysteine-type endopeptidas...,89,0,0.13,1.00000,1,1,0
BP,GO:0006921,cellular component disassembly involved ...,32,0,0.05,1.00000,1,1,0
BP,GO:0006925,inflammatory cell apoptotic process,22,0,0.03,1.00000,1,1,0
BP,GO:0006929,substrate-dependent cell migration,25,0,0.04,1.00000,1,1,0
BP,GO:0006940,regulation of smooth muscle contraction,65,0,0.09,1.00000,1,1,0
BP,GO:0006949,syncytium formation,67,0,0.1,1.00000,1,1,0
BP,GO:0006953,acute-phase response,59,0,0.08,1.00000,1,1,0
BP,GO:0006956,complement activation,141,0,0.2,1.00000,1,1,0
BP,GO:0006957,"complement activation, alternative pathw...",25,0,0.04,1.00000,1,1,0
BP,GO:0006958,"complement activation, classical pathway",112,0,0.16,1.00000,1,1,0
BP,GO:0006959,humoral immune response,386,0,0.55,1.00000,1,1,0
BP,GO:0006968,cellular defense response,174,0,0.25,1.00000,1,1,0
BP,GO:0006970,response to osmotic stress,93,0,0.13,1.00000,1,1,0
BP,GO:0006972,hyperosmotic response,28,0,0.04,1.00000,1,1,0
BP,GO:0006984,ER-nucleus signaling pathway,49,0,0.07,1.00000,1,1,0
BP,GO:0006986,response to unfolded protein,158,0,0.23,1.00000,1,1,0
BP,GO:0006997,nucleus organization,137,0,0.2,1.00000,1,1,0
BP,GO:0006998,nuclear envelope organization,49,0,0.07,1.00000,1,1,0
BP,GO:0007004,telomere maintenance via telomerase,75,0,0.11,1.00000,1,1,0
BP,GO:0007007,inner mitochondrial membrane organizatio...,42,0,0.06,1.00000,1,1,0
BP,GO:0007009,plasma membrane organization,163,0,0.23,1.00000,1,1,0
BP,GO:0007019,microtubule depolymerization,47,0,0.07,1.00000,1,1,0
BP,GO:0007020,microtubule nucleation,47,0,0.07,1.00000,1,1,0
BP,GO:0007026,negative regulation of microtubule depol...,28,0,0.04,1.00000,1,1,0
BP,GO:0007029,endoplasmic reticulum organization,95,0,0.14,1.00000,1,1,0
BP,GO:0007030,Golgi organization,173,0,0.25,1.00000,1,1,0
BP,GO:0007031,peroxisome organization,37,0,0.05,1.00000,1,1,0
BP,GO:0007032,endosome organization,86,0,0.12,1.00000,1,1,0
BP,GO:0007033,vacuole organization,201,0,0.29,1.00000,1,1,0
BP,GO:0007034,vacuolar transport,175,0,0.25,1.00000,1,1,0
BP,GO:0007035,vacuolar acidification,25,0,0.04,1.00000,1,1,0
BP,GO:0007039,protein catabolic process in the vacuole,21,0,0.03,1.00000,1,1,0
BP,GO:0007040,lysosome organization,77,0,0.11,1.00000,1,1,0
BP,GO:0007041,lysosomal transport,129,0,0.19,1.00000,1,1,0
BP,GO:0007080,mitotic metaphase plate congression,56,0,0.08,1.00000,1,1,0
BP,GO:0007088,regulation of mitotic nuclear division,111,0,0.16,1.00000,1,1,0
BP,GO:0007091,metaphase/anaphase transition of mitotic...,62,0,0.09,1.00000,1,1,0
BP,GO:0007094,mitotic spindle assembly checkpoint sign...,38,0,0.05,1.00000,1,1,0
BP,GO:0007095,mitotic G2 DNA damage checkpoint signali...,41,0,0.06,1.00000,1,1,0
BP,GO:0007099,centriole replication,44,0,0.06,1.00000,1,1,0
BP,GO:0007127,meiosis I,152,0,0.22,1.00000,1,1,0
BP,GO:0007129,homologous chromosome pairing at meiosis,66,0,0.09,1.00000,1,1,0
BP,GO:0007130,synaptonemal complex assembly,36,0,0.05,1.00000,1,1,0
BP,GO:0007131,reciprocal meiotic recombination,68,0,0.1,1.00000,1,1,0
BP,GO:0007140,male meiotic nuclear division,52,0,0.07,1.00000,1,1,0
BP,GO:0007141,male meiosis I,30,0,0.04,1.00000,1,1,0
BP,GO:0007143,female meiotic nuclear division,33,0,0.05,1.00000,1,1,0
BP,GO:0007157,heterophilic cell-cell adhesion via plas...,52,0,0.07,1.00000,1,1,0
BP,GO:0007164,establishment of tissue polarity,74,0,0.11,1.00000,1,1,0
BP,GO:0007173,epidermal growth factor receptor signali...,110,0,0.16,1.00000,1,1,0
BP,GO:0007176,regulation of epidermal growth factor-ac...,30,0,0.04,1.00000,1,1,0
BP,GO:0007178,transmembrane receptor protein serine/th...,379,0,0.54,1.00000,1,1,0
BP,GO:0007179,transforming growth factor beta receptor...,209,0,0.3,1.00000,1,1,0
BP,GO:0007187,G protein-coupled receptor signaling pat...,69,0,0.1,1.00000,1,1,0
BP,GO:0007189,adenylate cyclase-activating G protein-c...,155,0,0.22,1.00000,1,1,0
BP,GO:0007190,activation of adenylate cyclase activity,36,0,0.05,1.00000,1,1,0
BP,GO:0007194,negative regulation of adenylate cyclase...,21,0,0.03,1.00000,1,1,0
BP,GO:0007200,phospholipase C-activating G protein-cou...,107,0,0.15,1.00000,1,1,0
BP,GO:0007202,activation of phospholipase C activity,30,0,0.04,1.00000,1,1,0
BP,GO:0007205,protein kinase C-activating G protein-co...,30,0,0.04,1.00000,1,1,0
BP,GO:0007210,serotonin receptor signaling pathway,41,0,0.06,1.00000,1,1,0
BP,GO:0007212,dopamine receptor signaling pathway,43,0,0.06,1.00000,1,1,0
BP,GO:0007214,gamma-aminobutyric acid signaling pathwa...,33,0,0.05,1.00000,1,1,0
BP,GO:0007218,neuropeptide signaling pathway,114,0,0.16,1.00000,1,1,0
BP,GO:0007219,Notch signaling pathway,185,0,0.27,1.00000,1,1,0
BP,GO:0007224,smoothened signaling pathway,144,0,0.21,1.00000,1,1,0
BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,329,0,0.47,1.00000,1,1,0
BP,GO:0007252,I-kappaB phosphorylation,28,0,0.04,1.00000,1,1,0
BP,GO:0007254,JNK cascade,188,0,0.27,1.00000,1,1,0
BP,GO:0007259,receptor signaling pathway via JAK-STAT,184,0,0.26,1.00000,1,1,0
BP,GO:0007260,tyrosine phosphorylation of STAT protein,99,0,0.14,1.00000,1,1,0
BP,GO:0007263,nitric oxide mediated signal transductio...,33,0,0.05,1.00000,1,1,0
BP,GO:0007265,Ras protein signal transduction,376,0,0.54,1.00000,1,1,0
BP,GO:0007266,Rho protein signal transduction,152,0,0.22,1.00000,1,1,0
BP,GO:0007269,neurotransmitter secretion,149,0,0.21,1.00000,1,1,0
BP,GO:0007271,"synaptic transmission, cholinergic",32,0,0.05,1.00000,1,1,0
BP,GO:0007274,neuromuscular synaptic transmission,26,0,0.04,1.00000,1,1,0
BP,GO:0007281,germ cell development,300,0,0.43,1.00000,1,1,0
BP,GO:0007286,spermatid development,179,0,0.26,1.00000,1,1,0
BP,GO:0007288,sperm axoneme assembly,25,0,0.04,1.00000,1,1,0
BP,GO:0007289,spermatid nucleus differentiation,22,0,0.03,1.00000,1,1,0
BP,GO:0007292,female gamete generation,152,0,0.22,1.00000,1,1,0
BP,GO:0007339,binding of sperm to zona pellucida,51,0,0.07,1.00000,1,1,0
BP,GO:0007340,acrosome reaction,40,0,0.06,1.00000,1,1,0
BP,GO:0007342,fusion of sperm to egg plasma membrane i...,26,0,0.04,1.00000,1,1,0
BP,GO:0007350,blastoderm segmentation,21,0,0.03,1.00000,1,1,0
BP,GO:0007368,determination of left/right symmetry,127,0,0.18,1.00000,1,1,0
BP,GO:0007369,gastrulation,203,0,0.29,1.00000,1,1,0
BP,GO:0007398,ectoderm development,30,0,0.04,1.00000,1,1,0
BP,GO:0007405,neuroblast proliferation,59,0,0.08,1.00000,1,1,0
BP,GO:0007413,axonal fasciculation,23,0,0.03,1.00000,1,1,0
BP,GO:0007416,synapse assembly,189,0,0.27,1.00000,1,1,0
BP,GO:0007431,salivary gland development,42,0,0.06,1.00000,1,1,0
BP,GO:0007435,salivary gland morphogenesis,40,0,0.06,1.00000,1,1,0
BP,GO:0007492,endoderm development,86,0,0.12,1.00000,1,1,0
BP,GO:0007498,mesoderm development,142,0,0.2,1.00000,1,1,0
BP,GO:0007517,muscle organ development,345,0,0.5,1.00000,1,1,0
BP,GO:0007519,skeletal muscle tissue development,166,0,0.24,1.00000,1,1,0
BP,GO:0007520,myoblast fusion,50,0,0.07,1.00000,1,1,0
BP,GO:0007528,neuromuscular junction development,45,0,0.06,1.00000,1,1,0
BP,GO:0007585,respiratory gaseous exchange by respirat...,70,0,0.1,1.00000,1,1,0
BP,GO:0007586,digestion,157,0,0.23,1.00000,1,1,0
BP,GO:0007588,excretion,65,0,0.09,1.00000,1,1,0
BP,GO:0007589,body fluid secretion,103,0,0.15,1.00000,1,1,0
BP,GO:0007595,lactation,55,0,0.08,1.00000,1,1,0
BP,GO:0007596,blood coagulation,247,0,0.36,1.00000,1,1,0
BP,GO:0007599,hemostasis,253,0,0.36,1.00000,1,1,0
BP,GO:0007601,visual perception,230,0,0.33,1.00000,1,1,0
BP,GO:0007602,phototransduction,52,0,0.07,1.00000,1,1,0
BP,GO:0007603,"phototransduction, visible light",22,0,0.03,1.00000,1,1,0
BP,GO:0007606,sensory perception of chemical stimulus,687,0,0.99,1.00000,1,1,0
BP,GO:0007608,sensory perception of smell,590,0,0.85,1.00000,1,1,0
BP,GO:0007617,mating behavior,22,0,0.03,1.00000,1,1,0
BP,GO:0007618,mating,46,0,0.07,1.00000,1,1,0
BP,GO:0007620,copulation,20,0,0.03,1.00000,1,1,0
BP,GO:0007622,rhythmic behavior,52,0,0.07,1.00000,1,1,0
BP,GO:0007628,adult walking behavior,28,0,0.04,1.00000,1,1,0
BP,GO:0007631,feeding behavior,101,0,0.15,1.00000,1,1,0
BP,GO:0008033,tRNA processing,145,0,0.21,1.00000,1,1,0
BP,GO:0008038,neuron recognition,51,0,0.07,1.00000,1,1,0
BP,GO:0008053,mitochondrial fusion,27,0,0.04,1.00000,1,1,0
BP,GO:0008089,anterograde axonal transport,52,0,0.07,1.00000,1,1,0
BP,GO:0008156,negative regulation of DNA replication,33,0,0.05,1.00000,1,1,0
BP,GO:0008202,steroid metabolic process,355,0,0.51,1.00000,1,1,0
BP,GO:0008203,cholesterol metabolic process,149,0,0.21,1.00000,1,1,0
BP,GO:0008206,bile acid metabolic process,52,0,0.07,1.00000,1,1,0
BP,GO:0008207,C21-steroid hormone metabolic process,37,0,0.05,1.00000,1,1,0
BP,GO:0008209,androgen metabolic process,35,0,0.05,1.00000,1,1,0
BP,GO:0008210,estrogen metabolic process,50,0,0.07,1.00000,1,1,0
BP,GO:0008211,glucocorticoid metabolic process,29,0,0.04,1.00000,1,1,0
BP,GO:0008214,protein dealkylation,33,0,0.05,1.00000,1,1,0
BP,GO:0008217,regulation of blood pressure,192,0,0.28,1.00000,1,1,0
BP,GO:0008277,regulation of G protein-coupled receptor...,144,0,0.21,1.00000,1,1,0
BP,GO:0008286,insulin receptor signaling pathway,118,0,0.17,1.00000,1,1,0
BP,GO:0008299,isoprenoid biosynthetic process,29,0,0.04,1.00000,1,1,0
BP,GO:0008333,endosome to lysosome transport,57,0,0.08,1.00000,1,1,0
BP,GO:0008344,adult locomotory behavior,73,0,0.1,1.00000,1,1,0
BP,GO:0008356,asymmetric cell division,26,0,0.04,1.00000,1,1,0
BP,GO:0008380,RNA splicing,492,0,0.71,1.00000,1,1,0
BP,GO:0008535,respiratory chain complex IV assembly,27,0,0.04,1.00000,1,1,0
BP,GO:0008543,fibroblast growth factor receptor signal...,82,0,0.12,1.00000,1,1,0
BP,GO:0008544,epidermis development,360,0,0.52,1.00000,1,1,0
BP,GO:0008585,female gonad development,96,0,0.14,1.00000,1,1,0
BP,GO:0008589,regulation of smoothened signaling pathw...,85,0,0.12,1.00000,1,1,0
BP,GO:0008593,regulation of Notch signaling pathway,98,0,0.14,1.00000,1,1,0
BP,GO:0008608,attachment of spindle microtubules to ki...,37,0,0.05,1.00000,1,1,0
BP,GO:0008610,lipid biosynthetic process,776,0,1.12,1.00000,1,1,0
BP,GO:0008625,extrinsic apoptotic signaling pathway vi...,97,0,0.14,1.00000,1,1,0
BP,GO:0008631,intrinsic apoptotic signaling pathway in...,45,0,0.06,1.00000,1,1,0
BP,GO:0008637,apoptotic mitochondrial changes,122,0,0.18,1.00000,1,1,0
BP,GO:0008643,carbohydrate transport,170,0,0.24,1.00000,1,1,0
BP,GO:0008645,hexose transmembrane transport,130,0,0.19,1.00000,1,1,0
BP,GO:0008652,cellular amino acid biosynthetic process,80,0,0.11,1.00000,1,1,0
BP,GO:0008654,phospholipid biosynthetic process,289,0,0.42,1.00000,1,1,0
BP,GO:0009060,aerobic respiration,205,0,0.29,1.00000,1,1,0
BP,GO:0009062,fatty acid catabolic process,105,0,0.15,1.00000,1,1,0
BP,GO:0009066,aspartate family amino acid metabolic pr...,52,0,0.07,1.00000,1,1,0
BP,GO:0009067,aspartate family amino acid biosynthetic...,22,0,0.03,1.00000,1,1,0
BP,GO:0009069,serine family amino acid metabolic proce...,42,0,0.06,1.00000,1,1,0
BP,GO:0009070,serine family amino acid biosynthetic pr...,21,0,0.03,1.00000,1,1,0
BP,GO:0009072,aromatic amino acid family metabolic pro...,31,0,0.04,1.00000,1,1,0
BP,GO:0009084,glutamine family amino acid biosynthetic...,20,0,0.03,1.00000,1,1,0
BP,GO:0009110,vitamin biosynthetic process,27,0,0.04,1.00000,1,1,0
BP,GO:0009112,nucleobase metabolic process,37,0,0.05,1.00000,1,1,0
BP,GO:0009116,nucleoside metabolic process,63,0,0.09,1.00000,1,1,0
BP,GO:0009119,ribonucleoside metabolic process,36,0,0.05,1.00000,1,1,0
BP,GO:0009124,nucleoside monophosphate biosynthetic pr...,43,0,0.06,1.00000,1,1,0
BP,GO:0009127,purine nucleoside monophosphate biosynth...,22,0,0.03,1.00000,1,1,0
BP,GO:0009129,pyrimidine nucleoside monophosphate meta...,20,0,0.03,1.00000,1,1,0
BP,GO:0009141,nucleoside triphosphate metabolic proces...,113,0,0.16,1.00000,1,1,0
BP,GO:0009142,nucleoside triphosphate biosynthetic pro...,86,0,0.12,1.00000,1,1,0
BP,GO:0009144,purine nucleoside triphosphate metabolic...,89,0,0.13,1.00000,1,1,0
BP,GO:0009145,purine nucleoside triphosphate biosynthe...,70,0,0.1,1.00000,1,1,0
BP,GO:0009147,pyrimidine nucleoside triphosphate metab...,24,0,0.03,1.00000,1,1,0
BP,GO:0009152,purine ribonucleotide biosynthetic proce...,181,0,0.26,1.00000,1,1,0
BP,GO:0009154,purine ribonucleotide catabolic process,44,0,0.06,1.00000,1,1,0
BP,GO:0009156,ribonucleoside monophosphate biosyntheti...,34,0,0.05,1.00000,1,1,0
BP,GO:0009162,deoxyribonucleoside monophosphate metabo...,23,0,0.03,1.00000,1,1,0
BP,GO:0009164,nucleoside catabolic process,27,0,0.04,1.00000,1,1,0
BP,GO:0009165,nucleotide biosynthetic process,268,0,0.39,1.00000,1,1,0
BP,GO:0009166,nucleotide catabolic process,75,0,0.11,1.00000,1,1,0
BP,GO:0009168,purine ribonucleoside monophosphate bios...,20,0,0.03,1.00000,1,1,0
BP,GO:0009187,cyclic nucleotide metabolic process,43,0,0.06,1.00000,1,1,0
BP,GO:0009190,cyclic nucleotide biosynthetic process,23,0,0.03,1.00000,1,1,0
BP,GO:0009199,ribonucleoside triphosphate metabolic pr...,90,0,0.13,1.00000,1,1,0
BP,GO:0009201,ribonucleoside triphosphate biosynthetic...,75,0,0.11,1.00000,1,1,0
BP,GO:0009205,purine ribonucleoside triphosphate metab...,83,0,0.12,1.00000,1,1,0
BP,GO:0009206,purine ribonucleoside triphosphate biosy...,69,0,0.1,1.00000,1,1,0
BP,GO:0009218,pyrimidine ribonucleotide metabolic proc...,28,0,0.04,1.00000,1,1,0
BP,GO:0009219,pyrimidine deoxyribonucleotide metabolic...,24,0,0.03,1.00000,1,1,0
BP,GO:0009220,pyrimidine ribonucleotide biosynthetic p...,21,0,0.03,1.00000,1,1,0
BP,GO:0009225,nucleotide-sugar metabolic process,37,0,0.05,1.00000,1,1,0
BP,GO:0009226,nucleotide-sugar biosynthetic process,20,0,0.03,1.00000,1,1,0
BP,GO:0009247,glycolipid biosynthetic process,75,0,0.11,1.00000,1,1,0
BP,GO:0009250,glucan biosynthetic process,45,0,0.06,1.00000,1,1,0
BP,GO:0009260,ribonucleotide biosynthetic process,194,0,0.28,1.00000,1,1,0
BP,GO:0009261,ribonucleotide catabolic process,49,0,0.07,1.00000,1,1,0
BP,GO:0009262,deoxyribonucleotide metabolic process,44,0,0.06,1.00000,1,1,0
BP,GO:0009264,deoxyribonucleotide catabolic process,30,0,0.04,1.00000,1,1,0
BP,GO:0009266,response to temperature stimulus,209,0,0.3,1.00000,1,1,0
BP,GO:0009267,cellular response to starvation,169,0,0.24,1.00000,1,1,0
BP,GO:0009268,response to pH,45,0,0.06,1.00000,1,1,0
BP,GO:0009301,snRNA transcription,21,0,0.03,1.00000,1,1,0
BP,GO:0009303,rRNA transcription,35,0,0.05,1.00000,1,1,0
BP,GO:0009306,protein secretion,396,0,0.57,1.00000,1,1,0
BP,GO:0009309,amine biosynthetic process,39,0,0.06,1.00000,1,1,0
BP,GO:0009310,amine catabolic process,32,0,0.05,1.00000,1,1,0
BP,GO:0009311,oligosaccharide metabolic process,76,0,0.11,1.00000,1,1,0
BP,GO:0009312,oligosaccharide biosynthetic process,33,0,0.05,1.00000,1,1,0
BP,GO:0009394,2'-deoxyribonucleotide metabolic process,40,0,0.06,1.00000,1,1,0
BP,GO:0009395,phospholipid catabolic process,57,0,0.08,1.00000,1,1,0
BP,GO:0009408,response to heat,140,0,0.2,1.00000,1,1,0
BP,GO:0009409,response to cold,51,0,0.07,1.00000,1,1,0
BP,GO:0009411,response to UV,158,0,0.23,1.00000,1,1,0
BP,GO:0009435,"NAD biosynthetic process",28,0,0.04,1.00000,1,1,0
BP,GO:0009451,RNA modification,172,0,0.25,1.00000,1,1,0
BP,GO:0009581,detection of external stimulus,141,0,0.2,1.00000,1,1,0
BP,GO:0009582,detection of abiotic stimulus,144,0,0.21,1.00000,1,1,0
BP,GO:0009583,detection of light stimulus,72,0,0.1,1.00000,1,1,0
BP,GO:0009584,detection of visible light,57,0,0.08,1.00000,1,1,0
BP,GO:0009593,detection of chemical stimulus,672,0,0.97,1.00000,1,1,0
BP,GO:0009595,detection of biotic stimulus,59,0,0.08,1.00000,1,1,0
BP,GO:0009612,response to mechanical stimulus,223,0,0.32,1.00000,1,1,0
BP,GO:0009615,response to virus,420,0,0.6,1.00000,1,1,0
BP,GO:0009620,response to fungus,75,0,0.11,1.00000,1,1,0
BP,GO:0009642,response to light intensity,25,0,0.04,1.00000,1,1,0
BP,GO:0009648,photoperiodism,33,0,0.05,1.00000,1,1,0
BP,GO:0009649,entrainment of circadian clock,34,0,0.05,1.00000,1,1,0
BP,GO:0009651,response to salt stress,34,0,0.05,1.00000,1,1,0
BP,GO:0009713,catechol-containing compound biosyntheti...,21,0,0.03,1.00000,1,1,0
BP,GO:0009743,response to carbohydrate,276,0,0.4,1.00000,1,1,0
BP,GO:0009746,response to hexose,241,0,0.35,1.00000,1,1,0
BP,GO:0009749,response to glucose,233,0,0.33,1.00000,1,1,0
BP,GO:0009798,axis specification,90,0,0.13,1.00000,1,1,0
BP,GO:0009799,specification of symmetry,138,0,0.2,1.00000,1,1,0
BP,GO:0009855,determination of bilateral symmetry,137,0,0.2,1.00000,1,1,0
BP,GO:0009880,embryonic pattern specification,68,0,0.1,1.00000,1,1,0
BP,GO:0009913,epidermal cell differentiation,223,0,0.32,1.00000,1,1,0
BP,GO:0009914,hormone transport,338,0,0.49,1.00000,1,1,0
BP,GO:0009948,anterior/posterior axis specification,54,0,0.08,1.00000,1,1,0
BP,GO:0009953,dorsal/ventral pattern formation,89,0,0.13,1.00000,1,1,0
BP,GO:0009954,proximal/distal pattern formation,42,0,0.06,1.00000,1,1,0
BP,GO:0009994,oocyte differentiation,53,0,0.08,1.00000,1,1,0
BP,GO:0010002,cardioblast differentiation,23,0,0.03,1.00000,1,1,0
BP,GO:0010039,response to iron ion,34,0,0.05,1.00000,1,1,0
BP,GO:0010042,response to manganese ion,21,0,0.03,1.00000,1,1,0
BP,GO:0010043,response to zinc ion,58,0,0.08,1.00000,1,1,0
BP,GO:0010092,specification of animal organ identity,36,0,0.05,1.00000,1,1,0
BP,GO:0010155,regulation of proton transport,26,0,0.04,1.00000,1,1,0
BP,GO:0010165,response to X-ray,33,0,0.05,1.00000,1,1,0
BP,GO:0010171,body morphogenesis,46,0,0.07,1.00000,1,1,0
BP,GO:0010226,response to lithium ion,26,0,0.04,1.00000,1,1,0
BP,GO:0010232,vascular transport,97,0,0.14,1.00000,1,1,0
BP,GO:0010256,endomembrane system organization,582,0,0.84,1.00000,1,1,0
BP,GO:0010257,"NADH dehydrogenase complex assembly",72,0,0.1,1.00000,1,1,0
BP,GO:0010259,multicellular organism aging,35,0,0.05,1.00000,1,1,0
BP,GO:0010310,regulation of hydrogen peroxide metaboli...,25,0,0.04,1.00000,1,1,0
BP,GO:0010324,membrane invagination,141,0,0.2,1.00000,1,1,0
BP,GO:0010389,regulation of G2/M transition of mitotic...,106,0,0.15,1.00000,1,1,0
BP,GO:0010390,histone monoubiquitination,36,0,0.05,1.00000,1,1,0
BP,GO:0010447,response to acidic pH,26,0,0.04,1.00000,1,1,0
BP,GO:0010453,regulation of cell fate commitment,30,0,0.04,1.00000,1,1,0
BP,GO:0010458,exit from mitosis,31,0,0.04,1.00000,1,1,0
BP,GO:0010460,positive regulation of heart rate,29,0,0.04,1.00000,1,1,0
BP,GO:0010463,mesenchymal cell proliferation,40,0,0.06,1.00000,1,1,0
BP,GO:0010464,regulation of mesenchymal cell prolifera...,28,0,0.04,1.00000,1,1,0
BP,GO:0010498,proteasomal protein catabolic process,554,0,0.8,1.00000,1,1,0
BP,GO:0010507,negative regulation of autophagy,103,0,0.15,1.00000,1,1,0
BP,GO:0010508,positive regulation of autophagy,135,0,0.19,1.00000,1,1,0
BP,GO:0010517,regulation of phospholipase activity,69,0,0.1,1.00000,1,1,0
BP,GO:0010518,positive regulation of phospholipase act...,58,0,0.08,1.00000,1,1,0
BP,GO:0010522,regulation of calcium ion transport into...,104,0,0.15,1.00000,1,1,0
BP,GO:0010523,negative regulation of calcium ion trans...,20,0,0.03,1.00000,1,1,0
BP,GO:0010524,positive regulation of calcium ion trans...,54,0,0.08,1.00000,1,1,0
BP,GO:0010528,regulation of transposition,29,0,0.04,1.00000,1,1,0
BP,GO:0010529,negative regulation of transposition,29,0,0.04,1.00000,1,1,0
BP,GO:0010543,regulation of platelet activation,50,0,0.07,1.00000,1,1,0
BP,GO:0010560,positive regulation of glycoprotein bios...,25,0,0.04,1.00000,1,1,0
BP,GO:0010565,regulation of cellular ketone metabolic ...,136,0,0.2,1.00000,1,1,0
BP,GO:0010569,regulation of double-strand break repair...,49,0,0.07,1.00000,1,1,0
BP,GO:0010573,vascular endothelial growth factor produ...,70,0,0.1,1.00000,1,1,0
BP,GO:0010574,regulation of vascular endothelial growt...,59,0,0.08,1.00000,1,1,0
BP,GO:0010575,positive regulation of vascular endothel...,29,0,0.04,1.00000,1,1,0
BP,GO:0010591,regulation of lamellipodium assembly,45,0,0.06,1.00000,1,1,0
BP,GO:0010592,positive regulation of lamellipodium ass...,32,0,0.05,1.00000,1,1,0
BP,GO:0010596,negative regulation of endothelial cell ...,111,0,0.16,1.00000,1,1,0
BP,GO:0010611,regulation of cardiac muscle hypertrophy,77,0,0.11,1.00000,1,1,0
BP,GO:0010613,positive regulation of cardiac muscle hy...,45,0,0.06,1.00000,1,1,0
BP,GO:0010614,negative regulation of cardiac muscle hy...,35,0,0.05,1.00000,1,1,0
BP,GO:0010633,negative regulation of epithelial cell m...,127,0,0.18,1.00000,1,1,0
BP,GO:0010640,regulation of platelet-derived growth fa...,23,0,0.03,1.00000,1,1,0
BP,GO:0010644,cell communication by electrical couplin...,34,0,0.05,1.00000,1,1,0
BP,GO:0010656,negative regulation of muscle cell apopt...,64,0,0.09,1.00000,1,1,0
BP,GO:0010657,muscle cell apoptotic process,103,0,0.15,1.00000,1,1,0
BP,GO:0010658,striated muscle cell apoptotic process,69,0,0.1,1.00000,1,1,0
BP,GO:0010659,cardiac muscle cell apoptotic process,67,0,0.1,1.00000,1,1,0
BP,GO:0010660,regulation of muscle cell apoptotic proc...,98,0,0.14,1.00000,1,1,0
BP,GO:0010661,positive regulation of muscle cell apopt...,35,0,0.05,1.00000,1,1,0
BP,GO:0010662,regulation of striated muscle cell apopt...,65,0,0.09,1.00000,1,1,0
BP,GO:0010664,negative regulation of striated muscle c...,47,0,0.07,1.00000,1,1,0
BP,GO:0010665,regulation of cardiac muscle cell apopto...,63,0,0.09,1.00000,1,1,0
BP,GO:0010667,negative regulation of cardiac muscle ce...,44,0,0.06,1.00000,1,1,0
BP,GO:0010669,epithelial structure maintenance,42,0,0.06,1.00000,1,1,0
BP,GO:0010675,regulation of cellular carbohydrate meta...,151,0,0.22,1.00000,1,1,0
BP,GO:0010676,positive regulation of cellular carbohyd...,55,0,0.08,1.00000,1,1,0
BP,GO:0010677,negative regulation of cellular carbohyd...,43,0,0.06,1.00000,1,1,0
BP,GO:0010712,regulation of collagen metabolic process,48,0,0.07,1.00000,1,1,0
BP,GO:0010714,positive regulation of collagen metaboli...,29,0,0.04,1.00000,1,1,0
BP,GO:0010715,regulation of extracellular matrix disas...,23,0,0.03,1.00000,1,1,0
BP,GO:0010717,regulation of epithelial to mesenchymal ...,105,0,0.15,1.00000,1,1,0
BP,GO:0010718,positive regulation of epithelial to mes...,53,0,0.08,1.00000,1,1,0
BP,GO:0010719,negative regulation of epithelial to mes...,40,0,0.06,1.00000,1,1,0
BP,GO:0010737,protein kinase A signaling,36,0,0.05,1.00000,1,1,0
BP,GO:0010738,regulation of protein kinase A signaling,21,0,0.03,1.00000,1,1,0
BP,GO:0010742,macrophage derived foam cell differentia...,39,0,0.06,1.00000,1,1,0
BP,GO:0010743,regulation of macrophage derived foam ce...,33,0,0.05,1.00000,1,1,0
BP,GO:0010744,positive regulation of macrophage derive...,20,0,0.03,1.00000,1,1,0
BP,GO:0010758,regulation of macrophage chemotaxis,31,0,0.04,1.00000,1,1,0
BP,GO:0010759,positive regulation of macrophage chemot...,20,0,0.03,1.00000,1,1,0
BP,GO:0010761,fibroblast migration,50,0,0.07,1.00000,1,1,0
BP,GO:0010762,regulation of fibroblast migration,39,0,0.06,1.00000,1,1,0
BP,GO:0010765,positive regulation of sodium ion transp...,38,0,0.05,1.00000,1,1,0
BP,GO:0010766,negative regulation of sodium ion transp...,21,0,0.03,1.00000,1,1,0
BP,GO:0010801,negative regulation of peptidyl-threonin...,21,0,0.03,1.00000,1,1,0
BP,GO:0010803,regulation of tumor necrosis factor-medi...,56,0,0.08,1.00000,1,1,0
BP,GO:0010804,negative regulation of tumor necrosis fa...,24,0,0.03,1.00000,1,1,0
BP,GO:0010812,negative regulation of cell-substrate ad...,75,0,0.11,1.00000,1,1,0
BP,GO:0010817,regulation of hormone levels,566,0,0.81,1.00000,1,1,0
BP,GO:0010818,T cell chemotaxis,34,0,0.05,1.00000,1,1,0
BP,GO:0010821,regulation of mitochondrion organization,164,0,0.24,1.00000,1,1,0
BP,GO:0010822,positive regulation of mitochondrion org...,79,0,0.11,1.00000,1,1,0
BP,GO:0010823,negative regulation of mitochondrion org...,59,0,0.08,1.00000,1,1,0
BP,GO:0010824,regulation of centrosome duplication,48,0,0.07,1.00000,1,1,0
BP,GO:0010827,regulation of glucose transmembrane tran...,87,0,0.13,1.00000,1,1,0
BP,GO:0010828,positive regulation of glucose transmemb...,49,0,0.07,1.00000,1,1,0
BP,GO:0010829,negative regulation of glucose transmemb...,26,0,0.04,1.00000,1,1,0
BP,GO:0010830,regulation of myotube differentiation,47,0,0.07,1.00000,1,1,0
BP,GO:0010833,telomere maintenance via telomere length...,88,0,0.13,1.00000,1,1,0
BP,GO:0010837,regulation of keratinocyte proliferation,37,0,0.05,1.00000,1,1,0
BP,GO:0010842,retina layer formation,36,0,0.05,1.00000,1,1,0
BP,GO:0010862,positive regulation of pathway-restricte...,55,0,0.08,1.00000,1,1,0
BP,GO:0010863,positive regulation of phospholipase C a...,41,0,0.06,1.00000,1,1,0
BP,GO:0010866,regulation of triglyceride biosynthetic ...,23,0,0.03,1.00000,1,1,0
BP,GO:0010874,regulation of cholesterol efflux,55,0,0.08,1.00000,1,1,0
BP,GO:0010875,positive regulation of cholesterol efflu...,28,0,0.04,1.00000,1,1,0
BP,GO:0010876,lipid localization,491,0,0.71,1.00000,1,1,0
BP,GO:0010878,cholesterol storage,22,0,0.03,1.00000,1,1,0
BP,GO:0010880,regulation of release of sequestered cal...,32,0,0.05,1.00000,1,1,0
BP,GO:0010881,regulation of cardiac muscle contraction...,24,0,0.03,1.00000,1,1,0
BP,GO:0010882,regulation of cardiac muscle contraction...,29,0,0.04,1.00000,1,1,0
BP,GO:0010883,regulation of lipid storage,67,0,0.1,1.00000,1,1,0
BP,GO:0010884,positive regulation of lipid storage,30,0,0.04,1.00000,1,1,0
BP,GO:0010885,regulation of cholesterol storage,20,0,0.03,1.00000,1,1,0
BP,GO:0010888,negative regulation of lipid storage,31,0,0.04,1.00000,1,1,0
BP,GO:0010893,positive regulation of steroid biosynthe...,27,0,0.04,1.00000,1,1,0
BP,GO:0010894,negative regulation of steroid biosynthe...,27,0,0.04,1.00000,1,1,0
BP,GO:0010906,regulation of glucose metabolic process,124,0,0.18,1.00000,1,1,0
BP,GO:0010907,positive regulation of glucose metabolic...,41,0,0.06,1.00000,1,1,0
BP,GO:0010921,regulation of phosphatase activity,107,0,0.15,1.00000,1,1,0
BP,GO:0010922,positive regulation of phosphatase activ...,37,0,0.05,1.00000,1,1,0
BP,GO:0010923,negative regulation of phosphatase activ...,51,0,0.07,1.00000,1,1,0
BP,GO:0010927,cellular component assembly involved in ...,111,0,0.16,1.00000,1,1,0
BP,GO:0010934,macrophage cytokine production,29,0,0.04,1.00000,1,1,0
BP,GO:0010935,regulation of macrophage cytokine produc...,29,0,0.04,1.00000,1,1,0
BP,GO:0010939,regulation of necrotic cell death,43,0,0.06,1.00000,1,1,0
BP,GO:0010954,positive regulation of protein processin...,26,0,0.04,1.00000,1,1,0
BP,GO:0010955,negative regulation of protein processin...,40,0,0.06,1.00000,1,1,0
BP,GO:0010962,regulation of glucan biosynthetic proces...,30,0,0.04,1.00000,1,1,0
BP,GO:0010965,regulation of mitotic sister chromatid s...,65,0,0.09,1.00000,1,1,0
BP,GO:0010971,positive regulation of G2/M transition o...,28,0,0.04,1.00000,1,1,0
BP,GO:0010972,negative regulation of G2/M transition o...,71,0,0.1,1.00000,1,1,0
BP,GO:0010977,negative regulation of neuron projection...,144,0,0.21,1.00000,1,1,0
BP,GO:0010984,regulation of lipoprotein particle clear...,34,0,0.05,1.00000,1,1,0
BP,GO:0010988,regulation of low-density lipoprotein pa...,22,0,0.03,1.00000,1,1,0
BP,GO:0010996,response to auditory stimulus,27,0,0.04,1.00000,1,1,0
BP,GO:0014002,astrocyte development,60,0,0.09,1.00000,1,1,0
BP,GO:0014003,oligodendrocyte development,44,0,0.06,1.00000,1,1,0
BP,GO:0014009,glial cell proliferation,65,0,0.09,1.00000,1,1,0
BP,GO:0014013,regulation of gliogenesis,119,0,0.17,1.00000,1,1,0
BP,GO:0014014,negative regulation of gliogenesis,46,0,0.07,1.00000,1,1,0
BP,GO:0014015,positive regulation of gliogenesis,79,0,0.11,1.00000,1,1,0
BP,GO:0014020,primary neural tube formation,104,0,0.15,1.00000,1,1,0
BP,GO:0014031,mesenchymal cell development,87,0,0.13,1.00000,1,1,0
BP,GO:0014032,neural crest cell development,82,0,0.12,1.00000,1,1,0
BP,GO:0014033,neural crest cell differentiation,93,0,0.13,1.00000,1,1,0
BP,GO:0014037,Schwann cell differentiation,42,0,0.06,1.00000,1,1,0
BP,GO:0014044,Schwann cell development,34,0,0.05,1.00000,1,1,0
BP,GO:0014046,dopamine secretion,37,0,0.05,1.00000,1,1,0
BP,GO:0014047,glutamate secretion,21,0,0.03,1.00000,1,1,0
BP,GO:0014059,regulation of dopamine secretion,37,0,0.05,1.00000,1,1,0
BP,GO:0014067,negative regulation of phosphatidylinosi...,20,0,0.03,1.00000,1,1,0
BP,GO:0014072,response to isoquinoline alkaloid,40,0,0.06,1.00000,1,1,0
BP,GO:0014706,striated muscle tissue development,412,0,0.59,1.00000,1,1,0
BP,GO:0014741,negative regulation of muscle hypertroph...,37,0,0.05,1.00000,1,1,0
BP,GO:0014742,positive regulation of muscle hypertroph...,46,0,0.07,1.00000,1,1,0
BP,GO:0014743,regulation of muscle hypertrophy,80,0,0.11,1.00000,1,1,0
BP,GO:0014744,positive regulation of muscle adaptation,20,0,0.03,1.00000,1,1,0
BP,GO:0014808,release of sequestered calcium ion into ...,38,0,0.05,1.00000,1,1,0
BP,GO:0014812,muscle cell migration,122,0,0.18,1.00000,1,1,0
BP,GO:0014829,vascular associated smooth muscle contra...,26,0,0.04,1.00000,1,1,0
BP,GO:0014850,response to muscle activity,28,0,0.04,1.00000,1,1,0
BP,GO:0014855,striated muscle cell proliferation,78,0,0.11,1.00000,1,1,0
BP,GO:0014887,cardiac muscle adaptation,30,0,0.04,1.00000,1,1,0
BP,GO:0014896,muscle hypertrophy,114,0,0.16,1.00000,1,1,0
BP,GO:0014897,striated muscle hypertrophy,112,0,0.16,1.00000,1,1,0
BP,GO:0014898,cardiac muscle hypertrophy in response t...,30,0,0.04,1.00000,1,1,0
BP,GO:0014902,myotube differentiation,127,0,0.18,1.00000,1,1,0
BP,GO:0014904,myotube cell development,38,0,0.05,1.00000,1,1,0
BP,GO:0014909,smooth muscle cell migration,109,0,0.16,1.00000,1,1,0
BP,GO:0014910,regulation of smooth muscle cell migrati...,95,0,0.14,1.00000,1,1,0
BP,GO:0014911,positive regulation of smooth muscle cel...,53,0,0.08,1.00000,1,1,0
BP,GO:0014912,negative regulation of smooth muscle cel...,47,0,0.07,1.00000,1,1,0
BP,GO:0015012,heparan sulfate proteoglycan biosyntheti...,27,0,0.04,1.00000,1,1,0
BP,GO:0015669,gas transport,20,0,0.03,1.00000,1,1,0
BP,GO:0015695,organic cation transport,44,0,0.06,1.00000,1,1,0
BP,GO:0015697,quaternary ammonium group transport,22,0,0.03,1.00000,1,1,0
BP,GO:0015698,inorganic anion transport,196,0,0.28,1.00000,1,1,0
BP,GO:0015701,bicarbonate transport,29,0,0.04,1.00000,1,1,0
BP,GO:0015711,organic anion transport,377,0,0.54,1.00000,1,1,0
BP,GO:0015718,monocarboxylic acid transport,118,0,0.17,1.00000,1,1,0
BP,GO:0015721,bile acid and bile salt transport,32,0,0.05,1.00000,1,1,0
BP,GO:0015740,C4-dicarboxylate transport,28,0,0.04,1.00000,1,1,0
BP,GO:0015748,organophosphate ester transport,157,0,0.23,1.00000,1,1,0
BP,GO:0015749,monosaccharide transmembrane transport,132,0,0.19,1.00000,1,1,0
BP,GO:0015800,acidic amino acid transport,58,0,0.08,1.00000,1,1,0
BP,GO:0015802,basic amino acid transport,20,0,0.03,1.00000,1,1,0
BP,GO:0015804,neutral amino acid transport,49,0,0.07,1.00000,1,1,0
BP,GO:0015807,L-amino acid transport,70,0,0.1,1.00000,1,1,0
BP,GO:0015813,L-glutamate transmembrane transport,28,0,0.04,1.00000,1,1,0
BP,GO:0015833,peptide transport,310,0,0.45,1.00000,1,1,0
BP,GO:0015837,amine transport,103,0,0.15,1.00000,1,1,0
BP,GO:0015844,monoamine transport,94,0,0.14,1.00000,1,1,0
BP,GO:0015849,organic acid transport,315,0,0.45,1.00000,1,1,0
BP,GO:0015850,organic hydroxy compound transport,315,0,0.45,1.00000,1,1,0
BP,GO:0015865,purine nucleotide transport,32,0,0.05,1.00000,1,1,0
BP,GO:0015868,purine ribonucleotide transport,31,0,0.04,1.00000,1,1,0
BP,GO:0015872,dopamine transport,54,0,0.08,1.00000,1,1,0
BP,GO:0015874,norepinephrine transport,26,0,0.04,1.00000,1,1,0
BP,GO:0015908,fatty acid transport,90,0,0.13,1.00000,1,1,0
BP,GO:0015909,long-chain fatty acid transport,68,0,0.1,1.00000,1,1,0
BP,GO:0015914,phospholipid transport,103,0,0.15,1.00000,1,1,0
BP,GO:0015918,sterol transport,141,0,0.2,1.00000,1,1,0
BP,GO:0015919,peroxisomal membrane transport,21,0,0.03,1.00000,1,1,0
BP,GO:0015931,nucleobase-containing compound transport,245,0,0.35,1.00000,1,1,0
BP,GO:0015936,coenzyme A metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0015980,energy derivation by oxidation of organi...,339,0,0.49,1.00000,1,1,0
BP,GO:0015985,"energy coupled proton transport, down el...",25,0,0.04,1.00000,1,1,0
BP,GO:0015986,ATP synthesis coupled proton transport,25,0,0.04,1.00000,1,1,0
BP,GO:0016024,CDP-diacylglycerol biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0016032,viral process,495,0,0.71,1.00000,1,1,0
BP,GO:0016042,lipid catabolic process,354,0,0.51,1.00000,1,1,0
BP,GO:0016045,detection of bacterium,36,0,0.05,1.00000,1,1,0
BP,GO:0016048,detection of temperature stimulus,24,0,0.03,1.00000,1,1,0
BP,GO:0016050,vesicle organization,311,0,0.45,1.00000,1,1,0
BP,GO:0016051,carbohydrate biosynthetic process,215,0,0.31,1.00000,1,1,0
BP,GO:0016052,carbohydrate catabolic process,168,0,0.24,1.00000,1,1,0
BP,GO:0016053,organic acid biosynthetic process,339,0,0.49,1.00000,1,1,0
BP,GO:0016055,Wnt signaling pathway,468,0,0.67,1.00000,1,1,0
BP,GO:0016073,snRNA metabolic process,48,0,0.07,1.00000,1,1,0
BP,GO:0016075,rRNA catabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0016079,synaptic vesicle exocytosis,108,0,0.16,1.00000,1,1,0
BP,GO:0016101,diterpenoid metabolic process,104,0,0.15,1.00000,1,1,0
BP,GO:0016125,sterol metabolic process,169,0,0.24,1.00000,1,1,0
BP,GO:0016126,sterol biosynthetic process,67,0,0.1,1.00000,1,1,0
BP,GO:0016137,glycoside metabolic process,23,0,0.03,1.00000,1,1,0
BP,GO:0016180,snRNA processing,37,0,0.05,1.00000,1,1,0
BP,GO:0016197,endosomal transport,251,0,0.36,1.00000,1,1,0
BP,GO:0016202,regulation of striated muscle tissue dev...,46,0,0.07,1.00000,1,1,0
BP,GO:0016226,iron-sulfur cluster assembly,26,0,0.04,1.00000,1,1,0
BP,GO:0016236,macroautophagy,323,0,0.46,1.00000,1,1,0
BP,GO:0016239,positive regulation of macroautophagy,67,0,0.1,1.00000,1,1,0
BP,GO:0016241,regulation of macroautophagy,161,0,0.23,1.00000,1,1,0
BP,GO:0016242,negative regulation of macroautophagy,42,0,0.06,1.00000,1,1,0
BP,GO:0016266,O-glycan processing,45,0,0.06,1.00000,1,1,0
BP,GO:0016331,morphogenesis of embryonic epithelium,161,0,0.23,1.00000,1,1,0
BP,GO:0016338,calcium-independent cell-cell adhesion v...,25,0,0.04,1.00000,1,1,0
BP,GO:0016339,calcium-dependent cell-cell adhesion via...,43,0,0.06,1.00000,1,1,0
BP,GO:0016486,peptide hormone processing,26,0,0.04,1.00000,1,1,0
BP,GO:0016540,protein autoprocessing,25,0,0.04,1.00000,1,1,0
BP,GO:0016553,base conversion or substitution editing,21,0,0.03,1.00000,1,1,0
BP,GO:0016556,mRNA modification,27,0,0.04,1.00000,1,1,0
BP,GO:0016572,histone phosphorylation,39,0,0.06,1.00000,1,1,0
BP,GO:0016573,histone acetylation,160,0,0.23,1.00000,1,1,0
BP,GO:0016574,histone ubiquitination,55,0,0.08,1.00000,1,1,0
BP,GO:0016575,histone deacetylation,84,0,0.12,1.00000,1,1,0
BP,GO:0016577,histone demethylation,31,0,0.04,1.00000,1,1,0
BP,GO:0016578,histone deubiquitination,24,0,0.03,1.00000,1,1,0
BP,GO:0016579,protein deubiquitination,144,0,0.21,1.00000,1,1,0
BP,GO:0016601,Rac protein signal transduction,52,0,0.07,1.00000,1,1,0
BP,GO:0016925,protein sumoylation,58,0,0.08,1.00000,1,1,0
BP,GO:0016973,poly(A)+ mRNA export from nucleus,23,0,0.03,1.00000,1,1,0
BP,GO:0017004,cytochrome complex assembly,37,0,0.05,1.00000,1,1,0
BP,GO:0017015,regulation of transforming growth factor...,135,0,0.19,1.00000,1,1,0
BP,GO:0017038,protein import,217,0,0.31,1.00000,1,1,0
BP,GO:0017121,plasma membrane phospholipid scrambling,23,0,0.03,1.00000,1,1,0
BP,GO:0017145,stem cell division,30,0,0.04,1.00000,1,1,0
BP,GO:0017156,calcium-ion regulated exocytosis,67,0,0.1,1.00000,1,1,0
BP,GO:0017157,regulation of exocytosis,216,0,0.31,1.00000,1,1,0
BP,GO:0017158,regulation of calcium ion-dependent exoc...,42,0,0.06,1.00000,1,1,0
BP,GO:0018027,peptidyl-lysine dimethylation,33,0,0.05,1.00000,1,1,0
BP,GO:0018126,protein hydroxylation,27,0,0.04,1.00000,1,1,0
BP,GO:0018149,peptide cross-linking,37,0,0.05,1.00000,1,1,0
BP,GO:0018195,peptidyl-arginine modification,31,0,0.04,1.00000,1,1,0
BP,GO:0018196,peptidyl-asparagine modification,25,0,0.04,1.00000,1,1,0
BP,GO:0018198,peptidyl-cysteine modification,50,0,0.07,1.00000,1,1,0
BP,GO:0018200,peptidyl-glutamic acid modification,33,0,0.05,1.00000,1,1,0
BP,GO:0018208,peptidyl-proline modification,59,0,0.08,1.00000,1,1,0
BP,GO:0018230,peptidyl-L-cysteine S-palmitoylation,24,0,0.03,1.00000,1,1,0
BP,GO:0018231,peptidyl-S-diacylglycerol-L-cysteine bio...,24,0,0.03,1.00000,1,1,0
BP,GO:0018279,protein N-linked glycosylation via aspar...,24,0,0.03,1.00000,1,1,0
BP,GO:0018345,protein palmitoylation,34,0,0.05,1.00000,1,1,0
BP,GO:0018393,internal peptidyl-lysine acetylation,178,0,0.26,1.00000,1,1,0
BP,GO:0018394,peptidyl-lysine acetylation,189,0,0.27,1.00000,1,1,0
BP,GO:0018904,ether metabolic process,29,0,0.04,1.00000,1,1,0
BP,GO:0019058,viral life cycle,390,0,0.56,1.00000,1,1,0
BP,GO:0019068,virion assembly,37,0,0.05,1.00000,1,1,0
BP,GO:0019076,viral release from host cell,56,0,0.08,1.00000,1,1,0
BP,GO:0019079,viral genome replication,143,0,0.21,1.00000,1,1,0
BP,GO:0019080,viral gene expression,118,0,0.17,1.00000,1,1,0
BP,GO:0019082,viral protein processing,32,0,0.05,1.00000,1,1,0
BP,GO:0019083,viral transcription,70,0,0.1,1.00000,1,1,0
BP,GO:0019098,reproductive behavior,29,0,0.04,1.00000,1,1,0
BP,GO:0019217,regulation of fatty acid metabolic proce...,94,0,0.14,1.00000,1,1,0
BP,GO:0019218,regulation of steroid metabolic process,110,0,0.16,1.00000,1,1,0
BP,GO:0019221,cytokine-mediated signaling pathway,570,0,0.82,1.00000,1,1,0
BP,GO:0019226,transmission of nerve impulse,71,0,0.1,1.00000,1,1,0
BP,GO:0019228,neuronal action potential,33,0,0.05,1.00000,1,1,0
BP,GO:0019229,regulation of vasoconstriction,66,0,0.09,1.00000,1,1,0
BP,GO:0019318,hexose metabolic process,254,0,0.37,1.00000,1,1,0
BP,GO:0019319,hexose biosynthetic process,84,0,0.12,1.00000,1,1,0
BP,GO:0019320,hexose catabolic process,34,0,0.05,1.00000,1,1,0
BP,GO:0019359,nicotinamide nucleotide biosynthetic pro...,31,0,0.04,1.00000,1,1,0
BP,GO:0019362,pyridine nucleotide metabolic process,35,0,0.05,1.00000,1,1,0
BP,GO:0019363,pyridine nucleotide biosynthetic process,31,0,0.04,1.00000,1,1,0
BP,GO:0019369,arachidonic acid metabolic process,65,0,0.09,1.00000,1,1,0
BP,GO:0019370,leukotriene biosynthetic process,24,0,0.03,1.00000,1,1,0
BP,GO:0019377,glycolipid catabolic process,25,0,0.04,1.00000,1,1,0
BP,GO:0019395,fatty acid oxidation,108,0,0.16,1.00000,1,1,0
BP,GO:0019400,alditol metabolic process,23,0,0.03,1.00000,1,1,0
BP,GO:0019430,removal of superoxide radicals,24,0,0.03,1.00000,1,1,0
BP,GO:0019432,triglyceride biosynthetic process,45,0,0.06,1.00000,1,1,0
BP,GO:0019433,triglyceride catabolic process,29,0,0.04,1.00000,1,1,0
BP,GO:0019585,glucuronate metabolic process,24,0,0.03,1.00000,1,1,0
BP,GO:0019646,aerobic electron transport chain,102,0,0.15,1.00000,1,1,0
BP,GO:0019674,"NAD metabolic process",32,0,0.05,1.00000,1,1,0
BP,GO:0019692,deoxyribose phosphate metabolic process,42,0,0.06,1.00000,1,1,0
BP,GO:0019730,antimicrobial humoral response,152,0,0.22,1.00000,1,1,0
BP,GO:0019731,antibacterial humoral response,81,0,0.12,1.00000,1,1,0
BP,GO:0019748,secondary metabolic process,70,0,0.1,1.00000,1,1,0
BP,GO:0019751,polyol metabolic process,118,0,0.17,1.00000,1,1,0
BP,GO:0019827,stem cell population maintenance,151,0,0.22,1.00000,1,1,0
BP,GO:0019835,cytolysis,44,0,0.06,1.00000,1,1,0
BP,GO:0019882,antigen processing and presentation,256,0,0.37,1.00000,1,1,0
BP,GO:0019883,antigen processing and presentation of e...,93,0,0.13,1.00000,1,1,0
BP,GO:0019884,antigen processing and presentation of e...,156,0,0.22,1.00000,1,1,0
BP,GO:0019885,antigen processing and presentation of e...,72,0,0.1,1.00000,1,1,0
BP,GO:0019886,antigen processing and presentation of e...,111,0,0.16,1.00000,1,1,0
BP,GO:0019896,axonal transport of mitochondrion,20,0,0.03,1.00000,1,1,0
BP,GO:0019915,lipid storage,100,0,0.14,1.00000,1,1,0
BP,GO:0019933,cAMP-mediated signaling,66,0,0.09,1.00000,1,1,0
BP,GO:0019934,cGMP-mediated signaling,32,0,0.05,1.00000,1,1,0
BP,GO:0019935,cyclic-nucleotide-mediated signaling,94,0,0.14,1.00000,1,1,0
BP,GO:0019985,translesion synthesis,21,0,0.03,1.00000,1,1,0
BP,GO:0021515,cell differentiation in spinal cord,51,0,0.07,1.00000,1,1,0
BP,GO:0021516,dorsal spinal cord development,21,0,0.03,1.00000,1,1,0
BP,GO:0021522,spinal cord motor neuron differentiation,30,0,0.04,1.00000,1,1,0
BP,GO:0021532,neural tube patterning,38,0,0.05,1.00000,1,1,0
BP,GO:0021533,cell differentiation in hindbrain,22,0,0.03,1.00000,1,1,0
BP,GO:0021536,diencephalon development,80,0,0.11,1.00000,1,1,0
BP,GO:0021542,dentate gyrus development,22,0,0.03,1.00000,1,1,0
BP,GO:0021544,subpallium development,24,0,0.03,1.00000,1,1,0
BP,GO:0021549,cerebellum development,108,0,0.16,1.00000,1,1,0
BP,GO:0021575,hindbrain morphogenesis,46,0,0.07,1.00000,1,1,0
BP,GO:0021587,cerebellum morphogenesis,42,0,0.06,1.00000,1,1,0
BP,GO:0021591,ventricular system development,39,0,0.06,1.00000,1,1,0
BP,GO:0021680,cerebellar Purkinje cell layer developme...,29,0,0.04,1.00000,1,1,0
BP,GO:0021692,cerebellar Purkinje cell layer morphogen...,20,0,0.03,1.00000,1,1,0
BP,GO:0021695,cerebellar cortex development,52,0,0.07,1.00000,1,1,0
BP,GO:0021696,cerebellar cortex morphogenesis,36,0,0.05,1.00000,1,1,0
BP,GO:0021697,cerebellar cortex formation,27,0,0.04,1.00000,1,1,0
BP,GO:0021762,substantia nigra development,48,0,0.07,1.00000,1,1,0
BP,GO:0021772,olfactory bulb development,29,0,0.04,1.00000,1,1,0
BP,GO:0021782,glial cell development,137,0,0.2,1.00000,1,1,0
BP,GO:0021846,cell proliferation in forebrain,25,0,0.04,1.00000,1,1,0
BP,GO:0021854,hypothalamus development,22,0,0.03,1.00000,1,1,0
BP,GO:0021871,forebrain regionalization,24,0,0.03,1.00000,1,1,0
BP,GO:0021872,forebrain generation of neurons,53,0,0.08,1.00000,1,1,0
BP,GO:0021879,forebrain neuron differentiation,44,0,0.06,1.00000,1,1,0
BP,GO:0021884,forebrain neuron development,23,0,0.03,1.00000,1,1,0
BP,GO:0021895,cerebral cortex neuron differentiation,23,0,0.03,1.00000,1,1,0
BP,GO:0021904,dorsal/ventral neural tube patterning,23,0,0.03,1.00000,1,1,0
BP,GO:0021915,neural tube development,164,0,0.24,1.00000,1,1,0
BP,GO:0021983,pituitary gland development,46,0,0.07,1.00000,1,1,0
BP,GO:0021988,olfactory lobe development,32,0,0.05,1.00000,1,1,0
BP,GO:0022010,central nervous system myelination,23,0,0.03,1.00000,1,1,0
BP,GO:0022011,myelination in peripheral nervous system,31,0,0.04,1.00000,1,1,0
BP,GO:0022037,metencephalon development,118,0,0.17,1.00000,1,1,0
BP,GO:0022401,negative adaptation of signaling pathway,25,0,0.04,1.00000,1,1,0
BP,GO:0022404,molting cycle process,91,0,0.13,1.00000,1,1,0
BP,GO:0022405,hair cycle process,91,0,0.13,1.00000,1,1,0
BP,GO:0022406,membrane docking,90,0,0.13,1.00000,1,1,0
BP,GO:0022409,positive regulation of cell-cell adhesio...,442,0,0.64,1.00000,1,1,0
BP,GO:0022410,circadian sleep/wake cycle process,24,0,0.03,1.00000,1,1,0
BP,GO:0022411,cellular component disassembly,486,0,0.7,1.00000,1,1,0
BP,GO:0022600,digestive system process,120,0,0.17,1.00000,1,1,0
BP,GO:0022602,ovulation cycle process,45,0,0.06,1.00000,1,1,0
BP,GO:0022612,gland morphogenesis,133,0,0.19,1.00000,1,1,0
BP,GO:0022616,DNA strand elongation,22,0,0.03,1.00000,1,1,0
BP,GO:0022617,extracellular matrix disassembly,80,0,0.11,1.00000,1,1,0
BP,GO:0022900,electron transport chain,192,0,0.28,1.00000,1,1,0
BP,GO:0022904,respiratory electron transport chain,130,0,0.19,1.00000,1,1,0
BP,GO:0023019,signal transduction involved in regulati...,21,0,0.03,1.00000,1,1,0
BP,GO:0023058,adaptation of signaling pathway,26,0,0.04,1.00000,1,1,0
BP,GO:0023061,signal release,509,0,0.73,1.00000,1,1,0
BP,GO:0030004,cellular monovalent inorganic cation hom...,107,0,0.15,1.00000,1,1,0
BP,GO:0030010,establishment of cell polarity,150,0,0.22,1.00000,1,1,0
BP,GO:0030031,cell projection assembly,577,0,0.83,1.00000,1,1,0
BP,GO:0030032,lamellipodium assembly,77,0,0.11,1.00000,1,1,0
BP,GO:0030038,contractile actin filament bundle assemb...,115,0,0.17,1.00000,1,1,0
BP,GO:0030042,actin filament depolymerization,61,0,0.09,1.00000,1,1,0
BP,GO:0030071,regulation of mitotic metaphase/anaphase...,60,0,0.09,1.00000,1,1,0
BP,GO:0030072,peptide hormone secretion,263,0,0.38,1.00000,1,1,0
BP,GO:0030073,insulin secretion,217,0,0.31,1.00000,1,1,0
BP,GO:0030100,regulation of endocytosis,235,0,0.34,1.00000,1,1,0
BP,GO:0030101,natural killer cell activation,144,0,0.21,1.00000,1,1,0
BP,GO:0030104,water homeostasis,68,0,0.1,1.00000,1,1,0
BP,GO:0030111,regulation of Wnt signaling pathway,341,0,0.49,1.00000,1,1,0
BP,GO:0030148,sphingolipid biosynthetic process,112,0,0.16,1.00000,1,1,0
BP,GO:0030149,sphingolipid catabolic process,40,0,0.06,1.00000,1,1,0
BP,GO:0030150,protein import into mitochondrial matrix,21,0,0.03,1.00000,1,1,0
BP,GO:0030166,proteoglycan biosynthetic process,59,0,0.08,1.00000,1,1,0
BP,GO:0030168,platelet activation,142,0,0.2,1.00000,1,1,0
BP,GO:0030177,positive regulation of Wnt signaling pat...,145,0,0.21,1.00000,1,1,0
BP,GO:0030178,negative regulation of Wnt signaling pat...,178,0,0.26,1.00000,1,1,0
BP,GO:0030193,regulation of blood coagulation,67,0,0.1,1.00000,1,1,0
BP,GO:0030194,positive regulation of blood coagulation,24,0,0.03,1.00000,1,1,0
BP,GO:0030195,negative regulation of blood coagulation,50,0,0.07,1.00000,1,1,0
BP,GO:0030198,extracellular matrix organization,350,0,0.5,1.00000,1,1,0
BP,GO:0030199,collagen fibril organization,78,0,0.11,1.00000,1,1,0
BP,GO:0030201,heparan sulfate proteoglycan metabolic p...,33,0,0.05,1.00000,1,1,0
BP,GO:0030203,glycosaminoglycan metabolic process,124,0,0.18,1.00000,1,1,0
BP,GO:0030204,chondroitin sulfate metabolic process,32,0,0.05,1.00000,1,1,0
BP,GO:0030212,hyaluronan metabolic process,31,0,0.04,1.00000,1,1,0
BP,GO:0030216,keratinocyte differentiation,148,0,0.21,1.00000,1,1,0
BP,GO:0030219,megakaryocyte differentiation,64,0,0.09,1.00000,1,1,0
BP,GO:0030225,macrophage differentiation,56,0,0.08,1.00000,1,1,0
BP,GO:0030239,myofibril assembly,67,0,0.1,1.00000,1,1,0
BP,GO:0030258,lipid modification,239,0,0.34,1.00000,1,1,0
BP,GO:0030261,chromosome condensation,48,0,0.07,1.00000,1,1,0
BP,GO:0030262,apoptotic nuclear changes,30,0,0.04,1.00000,1,1,0
BP,GO:0030277,maintenance of gastrointestinal epitheli...,34,0,0.05,1.00000,1,1,0
BP,GO:0030278,regulation of ossification,121,0,0.17,1.00000,1,1,0
BP,GO:0030279,negative regulation of ossification,43,0,0.06,1.00000,1,1,0
BP,GO:0030282,bone mineralization,126,0,0.18,1.00000,1,1,0
BP,GO:0030301,cholesterol transport,128,0,0.18,1.00000,1,1,0
BP,GO:0030307,positive regulation of cell growth,191,0,0.27,1.00000,1,1,0
BP,GO:0030308,negative regulation of cell growth,213,0,0.31,1.00000,1,1,0
BP,GO:0030317,flagellated sperm motility,115,0,0.17,1.00000,1,1,0
BP,GO:0030318,melanocyte differentiation,26,0,0.04,1.00000,1,1,0
BP,GO:0030323,respiratory tube development,197,0,0.28,1.00000,1,1,0
BP,GO:0030324,lung development,193,0,0.28,1.00000,1,1,0
BP,GO:0030325,adrenal gland development,25,0,0.04,1.00000,1,1,0
BP,GO:0030326,embryonic limb morphogenesis,127,0,0.18,1.00000,1,1,0
BP,GO:0030336,negative regulation of cell migration,377,0,0.54,1.00000,1,1,0
BP,GO:0030433,ubiquitin-dependent ERAD pathway,100,0,0.14,1.00000,1,1,0
BP,GO:0030449,regulation of complement activation,21,0,0.03,1.00000,1,1,0
BP,GO:0030488,tRNA methylation,42,0,0.06,1.00000,1,1,0
BP,GO:0030490,maturation of SSU-rRNA,57,0,0.08,1.00000,1,1,0
BP,GO:0030500,regulation of bone mineralization,84,0,0.12,1.00000,1,1,0
BP,GO:0030501,positive regulation of bone mineralizati...,41,0,0.06,1.00000,1,1,0
BP,GO:0030502,negative regulation of bone mineralizati...,26,0,0.04,1.00000,1,1,0
BP,GO:0030509,BMP signaling pathway,157,0,0.23,1.00000,1,1,0
BP,GO:0030510,regulation of BMP signaling pathway,101,0,0.15,1.00000,1,1,0
BP,GO:0030511,positive regulation of transforming grow...,33,0,0.05,1.00000,1,1,0
BP,GO:0030512,negative regulation of transforming grow...,87,0,0.13,1.00000,1,1,0
BP,GO:0030513,positive regulation of BMP signaling pat...,39,0,0.06,1.00000,1,1,0
BP,GO:0030514,negative regulation of BMP signaling pat...,55,0,0.08,1.00000,1,1,0
BP,GO:0030517,negative regulation of axon extension,46,0,0.07,1.00000,1,1,0
BP,GO:0030520,intracellular estrogen receptor signalin...,59,0,0.08,1.00000,1,1,0
BP,GO:0030534,adult behavior,141,0,0.2,1.00000,1,1,0
BP,GO:0030539,male genitalia development,24,0,0.03,1.00000,1,1,0
BP,GO:0030574,collagen catabolic process,48,0,0.07,1.00000,1,1,0
BP,GO:0030593,neutrophil chemotaxis,118,0,0.17,1.00000,1,1,0
BP,GO:0030595,leukocyte chemotaxis,268,0,0.39,1.00000,1,1,0
BP,GO:0030641,regulation of cellular pH,84,0,0.12,1.00000,1,1,0
BP,GO:0030730,sequestering of triglyceride,26,0,0.04,1.00000,1,1,0
BP,GO:0030808,regulation of nucleotide biosynthetic pr...,43,0,0.06,1.00000,1,1,0
BP,GO:0030810,positive regulation of nucleotide biosyn...,23,0,0.03,1.00000,1,1,0
BP,GO:0030834,regulation of actin filament depolymeriz...,56,0,0.08,1.00000,1,1,0
BP,GO:0030835,negative regulation of actin filament de...,47,0,0.07,1.00000,1,1,0
BP,GO:0030837,negative regulation of actin filament po...,67,0,0.1,1.00000,1,1,0
BP,GO:0030850,prostate gland development,47,0,0.07,1.00000,1,1,0
BP,GO:0030851,granulocyte differentiation,35,0,0.05,1.00000,1,1,0
BP,GO:0030856,regulation of epithelial cell differenti...,172,0,0.25,1.00000,1,1,0
BP,GO:0030857,negative regulation of epithelial cell d...,57,0,0.08,1.00000,1,1,0
BP,GO:0030858,positive regulation of epithelial cell d...,65,0,0.09,1.00000,1,1,0
BP,GO:0030859,polarized epithelial cell differentiatio...,26,0,0.04,1.00000,1,1,0
BP,GO:0030878,thyroid gland development,24,0,0.03,1.00000,1,1,0
BP,GO:0030879,mammary gland development,154,0,0.22,1.00000,1,1,0
BP,GO:0030888,regulation of B cell proliferation,68,0,0.1,1.00000,1,1,0
BP,GO:0030889,negative regulation of B cell proliferat...,20,0,0.03,1.00000,1,1,0
BP,GO:0030890,positive regulation of B cell proliferat...,44,0,0.06,1.00000,1,1,0
BP,GO:0030901,midbrain development,99,0,0.14,1.00000,1,1,0
BP,GO:0030902,hindbrain development,163,0,0.23,1.00000,1,1,0
BP,GO:0030947,regulation of vascular endothelial growt...,33,0,0.05,1.00000,1,1,0
BP,GO:0030968,endoplasmic reticulum unfolded protein r...,79,0,0.11,1.00000,1,1,0
BP,GO:0030970,"retrograde protein transport, ER to cyto...",29,0,0.04,1.00000,1,1,0
BP,GO:0031016,pancreas development,79,0,0.11,1.00000,1,1,0
BP,GO:0031018,endocrine pancreas development,47,0,0.07,1.00000,1,1,0
BP,GO:0031032,actomyosin structure organization,208,0,0.3,1.00000,1,1,0
BP,GO:0031057,negative regulation of histone modificat...,52,0,0.07,1.00000,1,1,0
BP,GO:0031058,positive regulation of histone modificat...,103,0,0.15,1.00000,1,1,0
BP,GO:0031061,negative regulation of histone methylati...,26,0,0.04,1.00000,1,1,0
BP,GO:0031062,positive regulation of histone methylati...,50,0,0.07,1.00000,1,1,0
BP,GO:0031063,regulation of histone deacetylation,32,0,0.05,1.00000,1,1,0
BP,GO:0031069,hair follicle morphogenesis,29,0,0.04,1.00000,1,1,0
BP,GO:0031076,embryonic camera-type eye development,36,0,0.05,1.00000,1,1,0
BP,GO:0031099,regeneration,207,0,0.3,1.00000,1,1,0
BP,GO:0031100,animal organ regeneration,83,0,0.12,1.00000,1,1,0
BP,GO:0031102,neuron projection regeneration,61,0,0.09,1.00000,1,1,0
BP,GO:0031103,axon regeneration,53,0,0.08,1.00000,1,1,0
BP,GO:0031109,microtubule polymerization or depolymeri...,140,0,0.2,1.00000,1,1,0
BP,GO:0031110,regulation of microtubule polymerization...,102,0,0.15,1.00000,1,1,0
BP,GO:0031111,negative regulation of microtubule polym...,42,0,0.06,1.00000,1,1,0
BP,GO:0031112,positive regulation of microtubule polym...,48,0,0.07,1.00000,1,1,0
BP,GO:0031113,regulation of microtubule polymerization,67,0,0.1,1.00000,1,1,0
BP,GO:0031114,regulation of microtubule depolymerizati...,32,0,0.05,1.00000,1,1,0
BP,GO:0031116,positive regulation of microtubule polym...,44,0,0.06,1.00000,1,1,0
BP,GO:0031123,RNA 3'-end processing,129,0,0.19,1.00000,1,1,0
BP,GO:0031124,mRNA 3'-end processing,74,0,0.11,1.00000,1,1,0
BP,GO:0031128,developmental induction,36,0,0.05,1.00000,1,1,0
BP,GO:0031145,anaphase-promoting complex-dependent cat...,21,0,0.03,1.00000,1,1,0
BP,GO:0031146,SCF-dependent proteasomal ubiquitin-depe...,50,0,0.07,1.00000,1,1,0
BP,GO:0031163,metallo-sulfur cluster assembly,26,0,0.04,1.00000,1,1,0
BP,GO:0031167,rRNA methylation,27,0,0.04,1.00000,1,1,0
BP,GO:0031214,biomineral tissue development,182,0,0.26,1.00000,1,1,0
BP,GO:0031279,regulation of cyclase activity,58,0,0.08,1.00000,1,1,0
BP,GO:0031280,negative regulation of cyclase activity,24,0,0.03,1.00000,1,1,0
BP,GO:0031281,positive regulation of cyclase activity,22,0,0.03,1.00000,1,1,0
BP,GO:0031294,lymphocyte costimulation,54,0,0.08,1.00000,1,1,0
BP,GO:0031295,T cell costimulation,52,0,0.07,1.00000,1,1,0
BP,GO:0031330,negative regulation of cellular cataboli...,298,0,0.43,1.00000,1,1,0
BP,GO:0031333,negative regulation of protein-containin...,146,0,0.21,1.00000,1,1,0
BP,GO:0031338,regulation of vesicle fusion,24,0,0.03,1.00000,1,1,0
BP,GO:0031341,regulation of cell killing,222,0,0.32,1.00000,1,1,0
BP,GO:0031342,negative regulation of cell killing,108,0,0.16,1.00000,1,1,0
BP,GO:0031343,positive regulation of cell killing,114,0,0.16,1.00000,1,1,0
BP,GO:0031365,N-terminal protein amino acid modificati...,31,0,0.04,1.00000,1,1,0
BP,GO:0031396,regulation of protein ubiquitination,232,0,0.33,1.00000,1,1,0
BP,GO:0031397,negative regulation of protein ubiquitin...,99,0,0.14,1.00000,1,1,0
BP,GO:0031398,positive regulation of protein ubiquitin...,120,0,0.17,1.00000,1,1,0
BP,GO:0031424,keratinization,64,0,0.09,1.00000,1,1,0
BP,GO:0031440,regulation of mRNA 3'-end processing,38,0,0.05,1.00000,1,1,0
BP,GO:0031498,chromatin disassembly,22,0,0.03,1.00000,1,1,0
BP,GO:0031529,ruffle organization,69,0,0.1,1.00000,1,1,0
BP,GO:0031573,mitotic intra-S DNA damage checkpoint si...,25,0,0.04,1.00000,1,1,0
BP,GO:0031577,spindle checkpoint signaling,39,0,0.06,1.00000,1,1,0
BP,GO:0031623,receptor internalization,136,0,0.2,1.00000,1,1,0
BP,GO:0031629,synaptic vesicle fusion to presynaptic a...,21,0,0.03,1.00000,1,1,0
BP,GO:0031639,plasminogen activation,25,0,0.04,1.00000,1,1,0
BP,GO:0031640,killing of cells of other organism,86,0,0.12,1.00000,1,1,0
BP,GO:0031645,negative regulation of nervous system pr...,21,0,0.03,1.00000,1,1,0
BP,GO:0031646,positive regulation of nervous system pr...,40,0,0.06,1.00000,1,1,0
BP,GO:0031649,heat generation,25,0,0.04,1.00000,1,1,0
BP,GO:0031650,regulation of heat generation,21,0,0.03,1.00000,1,1,0
BP,GO:0031663,lipopolysaccharide-mediated signaling pa...,79,0,0.11,1.00000,1,1,0
BP,GO:0031664,regulation of lipopolysaccharide-mediate...,34,0,0.05,1.00000,1,1,0
BP,GO:0031665,negative regulation of lipopolysaccharid...,22,0,0.03,1.00000,1,1,0
BP,GO:0031668,cellular response to extracellular stimu...,267,0,0.38,1.00000,1,1,0
BP,GO:0031669,cellular response to nutrient levels,229,0,0.33,1.00000,1,1,0
BP,GO:0031670,cellular response to nutrient,46,0,0.07,1.00000,1,1,0
BP,GO:0031952,regulation of protein autophosphorylatio...,47,0,0.07,1.00000,1,1,0
BP,GO:0031954,positive regulation of protein autophosp...,29,0,0.04,1.00000,1,1,0
BP,GO:0031960,response to corticosteroid,183,0,0.26,1.00000,1,1,0
BP,GO:0031998,regulation of fatty acid beta-oxidation,22,0,0.03,1.00000,1,1,0
BP,GO:0032007,negative regulation of TOR signaling,44,0,0.06,1.00000,1,1,0
BP,GO:0032011,ARF protein signal transduction,20,0,0.03,1.00000,1,1,0
BP,GO:0032012,regulation of ARF protein signal transdu...,20,0,0.03,1.00000,1,1,0
BP,GO:0032024,positive regulation of insulin secretion,87,0,0.13,1.00000,1,1,0
BP,GO:0032048,cardiolipin metabolic process,20,0,0.03,1.00000,1,1,0
BP,GO:0032069,regulation of nuclease activity,26,0,0.04,1.00000,1,1,0
BP,GO:0032088,negative regulation of NF-kappaB transcr...,118,0,0.17,1.00000,1,1,0
BP,GO:0032091,negative regulation of protein binding,97,0,0.14,1.00000,1,1,0
BP,GO:0032092,positive regulation of protein binding,97,0,0.14,1.00000,1,1,0
BP,GO:0032094,response to food,41,0,0.06,1.00000,1,1,0
BP,GO:0032098,regulation of appetite,23,0,0.03,1.00000,1,1,0
BP,GO:0032104,regulation of response to extracellular ...,25,0,0.04,1.00000,1,1,0
BP,GO:0032107,regulation of response to nutrient level...,25,0,0.04,1.00000,1,1,0
BP,GO:0032148,activation of protein kinase B activity,31,0,0.04,1.00000,1,1,0
BP,GO:0032196,transposition,34,0,0.05,1.00000,1,1,0
BP,GO:0032205,negative regulation of telomere maintena...,39,0,0.06,1.00000,1,1,0
BP,GO:0032210,regulation of telomere maintenance via t...,59,0,0.08,1.00000,1,1,0
BP,GO:0032211,negative regulation of telomere maintena...,23,0,0.03,1.00000,1,1,0
BP,GO:0032212,positive regulation of telomere maintena...,37,0,0.05,1.00000,1,1,0
BP,GO:0032228,"regulation of synaptic transmission, GAB...",37,0,0.05,1.00000,1,1,0
BP,GO:0032231,regulation of actin filament bundle asse...,113,0,0.16,1.00000,1,1,0
BP,GO:0032232,negative regulation of actin filament bu...,38,0,0.05,1.00000,1,1,0
BP,GO:0032233,positive regulation of actin filament bu...,67,0,0.1,1.00000,1,1,0
BP,GO:0032272,negative regulation of protein polymeriz...,83,0,0.12,1.00000,1,1,0
BP,GO:0032288,myelin assembly,21,0,0.03,1.00000,1,1,0
BP,GO:0032291,axon ensheathment in central nervous sys...,23,0,0.03,1.00000,1,1,0
BP,GO:0032292,peripheral nervous system axon ensheathm...,31,0,0.04,1.00000,1,1,0
BP,GO:0032303,regulation of icosanoid secretion,22,0,0.03,1.00000,1,1,0
BP,GO:0032309,icosanoid secretion,47,0,0.07,1.00000,1,1,0
BP,GO:0032330,regulation of chondrocyte differentiatio...,57,0,0.08,1.00000,1,1,0
BP,GO:0032331,negative regulation of chondrocyte diffe...,28,0,0.04,1.00000,1,1,0
BP,GO:0032332,positive regulation of chondrocyte diffe...,20,0,0.03,1.00000,1,1,0
BP,GO:0032350,regulation of hormone metabolic process,35,0,0.05,1.00000,1,1,0
BP,GO:0032365,intracellular lipid transport,46,0,0.07,1.00000,1,1,0
BP,GO:0032366,intracellular sterol transport,31,0,0.04,1.00000,1,1,0
BP,GO:0032367,intracellular cholesterol transport,31,0,0.04,1.00000,1,1,0
BP,GO:0032368,regulation of lipid transport,157,0,0.23,1.00000,1,1,0
BP,GO:0032369,negative regulation of lipid transport,49,0,0.07,1.00000,1,1,0
BP,GO:0032370,positive regulation of lipid transport,87,0,0.13,1.00000,1,1,0
BP,GO:0032371,regulation of sterol transport,82,0,0.12,1.00000,1,1,0
BP,GO:0032372,negative regulation of sterol transport,31,0,0.04,1.00000,1,1,0
BP,GO:0032373,positive regulation of sterol transport,40,0,0.06,1.00000,1,1,0
BP,GO:0032374,regulation of cholesterol transport,82,0,0.12,1.00000,1,1,0
BP,GO:0032375,negative regulation of cholesterol trans...,31,0,0.04,1.00000,1,1,0
BP,GO:0032376,positive regulation of cholesterol trans...,40,0,0.06,1.00000,1,1,0
BP,GO:0032387,negative regulation of intracellular tra...,60,0,0.09,1.00000,1,1,0
BP,GO:0032410,negative regulation of transporter activ...,117,0,0.17,1.00000,1,1,0
BP,GO:0032413,negative regulation of ion transmembrane...,94,0,0.14,1.00000,1,1,0
BP,GO:0032418,lysosome localization,82,0,0.12,1.00000,1,1,0
BP,GO:0032434,regulation of proteasomal ubiquitin-depe...,160,0,0.23,1.00000,1,1,0
BP,GO:0032435,negative regulation of proteasomal ubiqu...,49,0,0.07,1.00000,1,1,0
BP,GO:0032436,positive regulation of proteasomal ubiqu...,102,0,0.15,1.00000,1,1,0
BP,GO:0032438,melanosome organization,28,0,0.04,1.00000,1,1,0
BP,GO:0032456,endocytic recycling,83,0,0.12,1.00000,1,1,0
BP,GO:0032467,positive regulation of cytokinesis,45,0,0.06,1.00000,1,1,0
BP,GO:0032479,regulation of type I interferon producti...,119,0,0.17,1.00000,1,1,0
BP,GO:0032480,negative regulation of type I interferon...,37,0,0.05,1.00000,1,1,0
BP,GO:0032481,positive regulation of type I interferon...,75,0,0.11,1.00000,1,1,0
BP,GO:0032482,Rab protein signal transduction,22,0,0.03,1.00000,1,1,0
BP,GO:0032495,response to muramyl dipeptide,20,0,0.03,1.00000,1,1,0
BP,GO:0032506,cytokinetic process,40,0,0.06,1.00000,1,1,0
BP,GO:0032507,maintenance of protein location in cell,66,0,0.09,1.00000,1,1,0
BP,GO:0032509,endosome transport via multivesicular bo...,34,0,0.05,1.00000,1,1,0
BP,GO:0032515,negative regulation of phosphoprotein ph...,41,0,0.06,1.00000,1,1,0
BP,GO:0032516,positive regulation of phosphoprotein ph...,22,0,0.03,1.00000,1,1,0
BP,GO:0032526,response to retinoic acid,124,0,0.18,1.00000,1,1,0
BP,GO:0032527,protein exit from endoplasmic reticulum,48,0,0.07,1.00000,1,1,0
BP,GO:0032528,microvillus organization,25,0,0.04,1.00000,1,1,0
BP,GO:0032543,mitochondrial translation,85,0,0.12,1.00000,1,1,0
BP,GO:0032570,response to progesterone,38,0,0.05,1.00000,1,1,0
BP,GO:0032604,granulocyte macrophage colony-stimulatin...,20,0,0.03,1.00000,1,1,0
BP,GO:0032606,type I interferon production,119,0,0.17,1.00000,1,1,0
BP,GO:0032607,interferon-alpha production,33,0,0.05,1.00000,1,1,0
BP,GO:0032608,interferon-beta production,69,0,0.1,1.00000,1,1,0
BP,GO:0032609,interferon-gamma production,173,0,0.25,1.00000,1,1,0
BP,GO:0032613,interleukin-10 production,86,0,0.12,1.00000,1,1,0
BP,GO:0032616,interleukin-13 production,29,0,0.04,1.00000,1,1,0
BP,GO:0032620,interleukin-17 production,46,0,0.07,1.00000,1,1,0
BP,GO:0032623,interleukin-2 production,74,0,0.11,1.00000,1,1,0
BP,GO:0032633,interleukin-4 production,44,0,0.06,1.00000,1,1,0
BP,GO:0032634,interleukin-5 production,22,0,0.03,1.00000,1,1,0
BP,GO:0032635,interleukin-6 production,209,0,0.3,1.00000,1,1,0
BP,GO:0032637,interleukin-8 production,125,0,0.18,1.00000,1,1,0
BP,GO:0032645,regulation of granulocyte macrophage col...,20,0,0.03,1.00000,1,1,0
BP,GO:0032647,regulation of interferon-alpha productio...,33,0,0.05,1.00000,1,1,0
BP,GO:0032648,regulation of interferon-beta production,69,0,0.1,1.00000,1,1,0
BP,GO:0032649,regulation of interferon-gamma productio...,173,0,0.25,1.00000,1,1,0
BP,GO:0032653,regulation of interleukin-10 production,86,0,0.12,1.00000,1,1,0
BP,GO:0032656,regulation of interleukin-13 production,29,0,0.04,1.00000,1,1,0
BP,GO:0032660,regulation of interleukin-17 production,46,0,0.07,1.00000,1,1,0
BP,GO:0032663,regulation of interleukin-2 production,74,0,0.11,1.00000,1,1,0
BP,GO:0032673,regulation of interleukin-4 production,44,0,0.06,1.00000,1,1,0
BP,GO:0032674,regulation of interleukin-5 production,22,0,0.03,1.00000,1,1,0
BP,GO:0032675,regulation of interleukin-6 production,209,0,0.3,1.00000,1,1,0
BP,GO:0032677,regulation of interleukin-8 production,124,0,0.18,1.00000,1,1,0
BP,GO:0032682,negative regulation of chemokine product...,31,0,0.04,1.00000,1,1,0
BP,GO:0032689,negative regulation of interferon-gamma ...,59,0,0.08,1.00000,1,1,0
BP,GO:0032691,negative regulation of interleukin-1 bet...,56,0,0.08,1.00000,1,1,0
BP,GO:0032692,negative regulation of interleukin-1 pro...,64,0,0.09,1.00000,1,1,0
BP,GO:0032693,negative regulation of interleukin-10 pr...,37,0,0.05,1.00000,1,1,0
BP,GO:0032695,negative regulation of interleukin-12 pr...,27,0,0.04,1.00000,1,1,0
BP,GO:0032700,negative regulation of interleukin-17 pr...,24,0,0.03,1.00000,1,1,0
BP,GO:0032703,negative regulation of interleukin-2 pro...,39,0,0.06,1.00000,1,1,0
BP,GO:0032715,negative regulation of interleukin-6 pro...,80,0,0.11,1.00000,1,1,0
BP,GO:0032717,negative regulation of interleukin-8 pro...,39,0,0.06,1.00000,1,1,0
BP,GO:0032720,negative regulation of tumor necrosis fa...,99,0,0.14,1.00000,1,1,0
BP,GO:0032722,positive regulation of chemokine product...,90,0,0.13,1.00000,1,1,0
BP,GO:0032727,positive regulation of interferon-alpha ...,24,0,0.03,1.00000,1,1,0
BP,GO:0032728,positive regulation of interferon-beta p...,48,0,0.07,1.00000,1,1,0
BP,GO:0032729,positive regulation of interferon-gamma ...,119,0,0.17,1.00000,1,1,0
BP,GO:0032731,positive regulation of interleukin-1 bet...,95,0,0.14,1.00000,1,1,0
BP,GO:0032732,positive regulation of interleukin-1 pro...,109,0,0.16,1.00000,1,1,0
BP,GO:0032733,positive regulation of interleukin-10 pr...,45,0,0.06,1.00000,1,1,0
BP,GO:0032735,positive regulation of interleukin-12 pr...,61,0,0.09,1.00000,1,1,0
BP,GO:0032740,positive regulation of interleukin-17 pr...,23,0,0.03,1.00000,1,1,0
BP,GO:0032743,positive regulation of interleukin-2 pro...,35,0,0.05,1.00000,1,1,0
BP,GO:0032753,positive regulation of interleukin-4 pro...,31,0,0.04,1.00000,1,1,0
BP,GO:0032755,positive regulation of interleukin-6 pro...,125,0,0.18,1.00000,1,1,0
BP,GO:0032757,positive regulation of interleukin-8 pro...,83,0,0.12,1.00000,1,1,0
BP,GO:0032760,positive regulation of tumor necrosis fa...,130,0,0.19,1.00000,1,1,0
BP,GO:0032768,regulation of monooxygenase activity,71,0,0.1,1.00000,1,1,0
BP,GO:0032770,positive regulation of monooxygenase act...,40,0,0.06,1.00000,1,1,0
BP,GO:0032781,positive regulation of ATPase activity,27,0,0.04,1.00000,1,1,0
BP,GO:0032784,regulation of DNA-templated transcriptio...,66,0,0.09,1.00000,1,1,0
BP,GO:0032785,negative regulation of DNA-templated tra...,24,0,0.03,1.00000,1,1,0
BP,GO:0032786,positive regulation of DNA-templated tra...,34,0,0.05,1.00000,1,1,0
BP,GO:0032787,monocarboxylic acid metabolic process,635,0,0.91,1.00000,1,1,0
BP,GO:0032801,receptor catabolic process,30,0,0.04,1.00000,1,1,0
BP,GO:0032814,regulation of natural killer cell activa...,52,0,0.07,1.00000,1,1,0
BP,GO:0032816,positive regulation of natural killer ce...,34,0,0.05,1.00000,1,1,0
BP,GO:0032874,positive regulation of stress-activated ...,143,0,0.21,1.00000,1,1,0
BP,GO:0032881,regulation of polysaccharide metabolic p...,47,0,0.07,1.00000,1,1,0
BP,GO:0032885,regulation of polysaccharide biosyntheti...,38,0,0.05,1.00000,1,1,0
BP,GO:0032890,regulation of organic acid transport,69,0,0.1,1.00000,1,1,0
BP,GO:0032891,negative regulation of organic acid tran...,23,0,0.03,1.00000,1,1,0
BP,GO:0032892,positive regulation of organic acid tran...,41,0,0.06,1.00000,1,1,0
BP,GO:0032897,negative regulation of viral transcripti...,28,0,0.04,1.00000,1,1,0
BP,GO:0032922,circadian regulation of gene expression,70,0,0.1,1.00000,1,1,0
BP,GO:0032924,activin receptor signaling pathway,55,0,0.08,1.00000,1,1,0
BP,GO:0032925,regulation of activin receptor signaling...,34,0,0.05,1.00000,1,1,0
BP,GO:0032928,regulation of superoxide anion generatio...,27,0,0.04,1.00000,1,1,0
BP,GO:0032930,positive regulation of superoxide anion ...,22,0,0.03,1.00000,1,1,0
BP,GO:0032940,secretion by cell,866,0,1.24,1.00000,1,1,0
BP,GO:0032941,secretion by tissue,40,0,0.06,1.00000,1,1,0
BP,GO:0032946,positive regulation of mononuclear cell ...,192,0,0.28,1.00000,1,1,0
BP,GO:0032958,inositol phosphate biosynthetic process,28,0,0.04,1.00000,1,1,0
BP,GO:0032963,collagen metabolic process,118,0,0.17,1.00000,1,1,0
BP,GO:0032964,collagen biosynthetic process,52,0,0.07,1.00000,1,1,0
BP,GO:0032965,regulation of collagen biosynthetic proc...,43,0,0.06,1.00000,1,1,0
BP,GO:0032967,positive regulation of collagen biosynth...,28,0,0.04,1.00000,1,1,0
BP,GO:0032981,mitochondrial respiratory chain complex ...,72,0,0.1,1.00000,1,1,0
BP,GO:0032984,protein-containing complex disassembly,242,0,0.35,1.00000,1,1,0
BP,GO:0032986,protein-DNA complex disassembly,22,0,0.03,1.00000,1,1,0
BP,GO:0033003,regulation of mast cell activation,43,0,0.06,1.00000,1,1,0
BP,GO:0033005,positive regulation of mast cell activat...,20,0,0.03,1.00000,1,1,0
BP,GO:0033006,regulation of mast cell activation invol...,32,0,0.05,1.00000,1,1,0
BP,GO:0033013,tetrapyrrole metabolic process,63,0,0.09,1.00000,1,1,0
BP,GO:0033014,tetrapyrrole biosynthetic process,33,0,0.05,1.00000,1,1,0
BP,GO:0033028,myeloid cell apoptotic process,31,0,0.04,1.00000,1,1,0
BP,GO:0033032,regulation of myeloid cell apoptotic pro...,26,0,0.04,1.00000,1,1,0
BP,GO:0033045,regulation of sister chromatid segregati...,73,0,0.1,1.00000,1,1,0
BP,GO:0033046,negative regulation of sister chromatid ...,43,0,0.06,1.00000,1,1,0
BP,GO:0033047,regulation of mitotic sister chromatid s...,46,0,0.07,1.00000,1,1,0
BP,GO:0033048,negative regulation of mitotic sister ch...,43,0,0.06,1.00000,1,1,0
BP,GO:0033081,regulation of T cell differentiation in ...,23,0,0.03,1.00000,1,1,0
BP,GO:0033108,mitochondrial respiratory chain complex ...,109,0,0.16,1.00000,1,1,0
BP,GO:0033119,negative regulation of RNA splicing,25,0,0.04,1.00000,1,1,0
BP,GO:0033120,positive regulation of RNA splicing,43,0,0.06,1.00000,1,1,0
BP,GO:0033135,regulation of peptidyl-serine phosphoryl...,155,0,0.22,1.00000,1,1,0
BP,GO:0033137,negative regulation of peptidyl-serine p...,32,0,0.05,1.00000,1,1,0
BP,GO:0033138,positive regulation of peptidyl-serine p...,116,0,0.17,1.00000,1,1,0
BP,GO:0033139,regulation of peptidyl-serine phosphoryl...,24,0,0.03,1.00000,1,1,0
BP,GO:0033141,positive regulation of peptidyl-serine p...,20,0,0.03,1.00000,1,1,0
BP,GO:0033146,regulation of intracellular estrogen rec...,36,0,0.05,1.00000,1,1,0
BP,GO:0033157,regulation of intracellular protein tran...,243,0,0.35,1.00000,1,1,0
BP,GO:0033173,calcineurin-NFAT signaling cascade,51,0,0.07,1.00000,1,1,0
BP,GO:0033194,response to hydroperoxide,24,0,0.03,1.00000,1,1,0
BP,GO:0033198,response to ATP,35,0,0.05,1.00000,1,1,0
BP,GO:0033209,tumor necrosis factor-mediated signaling...,120,0,0.17,1.00000,1,1,0
BP,GO:0033233,regulation of protein sumoylation,25,0,0.04,1.00000,1,1,0
BP,GO:0033238,regulation of cellular amine metabolic p...,34,0,0.05,1.00000,1,1,0
BP,GO:0033280,response to vitamin D,35,0,0.05,1.00000,1,1,0
BP,GO:0033344,cholesterol efflux,79,0,0.11,1.00000,1,1,0
BP,GO:0033363,secretory granule organization,37,0,0.05,1.00000,1,1,0
BP,GO:0033500,carbohydrate homeostasis,281,0,0.4,1.00000,1,1,0
BP,GO:0033522,histone H2A ubiquitination,34,0,0.05,1.00000,1,1,0
BP,GO:0033559,unsaturated fatty acid metabolic process,125,0,0.18,1.00000,1,1,0
BP,GO:0033561,regulation of water loss via skin,28,0,0.04,1.00000,1,1,0
BP,GO:0033574,response to testosterone,51,0,0.07,1.00000,1,1,0
BP,GO:0033598,mammary gland epithelial cell proliferat...,27,0,0.04,1.00000,1,1,0
BP,GO:0033617,mitochondrial cytochrome c oxidase assem...,23,0,0.03,1.00000,1,1,0
BP,GO:0033619,membrane protein proteolysis,68,0,0.1,1.00000,1,1,0
BP,GO:0033622,integrin activation,25,0,0.04,1.00000,1,1,0
BP,GO:0033627,cell adhesion mediated by integrin,74,0,0.11,1.00000,1,1,0
BP,GO:0033628,regulation of cell adhesion mediated by ...,50,0,0.07,1.00000,1,1,0
BP,GO:0033630,positive regulation of cell adhesion med...,23,0,0.03,1.00000,1,1,0
BP,GO:0033673,negative regulation of kinase activity,263,0,0.38,1.00000,1,1,0
BP,GO:0033687,osteoblast proliferation,35,0,0.05,1.00000,1,1,0
BP,GO:0033688,regulation of osteoblast proliferation,30,0,0.04,1.00000,1,1,0
BP,GO:0033692,cellular polysaccharide biosynthetic pro...,67,0,0.1,1.00000,1,1,0
BP,GO:0033762,response to glucagon,22,0,0.03,1.00000,1,1,0
BP,GO:0033865,nucleoside bisphosphate metabolic proces...,142,0,0.2,1.00000,1,1,0
BP,GO:0033866,nucleoside bisphosphate biosynthetic pro...,69,0,0.1,1.00000,1,1,0
BP,GO:0033875,ribonucleoside bisphosphate metabolic pr...,142,0,0.2,1.00000,1,1,0
BP,GO:0034030,ribonucleoside bisphosphate biosynthetic...,69,0,0.1,1.00000,1,1,0
BP,GO:0034032,purine nucleoside bisphosphate metabolic...,142,0,0.2,1.00000,1,1,0
BP,GO:0034033,purine nucleoside bisphosphate biosynthe...,69,0,0.1,1.00000,1,1,0
BP,GO:0034035,purine ribonucleoside bisphosphate metab...,21,0,0.03,1.00000,1,1,0
BP,GO:0034067,protein localization to Golgi apparatus,29,0,0.04,1.00000,1,1,0
BP,GO:0034097,response to cytokine,1062,0,1.53,1.00000,1,1,0
BP,GO:0034103,regulation of tissue remodeling,91,0,0.13,1.00000,1,1,0
BP,GO:0034104,negative regulation of tissue remodeling,23,0,0.03,1.00000,1,1,0
BP,GO:0034105,positive regulation of tissue remodeling,23,0,0.03,1.00000,1,1,0
BP,GO:0034109,homotypic cell-cell adhesion,108,0,0.16,1.00000,1,1,0
BP,GO:0034110,regulation of homotypic cell-cell adhesi...,44,0,0.06,1.00000,1,1,0
BP,GO:0034112,positive regulation of homotypic cell-ce...,23,0,0.03,1.00000,1,1,0
BP,GO:0034113,heterotypic cell-cell adhesion,87,0,0.13,1.00000,1,1,0
BP,GO:0034114,regulation of heterotypic cell-cell adhe...,47,0,0.07,1.00000,1,1,0
BP,GO:0034116,positive regulation of heterotypic cell-...,37,0,0.05,1.00000,1,1,0
BP,GO:0034121,regulation of toll-like receptor signali...,97,0,0.14,1.00000,1,1,0
BP,GO:0034122,negative regulation of toll-like recepto...,54,0,0.08,1.00000,1,1,0
BP,GO:0034123,positive regulation of toll-like recepto...,36,0,0.05,1.00000,1,1,0
BP,GO:0034138,toll-like receptor 3 signaling pathway,23,0,0.03,1.00000,1,1,0
BP,GO:0034142,toll-like receptor 4 signaling pathway,47,0,0.07,1.00000,1,1,0
BP,GO:0034143,regulation of toll-like receptor 4 signa...,31,0,0.04,1.00000,1,1,0
BP,GO:0034162,toll-like receptor 9 signaling pathway,21,0,0.03,1.00000,1,1,0
BP,GO:0034198,cellular response to amino acid starvati...,47,0,0.07,1.00000,1,1,0
BP,GO:0034204,lipid translocation,58,0,0.08,1.00000,1,1,0
BP,GO:0034205,amyloid-beta formation,66,0,0.09,1.00000,1,1,0
BP,GO:0034219,carbohydrate transmembrane transport,134,0,0.19,1.00000,1,1,0
BP,GO:0034243,regulation of transcription elongation f...,38,0,0.05,1.00000,1,1,0
BP,GO:0034244,negative regulation of transcription elo...,22,0,0.03,1.00000,1,1,0
BP,GO:0034260,negative regulation of GTPase activity,40,0,0.06,1.00000,1,1,0
BP,GO:0034284,response to monosaccharide,247,0,0.36,1.00000,1,1,0
BP,GO:0034308,primary alcohol metabolic process,120,0,0.17,1.00000,1,1,0
BP,GO:0034311,diol metabolic process,30,0,0.04,1.00000,1,1,0
BP,GO:0034312,diol biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0034314,Arp2/3 complex-mediated actin nucleation,46,0,0.07,1.00000,1,1,0
BP,GO:0034315,regulation of Arp2/3 complex-mediated ac...,23,0,0.03,1.00000,1,1,0
BP,GO:0034332,adherens junction organization,52,0,0.07,1.00000,1,1,0
BP,GO:0034340,response to type I interferon,62,0,0.09,1.00000,1,1,0
BP,GO:0034341,response to interferon-gamma,176,0,0.25,1.00000,1,1,0
BP,GO:0034367,protein-containing complex remodeling,39,0,0.06,1.00000,1,1,0
BP,GO:0034368,protein-lipid complex remodeling,37,0,0.05,1.00000,1,1,0
BP,GO:0034369,plasma lipoprotein particle remodeling,37,0,0.05,1.00000,1,1,0
BP,GO:0034375,high-density lipoprotein particle remode...,22,0,0.03,1.00000,1,1,0
BP,GO:0034377,plasma lipoprotein particle assembly,35,0,0.05,1.00000,1,1,0
BP,GO:0034380,high-density lipoprotein particle assemb...,22,0,0.03,1.00000,1,1,0
BP,GO:0034381,plasma lipoprotein particle clearance,60,0,0.09,1.00000,1,1,0
BP,GO:0034383,low-density lipoprotein particle clearan...,35,0,0.05,1.00000,1,1,0
BP,GO:0034384,high-density lipoprotein particle cleara...,21,0,0.03,1.00000,1,1,0
BP,GO:0034389,lipid droplet organization,27,0,0.04,1.00000,1,1,0
BP,GO:0034390,smooth muscle cell apoptotic process,31,0,0.04,1.00000,1,1,0
BP,GO:0034391,regulation of smooth muscle cell apoptot...,31,0,0.04,1.00000,1,1,0
BP,GO:0034394,protein localization to cell surface,84,0,0.12,1.00000,1,1,0
BP,GO:0034405,response to fluid shear stress,36,0,0.05,1.00000,1,1,0
BP,GO:0034440,lipid oxidation,114,0,0.16,1.00000,1,1,0
BP,GO:0034453,microtubule anchoring,28,0,0.04,1.00000,1,1,0
BP,GO:0034471,ncRNA 5'-end processing,29,0,0.04,1.00000,1,1,0
BP,GO:0034472,snRNA 3'-end processing,31,0,0.04,1.00000,1,1,0
BP,GO:0034501,protein localization to kinetochore,21,0,0.03,1.00000,1,1,0
BP,GO:0034504,protein localization to nucleus,317,0,0.46,1.00000,1,1,0
BP,GO:0034505,tooth mineralization,30,0,0.04,1.00000,1,1,0
BP,GO:0034508,centromere complex assembly,31,0,0.04,1.00000,1,1,0
BP,GO:0034605,cellular response to heat,86,0,0.12,1.00000,1,1,0
BP,GO:0034612,response to tumor necrosis factor,303,0,0.44,1.00000,1,1,0
BP,GO:0034620,cellular response to unfolded protein,118,0,0.17,1.00000,1,1,0
BP,GO:0034637,cellular carbohydrate biosynthetic proce...,81,0,0.12,1.00000,1,1,0
BP,GO:0034643,establishment of mitochondrion localizat...,28,0,0.04,1.00000,1,1,0
BP,GO:0034644,cellular response to UV,96,0,0.14,1.00000,1,1,0
BP,GO:0034656,nucleobase-containing small molecule cat...,32,0,0.05,1.00000,1,1,0
BP,GO:0034661,ncRNA catabolic process,44,0,0.06,1.00000,1,1,0
BP,GO:0034694,response to prostaglandin,31,0,0.04,1.00000,1,1,0
BP,GO:0034695,response to prostaglandin E,24,0,0.03,1.00000,1,1,0
BP,GO:0034698,response to gonadotropin,27,0,0.04,1.00000,1,1,0
BP,GO:0034723,DNA replication-dependent nucleosome org...,34,0,0.05,1.00000,1,1,0
BP,GO:0034754,cellular hormone metabolic process,166,0,0.24,1.00000,1,1,0
BP,GO:0034755,iron ion transmembrane transport,25,0,0.04,1.00000,1,1,0
BP,GO:0034763,negative regulation of transmembrane tra...,160,0,0.23,1.00000,1,1,0
BP,GO:0034766,negative regulation of ion transmembrane...,119,0,0.17,1.00000,1,1,0
BP,GO:0035019,somatic stem cell population maintenance,49,0,0.07,1.00000,1,1,0
BP,GO:0035020,regulation of Rac protein signal transdu...,22,0,0.03,1.00000,1,1,0
BP,GO:0035023,regulation of Rho protein signal transdu...,97,0,0.14,1.00000,1,1,0
BP,GO:0035024,negative regulation of Rho protein signa...,24,0,0.03,1.00000,1,1,0
BP,GO:0035025,positive regulation of Rho protein signa...,34,0,0.05,1.00000,1,1,0
BP,GO:0035036,sperm-egg recognition,59,0,0.08,1.00000,1,1,0
BP,GO:0035050,embryonic heart tube development,81,0,0.12,1.00000,1,1,0
BP,GO:0035051,cardiocyte differentiation,173,0,0.25,1.00000,1,1,0
BP,GO:0035065,regulation of histone acetylation,56,0,0.08,1.00000,1,1,0
BP,GO:0035066,positive regulation of histone acetylati...,31,0,0.04,1.00000,1,1,0
BP,GO:0035082,axoneme assembly,83,0,0.12,1.00000,1,1,0
BP,GO:0035089,establishment of apical/basal cell polar...,23,0,0.03,1.00000,1,1,0
BP,GO:0035094,response to nicotine,59,0,0.08,1.00000,1,1,0
BP,GO:0035113,embryonic appendage morphogenesis,127,0,0.18,1.00000,1,1,0
BP,GO:0035115,embryonic forelimb morphogenesis,34,0,0.05,1.00000,1,1,0
BP,GO:0035116,embryonic hindlimb morphogenesis,29,0,0.04,1.00000,1,1,0
BP,GO:0035137,hindlimb morphogenesis,36,0,0.05,1.00000,1,1,0
BP,GO:0035148,tube formation,163,0,0.23,1.00000,1,1,0
BP,GO:0035150,regulation of tube size,145,0,0.21,1.00000,1,1,0
BP,GO:0035162,embryonic hemopoiesis,24,0,0.03,1.00000,1,1,0
BP,GO:0035176,social behavior,57,0,0.08,1.00000,1,1,0
BP,GO:0035188,hatching,31,0,0.04,1.00000,1,1,0
BP,GO:0035265,organ growth,197,0,0.28,1.00000,1,1,0
BP,GO:0035268,protein mannosylation,22,0,0.03,1.00000,1,1,0
BP,GO:0035270,endocrine system development,133,0,0.19,1.00000,1,1,0
BP,GO:0035272,exocrine system development,53,0,0.08,1.00000,1,1,0
BP,GO:0035296,regulation of tube diameter,143,0,0.21,1.00000,1,1,0
BP,GO:0035303,regulation of dephosphorylation,159,0,0.23,1.00000,1,1,0
BP,GO:0035304,regulation of protein dephosphorylation,119,0,0.17,1.00000,1,1,0
BP,GO:0035305,negative regulation of dephosphorylation,62,0,0.09,1.00000,1,1,0
BP,GO:0035306,positive regulation of dephosphorylation,68,0,0.1,1.00000,1,1,0
BP,GO:0035307,positive regulation of protein dephospho...,52,0,0.07,1.00000,1,1,0
BP,GO:0035308,negative regulation of protein dephospho...,51,0,0.07,1.00000,1,1,0
BP,GO:0035313,"wound healing, spreading of epidermal ce...",20,0,0.03,1.00000,1,1,0
BP,GO:0035315,hair cell differentiation,59,0,0.08,1.00000,1,1,0
BP,GO:0035329,hippo signaling,41,0,0.06,1.00000,1,1,0
BP,GO:0035330,regulation of hippo signaling,22,0,0.03,1.00000,1,1,0
BP,GO:0035335,peptidyl-tyrosine dephosphorylation,108,0,0.16,1.00000,1,1,0
BP,GO:0035336,long-chain fatty-acyl-CoA metabolic proc...,26,0,0.04,1.00000,1,1,0
BP,GO:0035337,fatty-acyl-CoA metabolic process,47,0,0.07,1.00000,1,1,0
BP,GO:0035357,peroxisome proliferator activated recept...,25,0,0.04,1.00000,1,1,0
BP,GO:0035383,thioester metabolic process,107,0,0.15,1.00000,1,1,0
BP,GO:0035384,thioester biosynthetic process,53,0,0.08,1.00000,1,1,0
BP,GO:0035455,response to interferon-alpha,22,0,0.03,1.00000,1,1,0
BP,GO:0035456,response to interferon-beta,33,0,0.05,1.00000,1,1,0
BP,GO:0035458,cellular response to interferon-beta,24,0,0.03,1.00000,1,1,0
BP,GO:0035459,vesicle cargo loading,32,0,0.05,1.00000,1,1,0
BP,GO:0035461,vitamin transmembrane transport,27,0,0.04,1.00000,1,1,0
BP,GO:0035518,histone H2A monoubiquitination,24,0,0.03,1.00000,1,1,0
BP,GO:0035561,regulation of chromatin binding,23,0,0.03,1.00000,1,1,0
BP,GO:0035567,non-canonical Wnt signaling pathway,74,0,0.11,1.00000,1,1,0
BP,GO:0035584,calcium-mediated signaling using intrace...,27,0,0.04,1.00000,1,1,0
BP,GO:0035590,purinergic nucleotide receptor signaling...,34,0,0.05,1.00000,1,1,0
BP,GO:0035592,establishment of protein localization to...,397,0,0.57,1.00000,1,1,0
BP,GO:0035601,protein deacylation,117,0,0.17,1.00000,1,1,0
BP,GO:0035633,maintenance of blood-brain barrier,37,0,0.05,1.00000,1,1,0
BP,GO:0035637,multicellular organismal signaling,166,0,0.24,1.00000,1,1,0
BP,GO:0035640,exploration behavior,24,0,0.03,1.00000,1,1,0
BP,GO:0035728,response to hepatocyte growth factor,22,0,0.03,1.00000,1,1,0
BP,GO:0035729,cellular response to hepatocyte growth f...,20,0,0.03,1.00000,1,1,0
BP,GO:0035740,"CD8-positive, alpha-beta T cell prolifer...",21,0,0.03,1.00000,1,1,0
BP,GO:0035767,endothelial cell chemotaxis,32,0,0.05,1.00000,1,1,0
BP,GO:0035773,insulin secretion involved in cellular r...,78,0,0.11,1.00000,1,1,0
BP,GO:0035774,positive regulation of insulin secretion...,41,0,0.06,1.00000,1,1,0
BP,GO:0035794,positive regulation of mitochondrial mem...,54,0,0.08,1.00000,1,1,0
BP,GO:0035809,regulation of urine volume,25,0,0.04,1.00000,1,1,0
BP,GO:0035812,renal sodium excretion,24,0,0.03,1.00000,1,1,0
BP,GO:0035813,regulation of renal sodium excretion,21,0,0.03,1.00000,1,1,0
BP,GO:0035821,modulation of process of other organism,123,0,0.18,1.00000,1,1,0
BP,GO:0035825,homologous recombination,70,0,0.1,1.00000,1,1,0
BP,GO:0035850,epithelial cell differentiation involved...,51,0,0.07,1.00000,1,1,0
BP,GO:0035855,megakaryocyte development,23,0,0.03,1.00000,1,1,0
BP,GO:0035872,"nucleotide-binding domain, leucine rich ...",34,0,0.05,1.00000,1,1,0
BP,GO:0035883,enteroendocrine cell differentiation,33,0,0.05,1.00000,1,1,0
BP,GO:0035886,vascular associated smooth muscle cell d...,38,0,0.05,1.00000,1,1,0
BP,GO:0035890,exit from host,56,0,0.08,1.00000,1,1,0
BP,GO:0035891,exit from host cell,56,0,0.08,1.00000,1,1,0
BP,GO:0035902,response to immobilization stress,26,0,0.04,1.00000,1,1,0
BP,GO:0035904,aorta development,58,0,0.08,1.00000,1,1,0
BP,GO:0035909,aorta morphogenesis,34,0,0.05,1.00000,1,1,0
BP,GO:0035914,skeletal muscle cell differentiation,68,0,0.1,1.00000,1,1,0
BP,GO:0035924,cellular response to vascular endothelia...,78,0,0.11,1.00000,1,1,0
BP,GO:0035929,steroid hormone secretion,28,0,0.04,1.00000,1,1,0
BP,GO:0035930,corticosteroid hormone secretion,23,0,0.03,1.00000,1,1,0
BP,GO:0035966,response to topologically incorrect prot...,193,0,0.28,1.00000,1,1,0
BP,GO:0035967,cellular response to topologically incor...,151,0,0.22,1.00000,1,1,0
BP,GO:0035987,endodermal cell differentiation,51,0,0.07,1.00000,1,1,0
BP,GO:0035988,chondrocyte proliferation,23,0,0.03,1.00000,1,1,0
BP,GO:0035994,response to muscle stretch,24,0,0.03,1.00000,1,1,0
BP,GO:0036003,positive regulation of transcription fro...,29,0,0.04,1.00000,1,1,0
BP,GO:0036010,protein localization to endosome,25,0,0.04,1.00000,1,1,0
BP,GO:0036037,"CD8-positive, alpha-beta T cell activati...",49,0,0.07,1.00000,1,1,0
BP,GO:0036119,response to platelet-derived growth fact...,23,0,0.03,1.00000,1,1,0
BP,GO:0036120,cellular response to platelet-derived gr...,22,0,0.03,1.00000,1,1,0
BP,GO:0036151,phosphatidylcholine acyl-chain remodelin...,24,0,0.03,1.00000,1,1,0
BP,GO:0036158,outer dynein arm assembly,22,0,0.03,1.00000,1,1,0
BP,GO:0036166,phenotypic switching,23,0,0.03,1.00000,1,1,0
BP,GO:0036230,granulocyte activation,49,0,0.07,1.00000,1,1,0
BP,GO:0036257,multivesicular body organization,33,0,0.05,1.00000,1,1,0
BP,GO:0036258,multivesicular body assembly,32,0,0.05,1.00000,1,1,0
BP,GO:0036296,response to increased oxygen levels,30,0,0.04,1.00000,1,1,0
BP,GO:0036297,interstrand cross-link repair,40,0,0.06,1.00000,1,1,0
BP,GO:0036303,lymph vessel morphogenesis,23,0,0.03,1.00000,1,1,0
BP,GO:0036314,response to sterol,40,0,0.06,1.00000,1,1,0
BP,GO:0036315,cellular response to sterol,27,0,0.04,1.00000,1,1,0
BP,GO:0036336,dendritic cell migration,36,0,0.05,1.00000,1,1,0
BP,GO:0036465,synaptic vesicle recycling,82,0,0.12,1.00000,1,1,0
BP,GO:0036473,cell death in response to oxidative stre...,96,0,0.14,1.00000,1,1,0
BP,GO:0036474,cell death in response to hydrogen perox...,31,0,0.04,1.00000,1,1,0
BP,GO:0036475,neuron death in response to oxidative st...,31,0,0.04,1.00000,1,1,0
BP,GO:0036498,IRE1-mediated unfolded protein response,20,0,0.03,1.00000,1,1,0
BP,GO:0036503,ERAD pathway,122,0,0.18,1.00000,1,1,0
BP,GO:0036507,protein demannosylation,23,0,0.03,1.00000,1,1,0
BP,GO:0036508,"protein alpha-1,2-demannosylation",23,0,0.03,1.00000,1,1,0
BP,GO:0038034,signal transduction in absence of ligand,81,0,0.12,1.00000,1,1,0
BP,GO:0038061,NIK/NF-kappaB signaling,171,0,0.25,1.00000,1,1,0
BP,GO:0038065,collagen-activated signaling pathway,41,0,0.06,1.00000,1,1,0
BP,GO:0038083,peptidyl-tyrosine autophosphorylation,29,0,0.04,1.00000,1,1,0
BP,GO:0038084,vascular endothelial growth factor signa...,51,0,0.07,1.00000,1,1,0
BP,GO:0038092,nodal signaling pathway,21,0,0.03,1.00000,1,1,0
BP,GO:0038093,Fc receptor signaling pathway,54,0,0.08,1.00000,1,1,0
BP,GO:0038094,Fc-gamma receptor signaling pathway,29,0,0.04,1.00000,1,1,0
BP,GO:0038095,Fc-epsilon receptor signaling pathway,27,0,0.04,1.00000,1,1,0
BP,GO:0038096,Fc-gamma receptor signaling pathway invo...,28,0,0.04,1.00000,1,1,0
BP,GO:0038127,ERBB signaling pathway,123,0,0.18,1.00000,1,1,0
BP,GO:0038179,neurotrophin signaling pathway,40,0,0.06,1.00000,1,1,0
BP,GO:0038202,TORC1 signaling,52,0,0.07,1.00000,1,1,0
BP,GO:0039528,cytoplasmic pattern recognition receptor...,44,0,0.06,1.00000,1,1,0
BP,GO:0039529,RIG-I signaling pathway,36,0,0.05,1.00000,1,1,0
BP,GO:0039531,regulation of viral-induced cytoplasmic ...,32,0,0.05,1.00000,1,1,0
BP,GO:0039535,regulation of RIG-I signaling pathway,28,0,0.04,1.00000,1,1,0
BP,GO:0039692,single stranded viral RNA replication vi...,22,0,0.03,1.00000,1,1,0
BP,GO:0039694,viral RNA genome replication,38,0,0.05,1.00000,1,1,0
BP,GO:0039702,viral budding via host ESCRT complex,23,0,0.03,1.00000,1,1,0
BP,GO:0040001,establishment of mitotic spindle localiz...,37,0,0.05,1.00000,1,1,0
BP,GO:0040013,negative regulation of locomotion,429,0,0.62,1.00000,1,1,0
BP,GO:0040014,regulation of multicellular organism gro...,62,0,0.09,1.00000,1,1,0
BP,GO:0040018,positive regulation of multicellular org...,30,0,0.04,1.00000,1,1,0
BP,GO:0040019,positive regulation of embryonic develop...,24,0,0.03,1.00000,1,1,0
BP,GO:0040020,regulation of meiotic nuclear division,35,0,0.05,1.00000,1,1,0
BP,GO:0040036,regulation of fibroblast growth factor r...,37,0,0.05,1.00000,1,1,0
BP,GO:0040037,negative regulation of fibroblast growth...,24,0,0.03,1.00000,1,1,0
BP,GO:0042026,protein refolding,35,0,0.05,1.00000,1,1,0
BP,GO:0042058,regulation of epidermal growth factor re...,74,0,0.11,1.00000,1,1,0
BP,GO:0042059,negative regulation of epidermal growth ...,28,0,0.04,1.00000,1,1,0
BP,GO:0042073,intraciliary transport,40,0,0.06,1.00000,1,1,0
BP,GO:0042088,T-helper 1 type immune response,52,0,0.07,1.00000,1,1,0
BP,GO:0042092,type 2 immune response,37,0,0.05,1.00000,1,1,0
BP,GO:0042100,B cell proliferation,104,0,0.15,1.00000,1,1,0
BP,GO:0042102,positive regulation of T cell proliferat...,154,0,0.22,1.00000,1,1,0
BP,GO:0042104,positive regulation of activated T cell ...,34,0,0.05,1.00000,1,1,0
BP,GO:0042119,neutrophil activation,40,0,0.06,1.00000,1,1,0
BP,GO:0042133,neurotransmitter metabolic process,42,0,0.06,1.00000,1,1,0
BP,GO:0042136,neurotransmitter biosynthetic process,26,0,0.04,1.00000,1,1,0
BP,GO:0042147,"retrograde transport, endosome to Golgi",105,0,0.15,1.00000,1,1,0
BP,GO:0042149,cellular response to glucose starvation,49,0,0.07,1.00000,1,1,0
BP,GO:0042157,lipoprotein metabolic process,146,0,0.21,1.00000,1,1,0
BP,GO:0042158,lipoprotein biosynthetic process,100,0,0.14,1.00000,1,1,0
BP,GO:0042168,heme metabolic process,46,0,0.07,1.00000,1,1,0
BP,GO:0042178,xenobiotic catabolic process,41,0,0.06,1.00000,1,1,0
BP,GO:0042180,cellular ketone metabolic process,218,0,0.31,1.00000,1,1,0
BP,GO:0042181,ketone biosynthetic process,43,0,0.06,1.00000,1,1,0
BP,GO:0042219,cellular modified amino acid catabolic p...,39,0,0.06,1.00000,1,1,0
BP,GO:0042246,tissue regeneration,73,0,0.1,1.00000,1,1,0
BP,GO:0042267,natural killer cell mediated cytotoxicit...,209,0,0.3,1.00000,1,1,0
BP,GO:0042269,regulation of natural killer cell mediat...,147,0,0.21,1.00000,1,1,0
BP,GO:0042270,protection from natural killer cell medi...,31,0,0.04,1.00000,1,1,0
BP,GO:0042273,ribosomal large subunit biogenesis,78,0,0.11,1.00000,1,1,0
BP,GO:0042278,purine nucleoside metabolic process,26,0,0.04,1.00000,1,1,0
BP,GO:0042303,molting cycle,117,0,0.17,1.00000,1,1,0
BP,GO:0042304,regulation of fatty acid biosynthetic pr...,49,0,0.07,1.00000,1,1,0
BP,GO:0042306,regulation of protein import into nucleu...,60,0,0.09,1.00000,1,1,0
BP,GO:0042307,positive regulation of protein import in...,41,0,0.06,1.00000,1,1,0
BP,GO:0042310,vasoconstriction,85,0,0.12,1.00000,1,1,0
BP,GO:0042311,vasodilation,47,0,0.07,1.00000,1,1,0
BP,GO:0042359,vitamin D metabolic process,28,0,0.04,1.00000,1,1,0
BP,GO:0042362,fat-soluble vitamin biosynthetic process,20,0,0.03,1.00000,1,1,0
BP,GO:0042398,cellular modified amino acid biosyntheti...,48,0,0.07,1.00000,1,1,0
BP,GO:0042401,cellular biogenic amine biosynthetic pro...,38,0,0.05,1.00000,1,1,0
BP,GO:0042402,cellular biogenic amine catabolic proces...,30,0,0.04,1.00000,1,1,0
BP,GO:0042403,thyroid hormone metabolic process,29,0,0.04,1.00000,1,1,0
BP,GO:0042423,catecholamine biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0042438,melanin biosynthetic process,27,0,0.04,1.00000,1,1,0
BP,GO:0042440,pigment metabolic process,94,0,0.14,1.00000,1,1,0
BP,GO:0042445,hormone metabolic process,251,0,0.36,1.00000,1,1,0
BP,GO:0042446,hormone biosynthetic process,79,0,0.11,1.00000,1,1,0
BP,GO:0042454,ribonucleoside catabolic process,22,0,0.03,1.00000,1,1,0
BP,GO:0042461,photoreceptor cell development,59,0,0.08,1.00000,1,1,0
BP,GO:0042462,eye photoreceptor cell development,45,0,0.06,1.00000,1,1,0
BP,GO:0042471,ear morphogenesis,124,0,0.18,1.00000,1,1,0
BP,GO:0042472,inner ear morphogenesis,105,0,0.15,1.00000,1,1,0
BP,GO:0042475,odontogenesis of dentin-containing tooth,93,0,0.13,1.00000,1,1,0
BP,GO:0042476,odontogenesis,134,0,0.19,1.00000,1,1,0
BP,GO:0042490,mechanoreceptor differentiation,79,0,0.11,1.00000,1,1,0
BP,GO:0042491,inner ear auditory receptor cell differe...,43,0,0.06,1.00000,1,1,0
BP,GO:0042501,serine phosphorylation of STAT protein,28,0,0.04,1.00000,1,1,0
BP,GO:0042509,regulation of tyrosine phosphorylation o...,96,0,0.14,1.00000,1,1,0
BP,GO:0042531,positive regulation of tyrosine phosphor...,78,0,0.11,1.00000,1,1,0
BP,GO:0042537,benzene-containing compound metabolic pr...,28,0,0.04,1.00000,1,1,0
BP,GO:0042551,neuron maturation,47,0,0.07,1.00000,1,1,0
BP,GO:0042554,superoxide anion generation,48,0,0.07,1.00000,1,1,0
BP,GO:0042558,pteridine-containing compound metabolic ...,35,0,0.05,1.00000,1,1,0
BP,GO:0042572,retinol metabolic process,66,0,0.09,1.00000,1,1,0
BP,GO:0042573,retinoic acid metabolic process,34,0,0.05,1.00000,1,1,0
BP,GO:0042574,retinal metabolic process,25,0,0.04,1.00000,1,1,0
BP,GO:0042590,antigen processing and presentation of e...,23,0,0.03,1.00000,1,1,0
BP,GO:0042593,glucose homeostasis,280,0,0.4,1.00000,1,1,0
BP,GO:0042594,response to starvation,211,0,0.3,1.00000,1,1,0
BP,GO:0042596,fear response,39,0,0.06,1.00000,1,1,0
BP,GO:0042632,cholesterol homeostasis,105,0,0.15,1.00000,1,1,0
BP,GO:0042633,hair cycle,117,0,0.17,1.00000,1,1,0
BP,GO:0042634,regulation of hair cycle,33,0,0.05,1.00000,1,1,0
BP,GO:0042692,muscle cell differentiation,416,0,0.6,1.00000,1,1,0
BP,GO:0042698,ovulation cycle,70,0,0.1,1.00000,1,1,0
BP,GO:0042730,fibrinolysis,26,0,0.04,1.00000,1,1,0
BP,GO:0042733,embryonic digit morphogenesis,56,0,0.08,1.00000,1,1,0
BP,GO:0042743,hydrogen peroxide metabolic process,62,0,0.09,1.00000,1,1,0
BP,GO:0042744,hydrogen peroxide catabolic process,33,0,0.05,1.00000,1,1,0
BP,GO:0042745,circadian sleep/wake cycle,27,0,0.04,1.00000,1,1,0
BP,GO:0042749,regulation of circadian sleep/wake cycle,22,0,0.03,1.00000,1,1,0
BP,GO:0042755,eating behavior,38,0,0.05,1.00000,1,1,0
BP,GO:0042759,long-chain fatty acid biosynthetic proce...,36,0,0.05,1.00000,1,1,0
BP,GO:0042771,intrinsic apoptotic signaling pathway in...,52,0,0.07,1.00000,1,1,0
BP,GO:0042773,ATP synthesis coupled electron transport,110,0,0.16,1.00000,1,1,0
BP,GO:0042775,mitochondrial ATP synthesis coupled elec...,110,0,0.16,1.00000,1,1,0
BP,GO:0042832,defense response to protozoan,28,0,0.04,1.00000,1,1,0
BP,GO:0042886,amide transport,347,0,0.5,1.00000,1,1,0
BP,GO:0042908,xenobiotic transport,52,0,0.07,1.00000,1,1,0
BP,GO:0042987,amyloid precursor protein catabolic proc...,84,0,0.12,1.00000,1,1,0
BP,GO:0043001,Golgi to plasma membrane protein transpo...,43,0,0.06,1.00000,1,1,0
BP,GO:0043011,myeloid dendritic cell differentiation,26,0,0.04,1.00000,1,1,0
BP,GO:0043029,T cell homeostasis,39,0,0.06,1.00000,1,1,0
BP,GO:0043030,regulation of macrophage activation,67,0,0.1,1.00000,1,1,0
BP,GO:0043031,negative regulation of macrophage activa...,20,0,0.03,1.00000,1,1,0
BP,GO:0043032,positive regulation of macrophage activa...,32,0,0.05,1.00000,1,1,0
BP,GO:0043038,amino acid activation,58,0,0.08,1.00000,1,1,0
BP,GO:0043039,tRNA aminoacylation,57,0,0.08,1.00000,1,1,0
BP,GO:0043062,extracellular structure organization,351,0,0.5,1.00000,1,1,0
BP,GO:0043090,amino acid import,54,0,0.08,1.00000,1,1,0
BP,GO:0043094,cellular metabolic compound salvage,28,0,0.04,1.00000,1,1,0
BP,GO:0043112,receptor metabolic process,193,0,0.28,1.00000,1,1,0
BP,GO:0043117,positive regulation of vascular permeabi...,20,0,0.03,1.00000,1,1,0
BP,GO:0043122,regulation of I-kappaB kinase/NF-kappaB ...,290,0,0.42,1.00000,1,1,0
BP,GO:0043123,positive regulation of I-kappaB kinase/N...,216,0,0.31,1.00000,1,1,0
BP,GO:0043124,negative regulation of I-kappaB kinase/N...,61,0,0.09,1.00000,1,1,0
BP,GO:0043149,stress fiber assembly,115,0,0.17,1.00000,1,1,0
BP,GO:0043153,entrainment of circadian clock by photop...,29,0,0.04,1.00000,1,1,0
BP,GO:0043154,negative regulation of cysteine-type end...,89,0,0.13,1.00000,1,1,0
BP,GO:0043161,proteasome-mediated ubiquitin-dependent ...,457,0,0.66,1.00000,1,1,0
BP,GO:0043162,ubiquitin-dependent protein catabolic pr...,24,0,0.03,1.00000,1,1,0
BP,GO:0043171,peptide catabolic process,33,0,0.05,1.00000,1,1,0
BP,GO:0043242,negative regulation of protein-containin...,92,0,0.13,1.00000,1,1,0
BP,GO:0043243,positive regulation of protein-containin...,45,0,0.06,1.00000,1,1,0
BP,GO:0043244,regulation of protein-containing complex...,135,0,0.19,1.00000,1,1,0
BP,GO:0043255,regulation of carbohydrate biosynthetic ...,100,0,0.14,1.00000,1,1,0
BP,GO:0043267,negative regulation of potassium ion tra...,41,0,0.06,1.00000,1,1,0
BP,GO:0043271,negative regulation of ion transport,184,0,0.26,1.00000,1,1,0
BP,GO:0043276,anoikis,34,0,0.05,1.00000,1,1,0
BP,GO:0043277,apoptotic cell clearance,66,0,0.09,1.00000,1,1,0
BP,GO:0043278,response to morphine,40,0,0.06,1.00000,1,1,0
BP,GO:0043280,positive regulation of cysteine-type end...,151,0,0.22,1.00000,1,1,0
BP,GO:0043281,regulation of cysteine-type endopeptidas...,235,0,0.34,1.00000,1,1,0
BP,GO:0043299,leukocyte degranulation,83,0,0.12,1.00000,1,1,0
BP,GO:0043300,regulation of leukocyte degranulation,53,0,0.08,1.00000,1,1,0
BP,GO:0043302,positive regulation of leukocyte degranu...,30,0,0.04,1.00000,1,1,0
BP,GO:0043303,mast cell degranulation,50,0,0.07,1.00000,1,1,0
BP,GO:0043304,regulation of mast cell degranulation,31,0,0.04,1.00000,1,1,0
BP,GO:0043330,response to exogenous dsRNA,58,0,0.08,1.00000,1,1,0
BP,GO:0043331,response to dsRNA,64,0,0.09,1.00000,1,1,0
BP,GO:0043368,positive T cell selection,39,0,0.06,1.00000,1,1,0
BP,GO:0043369,"CD4-positive or CD8-positive, alpha-beta...",23,0,0.03,1.00000,1,1,0
BP,GO:0043370,"regulation of CD4-positive, alpha-beta T...",63,0,0.09,1.00000,1,1,0
BP,GO:0043371,"negative regulation of CD4-positive, alp...",22,0,0.03,1.00000,1,1,0
BP,GO:0043372,"positive regulation of CD4-positive, alp...",44,0,0.06,1.00000,1,1,0
BP,GO:0043373,"CD4-positive, alpha-beta T cell lineage ...",21,0,0.03,1.00000,1,1,0
BP,GO:0043379,memory T cell differentiation,25,0,0.04,1.00000,1,1,0
BP,GO:0043380,regulation of memory T cell differentiat...,24,0,0.03,1.00000,1,1,0
BP,GO:0043382,positive regulation of memory T cell dif...,21,0,0.03,1.00000,1,1,0
BP,GO:0043388,positive regulation of DNA binding,59,0,0.08,1.00000,1,1,0
BP,GO:0043392,negative regulation of DNA binding,53,0,0.08,1.00000,1,1,0
BP,GO:0043393,regulation of protein binding,212,0,0.3,1.00000,1,1,0
BP,GO:0043403,skeletal muscle tissue regeneration,37,0,0.05,1.00000,1,1,0
BP,GO:0043405,regulation of MAP kinase activity,203,0,0.29,1.00000,1,1,0
BP,GO:0043406,positive regulation of MAP kinase activi...,130,0,0.19,1.00000,1,1,0
BP,GO:0043407,negative regulation of MAP kinase activi...,60,0,0.09,1.00000,1,1,0
BP,GO:0043433,negative regulation of DNA-binding trans...,214,0,0.31,1.00000,1,1,0
BP,GO:0043457,regulation of cellular respiration,49,0,0.07,1.00000,1,1,0
BP,GO:0043462,regulation of ATPase activity,49,0,0.07,1.00000,1,1,0
BP,GO:0043467,regulation of generation of precursor me...,134,0,0.19,1.00000,1,1,0
BP,GO:0043470,regulation of carbohydrate catabolic pro...,58,0,0.08,1.00000,1,1,0
BP,GO:0043484,regulation of RNA splicing,159,0,0.23,1.00000,1,1,0
BP,GO:0043486,histone exchange,23,0,0.03,1.00000,1,1,0
BP,GO:0043489,RNA stabilization,68,0,0.1,1.00000,1,1,0
BP,GO:0043506,regulation of JUN kinase activity,79,0,0.11,1.00000,1,1,0
BP,GO:0043507,positive regulation of JUN kinase activi...,56,0,0.08,1.00000,1,1,0
BP,GO:0043516,"regulation of DNA damage response, signa...",35,0,0.05,1.00000,1,1,0
BP,GO:0043523,regulation of neuron apoptotic process,232,0,0.33,1.00000,1,1,0
BP,GO:0043524,negative regulation of neuron apoptotic ...,156,0,0.22,1.00000,1,1,0
BP,GO:0043525,positive regulation of neuron apoptotic ...,67,0,0.1,1.00000,1,1,0
BP,GO:0043534,blood vessel endothelial cell migration,195,0,0.28,1.00000,1,1,0
BP,GO:0043535,regulation of blood vessel endothelial c...,168,0,0.24,1.00000,1,1,0
BP,GO:0043536,positive regulation of blood vessel endo...,80,0,0.11,1.00000,1,1,0
BP,GO:0043537,negative regulation of blood vessel endo...,91,0,0.13,1.00000,1,1,0
BP,GO:0043543,protein acylation,266,0,0.38,1.00000,1,1,0
BP,GO:0043547,positive regulation of GTPase activity,296,0,0.43,1.00000,1,1,0
BP,GO:0043555,regulation of translation in response to...,22,0,0.03,1.00000,1,1,0
BP,GO:0043567,regulation of insulin-like growth factor...,24,0,0.03,1.00000,1,1,0
BP,GO:0043574,peroxisomal transport,23,0,0.03,1.00000,1,1,0
BP,GO:0043576,regulation of respiratory gaseous exchan...,22,0,0.03,1.00000,1,1,0
BP,GO:0043586,tongue development,20,0,0.03,1.00000,1,1,0
BP,GO:0043588,skin development,290,0,0.42,1.00000,1,1,0
BP,GO:0043616,keratinocyte proliferation,48,0,0.07,1.00000,1,1,0
BP,GO:0043618,regulation of transcription from RNA pol...,57,0,0.08,1.00000,1,1,0
BP,GO:0043620,regulation of DNA-templated transcriptio...,64,0,0.09,1.00000,1,1,0
BP,GO:0043624,cellular protein complex disassembly,142,0,0.2,1.00000,1,1,0
BP,GO:0043628,ncRNA 3'-end processing,52,0,0.07,1.00000,1,1,0
BP,GO:0043631,RNA polyadenylation,56,0,0.08,1.00000,1,1,0
BP,GO:0043647,inositol phosphate metabolic process,56,0,0.08,1.00000,1,1,0
BP,GO:0043648,dicarboxylic acid metabolic process,101,0,0.15,1.00000,1,1,0
BP,GO:0043651,linoleic acid metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0043652,engulfment of apoptotic cell,20,0,0.03,1.00000,1,1,0
BP,GO:0043666,regulation of phosphoprotein phosphatase...,79,0,0.11,1.00000,1,1,0
BP,GO:0043687,post-translational protein modification,41,0,0.06,1.00000,1,1,0
BP,GO:0043691,reverse cholesterol transport,27,0,0.04,1.00000,1,1,0
BP,GO:0043903,regulation of biological process involve...,113,0,0.16,1.00000,1,1,0
BP,GO:0043931,ossification involved in bone maturation,26,0,0.04,1.00000,1,1,0
BP,GO:0043949,regulation of cAMP-mediated signaling,39,0,0.06,1.00000,1,1,0
BP,GO:0043966,histone H3 acetylation,65,0,0.09,1.00000,1,1,0
BP,GO:0043967,histone H4 acetylation,71,0,0.1,1.00000,1,1,0
BP,GO:0043984,histone H4-K16 acetylation,22,0,0.03,1.00000,1,1,0
BP,GO:0044003,modulation by symbiont of host process,21,0,0.03,1.00000,1,1,0
BP,GO:0044030,regulation of DNA methylation,35,0,0.05,1.00000,1,1,0
BP,GO:0044042,glucan metabolic process,76,0,0.11,1.00000,1,1,0
BP,GO:0044058,regulation of digestive system process,47,0,0.07,1.00000,1,1,0
BP,GO:0044060,regulation of endocrine process,40,0,0.06,1.00000,1,1,0
BP,GO:0044062,regulation of excretion,24,0,0.03,1.00000,1,1,0
BP,GO:0044070,regulation of anion transport,91,0,0.13,1.00000,1,1,0
BP,GO:0044088,regulation of vacuole organization,60,0,0.09,1.00000,1,1,0
BP,GO:0044091,membrane biogenesis,67,0,0.1,1.00000,1,1,0
BP,GO:0044241,lipid digestion,21,0,0.03,1.00000,1,1,0
BP,GO:0044242,cellular lipid catabolic process,237,0,0.34,1.00000,1,1,0
BP,GO:0044247,cellular polysaccharide catabolic proces...,20,0,0.03,1.00000,1,1,0
BP,GO:0044255,cellular lipid metabolic process,1106,0,1.59,1.00000,1,1,0
BP,GO:0044262,cellular carbohydrate metabolic process,292,0,0.42,1.00000,1,1,0
BP,GO:0044264,cellular polysaccharide metabolic proces...,100,0,0.14,1.00000,1,1,0
BP,GO:0044272,sulfur compound biosynthetic process,162,0,0.23,1.00000,1,1,0
BP,GO:0044273,sulfur compound catabolic process,36,0,0.05,1.00000,1,1,0
BP,GO:0044275,cellular carbohydrate catabolic process,42,0,0.06,1.00000,1,1,0
BP,GO:0044283,small molecule biosynthetic process,593,0,0.85,1.00000,1,1,0
BP,GO:0044319,"wound healing, spreading of cells",41,0,0.06,1.00000,1,1,0
BP,GO:0044320,cellular response to leptin stimulus,20,0,0.03,1.00000,1,1,0
BP,GO:0044321,response to leptin,25,0,0.04,1.00000,1,1,0
BP,GO:0044331,cell-cell adhesion mediated by cadherin,43,0,0.06,1.00000,1,1,0
BP,GO:0044342,type B pancreatic cell proliferation,21,0,0.03,1.00000,1,1,0
BP,GO:0044344,cellular response to fibroblast growth f...,115,0,0.17,1.00000,1,1,0
BP,GO:0044346,fibroblast apoptotic process,22,0,0.03,1.00000,1,1,0
BP,GO:0044380,protein localization to cytoskeleton,61,0,0.09,1.00000,1,1,0
BP,GO:0044403,biological process involved in symbiotic...,373,0,0.54,1.00000,1,1,0
BP,GO:0044409,entry into host,202,0,0.29,1.00000,1,1,0
BP,GO:0044458,motile cilium assembly,48,0,0.07,1.00000,1,1,0
BP,GO:0044546,NLRP3 inflammasome complex assembly,25,0,0.04,1.00000,1,1,0
BP,GO:0044550,secondary metabolite biosynthetic proces...,29,0,0.04,1.00000,1,1,0
BP,GO:0044743,protein transmembrane import into intrac...,38,0,0.05,1.00000,1,1,0
BP,GO:0044766,multi-organism transport,28,0,0.04,1.00000,1,1,0
BP,GO:0044782,cilium organization,380,0,0.55,1.00000,1,1,0
BP,GO:0044784,metaphase/anaphase transition of cell cy...,66,0,0.09,1.00000,1,1,0
BP,GO:0044788,modulation by host of viral process,32,0,0.05,1.00000,1,1,0
BP,GO:0044818,mitotic G2/M transition checkpoint,55,0,0.08,1.00000,1,1,0
BP,GO:0044827,modulation by host of viral genome repli...,20,0,0.03,1.00000,1,1,0
BP,GO:0044839,cell cycle G2/M phase transition,161,0,0.23,1.00000,1,1,0
BP,GO:0045010,actin nucleation,59,0,0.08,1.00000,1,1,0
BP,GO:0045017,glycerolipid biosynthetic process,290,0,0.42,1.00000,1,1,0
BP,GO:0045022,early endosome to late endosome transpor...,42,0,0.06,1.00000,1,1,0
BP,GO:0045023,G0 to G1 transition,22,0,0.03,1.00000,1,1,0
BP,GO:0045026,plasma membrane fusion,32,0,0.05,1.00000,1,1,0
BP,GO:0045047,protein targeting to ER,41,0,0.06,1.00000,1,1,0
BP,GO:0045048,protein insertion into ER membrane,29,0,0.04,1.00000,1,1,0
BP,GO:0045055,regulated exocytosis,244,0,0.35,1.00000,1,1,0
BP,GO:0045056,transcytosis,27,0,0.04,1.00000,1,1,0
BP,GO:0045058,T cell selection,52,0,0.07,1.00000,1,1,0
BP,GO:0045061,thymic T cell selection,23,0,0.03,1.00000,1,1,0
BP,GO:0045063,T-helper 1 cell differentiation,20,0,0.03,1.00000,1,1,0
BP,GO:0045066,regulatory T cell differentiation,58,0,0.08,1.00000,1,1,0
BP,GO:0045069,regulation of viral genome replication,94,0,0.14,1.00000,1,1,0
BP,GO:0045070,positive regulation of viral genome repl...,31,0,0.04,1.00000,1,1,0
BP,GO:0045071,negative regulation of viral genome repl...,65,0,0.09,1.00000,1,1,0
BP,GO:0045091,regulation of single stranded viral RNA ...,20,0,0.03,1.00000,1,1,0
BP,GO:0045109,intermediate filament organization,26,0,0.04,1.00000,1,1,0
BP,GO:0045116,protein neddylation,26,0,0.04,1.00000,1,1,0
BP,GO:0045123,cellular extravasation,88,0,0.13,1.00000,1,1,0
BP,GO:0045124,regulation of bone resorption,47,0,0.07,1.00000,1,1,0
BP,GO:0045132,meiotic chromosome segregation,108,0,0.16,1.00000,1,1,0
BP,GO:0045143,homologous chromosome segregation,77,0,0.11,1.00000,1,1,0
BP,GO:0045185,maintenance of protein location,95,0,0.14,1.00000,1,1,0
BP,GO:0045214,sarcomere organization,44,0,0.06,1.00000,1,1,0
BP,GO:0045229,external encapsulating structure organiz...,354,0,0.51,1.00000,1,1,0
BP,GO:0045292,"mRNA cis splicing, via spliceosome",43,0,0.06,1.00000,1,1,0
BP,GO:0045324,late endosome to vacuole transport,27,0,0.04,1.00000,1,1,0
BP,GO:0045332,phospholipid translocation,53,0,0.08,1.00000,1,1,0
BP,GO:0045333,cellular respiration,249,0,0.36,1.00000,1,1,0
BP,GO:0045428,regulation of nitric oxide biosynthetic ...,80,0,0.11,1.00000,1,1,0
BP,GO:0045429,positive regulation of nitric oxide bios...,58,0,0.08,1.00000,1,1,0
BP,GO:0045444,fat cell differentiation,258,0,0.37,1.00000,1,1,0
BP,GO:0045445,myoblast differentiation,97,0,0.14,1.00000,1,1,0
BP,GO:0045446,endothelial cell differentiation,135,0,0.19,1.00000,1,1,0
BP,GO:0045453,bone resorption,68,0,0.1,1.00000,1,1,0
BP,GO:0045454,cell redox homeostasis,35,0,0.05,1.00000,1,1,0
BP,GO:0045540,regulation of cholesterol biosynthetic p...,22,0,0.03,1.00000,1,1,0
BP,GO:0045576,mast cell activation,64,0,0.09,1.00000,1,1,0
BP,GO:0045577,regulation of B cell differentiation,31,0,0.04,1.00000,1,1,0
BP,GO:0045580,regulation of T cell differentiation,180,0,0.26,1.00000,1,1,0
BP,GO:0045581,negative regulation of T cell differenti...,51,0,0.07,1.00000,1,1,0
BP,GO:0045582,positive regulation of T cell differenti...,119,0,0.17,1.00000,1,1,0
BP,GO:0045589,regulation of regulatory T cell differen...,55,0,0.08,1.00000,1,1,0
BP,GO:0045591,positive regulation of regulatory T cell...,44,0,0.06,1.00000,1,1,0
BP,GO:0045598,regulation of fat cell differentiation,159,0,0.23,1.00000,1,1,0
BP,GO:0045599,negative regulation of fat cell differen...,67,0,0.1,1.00000,1,1,0
BP,GO:0045600,positive regulation of fat cell differen...,68,0,0.1,1.00000,1,1,0
BP,GO:0045601,regulation of endothelial cell different...,60,0,0.09,1.00000,1,1,0
BP,GO:0045604,regulation of epidermal cell differentia...,61,0,0.09,1.00000,1,1,0
BP,GO:0045606,positive regulation of epidermal cell di...,27,0,0.04,1.00000,1,1,0
BP,GO:0045616,regulation of keratinocyte differentiati...,38,0,0.05,1.00000,1,1,0
BP,GO:0045620,negative regulation of lymphocyte differ...,59,0,0.08,1.00000,1,1,0
BP,GO:0045622,regulation of T-helper cell differentiat...,51,0,0.07,1.00000,1,1,0
BP,GO:0045624,positive regulation of T-helper cell dif...,22,0,0.03,1.00000,1,1,0
BP,GO:0045638,negative regulation of myeloid cell diff...,106,0,0.15,1.00000,1,1,0
BP,GO:0045649,regulation of macrophage differentiation,25,0,0.04,1.00000,1,1,0
BP,GO:0045652,regulation of megakaryocyte differentiat...,37,0,0.05,1.00000,1,1,0
BP,GO:0045661,regulation of myoblast differentiation,60,0,0.09,1.00000,1,1,0
BP,GO:0045662,negative regulation of myoblast differen...,32,0,0.05,1.00000,1,1,0
BP,GO:0045663,positive regulation of myoblast differen...,22,0,0.03,1.00000,1,1,0
BP,GO:0045665,negative regulation of neuron differenti...,72,0,0.1,1.00000,1,1,0
BP,GO:0045667,regulation of osteoblast differentiation,152,0,0.22,1.00000,1,1,0
BP,GO:0045668,negative regulation of osteoblast differ...,64,0,0.09,1.00000,1,1,0
BP,GO:0045669,positive regulation of osteoblast differ...,75,0,0.11,1.00000,1,1,0
BP,GO:0045670,regulation of osteoclast differentiation,85,0,0.12,1.00000,1,1,0
BP,GO:0045671,negative regulation of osteoclast differ...,42,0,0.06,1.00000,1,1,0
BP,GO:0045672,positive regulation of osteoclast differ...,33,0,0.05,1.00000,1,1,0
BP,GO:0045682,regulation of epidermis development,68,0,0.1,1.00000,1,1,0
BP,GO:0045684,positive regulation of epidermis develop...,32,0,0.05,1.00000,1,1,0
BP,GO:0045685,regulation of glial cell differentiation,78,0,0.11,1.00000,1,1,0
BP,GO:0045686,negative regulation of glial cell differ...,30,0,0.04,1.00000,1,1,0
BP,GO:0045687,positive regulation of glial cell differ...,42,0,0.06,1.00000,1,1,0
BP,GO:0045717,negative regulation of fatty acid biosyn...,21,0,0.03,1.00000,1,1,0
BP,GO:0045723,positive regulation of fatty acid biosyn...,23,0,0.03,1.00000,1,1,0
BP,GO:0045724,positive regulation of cilium assembly,24,0,0.03,1.00000,1,1,0
BP,GO:0045730,respiratory burst,38,0,0.05,1.00000,1,1,0
BP,GO:0045732,positive regulation of protein catabolic...,268,0,0.39,1.00000,1,1,0
BP,GO:0045736,negative regulation of cyclin-dependent ...,35,0,0.05,1.00000,1,1,0
BP,GO:0045737,positive regulation of cyclin-dependent ...,29,0,0.04,1.00000,1,1,0
BP,GO:0045738,negative regulation of DNA repair,38,0,0.05,1.00000,1,1,0
BP,GO:0045742,positive regulation of epidermal growth ...,37,0,0.05,1.00000,1,1,0
BP,GO:0045744,negative regulation of G protein-coupled...,58,0,0.08,1.00000,1,1,0
BP,GO:0045745,positive regulation of G protein-coupled...,27,0,0.04,1.00000,1,1,0
BP,GO:0045746,negative regulation of Notch signaling p...,37,0,0.05,1.00000,1,1,0
BP,GO:0045747,positive regulation of Notch signaling p...,49,0,0.07,1.00000,1,1,0
BP,GO:0045761,regulation of adenylate cyclase activity,38,0,0.05,1.00000,1,1,0
BP,GO:0045773,positive regulation of axon extension,48,0,0.07,1.00000,1,1,0
BP,GO:0045776,negative regulation of blood pressure,44,0,0.06,1.00000,1,1,0
BP,GO:0045777,positive regulation of blood pressure,40,0,0.06,1.00000,1,1,0
BP,GO:0045778,positive regulation of ossification,50,0,0.07,1.00000,1,1,0
BP,GO:0045780,positive regulation of bone resorption,21,0,0.03,1.00000,1,1,0
BP,GO:0045806,negative regulation of endocytosis,58,0,0.08,1.00000,1,1,0
BP,GO:0045807,positive regulation of endocytosis,116,0,0.17,1.00000,1,1,0
BP,GO:0045822,negative regulation of heart contraction,25,0,0.04,1.00000,1,1,0
BP,GO:0045823,positive regulation of heart contraction,41,0,0.06,1.00000,1,1,0
BP,GO:0045824,negative regulation of innate immune res...,150,0,0.22,1.00000,1,1,0
BP,GO:0045833,negative regulation of lipid metabolic p...,111,0,0.16,1.00000,1,1,0
BP,GO:0045839,negative regulation of mitotic nuclear d...,48,0,0.07,1.00000,1,1,0
BP,GO:0045840,positive regulation of mitotic nuclear d...,43,0,0.06,1.00000,1,1,0
BP,GO:0045841,negative regulation of mitotic metaphase...,40,0,0.06,1.00000,1,1,0
BP,GO:0045844,positive regulation of striated muscle t...,28,0,0.04,1.00000,1,1,0
BP,GO:0045851,pH reduction,48,0,0.07,1.00000,1,1,0
BP,GO:0045879,negative regulation of smoothened signal...,35,0,0.05,1.00000,1,1,0
BP,GO:0045880,positive regulation of smoothened signal...,36,0,0.05,1.00000,1,1,0
BP,GO:0045907,positive regulation of vasoconstriction,35,0,0.05,1.00000,1,1,0
BP,GO:0045910,negative regulation of DNA recombination,44,0,0.06,1.00000,1,1,0
BP,GO:0045912,negative regulation of carbohydrate meta...,49,0,0.07,1.00000,1,1,0
BP,GO:0045913,positive regulation of carbohydrate meta...,75,0,0.11,1.00000,1,1,0
BP,GO:0045920,negative regulation of exocytosis,38,0,0.05,1.00000,1,1,0
BP,GO:0045921,positive regulation of exocytosis,93,0,0.13,1.00000,1,1,0
BP,GO:0045922,negative regulation of fatty acid metabo...,35,0,0.05,1.00000,1,1,0
BP,GO:0045923,positive regulation of fatty acid metabo...,39,0,0.06,1.00000,1,1,0
BP,GO:0045926,negative regulation of growth,275,0,0.4,1.00000,1,1,0
BP,GO:0045931,positive regulation of mitotic cell cycl...,134,0,0.19,1.00000,1,1,0
BP,GO:0045932,negative regulation of muscle contractio...,23,0,0.03,1.00000,1,1,0
BP,GO:0045933,positive regulation of muscle contractio...,48,0,0.07,1.00000,1,1,0
BP,GO:0045939,negative regulation of steroid metabolic...,30,0,0.04,1.00000,1,1,0
BP,GO:0045940,positive regulation of steroid metabolic...,38,0,0.05,1.00000,1,1,0
BP,GO:0045943,positive regulation of transcription by ...,24,0,0.03,1.00000,1,1,0
BP,GO:0045948,positive regulation of translational ini...,38,0,0.05,1.00000,1,1,0
BP,GO:0045953,negative regulation of natural killer ce...,97,0,0.14,1.00000,1,1,0
BP,GO:0045954,positive regulation of natural killer ce...,45,0,0.06,1.00000,1,1,0
BP,GO:0045980,negative regulation of nucleotide metabo...,25,0,0.04,1.00000,1,1,0
BP,GO:0045981,positive regulation of nucleotide metabo...,42,0,0.06,1.00000,1,1,0
BP,GO:0045987,positive regulation of smooth muscle con...,32,0,0.05,1.00000,1,1,0
BP,GO:0045995,regulation of embryonic development,73,0,0.1,1.00000,1,1,0
BP,GO:0046006,regulation of activated T cell prolifera...,58,0,0.08,1.00000,1,1,0
BP,GO:0046007,negative regulation of activated T cell ...,21,0,0.03,1.00000,1,1,0
BP,GO:0046031,ADP metabolic process,94,0,0.14,1.00000,1,1,0
BP,GO:0046034,ATP metabolic process,310,0,0.45,1.00000,1,1,0
BP,GO:0046039,GTP metabolic process,24,0,0.03,1.00000,1,1,0
BP,GO:0046058,cAMP metabolic process,25,0,0.04,1.00000,1,1,0
BP,GO:0046112,nucleobase biosynthetic process,20,0,0.03,1.00000,1,1,0
BP,GO:0046128,purine ribonucleoside metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0046148,pigment biosynthetic process,70,0,0.1,1.00000,1,1,0
BP,GO:0046164,alcohol catabolic process,57,0,0.08,1.00000,1,1,0
BP,GO:0046165,alcohol biosynthetic process,144,0,0.21,1.00000,1,1,0
BP,GO:0046173,polyol biosynthetic process,63,0,0.09,1.00000,1,1,0
BP,GO:0046174,polyol catabolic process,28,0,0.04,1.00000,1,1,0
BP,GO:0046189,phenol-containing compound biosynthetic ...,50,0,0.07,1.00000,1,1,0
BP,GO:0046209,nitric oxide metabolic process,99,0,0.14,1.00000,1,1,0
BP,GO:0046320,regulation of fatty acid oxidation,34,0,0.05,1.00000,1,1,0
BP,GO:0046323,glucose import,87,0,0.13,1.00000,1,1,0
BP,GO:0046324,regulation of glucose import,69,0,0.1,1.00000,1,1,0
BP,GO:0046325,negative regulation of glucose import,21,0,0.03,1.00000,1,1,0
BP,GO:0046326,positive regulation of glucose import,42,0,0.06,1.00000,1,1,0
BP,GO:0046328,regulation of JNK cascade,150,0,0.22,1.00000,1,1,0
BP,GO:0046329,negative regulation of JNK cascade,39,0,0.06,1.00000,1,1,0
BP,GO:0046330,positive regulation of JNK cascade,105,0,0.15,1.00000,1,1,0
BP,GO:0046337,phosphatidylethanolamine metabolic proce...,29,0,0.04,1.00000,1,1,0
BP,GO:0046339,diacylglycerol metabolic process,27,0,0.04,1.00000,1,1,0
BP,GO:0046341,CDP-diacylglycerol metabolic process,22,0,0.03,1.00000,1,1,0
BP,GO:0046364,monosaccharide biosynthetic process,88,0,0.13,1.00000,1,1,0
BP,GO:0046365,monosaccharide catabolic process,40,0,0.06,1.00000,1,1,0
BP,GO:0046386,deoxyribose phosphate catabolic process,31,0,0.04,1.00000,1,1,0
BP,GO:0046390,ribose phosphate biosynthetic process,202,0,0.29,1.00000,1,1,0
BP,GO:0046394,carboxylic acid biosynthetic process,337,0,0.48,1.00000,1,1,0
BP,GO:0046425,regulation of receptor signaling pathway...,115,0,0.17,1.00000,1,1,0
BP,GO:0046426,negative regulation of receptor signalin...,30,0,0.04,1.00000,1,1,0
BP,GO:0046427,positive regulation of receptor signalin...,53,0,0.08,1.00000,1,1,0
BP,GO:0046434,organophosphate catabolic process,166,0,0.24,1.00000,1,1,0
BP,GO:0046456,icosanoid biosynthetic process,61,0,0.09,1.00000,1,1,0
BP,GO:0046457,prostanoid biosynthetic process,33,0,0.05,1.00000,1,1,0
BP,GO:0046460,neutral lipid biosynthetic process,53,0,0.08,1.00000,1,1,0
BP,GO:0046461,neutral lipid catabolic process,45,0,0.06,1.00000,1,1,0
BP,GO:0046462,monoacylglycerol metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0046463,acylglycerol biosynthetic process,53,0,0.08,1.00000,1,1,0
BP,GO:0046464,acylglycerol catabolic process,45,0,0.06,1.00000,1,1,0
BP,GO:0046466,membrane lipid catabolic process,45,0,0.06,1.00000,1,1,0
BP,GO:0046467,membrane lipid biosynthetic process,153,0,0.22,1.00000,1,1,0
BP,GO:0046470,phosphatidylcholine metabolic process,92,0,0.13,1.00000,1,1,0
BP,GO:0046471,phosphatidylglycerol metabolic process,40,0,0.06,1.00000,1,1,0
BP,GO:0046473,phosphatidic acid metabolic process,47,0,0.07,1.00000,1,1,0
BP,GO:0046474,glycerophospholipid biosynthetic process,246,0,0.35,1.00000,1,1,0
BP,GO:0046475,glycerophospholipid catabolic process,39,0,0.06,1.00000,1,1,0
BP,GO:0046479,glycosphingolipid catabolic process,23,0,0.03,1.00000,1,1,0
BP,GO:0046485,ether lipid metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0046486,glycerolipid metabolic process,449,0,0.65,1.00000,1,1,0
BP,GO:0046488,phosphatidylinositol metabolic process,176,0,0.25,1.00000,1,1,0
BP,GO:0046496,nicotinamide nucleotide metabolic proces...,35,0,0.05,1.00000,1,1,0
BP,GO:0046503,glycerolipid catabolic process,72,0,0.1,1.00000,1,1,0
BP,GO:0046513,ceramide biosynthetic process,73,0,0.1,1.00000,1,1,0
BP,GO:0046514,ceramide catabolic process,30,0,0.04,1.00000,1,1,0
BP,GO:0046519,sphingoid metabolic process,23,0,0.03,1.00000,1,1,0
BP,GO:0046530,photoreceptor cell differentiation,74,0,0.11,1.00000,1,1,0
BP,GO:0046545,development of primary female sexual cha...,101,0,0.15,1.00000,1,1,0
BP,GO:0046578,regulation of Ras protein signal transdu...,215,0,0.31,1.00000,1,1,0
BP,GO:0046579,positive regulation of Ras protein signa...,71,0,0.1,1.00000,1,1,0
BP,GO:0046580,negative regulation of Ras protein signa...,53,0,0.08,1.00000,1,1,0
BP,GO:0046596,regulation of viral entry into host cell,75,0,0.11,1.00000,1,1,0
BP,GO:0046597,negative regulation of viral entry into ...,43,0,0.06,1.00000,1,1,0
BP,GO:0046599,regulation of centriole replication,22,0,0.03,1.00000,1,1,0
BP,GO:0046605,regulation of centrosome cycle,53,0,0.08,1.00000,1,1,0
BP,GO:0046618,xenobiotic export,25,0,0.04,1.00000,1,1,0
BP,GO:0046620,regulation of organ growth,115,0,0.17,1.00000,1,1,0
BP,GO:0046621,negative regulation of organ growth,41,0,0.06,1.00000,1,1,0
BP,GO:0046622,positive regulation of organ growth,63,0,0.09,1.00000,1,1,0
BP,GO:0046626,regulation of insulin receptor signaling...,67,0,0.1,1.00000,1,1,0
BP,GO:0046627,negative regulation of insulin receptor ...,36,0,0.05,1.00000,1,1,0
BP,GO:0046628,positive regulation of insulin receptor ...,22,0,0.03,1.00000,1,1,0
BP,GO:0046629,gamma-delta T cell activation,36,0,0.05,1.00000,1,1,0
BP,GO:0046633,alpha-beta T cell proliferation,57,0,0.08,1.00000,1,1,0
BP,GO:0046634,regulation of alpha-beta T cell activati...,160,0,0.23,1.00000,1,1,0
BP,GO:0046635,positive regulation of alpha-beta T cell...,99,0,0.14,1.00000,1,1,0
BP,GO:0046636,negative regulation of alpha-beta T cell...,61,0,0.09,1.00000,1,1,0
BP,GO:0046637,regulation of alpha-beta T cell differen...,84,0,0.12,1.00000,1,1,0
BP,GO:0046638,positive regulation of alpha-beta T cell...,66,0,0.09,1.00000,1,1,0
BP,GO:0046639,negative regulation of alpha-beta T cell...,26,0,0.04,1.00000,1,1,0
BP,GO:0046640,regulation of alpha-beta T cell prolifer...,54,0,0.08,1.00000,1,1,0
BP,GO:0046641,positive regulation of alpha-beta T cell...,35,0,0.05,1.00000,1,1,0
BP,GO:0046653,tetrahydrofolate metabolic process,21,0,0.03,1.00000,1,1,0
BP,GO:0046660,female sex differentiation,117,0,0.17,1.00000,1,1,0
BP,GO:0046676,negative regulation of insulin secretion,39,0,0.06,1.00000,1,1,0
BP,GO:0046677,response to antibiotic,53,0,0.08,1.00000,1,1,0
BP,GO:0046685,response to arsenic-containing substance,42,0,0.06,1.00000,1,1,0
BP,GO:0046686,response to cadmium ion,75,0,0.11,1.00000,1,1,0
BP,GO:0046688,response to copper ion,47,0,0.07,1.00000,1,1,0
BP,GO:0046697,decidualization,27,0,0.04,1.00000,1,1,0
BP,GO:0046717,acid secretion,49,0,0.07,1.00000,1,1,0
BP,GO:0046718,viral entry into host cell,195,0,0.28,1.00000,1,1,0
BP,GO:0046755,viral budding,28,0,0.04,1.00000,1,1,0
BP,GO:0046782,regulation of viral transcription,32,0,0.05,1.00000,1,1,0
BP,GO:0046785,microtubule polymerization,99,0,0.14,1.00000,1,1,0
BP,GO:0046794,transport of virus,26,0,0.04,1.00000,1,1,0
BP,GO:0046822,regulation of nucleocytoplasmic transpor...,109,0,0.16,1.00000,1,1,0
BP,GO:0046823,negative regulation of nucleocytoplasmic...,21,0,0.03,1.00000,1,1,0
BP,GO:0046824,positive regulation of nucleocytoplasmic...,64,0,0.09,1.00000,1,1,0
BP,GO:0046825,regulation of protein export from nucleu...,33,0,0.05,1.00000,1,1,0
BP,GO:0046835,carbohydrate phosphorylation,26,0,0.04,1.00000,1,1,0
BP,GO:0046839,phospholipid dephosphorylation,53,0,0.08,1.00000,1,1,0
BP,GO:0046847,filopodium assembly,65,0,0.09,1.00000,1,1,0
BP,GO:0046849,bone remodeling,94,0,0.14,1.00000,1,1,0
BP,GO:0046850,regulation of bone remodeling,56,0,0.08,1.00000,1,1,0
BP,GO:0046851,negative regulation of bone remodeling,21,0,0.03,1.00000,1,1,0
BP,GO:0046854,phosphatidylinositol phosphate biosynthe...,66,0,0.09,1.00000,1,1,0
BP,GO:0046856,phosphatidylinositol dephosphorylation,36,0,0.05,1.00000,1,1,0
BP,GO:0046879,hormone secretion,327,0,0.47,1.00000,1,1,0
BP,GO:0046883,regulation of hormone secretion,277,0,0.4,1.00000,1,1,0
BP,GO:0046885,regulation of hormone biosynthetic proce...,21,0,0.03,1.00000,1,1,0
BP,GO:0046887,positive regulation of hormone secretion,143,0,0.21,1.00000,1,1,0
BP,GO:0046888,negative regulation of hormone secretion,66,0,0.09,1.00000,1,1,0
BP,GO:0046889,positive regulation of lipid biosyntheti...,89,0,0.13,1.00000,1,1,0
BP,GO:0046890,regulation of lipid biosynthetic process,180,0,0.26,1.00000,1,1,0
BP,GO:0046903,secretion,1021,0,1.47,1.00000,1,1,0
BP,GO:0046916,cellular transition metal ion homeostasi...,119,0,0.17,1.00000,1,1,0
BP,GO:0046928,regulation of neurotransmitter secretion,86,0,0.12,1.00000,1,1,0
BP,GO:0046931,pore complex assembly,21,0,0.03,1.00000,1,1,0
BP,GO:0046939,nucleotide phosphorylation,104,0,0.15,1.00000,1,1,0
BP,GO:0046942,carboxylic acid transport,286,0,0.41,1.00000,1,1,0
BP,GO:0046949,fatty-acyl-CoA biosynthetic process,33,0,0.05,1.00000,1,1,0
BP,GO:0047497,mitochondrion transport along microtubul...,28,0,0.04,1.00000,1,1,0
BP,GO:0048002,antigen processing and presentation of p...,199,0,0.29,1.00000,1,1,0
BP,GO:0048008,platelet-derived growth factor receptor ...,58,0,0.08,1.00000,1,1,0
BP,GO:0048009,insulin-like growth factor receptor sign...,38,0,0.05,1.00000,1,1,0
BP,GO:0048010,vascular endothelial growth factor recep...,60,0,0.09,1.00000,1,1,0
BP,GO:0048011,neurotrophin TRK receptor signaling path...,28,0,0.04,1.00000,1,1,0
BP,GO:0048012,hepatocyte growth factor receptor signal...,23,0,0.03,1.00000,1,1,0
BP,GO:0048013,ephrin receptor signaling pathway,53,0,0.08,1.00000,1,1,0
BP,GO:0048024,"regulation of mRNA splicing, via spliceo...",106,0,0.15,1.00000,1,1,0
BP,GO:0048025,"negative regulation of mRNA splicing, vi...",20,0,0.03,1.00000,1,1,0
BP,GO:0048026,"positive regulation of mRNA splicing, vi...",23,0,0.03,1.00000,1,1,0
BP,GO:0048048,embryonic eye morphogenesis,34,0,0.05,1.00000,1,1,0
BP,GO:0048066,developmental pigmentation,46,0,0.07,1.00000,1,1,0
BP,GO:0048143,astrocyte activation,41,0,0.06,1.00000,1,1,0
BP,GO:0048147,negative regulation of fibroblast prolif...,36,0,0.05,1.00000,1,1,0
BP,GO:0048148,behavioral response to cocaine,21,0,0.03,1.00000,1,1,0
BP,GO:0048199,"vesicle targeting, to, from or within Go...",22,0,0.03,1.00000,1,1,0
BP,GO:0048240,sperm capacitation,32,0,0.05,1.00000,1,1,0
BP,GO:0048245,eosinophil chemotaxis,25,0,0.04,1.00000,1,1,0
BP,GO:0048246,macrophage chemotaxis,46,0,0.07,1.00000,1,1,0
BP,GO:0048247,lymphocyte chemotaxis,81,0,0.12,1.00000,1,1,0
BP,GO:0048255,mRNA stabilization,57,0,0.08,1.00000,1,1,0
BP,GO:0048259,regulation of receptor-mediated endocyto...,125,0,0.18,1.00000,1,1,0
BP,GO:0048260,positive regulation of receptor-mediated...,57,0,0.08,1.00000,1,1,0
BP,GO:0048261,negative regulation of receptor-mediated...,35,0,0.05,1.00000,1,1,0
BP,GO:0048278,vesicle docking,63,0,0.09,1.00000,1,1,0
BP,GO:0048284,organelle fusion,148,0,0.21,1.00000,1,1,0
BP,GO:0048286,lung alveolus development,42,0,0.06,1.00000,1,1,0
BP,GO:0048332,mesoderm morphogenesis,85,0,0.12,1.00000,1,1,0
BP,GO:0048333,mesodermal cell differentiation,40,0,0.06,1.00000,1,1,0
BP,GO:0048384,retinoic acid receptor signaling pathway,38,0,0.05,1.00000,1,1,0
BP,GO:0048469,cell maturation,180,0,0.26,1.00000,1,1,0
BP,GO:0048477,oogenesis,99,0,0.14,1.00000,1,1,0
BP,GO:0048488,synaptic vesicle endocytosis,67,0,0.1,1.00000,1,1,0
BP,GO:0048489,synaptic vesicle transport,45,0,0.06,1.00000,1,1,0
BP,GO:0048490,anterograde synaptic vesicle transport,20,0,0.03,1.00000,1,1,0
BP,GO:0048499,synaptic vesicle membrane organization,26,0,0.04,1.00000,1,1,0
BP,GO:0048512,circadian behavior,49,0,0.07,1.00000,1,1,0
BP,GO:0048515,spermatid differentiation,186,0,0.27,1.00000,1,1,0
BP,GO:0048520,positive regulation of behavior,28,0,0.04,1.00000,1,1,0
BP,GO:0048524,positive regulation of viral process,72,0,0.1,1.00000,1,1,0
BP,GO:0048525,negative regulation of viral process,136,0,0.2,1.00000,1,1,0
BP,GO:0048535,lymph node development,32,0,0.05,1.00000,1,1,0
BP,GO:0048546,digestive tract morphogenesis,47,0,0.07,1.00000,1,1,0
BP,GO:0048565,digestive tract development,144,0,0.21,1.00000,1,1,0
BP,GO:0048566,embryonic digestive tract development,46,0,0.07,1.00000,1,1,0
BP,GO:0048592,eye morphogenesis,170,0,0.24,1.00000,1,1,0
BP,GO:0048593,camera-type eye morphogenesis,139,0,0.2,1.00000,1,1,0
BP,GO:0048596,embryonic camera-type eye morphogenesis,26,0,0.04,1.00000,1,1,0
BP,GO:0048599,oocyte development,49,0,0.07,1.00000,1,1,0
BP,GO:0048634,regulation of muscle organ development,50,0,0.07,1.00000,1,1,0
BP,GO:0048636,positive regulation of muscle organ deve...,28,0,0.04,1.00000,1,1,0
BP,GO:0048640,negative regulation of developmental gro...,117,0,0.17,1.00000,1,1,0
BP,GO:0048641,regulation of skeletal muscle tissue dev...,32,0,0.05,1.00000,1,1,0
BP,GO:0048643,positive regulation of skeletal muscle t...,26,0,0.04,1.00000,1,1,0
BP,GO:0048644,muscle organ morphogenesis,78,0,0.11,1.00000,1,1,0
BP,GO:0048645,animal organ formation,65,0,0.09,1.00000,1,1,0
BP,GO:0048662,negative regulation of smooth muscle cel...,81,0,0.12,1.00000,1,1,0
BP,GO:0048663,neuron fate commitment,70,0,0.1,1.00000,1,1,0
BP,GO:0048665,neuron fate specification,36,0,0.05,1.00000,1,1,0
BP,GO:0048668,collateral sprouting,28,0,0.04,1.00000,1,1,0
BP,GO:0048670,regulation of collateral sprouting,22,0,0.03,1.00000,1,1,0
BP,GO:0048678,response to axon injury,89,0,0.13,1.00000,1,1,0
BP,GO:0048679,regulation of axon regeneration,31,0,0.04,1.00000,1,1,0
BP,GO:0048701,embryonic cranial skeleton morphogenesis,48,0,0.07,1.00000,1,1,0
BP,GO:0048708,astrocyte differentiation,99,0,0.14,1.00000,1,1,0
BP,GO:0048709,oligodendrocyte differentiation,97,0,0.14,1.00000,1,1,0
BP,GO:0048710,regulation of astrocyte differentiation,33,0,0.05,1.00000,1,1,0
BP,GO:0048713,regulation of oligodendrocyte differenti...,39,0,0.06,1.00000,1,1,0
BP,GO:0048714,positive regulation of oligodendrocyte d...,21,0,0.03,1.00000,1,1,0
BP,GO:0048730,epidermis morphogenesis,33,0,0.05,1.00000,1,1,0
BP,GO:0048738,cardiac muscle tissue development,254,0,0.37,1.00000,1,1,0
BP,GO:0048741,skeletal muscle fiber development,35,0,0.05,1.00000,1,1,0
BP,GO:0048753,pigment granule organization,29,0,0.04,1.00000,1,1,0
BP,GO:0048762,mesenchymal cell differentiation,252,0,0.36,1.00000,1,1,0
BP,GO:0048771,tissue remodeling,179,0,0.26,1.00000,1,1,0
BP,GO:0048799,animal organ maturation,33,0,0.05,1.00000,1,1,0
BP,GO:0048806,genitalia development,47,0,0.07,1.00000,1,1,0
BP,GO:0048821,erythrocyte development,35,0,0.05,1.00000,1,1,0
BP,GO:0048843,negative regulation of axon extension in...,29,0,0.04,1.00000,1,1,0
BP,GO:0048844,artery morphogenesis,76,0,0.11,1.00000,1,1,0
BP,GO:0048854,brain morphogenesis,37,0,0.05,1.00000,1,1,0
BP,GO:0048857,neural nucleus development,69,0,0.1,1.00000,1,1,0
BP,GO:0048864,stem cell development,88,0,0.13,1.00000,1,1,0
BP,GO:0048873,homeostasis of number of cells within a ...,28,0,0.04,1.00000,1,1,0
BP,GO:0050427,3'-phosphoadenosine 5'-phosphosulfate me...,21,0,0.03,1.00000,1,1,0
BP,GO:0050432,catecholamine secretion,61,0,0.09,1.00000,1,1,0
BP,GO:0050433,regulation of catecholamine secretion,58,0,0.08,1.00000,1,1,0
BP,GO:0050435,amyloid-beta metabolic process,76,0,0.11,1.00000,1,1,0
BP,GO:0050482,arachidonic acid secretion,33,0,0.05,1.00000,1,1,0
BP,GO:0050650,chondroitin sulfate proteoglycan biosynt...,24,0,0.03,1.00000,1,1,0
BP,GO:0050654,chondroitin sulfate proteoglycan metabol...,37,0,0.05,1.00000,1,1,0
BP,GO:0050657,nucleic acid transport,183,0,0.26,1.00000,1,1,0
BP,GO:0050658,RNA transport,183,0,0.26,1.00000,1,1,0
BP,GO:0050665,hydrogen peroxide biosynthetic process,21,0,0.03,1.00000,1,1,0
BP,GO:0050671,positive regulation of lymphocyte prolif...,191,0,0.27,1.00000,1,1,0
BP,GO:0050684,regulation of mRNA processing,151,0,0.22,1.00000,1,1,0
BP,GO:0050685,positive regulation of mRNA processing,36,0,0.05,1.00000,1,1,0
BP,GO:0050686,negative regulation of mRNA processing,34,0,0.05,1.00000,1,1,0
BP,GO:0050687,negative regulation of defense response ...,31,0,0.04,1.00000,1,1,0
BP,GO:0050688,regulation of defense response to virus,82,0,0.12,1.00000,1,1,0
BP,GO:0050691,regulation of defense response to virus ...,54,0,0.08,1.00000,1,1,0
BP,GO:0050708,regulation of protein secretion,297,0,0.43,1.00000,1,1,0
BP,GO:0050709,negative regulation of protein secretion,76,0,0.11,1.00000,1,1,0
BP,GO:0050714,positive regulation of protein secretion,149,0,0.21,1.00000,1,1,0
BP,GO:0050729,positive regulation of inflammatory resp...,178,0,0.26,1.00000,1,1,0
BP,GO:0050732,negative regulation of peptidyl-tyrosine...,67,0,0.1,1.00000,1,1,0
BP,GO:0050764,regulation of phagocytosis,119,0,0.17,1.00000,1,1,0
BP,GO:0050765,negative regulation of phagocytosis,25,0,0.04,1.00000,1,1,0
BP,GO:0050766,positive regulation of phagocytosis,88,0,0.13,1.00000,1,1,0
BP,GO:0050771,negative regulation of axonogenesis,69,0,0.1,1.00000,1,1,0
BP,GO:0050777,negative regulation of immune response,301,0,0.43,1.00000,1,1,0
BP,GO:0050792,regulation of viral process,214,0,0.31,1.00000,1,1,0
BP,GO:0050796,regulation of insulin secretion,185,0,0.27,1.00000,1,1,0
BP,GO:0050798,activated T cell proliferation,61,0,0.09,1.00000,1,1,0
BP,GO:0050802,"circadian sleep/wake cycle, sleep",21,0,0.03,1.00000,1,1,0
BP,GO:0050810,regulation of steroid biosynthetic proce...,77,0,0.11,1.00000,1,1,0
BP,GO:0050817,coagulation,252,0,0.36,1.00000,1,1,0
BP,GO:0050818,regulation of coagulation,72,0,0.1,1.00000,1,1,0
BP,GO:0050819,negative regulation of coagulation,54,0,0.08,1.00000,1,1,0
BP,GO:0050820,positive regulation of coagulation,25,0,0.04,1.00000,1,1,0
BP,GO:0050821,protein stabilization,220,0,0.32,1.00000,1,1,0
BP,GO:0050829,defense response to Gram-negative bacter...,116,0,0.17,1.00000,1,1,0
BP,GO:0050830,defense response to Gram-positive bacter...,158,0,0.23,1.00000,1,1,0
BP,GO:0050832,defense response to fungus,64,0,0.09,1.00000,1,1,0
BP,GO:0050850,positive regulation of calcium-mediated ...,43,0,0.06,1.00000,1,1,0
BP,GO:0050852,T cell receptor signaling pathway,174,0,0.25,1.00000,1,1,0
BP,GO:0050856,regulation of T cell receptor signaling ...,45,0,0.06,1.00000,1,1,0
BP,GO:0050858,negative regulation of antigen receptor-...,36,0,0.05,1.00000,1,1,0
BP,GO:0050860,negative regulation of T cell receptor s...,26,0,0.04,1.00000,1,1,0
BP,GO:0050869,negative regulation of B cell activation,36,0,0.05,1.00000,1,1,0
BP,GO:0050870,positive regulation of T cell activation,344,0,0.49,1.00000,1,1,0
BP,GO:0050873,brown fat cell differentiation,53,0,0.08,1.00000,1,1,0
BP,GO:0050878,regulation of body fluid levels,425,0,0.61,1.00000,1,1,0
BP,GO:0050886,endocrine process,91,0,0.13,1.00000,1,1,0
BP,GO:0050891,multicellular organismal water homeostas...,59,0,0.08,1.00000,1,1,0
BP,GO:0050892,intestinal absorption,42,0,0.06,1.00000,1,1,0
BP,GO:0050900,leukocyte migration,428,0,0.62,1.00000,1,1,0
BP,GO:0050901,leukocyte tethering or rolling,41,0,0.06,1.00000,1,1,0
BP,GO:0050906,detection of stimulus involved in sensor...,701,0,1.01,1.00000,1,1,0
BP,GO:0050907,detection of chemical stimulus involved ...,634,0,0.91,1.00000,1,1,0
BP,GO:0050908,detection of light stimulus involved in ...,23,0,0.03,1.00000,1,1,0
BP,GO:0050909,sensory perception of taste,90,0,0.13,1.00000,1,1,0
BP,GO:0050911,detection of chemical stimulus involved ...,564,0,0.81,1.00000,1,1,0
BP,GO:0050912,detection of chemical stimulus involved ...,67,0,0.1,1.00000,1,1,0
BP,GO:0050913,sensory perception of bitter taste,67,0,0.1,1.00000,1,1,0
BP,GO:0050918,positive chemotaxis,92,0,0.13,1.00000,1,1,0
BP,GO:0050921,positive regulation of chemotaxis,166,0,0.24,1.00000,1,1,0
BP,GO:0050922,negative regulation of chemotaxis,78,0,0.11,1.00000,1,1,0
BP,GO:0050926,regulation of positive chemotaxis,33,0,0.05,1.00000,1,1,0
BP,GO:0050927,positive regulation of positive chemotax...,32,0,0.05,1.00000,1,1,0
BP,GO:0050930,induction of positive chemotaxis,21,0,0.03,1.00000,1,1,0
BP,GO:0050931,pigment cell differentiation,35,0,0.05,1.00000,1,1,0
BP,GO:0050951,sensory perception of temperature stimul...,25,0,0.04,1.00000,1,1,0
BP,GO:0050962,detection of light stimulus involved in ...,23,0,0.03,1.00000,1,1,0
BP,GO:0050974,detection of mechanical stimulus involve...,34,0,0.05,1.00000,1,1,0
BP,GO:0050982,detection of mechanical stimulus,52,0,0.07,1.00000,1,1,0
BP,GO:0050994,regulation of lipid catabolic process,70,0,0.1,1.00000,1,1,0
BP,GO:0050995,negative regulation of lipid catabolic p...,32,0,0.05,1.00000,1,1,0
BP,GO:0050996,positive regulation of lipid catabolic p...,29,0,0.04,1.00000,1,1,0
BP,GO:0050999,regulation of nitric-oxide synthase acti...,56,0,0.08,1.00000,1,1,0
BP,GO:0051000,positive regulation of nitric-oxide synt...,30,0,0.04,1.00000,1,1,0
BP,GO:0051004,regulation of lipoprotein lipase activit...,20,0,0.03,1.00000,1,1,0
BP,GO:0051016,barbed-end actin filament capping,28,0,0.04,1.00000,1,1,0
BP,GO:0051017,actin filament bundle assembly,171,0,0.25,1.00000,1,1,0
BP,GO:0051028,mRNA transport,143,0,0.21,1.00000,1,1,0
BP,GO:0051043,regulation of membrane protein ectodomai...,32,0,0.05,1.00000,1,1,0
BP,GO:0051044,positive regulation of membrane protein ...,24,0,0.03,1.00000,1,1,0
BP,GO:0051046,regulation of secretion,675,0,0.97,1.00000,1,1,0
BP,GO:0051047,positive regulation of secretion,332,0,0.48,1.00000,1,1,0
BP,GO:0051048,negative regulation of secretion,185,0,0.27,1.00000,1,1,0
BP,GO:0051051,negative regulation of transport,524,0,0.75,1.00000,1,1,0
BP,GO:0051053,negative regulation of DNA metabolic pro...,130,0,0.19,1.00000,1,1,0
BP,GO:0051055,negative regulation of lipid biosyntheti...,60,0,0.09,1.00000,1,1,0
BP,GO:0051058,negative regulation of small GTPase medi...,60,0,0.09,1.00000,1,1,0
BP,GO:0051084,'de novo' posttranslational protein fold...,49,0,0.07,1.00000,1,1,0
BP,GO:0051085,chaperone cofactor-dependent protein ref...,44,0,0.06,1.00000,1,1,0
BP,GO:0051092,positive regulation of NF-kappaB transcr...,197,0,0.28,1.00000,1,1,0
BP,GO:0051098,regulation of binding,401,0,0.58,1.00000,1,1,0
BP,GO:0051099,positive regulation of binding,188,0,0.27,1.00000,1,1,0
BP,GO:0051100,negative regulation of binding,172,0,0.25,1.00000,1,1,0
BP,GO:0051101,regulation of DNA binding,134,0,0.19,1.00000,1,1,0
BP,GO:0051123,RNA polymerase II preinitiation complex ...,25,0,0.04,1.00000,1,1,0
BP,GO:0051125,regulation of actin nucleation,33,0,0.05,1.00000,1,1,0
BP,GO:0051131,chaperone-mediated protein complex assem...,31,0,0.04,1.00000,1,1,0
BP,GO:0051145,smooth muscle cell differentiation,74,0,0.11,1.00000,1,1,0
BP,GO:0051146,striated muscle cell differentiation,311,0,0.45,1.00000,1,1,0
BP,GO:0051147,regulation of muscle cell differentiatio...,167,0,0.24,1.00000,1,1,0
BP,GO:0051148,negative regulation of muscle cell diffe...,70,0,0.1,1.00000,1,1,0
BP,GO:0051149,positive regulation of muscle cell diffe...,91,0,0.13,1.00000,1,1,0
BP,GO:0051150,regulation of smooth muscle cell differe...,44,0,0.06,1.00000,1,1,0
BP,GO:0051151,negative regulation of smooth muscle cel...,22,0,0.03,1.00000,1,1,0
BP,GO:0051152,positive regulation of smooth muscle cel...,21,0,0.03,1.00000,1,1,0
BP,GO:0051153,regulation of striated muscle cell diffe...,111,0,0.16,1.00000,1,1,0
BP,GO:0051154,negative regulation of striated muscle c...,41,0,0.06,1.00000,1,1,0
BP,GO:0051155,positive regulation of striated muscle c...,67,0,0.1,1.00000,1,1,0
BP,GO:0051156,glucose 6-phosphate metabolic process,26,0,0.04,1.00000,1,1,0
BP,GO:0051168,nuclear export,172,0,0.25,1.00000,1,1,0
BP,GO:0051169,nuclear transport,328,0,0.47,1.00000,1,1,0
BP,GO:0051170,import into nucleus,167,0,0.24,1.00000,1,1,0
BP,GO:0051180,vitamin transport,56,0,0.08,1.00000,1,1,0
BP,GO:0051204,protein insertion into mitochondrial mem...,29,0,0.04,1.00000,1,1,0
BP,GO:0051205,protein insertion into membrane,69,0,0.1,1.00000,1,1,0
BP,GO:0051216,cartilage development,200,0,0.29,1.00000,1,1,0
BP,GO:0051220,cytoplasmic sequestering of protein,23,0,0.03,1.00000,1,1,0
BP,GO:0051222,positive regulation of protein transport,335,0,0.48,1.00000,1,1,0
BP,GO:0051223,regulation of protein transport,560,0,0.8,1.00000,1,1,0
BP,GO:0051224,negative regulation of protein transport,133,0,0.19,1.00000,1,1,0
BP,GO:0051236,establishment of RNA localization,186,0,0.27,1.00000,1,1,0
BP,GO:0051259,protein complex oligomerization,266,0,0.38,1.00000,1,1,0
BP,GO:0051260,protein homooligomerization,198,0,0.28,1.00000,1,1,0
BP,GO:0051261,protein depolymerization,117,0,0.17,1.00000,1,1,0
BP,GO:0051262,protein tetramerization,104,0,0.15,1.00000,1,1,0
BP,GO:0051271,negative regulation of cellular componen...,401,0,0.58,1.00000,1,1,0
BP,GO:0051279,regulation of release of sequestered cal...,81,0,0.12,1.00000,1,1,0
BP,GO:0051281,positive regulation of release of seques...,40,0,0.06,1.00000,1,1,0
BP,GO:0051289,protein homotetramerization,63,0,0.09,1.00000,1,1,0
BP,GO:0051290,protein heterotetramerization,20,0,0.03,1.00000,1,1,0
BP,GO:0051291,protein heterooligomerization,30,0,0.04,1.00000,1,1,0
BP,GO:0051294,establishment of spindle orientation,40,0,0.06,1.00000,1,1,0
BP,GO:0051298,centrosome duplication,80,0,0.11,1.00000,1,1,0
BP,GO:0051304,chromosome separation,99,0,0.14,1.00000,1,1,0
BP,GO:0051306,mitotic sister chromatid separation,67,0,0.1,1.00000,1,1,0
BP,GO:0051307,meiotic chromosome separation,27,0,0.04,1.00000,1,1,0
BP,GO:0051339,regulation of lyase activity,56,0,0.08,1.00000,1,1,0
BP,GO:0051341,regulation of oxidoreductase activity,122,0,0.18,1.00000,1,1,0
BP,GO:0051348,negative regulation of transferase activ...,296,0,0.43,1.00000,1,1,0
BP,GO:0051349,positive regulation of lyase activity,23,0,0.03,1.00000,1,1,0
BP,GO:0051350,negative regulation of lyase activity,27,0,0.04,1.00000,1,1,0
BP,GO:0051353,positive regulation of oxidoreductase ac...,66,0,0.09,1.00000,1,1,0
BP,GO:0051354,negative regulation of oxidoreductase ac...,38,0,0.05,1.00000,1,1,0
BP,GO:0051383,kinetochore organization,24,0,0.03,1.00000,1,1,0
BP,GO:0051384,response to glucocorticoid,164,0,0.24,1.00000,1,1,0
BP,GO:0051385,response to mineralocorticoid,36,0,0.05,1.00000,1,1,0
BP,GO:0051402,neuron apoptotic process,265,0,0.38,1.00000,1,1,0
BP,GO:0051412,response to corticosterone,22,0,0.03,1.00000,1,1,0
BP,GO:0051438,regulation of ubiquitin-protein transfer...,54,0,0.08,1.00000,1,1,0
BP,GO:0051443,positive regulation of ubiquitin-protein...,32,0,0.05,1.00000,1,1,0
BP,GO:0051445,regulation of meiotic cell cycle,52,0,0.07,1.00000,1,1,0
BP,GO:0051446,positive regulation of meiotic cell cycl...,25,0,0.04,1.00000,1,1,0
BP,GO:0051450,myoblast proliferation,26,0,0.04,1.00000,1,1,0
BP,GO:0051452,intracellular pH reduction,43,0,0.06,1.00000,1,1,0
BP,GO:0051453,regulation of intracellular pH,78,0,0.11,1.00000,1,1,0
BP,GO:0051457,maintenance of protein location in nucle...,24,0,0.03,1.00000,1,1,0
BP,GO:0051482,positive regulation of cytosolic calcium...,36,0,0.05,1.00000,1,1,0
BP,GO:0051489,regulation of filopodium assembly,48,0,0.07,1.00000,1,1,0
BP,GO:0051491,positive regulation of filopodium assemb...,30,0,0.04,1.00000,1,1,0
BP,GO:0051492,regulation of stress fiber assembly,99,0,0.14,1.00000,1,1,0
BP,GO:0051494,negative regulation of cytoskeleton orga...,171,0,0.25,1.00000,1,1,0
BP,GO:0051496,positive regulation of stress fiber asse...,56,0,0.08,1.00000,1,1,0
BP,GO:0051497,negative regulation of stress fiber asse...,35,0,0.05,1.00000,1,1,0
BP,GO:0051503,adenine nucleotide transport,30,0,0.04,1.00000,1,1,0
BP,GO:0051546,keratinocyte migration,22,0,0.03,1.00000,1,1,0
BP,GO:0051560,mitochondrial calcium ion homeostasis,29,0,0.04,1.00000,1,1,0
BP,GO:0051569,regulation of histone H3-K4 methylation,42,0,0.06,1.00000,1,1,0
BP,GO:0051571,positive regulation of histone H3-K4 met...,24,0,0.03,1.00000,1,1,0
BP,GO:0051580,regulation of neurotransmitter uptake,25,0,0.04,1.00000,1,1,0
BP,GO:0051588,regulation of neurotransmitter transport,108,0,0.16,1.00000,1,1,0
BP,GO:0051590,positive regulation of neurotransmitter ...,24,0,0.03,1.00000,1,1,0
BP,GO:0051592,response to calcium ion,154,0,0.22,1.00000,1,1,0
BP,GO:0051602,response to electrical stimulus,50,0,0.07,1.00000,1,1,0
BP,GO:0051606,detection of stimulus,866,0,1.24,1.00000,1,1,0
BP,GO:0051607,defense response to virus,306,0,0.44,1.00000,1,1,0
BP,GO:0051646,mitochondrion localization,53,0,0.08,1.00000,1,1,0
BP,GO:0051654,establishment of mitochondrion localizat...,32,0,0.05,1.00000,1,1,0
BP,GO:0051693,actin filament capping,43,0,0.06,1.00000,1,1,0
BP,GO:0051701,biological process involved in interacti...,271,0,0.39,1.00000,1,1,0
BP,GO:0051702,biological process involved in interacti...,112,0,0.16,1.00000,1,1,0
BP,GO:0051703,biological process involved in intraspec...,59,0,0.08,1.00000,1,1,0
BP,GO:0051767,nitric-oxide synthase biosynthetic proce...,21,0,0.03,1.00000,1,1,0
BP,GO:0051769,regulation of nitric-oxide synthase bios...,21,0,0.03,1.00000,1,1,0
BP,GO:0051781,positive regulation of cell division,93,0,0.13,1.00000,1,1,0
BP,GO:0051783,regulation of nuclear division,142,0,0.2,1.00000,1,1,0
BP,GO:0051784,negative regulation of nuclear division,56,0,0.08,1.00000,1,1,0
BP,GO:0051785,positive regulation of nuclear division,58,0,0.08,1.00000,1,1,0
BP,GO:0051788,response to misfolded protein,38,0,0.05,1.00000,1,1,0
BP,GO:0051797,regulation of hair follicle development,24,0,0.03,1.00000,1,1,0
BP,GO:0051817,modulation of process of other organism ...,93,0,0.13,1.00000,1,1,0
BP,GO:0051851,modulation by host of symbiont process,70,0,0.1,1.00000,1,1,0
BP,GO:0051865,protein autoubiquitination,76,0,0.11,1.00000,1,1,0
BP,GO:0051873,killing by host of symbiont cells,37,0,0.05,1.00000,1,1,0
BP,GO:0051881,regulation of mitochondrial membrane pot...,84,0,0.12,1.00000,1,1,0
BP,GO:0051882,mitochondrial depolarization,24,0,0.03,1.00000,1,1,0
BP,GO:0051883,killing of cells in other organism invol...,37,0,0.05,1.00000,1,1,0
BP,GO:0051895,negative regulation of focal adhesion as...,21,0,0.03,1.00000,1,1,0
BP,GO:0051899,membrane depolarization,85,0,0.12,1.00000,1,1,0
BP,GO:0051900,regulation of mitochondrial depolarizati...,20,0,0.03,1.00000,1,1,0
BP,GO:0051923,sulfation,24,0,0.03,1.00000,1,1,0
BP,GO:0051926,negative regulation of calcium ion trans...,89,0,0.13,1.00000,1,1,0
BP,GO:0051930,regulation of sensory perception of pain,41,0,0.06,1.00000,1,1,0
BP,GO:0051931,regulation of sensory perception,42,0,0.06,1.00000,1,1,0
BP,GO:0051932,"synaptic transmission, GABAergic",55,0,0.08,1.00000,1,1,0
BP,GO:0051937,catecholamine transport,79,0,0.11,1.00000,1,1,0
BP,GO:0051952,regulation of amine transport,95,0,0.14,1.00000,1,1,0
BP,GO:0051953,negative regulation of amine transport,29,0,0.04,1.00000,1,1,0
BP,GO:0051954,positive regulation of amine transport,38,0,0.05,1.00000,1,1,0
BP,GO:0051955,regulation of amino acid transport,37,0,0.05,1.00000,1,1,0
BP,GO:0051963,regulation of synapse assembly,109,0,0.16,1.00000,1,1,0
BP,GO:0051965,positive regulation of synapse assembly,68,0,0.1,1.00000,1,1,0
BP,GO:0051972,regulation of telomerase activity,54,0,0.08,1.00000,1,1,0
BP,GO:0051973,positive regulation of telomerase activi...,39,0,0.06,1.00000,1,1,0
BP,GO:0051983,regulation of chromosome segregation,93,0,0.13,1.00000,1,1,0
BP,GO:0051985,negative regulation of chromosome segreg...,45,0,0.06,1.00000,1,1,0
BP,GO:0052126,movement in host environment,234,0,0.34,1.00000,1,1,0
BP,GO:0052372,modulation by symbiont of entry into hos...,82,0,0.12,1.00000,1,1,0
BP,GO:0052652,cyclic purine nucleotide metabolic proce...,23,0,0.03,1.00000,1,1,0
BP,GO:0052695,cellular glucuronidation,22,0,0.03,1.00000,1,1,0
BP,GO:0055001,muscle cell development,204,0,0.29,1.00000,1,1,0
BP,GO:0055002,striated muscle cell development,68,0,0.1,1.00000,1,1,0
BP,GO:0055006,cardiac cell development,104,0,0.15,1.00000,1,1,0
BP,GO:0055007,cardiac muscle cell differentiation,141,0,0.2,1.00000,1,1,0
BP,GO:0055008,cardiac muscle tissue morphogenesis,61,0,0.09,1.00000,1,1,0
BP,GO:0055010,ventricular cardiac muscle tissue morpho...,47,0,0.07,1.00000,1,1,0
BP,GO:0055013,cardiac muscle cell development,98,0,0.14,1.00000,1,1,0
BP,GO:0055017,cardiac muscle tissue growth,107,0,0.15,1.00000,1,1,0
BP,GO:0055021,regulation of cardiac muscle tissue grow...,81,0,0.12,1.00000,1,1,0
BP,GO:0055022,negative regulation of cardiac muscle ti...,33,0,0.05,1.00000,1,1,0
BP,GO:0055023,positive regulation of cardiac muscle ti...,48,0,0.07,1.00000,1,1,0
BP,GO:0055067,monovalent inorganic cation homeostasis,157,0,0.23,1.00000,1,1,0
BP,GO:0055069,zinc ion homeostasis,45,0,0.06,1.00000,1,1,0
BP,GO:0055072,iron ion homeostasis,86,0,0.12,1.00000,1,1,0
BP,GO:0055075,potassium ion homeostasis,33,0,0.05,1.00000,1,1,0
BP,GO:0055076,transition metal ion homeostasis,144,0,0.21,1.00000,1,1,0
BP,GO:0055078,sodium ion homeostasis,58,0,0.08,1.00000,1,1,0
BP,GO:0055081,anion homeostasis,44,0,0.06,1.00000,1,1,0
BP,GO:0055088,lipid homeostasis,181,0,0.26,1.00000,1,1,0
BP,GO:0055090,acylglycerol homeostasis,43,0,0.06,1.00000,1,1,0
BP,GO:0055092,sterol homeostasis,106,0,0.15,1.00000,1,1,0
BP,GO:0055093,response to hyperoxia,22,0,0.03,1.00000,1,1,0
BP,GO:0055094,response to lipoprotein particle,35,0,0.05,1.00000,1,1,0
BP,GO:0055123,digestive system development,154,0,0.22,1.00000,1,1,0
BP,GO:0060037,pharyngeal system development,26,0,0.04,1.00000,1,1,0
BP,GO:0060038,cardiac muscle cell proliferation,61,0,0.09,1.00000,1,1,0
BP,GO:0060041,retina development in camera-type eye,162,0,0.23,1.00000,1,1,0
BP,GO:0060042,retina morphogenesis in camera-type eye,70,0,0.1,1.00000,1,1,0
BP,GO:0060043,regulation of cardiac muscle cell prolif...,52,0,0.07,1.00000,1,1,0
BP,GO:0060044,negative regulation of cardiac muscle ce...,21,0,0.03,1.00000,1,1,0
BP,GO:0060045,positive regulation of cardiac muscle ce...,31,0,0.04,1.00000,1,1,0
BP,GO:0060055,angiogenesis involved in wound healing,40,0,0.06,1.00000,1,1,0
BP,GO:0060065,uterus development,22,0,0.03,1.00000,1,1,0
BP,GO:0060070,canonical Wnt signaling pathway,315,0,0.45,1.00000,1,1,0
BP,GO:0060071,"Wnt signaling pathway, planar cell polar...",54,0,0.08,1.00000,1,1,0
BP,GO:0060113,inner ear receptor cell differentiation,67,0,0.1,1.00000,1,1,0
BP,GO:0060117,auditory receptor cell development,24,0,0.03,1.00000,1,1,0
BP,GO:0060119,inner ear receptor cell development,49,0,0.07,1.00000,1,1,0
BP,GO:0060122,inner ear receptor cell stereocilium org...,35,0,0.05,1.00000,1,1,0
BP,GO:0060135,maternal process involved in female preg...,63,0,0.09,1.00000,1,1,0
BP,GO:0060142,regulation of syncytium formation by pla...,35,0,0.05,1.00000,1,1,0
BP,GO:0060143,positive regulation of syncytium formati...,31,0,0.04,1.00000,1,1,0
BP,GO:0060149,negative regulation of posttranscription...,36,0,0.05,1.00000,1,1,0
BP,GO:0060191,regulation of lipase activity,93,0,0.13,1.00000,1,1,0
BP,GO:0060193,positive regulation of lipase activity,71,0,0.1,1.00000,1,1,0
BP,GO:0060219,camera-type eye photoreceptor cell diffe...,27,0,0.04,1.00000,1,1,0
BP,GO:0060231,mesenchymal to epithelial transition,23,0,0.03,1.00000,1,1,0
BP,GO:0060251,regulation of glial cell proliferation,49,0,0.07,1.00000,1,1,0
BP,GO:0060252,positive regulation of glial cell prolif...,33,0,0.05,1.00000,1,1,0
BP,GO:0060259,regulation of feeding behavior,29,0,0.04,1.00000,1,1,0
BP,GO:0060260,regulation of transcription initiation f...,36,0,0.05,1.00000,1,1,0
BP,GO:0060261,positive regulation of transcription ini...,28,0,0.04,1.00000,1,1,0
BP,GO:0060271,cilium assembly,349,0,0.5,1.00000,1,1,0
BP,GO:0060285,cilium-dependent cell motility,143,0,0.21,1.00000,1,1,0
BP,GO:0060292,long-term synaptic depression,50,0,0.07,1.00000,1,1,0
BP,GO:0060294,cilium movement involved in cell motilit...,130,0,0.19,1.00000,1,1,0
BP,GO:0060295,regulation of cilium movement involved i...,27,0,0.04,1.00000,1,1,0
BP,GO:0060306,regulation of membrane repolarization,39,0,0.06,1.00000,1,1,0
BP,GO:0060307,regulation of ventricular cardiac muscle...,24,0,0.03,1.00000,1,1,0
BP,GO:0060314,regulation of ryanodine-sensitive calciu...,27,0,0.04,1.00000,1,1,0
BP,GO:0060317,cardiac epithelial to mesenchymal transi...,32,0,0.05,1.00000,1,1,0
BP,GO:0060323,head morphogenesis,35,0,0.05,1.00000,1,1,0
BP,GO:0060324,face development,45,0,0.06,1.00000,1,1,0
BP,GO:0060325,face morphogenesis,29,0,0.04,1.00000,1,1,0
BP,GO:0060326,cell chemotaxis,360,0,0.52,1.00000,1,1,0
BP,GO:0060333,interferon-gamma-mediated signaling path...,28,0,0.04,1.00000,1,1,0
BP,GO:0060337,type I interferon signaling pathway,54,0,0.08,1.00000,1,1,0
BP,GO:0060338,regulation of type I interferon-mediated...,38,0,0.05,1.00000,1,1,0
BP,GO:0060339,negative regulation of type I interferon...,20,0,0.03,1.00000,1,1,0
BP,GO:0060351,cartilage development involved in endoch...,30,0,0.04,1.00000,1,1,0
BP,GO:0060352,cell adhesion molecule production,39,0,0.06,1.00000,1,1,0
BP,GO:0060353,regulation of cell adhesion molecule pro...,36,0,0.05,1.00000,1,1,0
BP,GO:0060354,negative regulation of cell adhesion mol...,20,0,0.03,1.00000,1,1,0
BP,GO:0060384,innervation,23,0,0.03,1.00000,1,1,0
BP,GO:0060389,pathway-restricted SMAD protein phosphor...,73,0,0.1,1.00000,1,1,0
BP,GO:0060390,regulation of SMAD protein signal transd...,31,0,0.04,1.00000,1,1,0
BP,GO:0060393,regulation of pathway-restricted SMAD pr...,70,0,0.1,1.00000,1,1,0
BP,GO:0060395,SMAD protein signal transduction,82,0,0.12,1.00000,1,1,0
BP,GO:0060396,growth hormone receptor signaling pathwa...,23,0,0.03,1.00000,1,1,0
BP,GO:0060415,muscle tissue morphogenesis,71,0,0.1,1.00000,1,1,0
BP,GO:0060416,response to growth hormone,37,0,0.05,1.00000,1,1,0
BP,GO:0060419,heart growth,115,0,0.17,1.00000,1,1,0
BP,GO:0060420,regulation of heart growth,88,0,0.13,1.00000,1,1,0
BP,GO:0060421,positive regulation of heart growth,52,0,0.07,1.00000,1,1,0
BP,GO:0060425,lung morphogenesis,58,0,0.08,1.00000,1,1,0
BP,GO:0060428,lung epithelium development,38,0,0.05,1.00000,1,1,0
BP,GO:0060441,epithelial tube branching involved in lu...,37,0,0.05,1.00000,1,1,0
BP,GO:0060443,mammary gland morphogenesis,49,0,0.07,1.00000,1,1,0
BP,GO:0060444,branching involved in mammary gland duct...,27,0,0.04,1.00000,1,1,0
BP,GO:0060445,branching involved in salivary gland mor...,29,0,0.04,1.00000,1,1,0
BP,GO:0060479,lung cell differentiation,24,0,0.03,1.00000,1,1,0
BP,GO:0060485,mesenchyme development,308,0,0.44,1.00000,1,1,0
BP,GO:0060487,lung epithelial cell differentiation,23,0,0.03,1.00000,1,1,0
BP,GO:0060491,regulation of cell projection assembly,202,0,0.29,1.00000,1,1,0
BP,GO:0060512,prostate gland morphogenesis,27,0,0.04,1.00000,1,1,0
BP,GO:0060538,skeletal muscle organ development,178,0,0.26,1.00000,1,1,0
BP,GO:0060541,respiratory system development,220,0,0.32,1.00000,1,1,0
BP,GO:0060544,regulation of necroptotic process,27,0,0.04,1.00000,1,1,0
BP,GO:0060547,negative regulation of necrotic cell dea...,23,0,0.03,1.00000,1,1,0
BP,GO:0060561,apoptotic process involved in morphogene...,25,0,0.04,1.00000,1,1,0
BP,GO:0060563,neuroepithelial cell differentiation,25,0,0.04,1.00000,1,1,0
BP,GO:0060571,morphogenesis of an epithelial fold,24,0,0.03,1.00000,1,1,0
BP,GO:0060575,intestinal epithelial cell differentiati...,24,0,0.03,1.00000,1,1,0
BP,GO:0060603,mammary gland duct morphogenesis,36,0,0.05,1.00000,1,1,0
BP,GO:0060606,tube closure,99,0,0.14,1.00000,1,1,0
BP,GO:0060612,adipose tissue development,41,0,0.06,1.00000,1,1,0
BP,GO:0060627,regulation of vesicle-mediated transport,589,0,0.85,1.00000,1,1,0
BP,GO:0060632,regulation of microtubule-based movement,53,0,0.08,1.00000,1,1,0
BP,GO:0060669,embryonic placenta morphogenesis,26,0,0.04,1.00000,1,1,0
BP,GO:0060674,placenta blood vessel development,31,0,0.04,1.00000,1,1,0
BP,GO:0060688,regulation of morphogenesis of a branchi...,64,0,0.09,1.00000,1,1,0
BP,GO:0060706,cell differentiation involved in embryon...,25,0,0.04,1.00000,1,1,0
BP,GO:0060713,labyrinthine layer morphogenesis,22,0,0.03,1.00000,1,1,0
BP,GO:0060740,prostate gland epithelium morphogenesis,25,0,0.04,1.00000,1,1,0
BP,GO:0060749,mammary gland alveolus development,24,0,0.03,1.00000,1,1,0
BP,GO:0060759,regulation of response to cytokine stimu...,185,0,0.27,1.00000,1,1,0
BP,GO:0060760,positive regulation of response to cytok...,75,0,0.11,1.00000,1,1,0
BP,GO:0060761,negative regulation of response to cytok...,91,0,0.13,1.00000,1,1,0
BP,GO:0060795,cell fate commitment involved in formati...,44,0,0.06,1.00000,1,1,0
BP,GO:0060828,regulation of canonical Wnt signaling pa...,260,0,0.37,1.00000,1,1,0
BP,GO:0060840,artery development,102,0,0.15,1.00000,1,1,0
BP,GO:0060907,positive regulation of macrophage cytoki...,24,0,0.03,1.00000,1,1,0
BP,GO:0060914,heart formation,32,0,0.05,1.00000,1,1,0
BP,GO:0060965,negative regulation of gene silencing by...,34,0,0.05,1.00000,1,1,0
BP,GO:0060967,negative regulation of gene silencing by...,36,0,0.05,1.00000,1,1,0
BP,GO:0060969,negative regulation of gene silencing,41,0,0.06,1.00000,1,1,0
BP,GO:0060972,left/right pattern formation,22,0,0.03,1.00000,1,1,0
BP,GO:0060976,coronary vasculature development,46,0,0.07,1.00000,1,1,0
BP,GO:0060986,endocrine hormone secretion,56,0,0.08,1.00000,1,1,0
BP,GO:0061005,cell differentiation involved in kidney ...,62,0,0.09,1.00000,1,1,0
BP,GO:0061008,hepaticobiliary system development,168,0,0.24,1.00000,1,1,0
BP,GO:0061025,membrane fusion,176,0,0.25,1.00000,1,1,0
BP,GO:0061028,establishment of endothelial barrier,55,0,0.08,1.00000,1,1,0
BP,GO:0061035,regulation of cartilage development,76,0,0.11,1.00000,1,1,0
BP,GO:0061036,positive regulation of cartilage develop...,32,0,0.05,1.00000,1,1,0
BP,GO:0061037,negative regulation of cartilage develop...,35,0,0.05,1.00000,1,1,0
BP,GO:0061041,regulation of wound healing,146,0,0.21,1.00000,1,1,0
BP,GO:0061042,vascular wound healing,31,0,0.04,1.00000,1,1,0
BP,GO:0061043,regulation of vascular wound healing,22,0,0.03,1.00000,1,1,0
BP,GO:0061045,negative regulation of wound healing,88,0,0.13,1.00000,1,1,0
BP,GO:0061049,cell growth involved in cardiac muscle c...,45,0,0.06,1.00000,1,1,0
BP,GO:0061050,regulation of cell growth involved in ca...,31,0,0.04,1.00000,1,1,0
BP,GO:0061061,muscle structure development,683,0,0.98,1.00000,1,1,0
BP,GO:0061077,chaperone-mediated protein folding,78,0,0.11,1.00000,1,1,0
BP,GO:0061081,positive regulation of myeloid leukocyte...,34,0,0.05,1.00000,1,1,0
BP,GO:0061082,myeloid leukocyte cytokine production,41,0,0.06,1.00000,1,1,0
BP,GO:0061099,negative regulation of protein tyrosine ...,39,0,0.06,1.00000,1,1,0
BP,GO:0061117,negative regulation of heart growth,33,0,0.05,1.00000,1,1,0
BP,GO:0061136,regulation of proteasomal protein catabo...,218,0,0.31,1.00000,1,1,0
BP,GO:0061162,establishment of monopolar cell polarity,25,0,0.04,1.00000,1,1,0
BP,GO:0061178,regulation of insulin secretion involved...,68,0,0.1,1.00000,1,1,0
BP,GO:0061180,mammary gland epithelium development,76,0,0.11,1.00000,1,1,0
BP,GO:0061311,cell surface receptor signaling pathway ...,30,0,0.04,1.00000,1,1,0
BP,GO:0061318,renal filtration cell differentiation,20,0,0.03,1.00000,1,1,0
BP,GO:0061337,cardiac conduction,102,0,0.15,1.00000,1,1,0
BP,GO:0061339,establishment or maintenance of monopola...,26,0,0.04,1.00000,1,1,0
BP,GO:0061351,neural precursor cell proliferation,148,0,0.21,1.00000,1,1,0
BP,GO:0061371,determination of heart left/right asymme...,70,0,0.1,1.00000,1,1,0
BP,GO:0061377,mammary gland lobule development,24,0,0.03,1.00000,1,1,0
BP,GO:0061436,establishment of skin barrier,25,0,0.04,1.00000,1,1,0
BP,GO:0061448,connective tissue development,262,0,0.38,1.00000,1,1,0
BP,GO:0061462,protein localization to lysosome,45,0,0.06,1.00000,1,1,0
BP,GO:0061512,protein localization to cilium,67,0,0.1,1.00000,1,1,0
BP,GO:0061572,actin filament bundle organization,175,0,0.25,1.00000,1,1,0
BP,GO:0061614,pri-miRNA transcription by RNA polymeras...,73,0,0.1,1.00000,1,1,0
BP,GO:0061640,cytoskeleton-dependent cytokinesis,102,0,0.15,1.00000,1,1,0
BP,GO:0061726,mitochondrion disassembly,85,0,0.12,1.00000,1,1,0
BP,GO:0061756,leukocyte adhesion to vascular endotheli...,66,0,0.09,1.00000,1,1,0
BP,GO:0061760,antifungal innate immune response,22,0,0.03,1.00000,1,1,0
BP,GO:0061844,antimicrobial humoral immune response me...,94,0,0.14,1.00000,1,1,0
BP,GO:0061912,selective autophagy,73,0,0.1,1.00000,1,1,0
BP,GO:0061951,establishment of protein localization to...,65,0,0.09,1.00000,1,1,0
BP,GO:0061982,meiosis I cell cycle process,160,0,0.23,1.00000,1,1,0
BP,GO:0062012,regulation of small molecule metabolic p...,351,0,0.5,1.00000,1,1,0
BP,GO:0062013,positive regulation of small molecule me...,150,0,0.22,1.00000,1,1,0
BP,GO:0062014,negative regulation of small molecule me...,105,0,0.15,1.00000,1,1,0
BP,GO:0062098,regulation of programmed necrotic cell d...,30,0,0.04,1.00000,1,1,0
BP,GO:0062125,regulation of mitochondrial gene express...,29,0,0.04,1.00000,1,1,0
BP,GO:0062149,detection of stimulus involved in sensor...,25,0,0.04,1.00000,1,1,0
BP,GO:0062207,regulation of pattern recognition recept...,143,0,0.21,1.00000,1,1,0
BP,GO:0062208,positive regulation of pattern recogniti...,68,0,0.1,1.00000,1,1,0
BP,GO:0065002,intracellular protein transmembrane tran...,53,0,0.08,1.00000,1,1,0
BP,GO:0065005,protein-lipid complex assembly,39,0,0.06,1.00000,1,1,0
BP,GO:0070050,neuron cellular homeostasis,35,0,0.05,1.00000,1,1,0
BP,GO:0070076,histone lysine demethylation,28,0,0.04,1.00000,1,1,0
BP,GO:0070098,chemokine-mediated signaling pathway,102,0,0.15,1.00000,1,1,0
BP,GO:0070102,interleukin-6-mediated signaling pathway,27,0,0.04,1.00000,1,1,0
BP,GO:0070129,regulation of mitochondrial translation,24,0,0.03,1.00000,1,1,0
BP,GO:0070166,enamel mineralization,23,0,0.03,1.00000,1,1,0
BP,GO:0070167,regulation of biomineral tissue developm...,103,0,0.15,1.00000,1,1,0
BP,GO:0070168,negative regulation of biomineral tissue...,35,0,0.05,1.00000,1,1,0
BP,GO:0070169,positive regulation of biomineral tissue...,50,0,0.07,1.00000,1,1,0
BP,GO:0070193,synaptonemal complex organization,39,0,0.06,1.00000,1,1,0
BP,GO:0070199,establishment of protein localization to...,25,0,0.04,1.00000,1,1,0
BP,GO:0070206,protein trimerization,25,0,0.04,1.00000,1,1,0
BP,GO:0070207,protein homotrimerization,23,0,0.03,1.00000,1,1,0
BP,GO:0070231,T cell apoptotic process,54,0,0.08,1.00000,1,1,0
BP,GO:0070232,regulation of T cell apoptotic process,37,0,0.05,1.00000,1,1,0
BP,GO:0070233,negative regulation of T cell apoptotic ...,20,0,0.03,1.00000,1,1,0
BP,GO:0070262,peptidyl-serine dephosphorylation,20,0,0.03,1.00000,1,1,0
BP,GO:0070265,necrotic cell death,71,0,0.1,1.00000,1,1,0
BP,GO:0070266,necroptotic process,49,0,0.07,1.00000,1,1,0
BP,GO:0070269,pyroptosis,26,0,0.04,1.00000,1,1,0
BP,GO:0070286,axonemal dynein complex assembly,37,0,0.05,1.00000,1,1,0
BP,GO:0070296,sarcoplasmic reticulum calcium ion trans...,45,0,0.06,1.00000,1,1,0
BP,GO:0070304,positive regulation of stress-activated ...,145,0,0.21,1.00000,1,1,0
BP,GO:0070306,lens fiber cell differentiation,37,0,0.05,1.00000,1,1,0
BP,GO:0070316,regulation of G0 to G1 transition,21,0,0.03,1.00000,1,1,0
BP,GO:0070328,triglyceride homeostasis,43,0,0.06,1.00000,1,1,0
BP,GO:0070423,nucleotide-binding oligomerization domai...,33,0,0.05,1.00000,1,1,0
BP,GO:0070424,regulation of nucleotide-binding oligome...,21,0,0.03,1.00000,1,1,0
BP,GO:0070431,nucleotide-binding oligomerization domai...,24,0,0.03,1.00000,1,1,0
BP,GO:0070498,interleukin-1-mediated signaling pathway,31,0,0.04,1.00000,1,1,0
BP,GO:0070527,platelet aggregation,83,0,0.12,1.00000,1,1,0
BP,GO:0070528,protein kinase C signaling,40,0,0.06,1.00000,1,1,0
BP,GO:0070534,protein K63-linked ubiquitination,72,0,0.1,1.00000,1,1,0
BP,GO:0070536,protein K63-linked deubiquitination,37,0,0.05,1.00000,1,1,0
BP,GO:0070542,response to fatty acid,66,0,0.09,1.00000,1,1,0
BP,GO:0070555,response to interleukin-1,169,0,0.24,1.00000,1,1,0
BP,GO:0070570,regulation of neuron projection regenera...,35,0,0.05,1.00000,1,1,0
BP,GO:0070584,mitochondrion morphogenesis,22,0,0.03,1.00000,1,1,0
BP,GO:0070585,protein localization to mitochondrion,141,0,0.2,1.00000,1,1,0
BP,GO:0070613,regulation of protein processing,79,0,0.11,1.00000,1,1,0
BP,GO:0070646,protein modification by small protein re...,162,0,0.23,1.00000,1,1,0
BP,GO:0070665,positive regulation of leukocyte prolife...,204,0,0.29,1.00000,1,1,0
BP,GO:0070670,response to interleukin-4,37,0,0.05,1.00000,1,1,0
BP,GO:0070723,response to cholesterol,35,0,0.05,1.00000,1,1,0
BP,GO:0070734,histone H3-K27 methylation,28,0,0.04,1.00000,1,1,0
BP,GO:0070741,response to interleukin-6,51,0,0.07,1.00000,1,1,0
BP,GO:0070841,inclusion body assembly,41,0,0.06,1.00000,1,1,0
BP,GO:0070848,response to growth factor,748,0,1.08,1.00000,1,1,0
BP,GO:0070849,response to epidermal growth factor,49,0,0.07,1.00000,1,1,0
BP,GO:0070861,regulation of protein exit from endoplas...,27,0,0.04,1.00000,1,1,0
BP,GO:0070873,regulation of glycogen metabolic process,39,0,0.06,1.00000,1,1,0
BP,GO:0070884,regulation of calcineurin-NFAT signaling...,41,0,0.06,1.00000,1,1,0
BP,GO:0070886,positive regulation of calcineurin-NFAT ...,22,0,0.03,1.00000,1,1,0
BP,GO:0070897,transcription preinitiation complex asse...,41,0,0.06,1.00000,1,1,0
BP,GO:0070920,regulation of production of small RNA in...,33,0,0.05,1.00000,1,1,0
BP,GO:0070932,histone H3 deacetylation,21,0,0.03,1.00000,1,1,0
BP,GO:0070935,3'-UTR-mediated mRNA stabilization,24,0,0.03,1.00000,1,1,0
BP,GO:0070936,protein K48-linked ubiquitination,74,0,0.11,1.00000,1,1,0
BP,GO:0070972,protein localization to endoplasmic reti...,74,0,0.11,1.00000,1,1,0
BP,GO:0070977,bone maturation,29,0,0.04,1.00000,1,1,0
BP,GO:0070979,protein K11-linked ubiquitination,29,0,0.04,1.00000,1,1,0
BP,GO:0070997,neuron death,442,0,0.64,1.00000,1,1,0
BP,GO:0071025,RNA surveillance,20,0,0.03,1.00000,1,1,0
BP,GO:0071108,protein K48-linked deubiquitination,37,0,0.05,1.00000,1,1,0
BP,GO:0071166,ribonucleoprotein complex localization,95,0,0.14,1.00000,1,1,0
BP,GO:0071168,protein localization to chromatin,32,0,0.05,1.00000,1,1,0
BP,GO:0071173,spindle assembly checkpoint signaling,38,0,0.05,1.00000,1,1,0
BP,GO:0071174,mitotic spindle checkpoint signaling,38,0,0.05,1.00000,1,1,0
BP,GO:0071214,cellular response to abiotic stimulus,349,0,0.5,1.00000,1,1,0
BP,GO:0071216,cellular response to biotic stimulus,296,0,0.43,1.00000,1,1,0
BP,GO:0071218,cellular response to misfolded protein,36,0,0.05,1.00000,1,1,0
BP,GO:0071219,cellular response to molecule of bacteri...,271,0,0.39,1.00000,1,1,0
BP,GO:0071222,cellular response to lipopolysaccharide,258,0,0.37,1.00000,1,1,0
BP,GO:0071243,cellular response to arsenic-containing ...,27,0,0.04,1.00000,1,1,0
BP,GO:0071248,cellular response to metal ion,208,0,0.3,1.00000,1,1,0
BP,GO:0071260,cellular response to mechanical stimulus,83,0,0.12,1.00000,1,1,0
BP,GO:0071276,cellular response to cadmium ion,45,0,0.06,1.00000,1,1,0
BP,GO:0071277,cellular response to calcium ion,88,0,0.13,1.00000,1,1,0
BP,GO:0071280,cellular response to copper ion,33,0,0.05,1.00000,1,1,0
BP,GO:0071294,cellular response to zinc ion,23,0,0.03,1.00000,1,1,0
BP,GO:0071295,cellular response to vitamin,33,0,0.05,1.00000,1,1,0
BP,GO:0071300,cellular response to retinoic acid,71,0,0.1,1.00000,1,1,0
BP,GO:0071305,cellular response to vitamin D,23,0,0.03,1.00000,1,1,0
BP,GO:0071312,cellular response to alkaloid,53,0,0.08,1.00000,1,1,0
BP,GO:0071320,cellular response to cAMP,54,0,0.08,1.00000,1,1,0
BP,GO:0071322,cellular response to carbohydrate stimul...,174,0,0.25,1.00000,1,1,0
BP,GO:0071326,cellular response to monosaccharide stim...,165,0,0.24,1.00000,1,1,0
BP,GO:0071331,cellular response to hexose stimulus,164,0,0.24,1.00000,1,1,0
BP,GO:0071333,cellular response to glucose stimulus,162,0,0.23,1.00000,1,1,0
BP,GO:0071345,cellular response to cytokine stimulus,946,0,1.36,1.00000,1,1,0
BP,GO:0071346,cellular response to interferon-gamma,147,0,0.21,1.00000,1,1,0
BP,GO:0071347,cellular response to interleukin-1,138,0,0.2,1.00000,1,1,0
BP,GO:0071353,cellular response to interleukin-4,34,0,0.05,1.00000,1,1,0
BP,GO:0071354,cellular response to interleukin-6,47,0,0.07,1.00000,1,1,0
BP,GO:0071356,cellular response to tumor necrosis fact...,271,0,0.39,1.00000,1,1,0
BP,GO:0071357,cellular response to type I interferon,56,0,0.08,1.00000,1,1,0
BP,GO:0071359,cellular response to dsRNA,30,0,0.04,1.00000,1,1,0
BP,GO:0071360,cellular response to exogenous dsRNA,26,0,0.04,1.00000,1,1,0
BP,GO:0071363,cellular response to growth factor stimu...,718,0,1.03,1.00000,1,1,0
BP,GO:0071364,cellular response to epidermal growth fa...,45,0,0.06,1.00000,1,1,0
BP,GO:0071378,cellular response to growth hormone stim...,24,0,0.03,1.00000,1,1,0
BP,GO:0071379,cellular response to prostaglandin stimu...,21,0,0.03,1.00000,1,1,0
BP,GO:0071384,cellular response to corticosteroid stim...,63,0,0.09,1.00000,1,1,0
BP,GO:0071385,cellular response to glucocorticoid stim...,58,0,0.08,1.00000,1,1,0
BP,GO:0071392,cellular response to estradiol stimulus,39,0,0.06,1.00000,1,1,0
BP,GO:0071397,cellular response to cholesterol,22,0,0.03,1.00000,1,1,0
BP,GO:0071398,cellular response to fatty acid,40,0,0.06,1.00000,1,1,0
BP,GO:0071402,cellular response to lipoprotein particl...,37,0,0.05,1.00000,1,1,0
BP,GO:0071404,cellular response to low-density lipopro...,23,0,0.03,1.00000,1,1,0
BP,GO:0071425,hematopoietic stem cell proliferation,27,0,0.04,1.00000,1,1,0
BP,GO:0071426,ribonucleoprotein complex export from nu...,85,0,0.12,1.00000,1,1,0
BP,GO:0071427,mRNA-containing ribonucleoprotein comple...,67,0,0.1,1.00000,1,1,0
BP,GO:0071450,cellular response to oxygen radical,26,0,0.04,1.00000,1,1,0
BP,GO:0071451,cellular response to superoxide,26,0,0.04,1.00000,1,1,0
BP,GO:0071459,"protein localization to chromosome, cent...",27,0,0.04,1.00000,1,1,0
BP,GO:0071466,cellular response to xenobiotic stimulus,191,0,0.27,1.00000,1,1,0
BP,GO:0071467,cellular response to pH,22,0,0.03,1.00000,1,1,0
BP,GO:0071470,cellular response to osmotic stress,43,0,0.06,1.00000,1,1,0
BP,GO:0071478,cellular response to radiation,199,0,0.29,1.00000,1,1,0
BP,GO:0071479,cellular response to ionizing radiation,75,0,0.11,1.00000,1,1,0
BP,GO:0071480,cellular response to gamma radiation,33,0,0.05,1.00000,1,1,0
BP,GO:0071482,cellular response to light stimulus,133,0,0.19,1.00000,1,1,0
BP,GO:0071496,cellular response to external stimulus,343,0,0.49,1.00000,1,1,0
BP,GO:0071498,cellular response to fluid shear stress,21,0,0.03,1.00000,1,1,0
BP,GO:0071539,protein localization to centrosome,35,0,0.05,1.00000,1,1,0
BP,GO:0071542,dopaminergic neuron differentiation,41,0,0.06,1.00000,1,1,0
BP,GO:0071545,inositol phosphate catabolic process,20,0,0.03,1.00000,1,1,0
BP,GO:0071548,response to dexamethasone,42,0,0.06,1.00000,1,1,0
BP,GO:0071549,cellular response to dexamethasone stimu...,31,0,0.04,1.00000,1,1,0
BP,GO:0071559,response to transforming growth factor b...,268,0,0.39,1.00000,1,1,0
BP,GO:0071560,cellular response to transforming growth...,262,0,0.38,1.00000,1,1,0
BP,GO:0071577,zinc ion transmembrane transport,31,0,0.04,1.00000,1,1,0
BP,GO:0071604,transforming growth factor beta producti...,48,0,0.07,1.00000,1,1,0
BP,GO:0071605,monocyte chemotactic protein-1 productio...,27,0,0.04,1.00000,1,1,0
BP,GO:0071616,acyl-CoA biosynthetic process,53,0,0.08,1.00000,1,1,0
BP,GO:0071621,granulocyte chemotaxis,140,0,0.2,1.00000,1,1,0
BP,GO:0071622,regulation of granulocyte chemotaxis,52,0,0.07,1.00000,1,1,0
BP,GO:0071624,positive regulation of granulocyte chemo...,27,0,0.04,1.00000,1,1,0
BP,GO:0071625,vocalization behavior,21,0,0.03,1.00000,1,1,0
BP,GO:0071634,regulation of transforming growth factor...,46,0,0.07,1.00000,1,1,0
BP,GO:0071636,positive regulation of transforming grow...,24,0,0.03,1.00000,1,1,0
BP,GO:0071637,regulation of monocyte chemotactic prote...,27,0,0.04,1.00000,1,1,0
BP,GO:0071639,positive regulation of monocyte chemotac...,22,0,0.03,1.00000,1,1,0
BP,GO:0071674,mononuclear cell migration,242,0,0.35,1.00000,1,1,0
BP,GO:0071675,regulation of mononuclear cell migration,143,0,0.21,1.00000,1,1,0
BP,GO:0071676,negative regulation of mononuclear cell ...,26,0,0.04,1.00000,1,1,0
BP,GO:0071677,positive regulation of mononuclear cell ...,90,0,0.13,1.00000,1,1,0
BP,GO:0071684,organism emergence from protective struc...,31,0,0.04,1.00000,1,1,0
BP,GO:0071692,protein localization to extracellular re...,404,0,0.58,1.00000,1,1,0
BP,GO:0071695,anatomical structure maturation,241,0,0.35,1.00000,1,1,0
BP,GO:0071709,membrane assembly,62,0,0.09,1.00000,1,1,0
BP,GO:0071711,basement membrane organization,32,0,0.05,1.00000,1,1,0
BP,GO:0071712,ER-associated misfolded protein cataboli...,24,0,0.03,1.00000,1,1,0
BP,GO:0071715,icosanoid transport,57,0,0.08,1.00000,1,1,0
BP,GO:0071731,response to nitric oxide,20,0,0.03,1.00000,1,1,0
BP,GO:0071763,nuclear membrane organization,35,0,0.05,1.00000,1,1,0
BP,GO:0071772,response to BMP,171,0,0.25,1.00000,1,1,0
BP,GO:0071773,cellular response to BMP stimulus,171,0,0.25,1.00000,1,1,0
BP,GO:0071774,response to fibroblast growth factor,122,0,0.18,1.00000,1,1,0
BP,GO:0071800,podosome assembly,26,0,0.04,1.00000,1,1,0
BP,GO:0071801,regulation of podosome assembly,20,0,0.03,1.00000,1,1,0
BP,GO:0071806,protein transmembrane transport,63,0,0.09,1.00000,1,1,0
BP,GO:0071816,tail-anchored membrane protein insertion...,24,0,0.03,1.00000,1,1,0
BP,GO:0071825,protein-lipid complex subunit organizati...,59,0,0.08,1.00000,1,1,0
BP,GO:0071827,plasma lipoprotein particle organization,55,0,0.08,1.00000,1,1,0
BP,GO:0071867,response to monoamine,118,0,0.17,1.00000,1,1,0
BP,GO:0071868,cellular response to monoamine stimulus,114,0,0.16,1.00000,1,1,0
BP,GO:0071869,response to catecholamine,118,0,0.17,1.00000,1,1,0
BP,GO:0071870,cellular response to catecholamine stimu...,114,0,0.16,1.00000,1,1,0
BP,GO:0071875,adrenergic receptor signaling pathway,34,0,0.05,1.00000,1,1,0
BP,GO:0071880,adenylate cyclase-activating adrenergic ...,27,0,0.04,1.00000,1,1,0
BP,GO:0071897,DNA biosynthetic process,190,0,0.27,1.00000,1,1,0
BP,GO:0071900,regulation of protein serine/threonine k...,395,0,0.57,1.00000,1,1,0
BP,GO:0071901,negative regulation of protein serine/th...,127,0,0.18,1.00000,1,1,0
BP,GO:0071902,positive regulation of protein serine/th...,219,0,0.31,1.00000,1,1,0
BP,GO:0071985,multivesicular body sorting pathway,40,0,0.06,1.00000,1,1,0
BP,GO:0072010,glomerular epithelium development,24,0,0.03,1.00000,1,1,0
BP,GO:0072077,renal vesicle morphogenesis,24,0,0.03,1.00000,1,1,0
BP,GO:0072079,nephron tubule formation,22,0,0.03,1.00000,1,1,0
BP,GO:0072087,renal vesicle development,25,0,0.04,1.00000,1,1,0
BP,GO:0072089,stem cell proliferation,73,0,0.1,1.00000,1,1,0
BP,GO:0072091,regulation of stem cell proliferation,45,0,0.06,1.00000,1,1,0
BP,GO:0072111,cell proliferation involved in kidney de...,21,0,0.03,1.00000,1,1,0
BP,GO:0072112,glomerular visceral epithelial cell diff...,20,0,0.03,1.00000,1,1,0
BP,GO:0072132,mesenchyme morphogenesis,52,0,0.07,1.00000,1,1,0
BP,GO:0072170,metanephric tubule development,23,0,0.03,1.00000,1,1,0
BP,GO:0072175,epithelial tube formation,146,0,0.21,1.00000,1,1,0
BP,GO:0072202,cell differentiation involved in metanep...,28,0,0.04,1.00000,1,1,0
BP,GO:0072207,metanephric epithelium development,27,0,0.04,1.00000,1,1,0
BP,GO:0072210,metanephric nephron development,46,0,0.07,1.00000,1,1,0
BP,GO:0072243,metanephric nephron epithelium developme...,22,0,0.03,1.00000,1,1,0
BP,GO:0072273,metanephric nephron morphogenesis,32,0,0.05,1.00000,1,1,0
BP,GO:0072283,metanephric renal vesicle morphogenesis,21,0,0.03,1.00000,1,1,0
BP,GO:0072311,glomerular epithelial cell differentiati...,21,0,0.03,1.00000,1,1,0
BP,GO:0072329,monocarboxylic acid catabolic process,127,0,0.18,1.00000,1,1,0
BP,GO:0072330,monocarboxylic acid biosynthetic process,233,0,0.33,1.00000,1,1,0
BP,GO:0072332,intrinsic apoptotic signaling pathway by...,88,0,0.13,1.00000,1,1,0
BP,GO:0072337,modified amino acid transport,33,0,0.05,1.00000,1,1,0
BP,GO:0072348,sulfur compound transport,63,0,0.09,1.00000,1,1,0
BP,GO:0072522,purine-containing compound biosynthetic ...,212,0,0.3,1.00000,1,1,0
BP,GO:0072523,purine-containing compound catabolic pro...,54,0,0.08,1.00000,1,1,0
BP,GO:0072524,pyridine-containing compound metabolic p...,40,0,0.06,1.00000,1,1,0
BP,GO:0072525,pyridine-containing compound biosyntheti...,34,0,0.05,1.00000,1,1,0
BP,GO:0072528,pyrimidine-containing compound biosynthe...,34,0,0.05,1.00000,1,1,0
BP,GO:0072530,purine-containing compound transmembrane...,24,0,0.03,1.00000,1,1,0
BP,GO:0072531,pyrimidine-containing compound transmemb...,21,0,0.03,1.00000,1,1,0
BP,GO:0072538,T-helper 17 type immune response,41,0,0.06,1.00000,1,1,0
BP,GO:0072539,T-helper 17 cell differentiation,29,0,0.04,1.00000,1,1,0
BP,GO:0072574,hepatocyte proliferation,23,0,0.03,1.00000,1,1,0
BP,GO:0072575,epithelial cell proliferation involved i...,23,0,0.03,1.00000,1,1,0
BP,GO:0072576,liver morphogenesis,24,0,0.03,1.00000,1,1,0
BP,GO:0072583,clathrin-dependent endocytosis,52,0,0.07,1.00000,1,1,0
BP,GO:0072593,reactive oxygen species metabolic proces...,263,0,0.38,1.00000,1,1,0
BP,GO:0072594,establishment of protein localization to...,447,0,0.64,1.00000,1,1,0
BP,GO:0072595,maintenance of protein localization in o...,43,0,0.06,1.00000,1,1,0
BP,GO:0072599,establishment of protein localization to...,45,0,0.06,1.00000,1,1,0
BP,GO:0072655,establishment of protein localization to...,135,0,0.19,1.00000,1,1,0
BP,GO:0072665,protein localization to vacuole,68,0,0.1,1.00000,1,1,0
BP,GO:0072666,establishment of protein localization to...,50,0,0.07,1.00000,1,1,0
BP,GO:0072676,lymphocyte migration,144,0,0.21,1.00000,1,1,0
BP,GO:0072677,eosinophil migration,29,0,0.04,1.00000,1,1,0
BP,GO:0072678,T cell migration,80,0,0.11,1.00000,1,1,0
BP,GO:0072698,protein localization to microtubule cyto...,56,0,0.08,1.00000,1,1,0
BP,GO:0080164,regulation of nitric oxide metabolic pro...,82,0,0.12,1.00000,1,1,0
BP,GO:0080171,lytic vacuole organization,77,0,0.11,1.00000,1,1,0
BP,GO:0085029,extracellular matrix assembly,53,0,0.08,1.00000,1,1,0
BP,GO:0086009,membrane repolarization,51,0,0.07,1.00000,1,1,0
BP,GO:0086010,membrane depolarization during action po...,37,0,0.05,1.00000,1,1,0
BP,GO:0086011,membrane repolarization during action po...,30,0,0.04,1.00000,1,1,0
BP,GO:0086012,membrane depolarization during cardiac m...,23,0,0.03,1.00000,1,1,0
BP,GO:0086013,membrane repolarization during cardiac m...,27,0,0.04,1.00000,1,1,0
BP,GO:0086014,atrial cardiac muscle cell action potent...,21,0,0.03,1.00000,1,1,0
BP,GO:0086019,cell-cell signaling involved in cardiac ...,36,0,0.05,1.00000,1,1,0
BP,GO:0086026,atrial cardiac muscle cell to AV node ce...,21,0,0.03,1.00000,1,1,0
BP,GO:0086064,cell communication by electrical couplin...,27,0,0.04,1.00000,1,1,0
BP,GO:0086065,cell communication involved in cardiac c...,61,0,0.09,1.00000,1,1,0
BP,GO:0086066,atrial cardiac muscle cell to AV node ce...,21,0,0.03,1.00000,1,1,0
BP,GO:0086091,regulation of heart rate by cardiac cond...,42,0,0.06,1.00000,1,1,0
BP,GO:0089718,amino acid import across plasma membrane,46,0,0.07,1.00000,1,1,0
BP,GO:0090022,regulation of neutrophil chemotaxis,32,0,0.05,1.00000,1,1,0
BP,GO:0090023,positive regulation of neutrophil chemot...,24,0,0.03,1.00000,1,1,0
BP,GO:0090025,regulation of monocyte chemotaxis,36,0,0.05,1.00000,1,1,0
BP,GO:0090026,positive regulation of monocyte chemotax...,27,0,0.04,1.00000,1,1,0
BP,GO:0090049,regulation of cell migration involved in...,81,0,0.12,1.00000,1,1,0
BP,GO:0090050,positive regulation of cell migration in...,38,0,0.05,1.00000,1,1,0
BP,GO:0090051,negative regulation of cell migration in...,42,0,0.06,1.00000,1,1,0
BP,GO:0090075,relaxation of muscle,35,0,0.05,1.00000,1,1,0
BP,GO:0090077,foam cell differentiation,39,0,0.06,1.00000,1,1,0
BP,GO:0090083,regulation of inclusion body assembly,26,0,0.04,1.00000,1,1,0
BP,GO:0090084,negative regulation of inclusion body as...,20,0,0.03,1.00000,1,1,0
BP,GO:0090087,regulation of peptide transport,223,0,0.32,1.00000,1,1,0
BP,GO:0090090,negative regulation of canonical Wnt sig...,141,0,0.2,1.00000,1,1,0
BP,GO:0090092,regulation of transmembrane receptor pro...,276,0,0.4,1.00000,1,1,0
BP,GO:0090100,positive regulation of transmembrane rec...,124,0,0.18,1.00000,1,1,0
BP,GO:0090101,negative regulation of transmembrane rec...,141,0,0.2,1.00000,1,1,0
BP,GO:0090102,cochlea development,52,0,0.07,1.00000,1,1,0
BP,GO:0090103,cochlea morphogenesis,23,0,0.03,1.00000,1,1,0
BP,GO:0090114,COPII-coated vesicle budding,30,0,0.04,1.00000,1,1,0
BP,GO:0090140,regulation of mitochondrial fission,36,0,0.05,1.00000,1,1,0
BP,GO:0090141,positive regulation of mitochondrial fis...,22,0,0.03,1.00000,1,1,0
BP,GO:0090150,establishment of protein localization to...,281,0,0.4,1.00000,1,1,0
BP,GO:0090151,establishment of protein localization to...,34,0,0.05,1.00000,1,1,0
BP,GO:0090162,establishment of epithelial cell polarit...,32,0,0.05,1.00000,1,1,0
BP,GO:0090174,organelle membrane fusion,117,0,0.17,1.00000,1,1,0
BP,GO:0090175,regulation of establishment of planar po...,58,0,0.08,1.00000,1,1,0
BP,GO:0090181,regulation of cholesterol metabolic proc...,36,0,0.05,1.00000,1,1,0
BP,GO:0090183,regulation of kidney development,34,0,0.05,1.00000,1,1,0
BP,GO:0090189,regulation of branching involved in uret...,24,0,0.03,1.00000,1,1,0
BP,GO:0090190,positive regulation of branching involve...,21,0,0.03,1.00000,1,1,0
BP,GO:0090199,regulation of release of cytochrome c fr...,52,0,0.07,1.00000,1,1,0
BP,GO:0090200,positive regulation of release of cytoch...,30,0,0.04,1.00000,1,1,0
BP,GO:0090201,negative regulation of release of cytoch...,21,0,0.03,1.00000,1,1,0
BP,GO:0090207,regulation of triglyceride metabolic pro...,49,0,0.07,1.00000,1,1,0
BP,GO:0090208,positive regulation of triglyceride meta...,24,0,0.03,1.00000,1,1,0
BP,GO:0090263,positive regulation of canonical Wnt sig...,109,0,0.16,1.00000,1,1,0
BP,GO:0090276,regulation of peptide hormone secretion,217,0,0.31,1.00000,1,1,0
BP,GO:0090277,positive regulation of peptide hormone s...,113,0,0.16,1.00000,1,1,0
BP,GO:0090278,negative regulation of peptide hormone s...,44,0,0.06,1.00000,1,1,0
BP,GO:0090279,regulation of calcium ion import,55,0,0.08,1.00000,1,1,0
BP,GO:0090280,positive regulation of calcium ion impor...,24,0,0.03,1.00000,1,1,0
BP,GO:0090281,negative regulation of calcium ion impor...,20,0,0.03,1.00000,1,1,0
BP,GO:0090287,regulation of cellular response to growt...,320,0,0.46,1.00000,1,1,0
BP,GO:0090288,negative regulation of cellular response...,115,0,0.17,1.00000,1,1,0
BP,GO:0090303,positive regulation of wound healing,62,0,0.09,1.00000,1,1,0
BP,GO:0090307,mitotic spindle assembly,80,0,0.11,1.00000,1,1,0
BP,GO:0090311,regulation of protein deacetylation,52,0,0.07,1.00000,1,1,0
BP,GO:0090312,positive regulation of protein deacetyla...,26,0,0.04,1.00000,1,1,0
BP,GO:0090313,regulation of protein targeting to membr...,39,0,0.06,1.00000,1,1,0
BP,GO:0090314,positive regulation of protein targeting...,32,0,0.05,1.00000,1,1,0
BP,GO:0090316,positive regulation of intracellular pro...,170,0,0.24,1.00000,1,1,0
BP,GO:0090317,negative regulation of intracellular pro...,44,0,0.06,1.00000,1,1,0
BP,GO:0090322,regulation of superoxide metabolic proce...,40,0,0.06,1.00000,1,1,0
BP,GO:0090330,regulation of platelet aggregation,35,0,0.05,1.00000,1,1,0
BP,GO:0090335,regulation of brown fat cell differentia...,25,0,0.04,1.00000,1,1,0
BP,GO:0090343,positive regulation of cell aging,72,0,0.1,1.00000,1,1,0
BP,GO:0090370,negative regulation of cholesterol efflu...,22,0,0.03,1.00000,1,1,0
BP,GO:0090382,phagosome maturation,26,0,0.04,1.00000,1,1,0
BP,GO:0090407,organophosphate biosynthetic process,599,0,0.86,1.00000,1,1,0
BP,GO:0090493,catecholamine uptake,21,0,0.03,1.00000,1,1,0
BP,GO:0090494,dopamine uptake,20,0,0.03,1.00000,1,1,0
BP,GO:0090503,"RNA phosphodiester bond hydrolysis, exon...",43,0,0.06,1.00000,1,1,0
BP,GO:0090504,epiboly,42,0,0.06,1.00000,1,1,0
BP,GO:0090505,epiboly involved in wound healing,41,0,0.06,1.00000,1,1,0
BP,GO:0090596,sensory organ morphogenesis,284,0,0.41,1.00000,1,1,0
BP,GO:0090630,activation of GTPase activity,134,0,0.19,1.00000,1,1,0
BP,GO:0090659,walking behavior,29,0,0.04,1.00000,1,1,0
BP,GO:0090670,RNA localization to Cajal body,21,0,0.03,1.00000,1,1,0
BP,GO:0090671,telomerase RNA localization to Cajal bod...,21,0,0.03,1.00000,1,1,0
BP,GO:0090672,telomerase RNA localization,21,0,0.03,1.00000,1,1,0
BP,GO:0090685,RNA localization to nucleus,21,0,0.03,1.00000,1,1,0
BP,GO:0090713,immunological memory process,30,0,0.04,1.00000,1,1,0
BP,GO:0090715,immunological memory formation process,26,0,0.04,1.00000,1,1,0
BP,GO:0095500,acetylcholine receptor signaling pathway,39,0,0.06,1.00000,1,1,0
BP,GO:0097006,regulation of plasma lipoprotein particl...,95,0,0.14,1.00000,1,1,0
BP,GO:0097009,energy homeostasis,38,0,0.05,1.00000,1,1,0
BP,GO:0097028,dendritic cell differentiation,81,0,0.12,1.00000,1,1,0
BP,GO:0097035,regulation of membrane lipid distributio...,65,0,0.09,1.00000,1,1,0
BP,GO:0097062,dendritic spine maintenance,22,0,0.03,1.00000,1,1,0
BP,GO:0097066,response to thyroid hormone,28,0,0.04,1.00000,1,1,0
BP,GO:0097107,postsynaptic density assembly,21,0,0.03,1.00000,1,1,0
BP,GO:0097150,neuronal stem cell population maintenanc...,23,0,0.03,1.00000,1,1,0
BP,GO:0097178,ruffle assembly,57,0,0.08,1.00000,1,1,0
BP,GO:0097186,amelogenesis,29,0,0.04,1.00000,1,1,0
BP,GO:0097192,extrinsic apoptotic signaling pathway in...,81,0,0.12,1.00000,1,1,0
BP,GO:0097194,execution phase of apoptosis,90,0,0.13,1.00000,1,1,0
BP,GO:0097205,renal filtration,26,0,0.04,1.00000,1,1,0
BP,GO:0097237,cellular response to toxic substance,139,0,0.2,1.00000,1,1,0
BP,GO:0097242,amyloid-beta clearance,45,0,0.06,1.00000,1,1,0
BP,GO:0097300,programmed necrotic cell death,56,0,0.08,1.00000,1,1,0
BP,GO:0097320,plasma membrane tubulation,21,0,0.03,1.00000,1,1,0
BP,GO:0097345,mitochondrial outer membrane permeabiliz...,43,0,0.06,1.00000,1,1,0
BP,GO:0097352,autophagosome maturation,42,0,0.06,1.00000,1,1,0
BP,GO:0097421,liver regeneration,41,0,0.06,1.00000,1,1,0
BP,GO:0097479,synaptic vesicle localization,58,0,0.08,1.00000,1,1,0
BP,GO:0097484,dendrite extension,40,0,0.06,1.00000,1,1,0
BP,GO:0097502,mannosylation,35,0,0.05,1.00000,1,1,0
BP,GO:0097503,sialylation,21,0,0.03,1.00000,1,1,0
BP,GO:0097529,myeloid leukocyte migration,256,0,0.37,1.00000,1,1,0
BP,GO:0097530,granulocyte migration,164,0,0.24,1.00000,1,1,0
BP,GO:0097581,lamellipodium organization,96,0,0.14,1.00000,1,1,0
BP,GO:0097696,receptor signaling pathway via STAT,195,0,0.28,1.00000,1,1,0
BP,GO:0097720,calcineurin-mediated signaling,56,0,0.08,1.00000,1,1,0
BP,GO:0097722,sperm motility,115,0,0.17,1.00000,1,1,0
BP,GO:0097734,extracellular exosome biogenesis,21,0,0.03,1.00000,1,1,0
BP,GO:0097746,blood vessel diameter maintenance,143,0,0.21,1.00000,1,1,0
BP,GO:0098534,centriole assembly,48,0,0.07,1.00000,1,1,0
BP,GO:0098543,detection of other organism,39,0,0.06,1.00000,1,1,0
BP,GO:0098581,detection of external biotic stimulus,48,0,0.07,1.00000,1,1,0
BP,GO:0098586,cellular response to virus,97,0,0.14,1.00000,1,1,0
BP,GO:0098656,anion transmembrane transport,263,0,0.38,1.00000,1,1,0
BP,GO:0098661,inorganic anion transmembrane transport,94,0,0.14,1.00000,1,1,0
BP,GO:0098664,G protein-coupled serotonin receptor sig...,36,0,0.05,1.00000,1,1,0
BP,GO:0098698,postsynaptic specialization assembly,24,0,0.03,1.00000,1,1,0
BP,GO:0098703,calcium ion import across plasma membran...,27,0,0.04,1.00000,1,1,0
BP,GO:0098719,sodium ion import across plasma membrane,23,0,0.03,1.00000,1,1,0
BP,GO:0098727,maintenance of cell number,154,0,0.22,1.00000,1,1,0
BP,GO:0098732,macromolecule deacylation,134,0,0.19,1.00000,1,1,0
BP,GO:0098734,macromolecule depalmitoylation,27,0,0.04,1.00000,1,1,0
BP,GO:0098743,cell aggregation,24,0,0.03,1.00000,1,1,0
BP,GO:0098754,detoxification,167,0,0.24,1.00000,1,1,0
BP,GO:0098773,skin epidermis development,93,0,0.13,1.00000,1,1,0
BP,GO:0098780,response to mitochondrial depolarisation,23,0,0.03,1.00000,1,1,0
BP,GO:0098781,ncRNA transcription,59,0,0.08,1.00000,1,1,0
BP,GO:0098801,regulation of renal system process,35,0,0.05,1.00000,1,1,0
BP,GO:0098810,neurotransmitter reuptake,38,0,0.05,1.00000,1,1,0
BP,GO:0098856,intestinal lipid absorption,21,0,0.03,1.00000,1,1,0
BP,GO:0098868,bone growth,29,0,0.04,1.00000,1,1,0
BP,GO:0098869,cellular oxidant detoxification,116,0,0.17,1.00000,1,1,0
BP,GO:0098876,vesicle-mediated transport to the plasma...,150,0,0.22,1.00000,1,1,0
BP,GO:0098926,postsynaptic signal transduction,48,0,0.07,1.00000,1,1,0
BP,GO:0098927,vesicle-mediated transport between endos...,45,0,0.06,1.00000,1,1,0
BP,GO:0098962,regulation of postsynaptic neurotransmit...,21,0,0.03,1.00000,1,1,0
BP,GO:0099003,vesicle-mediated transport in synapse,210,0,0.3,1.00000,1,1,0
BP,GO:0099024,plasma membrane invagination,131,0,0.19,1.00000,1,1,0
BP,GO:0099054,presynapse assembly,54,0,0.08,1.00000,1,1,0
BP,GO:0099068,postsynapse assembly,33,0,0.05,1.00000,1,1,0
BP,GO:0099116,tRNA 5'-end processing,23,0,0.03,1.00000,1,1,0
BP,GO:0099172,presynapse organization,57,0,0.08,1.00000,1,1,0
BP,GO:0099174,regulation of presynapse organization,35,0,0.05,1.00000,1,1,0
BP,GO:0099500,vesicle fusion to plasma membrane,21,0,0.03,1.00000,1,1,0
BP,GO:0099504,synaptic vesicle cycle,190,0,0.27,1.00000,1,1,0
BP,GO:0099514,synaptic vesicle cytoskeletal transport,20,0,0.03,1.00000,1,1,0
BP,GO:0099517,synaptic vesicle transport along microtu...,20,0,0.03,1.00000,1,1,0
BP,GO:0099560,synaptic membrane adhesion,26,0,0.04,1.00000,1,1,0
BP,GO:0099563,modification of synaptic structure,25,0,0.04,1.00000,1,1,0
BP,GO:0099590,neurotransmitter receptor internalizatio...,25,0,0.04,1.00000,1,1,0
BP,GO:0099622,cardiac muscle cell membrane repolarizat...,40,0,0.06,1.00000,1,1,0
BP,GO:0099623,regulation of cardiac muscle cell membra...,29,0,0.04,1.00000,1,1,0
BP,GO:0099625,ventricular cardiac muscle cell membrane...,28,0,0.04,1.00000,1,1,0
BP,GO:0099637,neurotransmitter receptor transport,27,0,0.04,1.00000,1,1,0
BP,GO:0099643,signal release from synapse,149,0,0.21,1.00000,1,1,0
BP,GO:0101023,vascular endothelial cell proliferation,49,0,0.07,1.00000,1,1,0
BP,GO:0104004,cellular response to environmental stimu...,349,0,0.5,1.00000,1,1,0
BP,GO:0106030,neuron projection fasciculation,23,0,0.03,1.00000,1,1,0
BP,GO:0106056,regulation of calcineurin-mediated signa...,42,0,0.06,1.00000,1,1,0
BP,GO:0106058,positive regulation of calcineurin-media...,22,0,0.03,1.00000,1,1,0
BP,GO:0106074,aminoacyl-tRNA metabolism involved in tr...,24,0,0.03,1.00000,1,1,0
BP,GO:0106118,regulation of sterol biosynthetic proces...,22,0,0.03,1.00000,1,1,0
BP,GO:0110020,regulation of actomyosin structure organ...,108,0,0.16,1.00000,1,1,0
BP,GO:0110110,positive regulation of animal organ morp...,33,0,0.05,1.00000,1,1,0
BP,GO:0110148,biomineralization,184,0,0.26,1.00000,1,1,0
BP,GO:0110149,regulation of biomineralization,105,0,0.15,1.00000,1,1,0
BP,GO:0110150,negative regulation of biomineralization,36,0,0.05,1.00000,1,1,0
BP,GO:0110151,positive regulation of biomineralization,51,0,0.07,1.00000,1,1,0
BP,GO:0110154,RNA decapping,25,0,0.04,1.00000,1,1,0
BP,GO:0120009,intermembrane lipid transfer,48,0,0.07,1.00000,1,1,0
BP,GO:0120031,plasma membrane bounded cell projection ...,562,0,0.81,1.00000,1,1,0
BP,GO:0120032,regulation of plasma membrane bounded ce...,200,0,0.29,1.00000,1,1,0
BP,GO:0120033,negative regulation of plasma membrane b...,32,0,0.05,1.00000,1,1,0
BP,GO:0120034,positive regulation of plasma membrane b...,115,0,0.17,1.00000,1,1,0
BP,GO:0120163,negative regulation of cold-induced ther...,48,0,0.07,1.00000,1,1,0
BP,GO:0120178,steroid hormone biosynthetic process,55,0,0.08,1.00000,1,1,0
BP,GO:0120254,olefinic compound metabolic process,171,0,0.25,1.00000,1,1,0
BP,GO:0120255,olefinic compound biosynthetic process,24,0,0.03,1.00000,1,1,0
BP,GO:0120316,sperm flagellum assembly,25,0,0.04,1.00000,1,1,0
BP,GO:0140013,meiotic nuclear division,211,0,0.3,1.00000,1,1,0
BP,GO:0140029,exocytic process,78,0,0.11,1.00000,1,1,0
BP,GO:0140053,mitochondrial gene expression,119,0,0.17,1.00000,1,1,0
BP,GO:0140056,organelle localization by membrane tethe...,81,0,0.12,1.00000,1,1,0
BP,GO:0140058,neuron projection arborization,33,0,0.05,1.00000,1,1,0
BP,GO:0140112,extracellular vesicle biogenesis,23,0,0.03,1.00000,1,1,0
BP,GO:0140131,positive regulation of lymphocyte chemot...,25,0,0.04,1.00000,1,1,0
BP,GO:0140238,presynaptic endocytosis,67,0,0.1,1.00000,1,1,0
BP,GO:0140253,cell-cell fusion,65,0,0.09,1.00000,1,1,0
BP,GO:0140353,lipid export from cell,49,0,0.07,1.00000,1,1,0
BP,GO:0140448,signaling receptor ligand precursor proc...,27,0,0.04,1.00000,1,1,0
BP,GO:0140467,integrated stress response signaling,22,0,0.03,1.00000,1,1,0
BP,GO:0140527,reciprocal homologous recombination,68,0,0.1,1.00000,1,1,0
BP,GO:0140546,defense response to symbiont,306,0,0.44,1.00000,1,1,0
BP,GO:0140632,inflammasome complex assembly,26,0,0.04,1.00000,1,1,0
BP,GO:0150076,neuroinflammatory response,55,0,0.08,1.00000,1,1,0
BP,GO:0150077,regulation of neuroinflammatory response,51,0,0.07,1.00000,1,1,0
BP,GO:0150078,positive regulation of neuroinflammatory...,27,0,0.04,1.00000,1,1,0
BP,GO:0150079,negative regulation of neuroinflammatory...,20,0,0.03,1.00000,1,1,0
BP,GO:0150104,transport across blood-brain barrier,96,0,0.14,1.00000,1,1,0
BP,GO:0150105,protein localization to cell-cell juncti...,24,0,0.03,1.00000,1,1,0
BP,GO:0150118,negative regulation of cell-substrate ju...,21,0,0.03,1.00000,1,1,0
BP,GO:0150146,cell junction disassembly,21,0,0.03,1.00000,1,1,0
BP,GO:0198738,cell-cell signaling by wnt,470,0,0.68,1.00000,1,1,0
BP,GO:1900006,positive regulation of dendrite developm...,20,0,0.03,1.00000,1,1,0
BP,GO:1900015,regulation of cytokine production involv...,101,0,0.15,1.00000,1,1,0
BP,GO:1900016,negative regulation of cytokine producti...,50,0,0.07,1.00000,1,1,0
BP,GO:1900017,positive regulation of cytokine producti...,41,0,0.06,1.00000,1,1,0
BP,GO:1900024,regulation of substrate adhesion-depende...,59,0,0.08,1.00000,1,1,0
BP,GO:1900026,positive regulation of substrate adhesio...,41,0,0.06,1.00000,1,1,0
BP,GO:1900027,regulation of ruffle assembly,38,0,0.05,1.00000,1,1,0
BP,GO:1900029,positive regulation of ruffle assembly,20,0,0.03,1.00000,1,1,0
BP,GO:1900034,regulation of cellular response to heat,21,0,0.03,1.00000,1,1,0
BP,GO:1900046,regulation of hemostasis,69,0,0.1,1.00000,1,1,0
BP,GO:1900047,negative regulation of hemostasis,51,0,0.07,1.00000,1,1,0
BP,GO:1900048,positive regulation of hemostasis,24,0,0.03,1.00000,1,1,0
BP,GO:1900076,regulation of cellular response to insul...,65,0,0.09,1.00000,1,1,0
BP,GO:1900077,negative regulation of cellular response...,38,0,0.05,1.00000,1,1,0
BP,GO:1900078,positive regulation of cellular response...,25,0,0.04,1.00000,1,1,0
BP,GO:1900087,positive regulation of G1/S transition o...,51,0,0.07,1.00000,1,1,0
BP,GO:1900101,regulation of endoplasmic reticulum unfo...,34,0,0.05,1.00000,1,1,0
BP,GO:1900117,regulation of execution phase of apoptos...,30,0,0.04,1.00000,1,1,0
BP,GO:1900118,negative regulation of execution phase o...,20,0,0.03,1.00000,1,1,0
BP,GO:1900120,regulation of receptor binding,25,0,0.04,1.00000,1,1,0
BP,GO:1900180,regulation of protein localization to nu...,152,0,0.22,1.00000,1,1,0
BP,GO:1900181,negative regulation of protein localizat...,45,0,0.06,1.00000,1,1,0
BP,GO:1900182,positive regulation of protein localizat...,91,0,0.13,1.00000,1,1,0
BP,GO:1900221,regulation of amyloid-beta clearance,26,0,0.04,1.00000,1,1,0
BP,GO:1900225,regulation of NLRP3 inflammasome complex...,24,0,0.03,1.00000,1,1,0
BP,GO:1900274,regulation of phospholipase C activity,43,0,0.06,1.00000,1,1,0
BP,GO:1900363,regulation of mRNA polyadenylation,26,0,0.04,1.00000,1,1,0
BP,GO:1900371,regulation of purine nucleotide biosynth...,42,0,0.06,1.00000,1,1,0
BP,GO:1900373,positive regulation of purine nucleotide...,23,0,0.03,1.00000,1,1,0
BP,GO:1900407,regulation of cellular response to oxida...,92,0,0.13,1.00000,1,1,0
BP,GO:1900452,regulation of long-term synaptic depress...,25,0,0.04,1.00000,1,1,0
BP,GO:1900542,regulation of purine nucleotide metaboli...,86,0,0.12,1.00000,1,1,0
BP,GO:1900543,negative regulation of purine nucleotide...,24,0,0.03,1.00000,1,1,0
BP,GO:1900544,positive regulation of purine nucleotide...,42,0,0.06,1.00000,1,1,0
BP,GO:1900745,positive regulation of p38MAPK cascade,40,0,0.06,1.00000,1,1,0
BP,GO:1900746,regulation of vascular endothelial growt...,29,0,0.04,1.00000,1,1,0
BP,GO:1901017,negative regulation of potassium ion tra...,30,0,0.04,1.00000,1,1,0
BP,GO:1901018,positive regulation of potassium ion tra...,27,0,0.04,1.00000,1,1,0
BP,GO:1901019,regulation of calcium ion transmembrane ...,101,0,0.15,1.00000,1,1,0
BP,GO:1901020,negative regulation of calcium ion trans...,47,0,0.07,1.00000,1,1,0
BP,GO:1901021,positive regulation of calcium ion trans...,39,0,0.06,1.00000,1,1,0
BP,GO:1901028,regulation of mitochondrial outer membra...,31,0,0.04,1.00000,1,1,0
BP,GO:1901031,regulation of response to reactive oxyge...,40,0,0.06,1.00000,1,1,0
BP,GO:1901032,negative regulation of response to react...,24,0,0.03,1.00000,1,1,0
BP,GO:1901071,glucosamine-containing compound metaboli...,26,0,0.04,1.00000,1,1,0
BP,GO:1901099,negative regulation of signal transducti...,48,0,0.07,1.00000,1,1,0
BP,GO:1901136,carbohydrate derivative catabolic proces...,185,0,0.27,1.00000,1,1,0
BP,GO:1901184,regulation of ERBB signaling pathway,80,0,0.11,1.00000,1,1,0
BP,GO:1901185,negative regulation of ERBB signaling pa...,32,0,0.05,1.00000,1,1,0
BP,GO:1901186,positive regulation of ERBB signaling pa...,39,0,0.06,1.00000,1,1,0
BP,GO:1901214,regulation of neuron death,401,0,0.58,1.00000,1,1,0
BP,GO:1901215,negative regulation of neuron death,271,0,0.39,1.00000,1,1,0
BP,GO:1901216,positive regulation of neuron death,113,0,0.16,1.00000,1,1,0
BP,GO:1901222,regulation of NIK/NF-kappaB signaling,137,0,0.2,1.00000,1,1,0
BP,GO:1901223,negative regulation of NIK/NF-kappaB sig...,47,0,0.07,1.00000,1,1,0
BP,GO:1901224,positive regulation of NIK/NF-kappaB sig...,87,0,0.13,1.00000,1,1,0
BP,GO:1901264,carbohydrate derivative transport,86,0,0.12,1.00000,1,1,0
BP,GO:1901292,nucleoside phosphate catabolic process,85,0,0.12,1.00000,1,1,0
BP,GO:1901293,nucleoside phosphate biosynthetic proces...,270,0,0.39,1.00000,1,1,0
BP,GO:1901380,negative regulation of potassium ion tra...,35,0,0.05,1.00000,1,1,0
BP,GO:1901381,positive regulation of potassium ion tra...,44,0,0.06,1.00000,1,1,0
BP,GO:1901385,regulation of voltage-gated calcium chan...,47,0,0.07,1.00000,1,1,0
BP,GO:1901386,negative regulation of voltage-gated cal...,26,0,0.04,1.00000,1,1,0
BP,GO:1901522,positive regulation of transcription fro...,23,0,0.03,1.00000,1,1,0
BP,GO:1901550,regulation of endothelial cell developme...,24,0,0.03,1.00000,1,1,0
BP,GO:1901568,fatty acid derivative metabolic process,91,0,0.13,1.00000,1,1,0
BP,GO:1901569,fatty acid derivative catabolic process,23,0,0.03,1.00000,1,1,0
BP,GO:1901570,fatty acid derivative biosynthetic proce...,60,0,0.09,1.00000,1,1,0
BP,GO:1901607,alpha-amino acid biosynthetic process,72,0,0.1,1.00000,1,1,0
BP,GO:1901616,organic hydroxy compound catabolic proce...,82,0,0.12,1.00000,1,1,0
BP,GO:1901617,organic hydroxy compound biosynthetic pr...,255,0,0.37,1.00000,1,1,0
BP,GO:1901623,regulation of lymphocyte chemotaxis,30,0,0.04,1.00000,1,1,0
BP,GO:1901654,response to ketone,210,0,0.3,1.00000,1,1,0
BP,GO:1901655,cellular response to ketone,103,0,0.15,1.00000,1,1,0
BP,GO:1901657,glycosyl compound metabolic process,90,0,0.13,1.00000,1,1,0
BP,GO:1901658,glycosyl compound catabolic process,38,0,0.05,1.00000,1,1,0
BP,GO:1901661,quinone metabolic process,40,0,0.06,1.00000,1,1,0
BP,GO:1901673,regulation of mitotic spindle assembly,27,0,0.04,1.00000,1,1,0
BP,GO:1901679,nucleotide transmembrane transport,20,0,0.03,1.00000,1,1,0
BP,GO:1901739,regulation of myoblast fusion,26,0,0.04,1.00000,1,1,0
BP,GO:1901741,positive regulation of myoblast fusion,22,0,0.03,1.00000,1,1,0
BP,GO:1901796,regulation of signal transduction by p53...,99,0,0.14,1.00000,1,1,0
BP,GO:1901797,negative regulation of signal transducti...,34,0,0.05,1.00000,1,1,0
BP,GO:1901798,positive regulation of signal transducti...,26,0,0.04,1.00000,1,1,0
BP,GO:1901799,negative regulation of proteasomal prote...,63,0,0.09,1.00000,1,1,0
BP,GO:1901800,positive regulation of proteasomal prote...,134,0,0.19,1.00000,1,1,0
BP,GO:1901861,regulation of muscle tissue development,48,0,0.07,1.00000,1,1,0
BP,GO:1901863,positive regulation of muscle tissue dev...,29,0,0.04,1.00000,1,1,0
BP,GO:1901879,regulation of protein depolymerization,90,0,0.13,1.00000,1,1,0
BP,GO:1901880,negative regulation of protein depolymer...,75,0,0.11,1.00000,1,1,0
BP,GO:1901889,negative regulation of cell junction ass...,42,0,0.06,1.00000,1,1,0
BP,GO:1901976,regulation of cell cycle checkpoint,46,0,0.07,1.00000,1,1,0
BP,GO:1901977,negative regulation of cell cycle checkp...,21,0,0.03,1.00000,1,1,0
BP,GO:1901983,regulation of protein acetylation,79,0,0.11,1.00000,1,1,0
BP,GO:1901984,negative regulation of protein acetylati...,24,0,0.03,1.00000,1,1,0
BP,GO:1901985,positive regulation of protein acetylati...,47,0,0.07,1.00000,1,1,0
BP,GO:1901989,positive regulation of cell cycle phase ...,135,0,0.19,1.00000,1,1,0
BP,GO:1901992,positive regulation of mitotic cell cycl...,99,0,0.14,1.00000,1,1,0
BP,GO:1901998,toxin transport,41,0,0.06,1.00000,1,1,0
BP,GO:1902003,regulation of amyloid-beta formation,57,0,0.08,1.00000,1,1,0
BP,GO:1902004,positive regulation of amyloid-beta form...,29,0,0.04,1.00000,1,1,0
BP,GO:1902017,regulation of cilium assembly,59,0,0.08,1.00000,1,1,0
BP,GO:1902019,regulation of cilium-dependent cell moti...,27,0,0.04,1.00000,1,1,0
BP,GO:1902041,regulation of extrinsic apoptotic signal...,50,0,0.07,1.00000,1,1,0
BP,GO:1902042,negative regulation of extrinsic apoptot...,31,0,0.04,1.00000,1,1,0
BP,GO:1902074,response to salt,24,0,0.03,1.00000,1,1,0
BP,GO:1902099,regulation of metaphase/anaphase transit...,64,0,0.09,1.00000,1,1,0
BP,GO:1902100,negative regulation of metaphase/anaphas...,42,0,0.06,1.00000,1,1,0
BP,GO:1902106,negative regulation of leukocyte differe...,123,0,0.18,1.00000,1,1,0
BP,GO:1902108,regulation of mitochondrial membrane per...,56,0,0.08,1.00000,1,1,0
BP,GO:1902110,positive regulation of mitochondrial mem...,49,0,0.07,1.00000,1,1,0
BP,GO:1902116,negative regulation of organelle assembl...,48,0,0.07,1.00000,1,1,0
BP,GO:1902175,regulation of oxidative stress-induced i...,29,0,0.04,1.00000,1,1,0
BP,GO:1902176,negative regulation of oxidative stress-...,20,0,0.03,1.00000,1,1,0
BP,GO:1902186,regulation of viral release from host ce...,48,0,0.07,1.00000,1,1,0
BP,GO:1902187,negative regulation of viral release fro...,28,0,0.04,1.00000,1,1,0
BP,GO:1902229,regulation of intrinsic apoptotic signal...,38,0,0.05,1.00000,1,1,0
BP,GO:1902230,negative regulation of intrinsic apoptot...,31,0,0.04,1.00000,1,1,0
BP,GO:1902235,regulation of endoplasmic reticulum stre...,37,0,0.05,1.00000,1,1,0
BP,GO:1902236,negative regulation of endoplasmic retic...,25,0,0.04,1.00000,1,1,0
BP,GO:1902253,regulation of intrinsic apoptotic signal...,33,0,0.05,1.00000,1,1,0
BP,GO:1902254,negative regulation of intrinsic apoptot...,24,0,0.03,1.00000,1,1,0
BP,GO:1902259,regulation of delayed rectifier potassiu...,21,0,0.03,1.00000,1,1,0
BP,GO:1902275,regulation of chromatin organization,34,0,0.05,1.00000,1,1,0
BP,GO:1902307,positive regulation of sodium ion transm...,23,0,0.03,1.00000,1,1,0
BP,GO:1902369,negative regulation of RNA catabolic pro...,78,0,0.11,1.00000,1,1,0
BP,GO:1902373,negative regulation of mRNA catabolic pr...,64,0,0.09,1.00000,1,1,0
BP,GO:1902410,mitotic cytokinetic process,24,0,0.03,1.00000,1,1,0
BP,GO:1902430,negative regulation of amyloid-beta form...,31,0,0.04,1.00000,1,1,0
BP,GO:1902475,L-alpha-amino acid transmembrane transpo...,66,0,0.09,1.00000,1,1,0
BP,GO:1902476,chloride transmembrane transport,68,0,0.1,1.00000,1,1,0
BP,GO:1902547,regulation of cellular response to vascu...,32,0,0.05,1.00000,1,1,0
BP,GO:1902579,multi-organism localization,28,0,0.04,1.00000,1,1,0
BP,GO:1902600,proton transmembrane transport,169,0,0.24,1.00000,1,1,0
BP,GO:1902622,regulation of neutrophil migration,41,0,0.06,1.00000,1,1,0
BP,GO:1902624,positive regulation of neutrophil migrat...,28,0,0.04,1.00000,1,1,0
BP,GO:1902644,tertiary alcohol metabolic process,22,0,0.03,1.00000,1,1,0
BP,GO:1902652,secondary alcohol metabolic process,159,0,0.23,1.00000,1,1,0
BP,GO:1902653,secondary alcohol biosynthetic process,60,0,0.09,1.00000,1,1,0
BP,GO:1902656,calcium ion import into cytosol,28,0,0.04,1.00000,1,1,0
BP,GO:1902686,mitochondrial outer membrane permeabiliz...,51,0,0.07,1.00000,1,1,0
BP,GO:1902692,regulation of neuroblast proliferation,33,0,0.05,1.00000,1,1,0
BP,GO:1902742,apoptotic process involved in developmen...,41,0,0.06,1.00000,1,1,0
BP,GO:1902743,regulation of lamellipodium organization,57,0,0.08,1.00000,1,1,0
BP,GO:1902745,positive regulation of lamellipodium org...,40,0,0.06,1.00000,1,1,0
BP,GO:1902749,regulation of cell cycle G2/M phase tran...,115,0,0.17,1.00000,1,1,0
BP,GO:1902750,negative regulation of cell cycle G2/M p...,73,0,0.1,1.00000,1,1,0
BP,GO:1902751,positive regulation of cell cycle G2/M p...,31,0,0.04,1.00000,1,1,0
BP,GO:1902808,positive regulation of cell cycle G1/S p...,63,0,0.09,1.00000,1,1,0
BP,GO:1902882,regulation of response to oxidative stre...,102,0,0.15,1.00000,1,1,0
BP,GO:1902883,negative regulation of response to oxida...,29,0,0.04,1.00000,1,1,0
BP,GO:1902893,regulation of pri-miRNA transcription by...,72,0,0.1,1.00000,1,1,0
BP,GO:1902894,negative regulation of pri-miRNA transcr...,28,0,0.04,1.00000,1,1,0
BP,GO:1902895,positive regulation of pri-miRNA transcr...,49,0,0.07,1.00000,1,1,0
BP,GO:1902902,negative regulation of autophagosome ass...,23,0,0.03,1.00000,1,1,0
BP,GO:1902904,negative regulation of supramolecular fi...,178,0,0.26,1.00000,1,1,0
BP,GO:1902914,regulation of protein polyubiquitination,29,0,0.04,1.00000,1,1,0
BP,GO:1902930,regulation of alcohol biosynthetic proce...,50,0,0.07,1.00000,1,1,0
BP,GO:1902932,positive regulation of alcohol biosynthe...,25,0,0.04,1.00000,1,1,0
BP,GO:1902991,regulation of amyloid precursor protein ...,70,0,0.1,1.00000,1,1,0
BP,GO:1902992,negative regulation of amyloid precursor...,35,0,0.05,1.00000,1,1,0
BP,GO:1902993,positive regulation of amyloid precursor...,40,0,0.06,1.00000,1,1,0
BP,GO:1903008,organelle disassembly,120,0,0.17,1.00000,1,1,0
BP,GO:1903020,positive regulation of glycoprotein meta...,28,0,0.04,1.00000,1,1,0
BP,GO:1903034,regulation of response to wounding,180,0,0.26,1.00000,1,1,0
BP,GO:1903035,negative regulation of response to wound...,104,0,0.15,1.00000,1,1,0
BP,GO:1903036,positive regulation of response to wound...,76,0,0.11,1.00000,1,1,0
BP,GO:1903039,positive regulation of leukocyte cell-ce...,376,0,0.54,1.00000,1,1,0
BP,GO:1903050,regulation of proteolysis involved in ce...,255,0,0.37,1.00000,1,1,0
BP,GO:1903051,negative regulation of proteolysis invol...,78,0,0.11,1.00000,1,1,0
BP,GO:1903052,positive regulation of proteolysis invol...,156,0,0.22,1.00000,1,1,0
BP,GO:1903053,regulation of extracellular matrix organ...,54,0,0.08,1.00000,1,1,0
BP,GO:1903055,positive regulation of extracellular mat...,25,0,0.04,1.00000,1,1,0
BP,GO:1903077,negative regulation of protein localizat...,25,0,0.04,1.00000,1,1,0
BP,GO:1903083,protein localization to condensed chromo...,21,0,0.03,1.00000,1,1,0
BP,GO:1903140,regulation of establishment of endotheli...,24,0,0.03,1.00000,1,1,0
BP,GO:1903146,regulation of autophagy of mitochondrion,34,0,0.05,1.00000,1,1,0
BP,GO:1903169,regulation of calcium ion transmembrane ...,168,0,0.24,1.00000,1,1,0
BP,GO:1903170,negative regulation of calcium ion trans...,54,0,0.08,1.00000,1,1,0
BP,GO:1903201,regulation of oxidative stress-induced c...,75,0,0.11,1.00000,1,1,0
BP,GO:1903202,negative regulation of oxidative stress-...,54,0,0.08,1.00000,1,1,0
BP,GO:1903203,regulation of oxidative stress-induced n...,27,0,0.04,1.00000,1,1,0
BP,GO:1903205,regulation of hydrogen peroxide-induced ...,27,0,0.04,1.00000,1,1,0
BP,GO:1903206,negative regulation of hydrogen peroxide...,20,0,0.03,1.00000,1,1,0
BP,GO:1903214,regulation of protein targeting to mitoc...,52,0,0.07,1.00000,1,1,0
BP,GO:1903305,regulation of regulated secretory pathwa...,146,0,0.21,1.00000,1,1,0
BP,GO:1903306,negative regulation of regulated secreto...,28,0,0.04,1.00000,1,1,0
BP,GO:1903307,positive regulation of regulated secreto...,58,0,0.08,1.00000,1,1,0
BP,GO:1903312,negative regulation of mRNA metabolic pr...,98,0,0.14,1.00000,1,1,0
BP,GO:1903317,regulation of protein maturation,81,0,0.12,1.00000,1,1,0
BP,GO:1903318,negative regulation of protein maturatio...,40,0,0.06,1.00000,1,1,0
BP,GO:1903319,positive regulation of protein maturatio...,28,0,0.04,1.00000,1,1,0
BP,GO:1903320,regulation of protein modification by sm...,264,0,0.38,1.00000,1,1,0
BP,GO:1903321,negative regulation of protein modificat...,111,0,0.16,1.00000,1,1,0
BP,GO:1903322,positive regulation of protein modificat...,139,0,0.2,1.00000,1,1,0
BP,GO:1903350,response to dopamine,96,0,0.14,1.00000,1,1,0
BP,GO:1903351,cellular response to dopamine,95,0,0.14,1.00000,1,1,0
BP,GO:1903362,regulation of cellular protein catabolic...,290,0,0.42,1.00000,1,1,0
BP,GO:1903363,negative regulation of cellular protein ...,89,0,0.13,1.00000,1,1,0
BP,GO:1903364,positive regulation of cellular protein ...,179,0,0.26,1.00000,1,1,0
BP,GO:1903409,reactive oxygen species biosynthetic pro...,70,0,0.1,1.00000,1,1,0
BP,GO:1903421,regulation of synaptic vesicle recycling,29,0,0.04,1.00000,1,1,0
BP,GO:1903426,regulation of reactive oxygen species bi...,58,0,0.08,1.00000,1,1,0
BP,GO:1903427,negative regulation of reactive oxygen s...,24,0,0.03,1.00000,1,1,0
BP,GO:1903428,positive regulation of reactive oxygen s...,26,0,0.04,1.00000,1,1,0
BP,GO:1903429,regulation of cell maturation,23,0,0.03,1.00000,1,1,0
BP,GO:1903432,regulation of TORC1 signaling,44,0,0.06,1.00000,1,1,0
BP,GO:1903509,liposaccharide metabolic process,117,0,0.17,1.00000,1,1,0
BP,GO:1903510,mucopolysaccharide metabolic process,90,0,0.13,1.00000,1,1,0
BP,GO:1903513,endoplasmic reticulum to cytosol transpo...,29,0,0.04,1.00000,1,1,0
BP,GO:1903514,release of sequestered calcium ion into ...,39,0,0.06,1.00000,1,1,0
BP,GO:1903523,negative regulation of blood circulation,32,0,0.05,1.00000,1,1,0
BP,GO:1903524,positive regulation of blood circulation,43,0,0.06,1.00000,1,1,0
BP,GO:1903530,regulation of secretion by cell,613,0,0.88,1.00000,1,1,0
BP,GO:1903531,negative regulation of secretion by cell,160,0,0.23,1.00000,1,1,0
BP,GO:1903532,positive regulation of secretion by cell,302,0,0.43,1.00000,1,1,0
BP,GO:1903533,regulation of protein targeting,92,0,0.13,1.00000,1,1,0
BP,GO:1903556,negative regulation of tumor necrosis fa...,101,0,0.15,1.00000,1,1,0
BP,GO:1903557,positive regulation of tumor necrosis fa...,134,0,0.19,1.00000,1,1,0
BP,GO:1903573,negative regulation of response to endop...,54,0,0.08,1.00000,1,1,0
BP,GO:1903578,regulation of ATP metabolic process,90,0,0.13,1.00000,1,1,0
BP,GO:1903579,negative regulation of ATP metabolic pro...,32,0,0.05,1.00000,1,1,0
BP,GO:1903580,positive regulation of ATP metabolic pro...,38,0,0.05,1.00000,1,1,0
BP,GO:1903587,regulation of blood vessel endothelial c...,49,0,0.07,1.00000,1,1,0
BP,GO:1903588,negative regulation of blood vessel endo...,25,0,0.04,1.00000,1,1,0
BP,GO:1903589,positive regulation of blood vessel endo...,24,0,0.03,1.00000,1,1,0
BP,GO:1903649,regulation of cytoplasmic transport,29,0,0.04,1.00000,1,1,0
BP,GO:1903670,regulation of sprouting angiogenesis,64,0,0.09,1.00000,1,1,0
BP,GO:1903671,negative regulation of sprouting angioge...,30,0,0.04,1.00000,1,1,0
BP,GO:1903672,positive regulation of sprouting angioge...,30,0,0.04,1.00000,1,1,0
BP,GO:1903707,negative regulation of hemopoiesis,127,0,0.18,1.00000,1,1,0
BP,GO:1903715,regulation of aerobic respiration,32,0,0.05,1.00000,1,1,0
BP,GO:1903725,regulation of phospholipid metabolic pro...,40,0,0.06,1.00000,1,1,0
BP,GO:1903747,regulation of establishment of protein l...,60,0,0.09,1.00000,1,1,0
BP,GO:1903749,positive regulation of establishment of ...,43,0,0.06,1.00000,1,1,0
BP,GO:1903779,regulation of cardiac conduction,29,0,0.04,1.00000,1,1,0
BP,GO:1903792,negative regulation of anion transport,26,0,0.04,1.00000,1,1,0
BP,GO:1903793,positive regulation of anion transport,45,0,0.06,1.00000,1,1,0
BP,GO:1903798,regulation of production of miRNAs invol...,32,0,0.05,1.00000,1,1,0
BP,GO:1903799,negative regulation of production of miR...,22,0,0.03,1.00000,1,1,0
BP,GO:1903817,negative regulation of voltage-gated pot...,20,0,0.03,1.00000,1,1,0
BP,GO:1903825,organic acid transmembrane transport,154,0,0.22,1.00000,1,1,0
BP,GO:1903828,negative regulation of cellular protein ...,134,0,0.19,1.00000,1,1,0
BP,GO:1903844,regulation of cellular response to trans...,138,0,0.2,1.00000,1,1,0
BP,GO:1903846,positive regulation of cellular response...,33,0,0.05,1.00000,1,1,0
BP,GO:1903859,regulation of dendrite extension,28,0,0.04,1.00000,1,1,0
BP,GO:1903861,positive regulation of dendrite extensio...,25,0,0.04,1.00000,1,1,0
BP,GO:1903900,regulation of viral life cycle,198,0,0.28,1.00000,1,1,0
BP,GO:1903901,negative regulation of viral life cycle,54,0,0.08,1.00000,1,1,0
BP,GO:1903902,positive regulation of viral life cycle,35,0,0.05,1.00000,1,1,0
BP,GO:1903955,positive regulation of protein targeting...,39,0,0.06,1.00000,1,1,0
BP,GO:1903959,regulation of anion transmembrane transp...,26,0,0.04,1.00000,1,1,0
BP,GO:1903963,arachidonate transport,33,0,0.05,1.00000,1,1,0
BP,GO:1903975,regulation of glial cell migration,22,0,0.03,1.00000,1,1,0
BP,GO:1903978,regulation of microglial cell activation,22,0,0.03,1.00000,1,1,0
BP,GO:1904029,regulation of cyclin-dependent protein k...,103,0,0.15,1.00000,1,1,0
BP,GO:1904030,negative regulation of cyclin-dependent ...,36,0,0.05,1.00000,1,1,0
BP,GO:1904031,positive regulation of cyclin-dependent ...,33,0,0.05,1.00000,1,1,0
BP,GO:1904037,positive regulation of epithelial cell a...,52,0,0.07,1.00000,1,1,0
BP,GO:1904046,negative regulation of vascular endothel...,28,0,0.04,1.00000,1,1,0
BP,GO:1904063,negative regulation of cation transmembr...,112,0,0.16,1.00000,1,1,0
BP,GO:1904263,positive regulation of TORC1 signaling,20,0,0.03,1.00000,1,1,0
BP,GO:1904292,regulation of ERAD pathway,26,0,0.04,1.00000,1,1,0
BP,GO:1904294,positive regulation of ERAD pathway,20,0,0.03,1.00000,1,1,0
BP,GO:1904353,regulation of telomere capping,28,0,0.04,1.00000,1,1,0
BP,GO:1904356,regulation of telomere maintenance via t...,68,0,0.1,1.00000,1,1,0
BP,GO:1904357,negative regulation of telomere maintena...,31,0,0.04,1.00000,1,1,0
BP,GO:1904358,positive regulation of telomere maintena...,41,0,0.06,1.00000,1,1,0
BP,GO:1904376,negative regulation of protein localizat...,27,0,0.04,1.00000,1,1,0
BP,GO:1904380,endoplasmic reticulum mannose trimming,20,0,0.03,1.00000,1,1,0
BP,GO:1904385,cellular response to angiotensin,26,0,0.04,1.00000,1,1,0
BP,GO:1904407,positive regulation of nitric oxide meta...,59,0,0.08,1.00000,1,1,0
BP,GO:1904427,positive regulation of calcium ion trans...,73,0,0.1,1.00000,1,1,0
BP,GO:1904589,regulation of protein import,64,0,0.09,1.00000,1,1,0
BP,GO:1904591,positive regulation of protein import,44,0,0.06,1.00000,1,1,0
BP,GO:1904645,response to amyloid-beta,65,0,0.09,1.00000,1,1,0
BP,GO:1904646,cellular response to amyloid-beta,52,0,0.07,1.00000,1,1,0
BP,GO:1904659,glucose transmembrane transport,126,0,0.18,1.00000,1,1,0
BP,GO:1904666,regulation of ubiquitin protein ligase a...,24,0,0.03,1.00000,1,1,0
BP,GO:1904705,regulation of vascular associated smooth...,106,0,0.15,1.00000,1,1,0
BP,GO:1904706,negative regulation of vascular associat...,44,0,0.06,1.00000,1,1,0
BP,GO:1904707,positive regulation of vascular associat...,64,0,0.09,1.00000,1,1,0
BP,GO:1904738,vascular associated smooth muscle cell m...,50,0,0.07,1.00000,1,1,0
BP,GO:1904752,regulation of vascular associated smooth...,49,0,0.07,1.00000,1,1,0
BP,GO:1904753,negative regulation of vascular associat...,25,0,0.04,1.00000,1,1,0
BP,GO:1904754,positive regulation of vascular associat...,25,0,0.04,1.00000,1,1,0
BP,GO:1904861,excitatory synapse assembly,29,0,0.04,1.00000,1,1,0
BP,GO:1904872,regulation of telomerase RNA localizatio...,20,0,0.03,1.00000,1,1,0
BP,GO:1904888,cranial skeletal system development,70,0,0.1,1.00000,1,1,0
BP,GO:1904892,regulation of receptor signaling pathway...,126,0,0.18,1.00000,1,1,0
BP,GO:1904893,negative regulation of receptor signalin...,36,0,0.05,1.00000,1,1,0
BP,GO:1904894,positive regulation of receptor signalin...,58,0,0.08,1.00000,1,1,0
BP,GO:1904948,midbrain dopaminergic neuron differentia...,20,0,0.03,1.00000,1,1,0
BP,GO:1904950,negative regulation of establishment of ...,139,0,0.2,1.00000,1,1,0
BP,GO:1904951,positive regulation of establishment of ...,352,0,0.51,1.00000,1,1,0
BP,GO:1904994,regulation of leukocyte adhesion to vasc...,49,0,0.07,1.00000,1,1,0
BP,GO:1904996,positive regulation of leukocyte adhesio...,34,0,0.05,1.00000,1,1,0
BP,GO:1905037,autophagosome organization,122,0,0.18,1.00000,1,1,0
BP,GO:1905039,carboxylic acid transmembrane transport,153,0,0.22,1.00000,1,1,0
BP,GO:1905048,regulation of metallopeptidase activity,25,0,0.04,1.00000,1,1,0
BP,GO:1905063,regulation of vascular associated smooth...,26,0,0.04,1.00000,1,1,0
BP,GO:1905144,response to acetylcholine,41,0,0.06,1.00000,1,1,0
BP,GO:1905145,cellular response to acetylcholine,41,0,0.06,1.00000,1,1,0
BP,GO:1905207,regulation of cardiocyte differentiation,40,0,0.06,1.00000,1,1,0
BP,GO:1905209,positive regulation of cardiocyte differ...,25,0,0.04,1.00000,1,1,0
BP,GO:1905245,regulation of aspartic-type peptidase ac...,27,0,0.04,1.00000,1,1,0
BP,GO:1905314,semi-lunar valve development,43,0,0.06,1.00000,1,1,0
BP,GO:1905332,positive regulation of morphogenesis of ...,40,0,0.06,1.00000,1,1,0
BP,GO:1905476,negative regulation of protein localizat...,34,0,0.05,1.00000,1,1,0
BP,GO:1905508,protein localization to microtubule orga...,37,0,0.05,1.00000,1,1,0
BP,GO:1905515,non-motile cilium assembly,63,0,0.09,1.00000,1,1,0
BP,GO:1905517,macrophage migration,63,0,0.09,1.00000,1,1,0
BP,GO:1905521,regulation of macrophage migration,47,0,0.07,1.00000,1,1,0
BP,GO:1905523,positive regulation of macrophage migrat...,29,0,0.04,1.00000,1,1,0
BP,GO:1905562,regulation of vascular endothelial cell ...,49,0,0.07,1.00000,1,1,0
BP,GO:1905563,negative regulation of vascular endothel...,25,0,0.04,1.00000,1,1,0
BP,GO:1905564,positive regulation of vascular endothel...,27,0,0.04,1.00000,1,1,0
BP,GO:1905606,regulation of presynapse assembly,35,0,0.05,1.00000,1,1,0
BP,GO:1905710,positive regulation of membrane permeabi...,60,0,0.09,1.00000,1,1,0
BP,GO:1905818,regulation of chromosome separation,73,0,0.1,1.00000,1,1,0
BP,GO:1905819,negative regulation of chromosome separa...,45,0,0.06,1.00000,1,1,0
BP,GO:1905874,regulation of postsynaptic density organ...,21,0,0.03,1.00000,1,1,0
BP,GO:1905897,regulation of response to endoplasmic re...,98,0,0.14,1.00000,1,1,0
BP,GO:1905898,positive regulation of response to endop...,41,0,0.06,1.00000,1,1,0
BP,GO:1905906,regulation of amyloid fibril formation,22,0,0.03,1.00000,1,1,0
BP,GO:1905952,regulation of lipid localization,197,0,0.28,1.00000,1,1,0
BP,GO:1905953,negative regulation of lipid localizatio...,76,0,0.11,1.00000,1,1,0
BP,GO:1905954,positive regulation of lipid localizatio...,114,0,0.16,1.00000,1,1,0
BP,GO:1990000,amyloid fibril formation,47,0,0.07,1.00000,1,1,0
BP,GO:1990089,response to nerve growth factor,60,0,0.09,1.00000,1,1,0
BP,GO:1990090,cellular response to nerve growth factor...,57,0,0.08,1.00000,1,1,0
BP,GO:1990182,exosomal secretion,20,0,0.03,1.00000,1,1,0
BP,GO:1990266,neutrophil migration,138,0,0.2,1.00000,1,1,0
BP,GO:1990542,mitochondrial transmembrane transport,105,0,0.15,1.00000,1,1,0
BP,GO:1990748,cellular detoxification,131,0,0.19,1.00000,1,1,0
BP,GO:1990776,response to angiotensin,29,0,0.04,1.00000,1,1,0
BP,GO:1990823,response to leukemia inhibitory factor,98,0,0.14,1.00000,1,1,0
BP,GO:1990830,cellular response to leukemia inhibitory...,97,0,0.14,1.00000,1,1,0
BP,GO:1990868,response to chemokine,111,0,0.16,1.00000,1,1,0
BP,GO:1990869,cellular response to chemokine,111,0,0.16,1.00000,1,1,0
BP,GO:1990874,vascular associated smooth muscle cell p...,107,0,0.15,1.00000,1,1,0
BP,GO:1990928,response to amino acid starvation,50,0,0.07,1.00000,1,1,0
BP,GO:1990961,xenobiotic detoxification by transmembra...,22,0,0.03,1.00000,1,1,0
BP,GO:2000001,regulation of DNA damage checkpoint,29,0,0.04,1.00000,1,1,0
BP,GO:2000008,regulation of protein localization to ce...,48,0,0.07,1.00000,1,1,0
BP,GO:2000010,positive regulation of protein localizat...,27,0,0.04,1.00000,1,1,0
BP,GO:2000027,regulation of animal organ morphogenesis,138,0,0.2,1.00000,1,1,0
BP,GO:2000036,regulation of stem cell population maint...,43,0,0.06,1.00000,1,1,0
BP,GO:2000047,regulation of cell-cell adhesion mediate...,36,0,0.05,1.00000,1,1,0
BP,GO:2000049,positive regulation of cell-cell adhesio...,20,0,0.03,1.00000,1,1,0
BP,GO:2000050,regulation of non-canonical Wnt signalin...,26,0,0.04,1.00000,1,1,0
BP,GO:2000058,regulation of ubiquitin-dependent protei...,192,0,0.28,1.00000,1,1,0
BP,GO:2000059,negative regulation of ubiquitin-depende...,62,0,0.09,1.00000,1,1,0
BP,GO:2000060,positive regulation of ubiquitin-depende...,121,0,0.17,1.00000,1,1,0
BP,GO:2000108,positive regulation of leukocyte apoptot...,29,0,0.04,1.00000,1,1,0
BP,GO:2000114,regulation of establishment of cell pola...,22,0,0.03,1.00000,1,1,0
BP,GO:2000117,negative regulation of cysteine-type end...,98,0,0.14,1.00000,1,1,0
BP,GO:2000142,regulation of DNA-templated transcriptio...,43,0,0.06,1.00000,1,1,0
BP,GO:2000144,positive regulation of DNA-templated tra...,34,0,0.05,1.00000,1,1,0
BP,GO:2000146,negative regulation of cell motility,393,0,0.56,1.00000,1,1,0
BP,GO:2000177,regulation of neural precursor cell prol...,89,0,0.13,1.00000,1,1,0
BP,GO:2000178,negative regulation of neural precursor ...,22,0,0.03,1.00000,1,1,0
BP,GO:2000179,positive regulation of neural precursor ...,55,0,0.08,1.00000,1,1,0
BP,GO:2000191,regulation of fatty acid transport,33,0,0.05,1.00000,1,1,0
BP,GO:2000193,positive regulation of fatty acid transp...,23,0,0.03,1.00000,1,1,0
BP,GO:2000209,regulation of anoikis,24,0,0.03,1.00000,1,1,0
BP,GO:2000242,negative regulation of reproductive proc...,66,0,0.09,1.00000,1,1,0
BP,GO:2000272,negative regulation of signaling recepto...,85,0,0.12,1.00000,1,1,0
BP,GO:2000278,regulation of DNA biosynthetic process,121,0,0.17,1.00000,1,1,0
BP,GO:2000279,negative regulation of DNA biosynthetic ...,41,0,0.06,1.00000,1,1,0
BP,GO:2000291,regulation of myoblast proliferation,22,0,0.03,1.00000,1,1,0
BP,GO:2000300,regulation of synaptic vesicle exocytosi...,54,0,0.08,1.00000,1,1,0
BP,GO:2000316,regulation of T-helper 17 type immune re...,28,0,0.04,1.00000,1,1,0
BP,GO:2000353,positive regulation of endothelial cell ...,32,0,0.05,1.00000,1,1,0
BP,GO:2000369,regulation of clathrin-dependent endocyt...,20,0,0.03,1.00000,1,1,0
BP,GO:2000377,regulation of reactive oxygen species me...,175,0,0.25,1.00000,1,1,0
BP,GO:2000378,negative regulation of reactive oxygen s...,59,0,0.08,1.00000,1,1,0
BP,GO:2000379,positive regulation of reactive oxygen s...,82,0,0.12,1.00000,1,1,0
BP,GO:2000401,regulation of lymphocyte migration,75,0,0.11,1.00000,1,1,0
BP,GO:2000403,positive regulation of lymphocyte migrat...,47,0,0.07,1.00000,1,1,0
BP,GO:2000404,regulation of T cell migration,52,0,0.07,1.00000,1,1,0
BP,GO:2000406,positive regulation of T cell migration,37,0,0.05,1.00000,1,1,0
BP,GO:2000425,regulation of apoptotic cell clearance,23,0,0.03,1.00000,1,1,0
BP,GO:2000427,positive regulation of apoptotic cell cl...,21,0,0.03,1.00000,1,1,0
BP,GO:2000479,regulation of cAMP-dependent protein kin...,23,0,0.03,1.00000,1,1,0
BP,GO:2000514,"regulation of CD4-positive, alpha-beta T...",100,0,0.14,1.00000,1,1,0
BP,GO:2000515,"negative regulation of CD4-positive, alp...",45,0,0.06,1.00000,1,1,0
BP,GO:2000516,"positive regulation of CD4-positive, alp...",53,0,0.08,1.00000,1,1,0
BP,GO:2000564,"regulation of CD8-positive, alpha-beta T...",21,0,0.03,1.00000,1,1,0
BP,GO:2000573,positive regulation of DNA biosynthetic ...,78,0,0.11,1.00000,1,1,0
BP,GO:2000648,positive regulation of stem cell prolife...,26,0,0.04,1.00000,1,1,0
BP,GO:2000649,regulation of sodium ion transmembrane t...,62,0,0.09,1.00000,1,1,0
BP,GO:2000677,regulation of transcription regulatory r...,50,0,0.07,1.00000,1,1,0
BP,GO:2000678,negative regulation of transcription reg...,20,0,0.03,1.00000,1,1,0
BP,GO:2000679,positive regulation of transcription reg...,24,0,0.03,1.00000,1,1,0
BP,GO:2000725,regulation of cardiac muscle cell differ...,25,0,0.04,1.00000,1,1,0
BP,GO:2000737,negative regulation of stem cell differe...,24,0,0.03,1.00000,1,1,0
BP,GO:2000738,positive regulation of stem cell differe...,21,0,0.03,1.00000,1,1,0
BP,GO:2000756,regulation of peptidyl-lysine acetylatio...,65,0,0.09,1.00000,1,1,0
BP,GO:2000757,negative regulation of peptidyl-lysine a...,20,0,0.03,1.00000,1,1,0
BP,GO:2000758,positive regulation of peptidyl-lysine a...,36,0,0.05,1.00000,1,1,0
BP,GO:2000774,positive regulation of cellular senescen...,69,0,0.1,1.00000,1,1,0
BP,GO:2000780,negative regulation of double-strand bre...,36,0,0.05,1.00000,1,1,0
BP,GO:2000785,regulation of autophagosome assembly,54,0,0.08,1.00000,1,1,0
BP,GO:2000810,regulation of bicellular tight junction ...,32,0,0.05,1.00000,1,1,0
BP,GO:2000816,negative regulation of mitotic sister ch...,43,0,0.06,1.00000,1,1,0
BP,GO:2000831,regulation of steroid hormone secretion,23,0,0.03,1.00000,1,1,0
BP,GO:2000846,regulation of corticosteroid hormone sec...,20,0,0.03,1.00000,1,1,0
BP,GO:2001014,regulation of skeletal muscle cell diffe...,21,0,0.03,1.00000,1,1,0
BP,GO:2001021,negative regulation of response to DNA d...,98,0,0.14,1.00000,1,1,0
BP,GO:2001026,regulation of endothelial cell chemotaxi...,24,0,0.03,1.00000,1,1,0
BP,GO:2001057,reactive nitrogen species metabolic proc...,100,0,0.14,1.00000,1,1,0
BP,GO:2001169,regulation of ATP biosynthetic process,25,0,0.04,1.00000,1,1,0
BP,GO:2001185,"regulation of CD8-positive, alpha-beta T...",40,0,0.06,1.00000,1,1,0
BP,GO:2001187,"positive regulation of CD8-positive, alp...",26,0,0.04,1.00000,1,1,0
BP,GO:2001198,regulation of dendritic cell differentia...,39,0,0.06,1.00000,1,1,0
BP,GO:2001235,positive regulation of apoptotic signali...,144,0,0.21,1.00000,1,1,0
BP,GO:2001238,positive regulation of extrinsic apoptot...,57,0,0.08,1.00000,1,1,0
BP,GO:2001239,regulation of extrinsic apoptotic signal...,58,0,0.08,1.00000,1,1,0
BP,GO:2001240,negative regulation of extrinsic apoptot...,48,0,0.07,1.00000,1,1,0
BP,GO:2001242,regulation of intrinsic apoptotic signal...,176,0,0.25,1.00000,1,1,0
BP,GO:2001243,negative regulation of intrinsic apoptot...,107,0,0.15,1.00000,1,1,0
BP,GO:2001244,positive regulation of intrinsic apoptot...,60,0,0.09,1.00000,1,1,0
BP,GO:2001258,negative regulation of cation channel ac...,65,0,0.09,1.00000,1,1,0
MF,GO:0043167,ion binding,6553,20,8.56,7.5e-06,0.006705,0.006705,2.34
MF,GO:0005262,calcium channel activity,126,4,0.16,2.1e-05,0.018774,0.009387,25
MF,GO:0015085,calcium ion transmembrane transporter ac...,142,4,0.19,3.3e-05,0.029502000000000004,0.009834,21.05
MF,GO:0005261,cation channel activity,347,5,0.45,7.7e-05,0.068838,0.0172095,11.11
MF,GO:0046873,metal ion transmembrane transporter acti...,460,5,0.6,0.00029,0.25926,0.0447,8.33
MF,GO:0005216,ion channel activity,466,5,0.61,0.00030,0.2682,0.0447,8.2
MF,GO:0015267,channel activity,514,5,0.67,0.00048,0.42912,0.04551272727272727,7.46
MF,GO:0099094,ligand-gated cation channel activity,118,3,0.15,0.00048,0.42912,0.04551272727272727,20
MF,GO:0022803,passive transmembrane transporter activi...,516,5,0.67,0.00049,0.43806,0.04551272727272727,7.46
MF,GO:0008066,glutamate receptor activity,27,2,0.04,0.00056,0.50064,0.04551272727272727,50
MF,GO:0099604,ligand-gated calcium channel activity,27,2,0.04,0.00056,0.50064,0.04551272727272727,50
MF,GO:0046872,metal ion binding,4619,14,6.03,0.00075,0.6705,0.0525225,2.32
MF,GO:0140658,ATP-dependent chromatin remodeler activi...,32,2,0.04,0.00079,0.70626,0.0525225,50
MF,GO:0043169,cation binding,4715,14,6.16,0.00094,0.84036,0.0525225,2.27
MF,GO:0015276,ligand-gated ion channel activity,149,3,0.19,0.00094,0.84036,0.0525225,15.79
MF,GO:0022834,ligand-gated channel activity,149,3,0.19,0.00094,0.84036,0.0525225,15.79
MF,GO:0022890,inorganic cation transmembrane transport...,638,5,0.83,0.00126,1,0.06406999999999999,6.02
MF,GO:0022836,gated channel activity,371,4,0.48,0.00129,1,0.06406999999999999,8.33
MF,GO:0036094,small molecule binding,2707,10,3.53,0.00147,1,0.06916736842105263,2.83
MF,GO:0001046,core promoter sequence-specific DNA bind...,45,2,0.06,0.00157,1,0.070179,33.33
MF,GO:0008324,cation transmembrane transporter activit...,700,5,0.91,0.00190,1,0.08088571428571428,5.49
MF,GO:0008022,protein C-terminus binding,201,3,0.26,0.00223,1,0.09061909090909091,11.54
MF,GO:0022824,transmitter-gated ion channel activity,63,2,0.08,0.00305,1,0.1119288,25
MF,GO:0022835,transmitter-gated channel activity,63,2,0.08,0.00305,1,0.1119288,25
MF,GO:0003779,actin binding,473,4,0.62,0.00313,1,0.1119288,6.45
MF,GO:0015318,inorganic molecular entity transmembrane...,794,5,1.04,0.00329,1,0.11312538461538463,4.81
MF,GO:0140097,"catalytic activity, acting on DNA",236,3,0.31,0.00351,1,0.11622000000000002,9.68
MF,GO:0003678,DNA helicase activity,72,2,0.09,0.00397,1,0.126054,22.22
MF,GO:0005524,ATP binding,1634,7,2.13,0.00412,1,0.126054,3.29
MF,GO:0043168,anion binding,2591,9,3.38,0.00423,1,0.126054,2.66
MF,GO:0005230,extracellular ligand-gated ion channel a...,77,2,0.1,0.00452,1,0.13035096774193547,20
MF,GO:0032559,adenyl ribonucleotide binding,1703,7,2.22,0.00518,1,0.14225117647058821,3.15
MF,GO:0030554,adenyl nucleotide binding,1716,7,2.24,0.00540,1,0.14225117647058821,3.12
MF,GO:0003677,DNA binding,2687,9,3.51,0.00541,1,0.14225117647058821,2.56
MF,GO:0043178,alcohol binding,92,2,0.12,0.00639,1,0.15918166666666667,16.67
MF,GO:0015075,ion transmembrane transporter activity,929,5,1.21,0.00641,1,0.15918166666666667,4.13
MF,GO:0140657,ATP-dependent activity,588,4,0.77,0.00675,1,0.16309459459459458,5.19
MF,GO:0008276,protein methyltransferase activity,96,2,0.13,0.00694,1,0.16327263157894736,15.38
MF,GO:0000166,nucleotide binding,2350,8,3.07,0.00837,1,0.1875165,2.61
MF,GO:1901265,nucleoside phosphate binding,2351,8,3.07,0.00839,1,0.1875165,2.61
MF,GO:0140640,"catalytic activity, acting on a nucleic ...",664,4,0.87,0.01028,1,0.22162883720930232,4.6
MF,GO:0008092,cytoskeletal protein binding,1050,5,1.37,0.01062,1,0.22162883720930232,3.65
MF,GO:0008094,"ATP-dependent activity, acting on DNA",120,2,0.16,0.01066,1,0.22162883720930232,12.5
MF,GO:0003774,cytoskeletal motor activity,122,2,0.16,0.01101,1,0.22210933333333335,12.5
MF,GO:0030594,neurotransmitter receptor activity,123,2,0.16,0.01118,1,0.22210933333333335,12.5
MF,GO:0035639,purine ribonucleoside triphosphate bindi...,1999,7,2.61,0.01225,1,0.23807608695652174,2.68
MF,GO:0140096,"catalytic activity, acting on a protein",2524,8,3.3,0.01273,1,0.2421408510638298,2.42
MF,GO:0032555,purine ribonucleotide binding,2075,7,2.71,0.01487,1,0.26803132075471703,2.58
MF,GO:0099106,ion channel regulator activity,145,2,0.19,0.01528,1,0.26803132075471703,10.53
MF,GO:0017076,purine nucleotide binding,2090,7,2.73,0.01543,1,0.26803132075471703,2.56
MF,GO:0032553,ribonucleotide binding,2093,7,2.73,0.01555,1,0.26803132075471703,2.56
MF,GO:0005509,calcium ion binding,754,4,0.98,0.01579,1,0.26803132075471703,4.08
MF,GO:0022843,voltage-gated cation channel activity,148,2,0.19,0.01589,1,0.26803132075471703,10.53
MF,GO:0016247,channel regulator activity,151,2,0.2,0.01650,1,0.2731666666666667,10
MF,GO:0016301,kinase activity,786,4,1.03,0.01813,1,0.29469490909090906,3.88
MF,GO:0008757,S-adenosylmethionine-dependent methyltra...,165,2,0.22,0.01949,1,0.3111439285714286,9.09
MF,GO:0022857,transmembrane transporter activity,1233,5,1.61,0.02014,1,0.31588000000000005,3.11
MF,GO:0004386,helicase activity,178,2,0.23,0.02246,1,0.3461937931034483,8.7
MF,GO:0003676,nucleic acid binding,4645,11,6.07,0.02550,1,0.380695,1.81
MF,GO:0043565,sequence-specific DNA binding,1793,6,2.34,0.02555,1,0.380695,2.56
MF,GO:0000339,RNA cap binding,21,1,0.03,0.02708,1,0.3842780952380952,33.33
MF,GO:0050145,nucleoside monophosphate kinase activity,21,1,0.03,0.02708,1,0.3842780952380952,33.33
MF,GO:0051010,microtubule plus-end binding,21,1,0.03,0.02708,1,0.3842780952380952,33.33
MF,GO:0005215,transporter activity,1357,5,1.77,0.02911,1,0.4066303125,2.82
MF,GO:0005516,calmodulin binding,211,2,0.28,0.03077,1,0.4177782089552239,7.14
MF,GO:0005244,voltage-gated ion channel activity,213,2,0.28,0.03131,1,0.4177782089552239,7.14
MF,GO:0022832,voltage-gated channel activity,213,2,0.28,0.03131,1,0.4177782089552239,7.14
MF,GO:0016772,"transferase activity, transferring phosp...",946,4,1.24,0.03304,1,0.43300695652173915,3.23
MF,GO:0008327,methyl-CpG binding,26,1,0.03,0.03342,1,0.43300695652173915,33.33
MF,GO:0008168,methyltransferase activity,224,2,0.29,0.03433,1,0.4383016216216216,6.9
MF,GO:0097367,carbohydrate derivative binding,2465,7,3.22,0.03504,1,0.4383016216216216,2.17
MF,GO:0004683,calmodulin-dependent protein kinase acti...,28,1,0.04,0.03595,1,0.4383016216216216,25
MF,GO:0070325,lipoprotein particle receptor binding,28,1,0.04,0.03595,1,0.4383016216216216,25
MF,GO:0016740,transferase activity,2483,7,3.24,0.03628,1,0.4383016216216216,2.16
MF,GO:0016741,"transferase activity, transferring one-c...",238,2,0.31,0.03834,1,0.4525286842105263,6.45
MF,GO:0051959,dynein light intermediate chain binding,30,1,0.04,0.03847,1,0.4525286842105263,25
MF,GO:0005217,intracellular ligand-gated ion channel a...,31,1,0.04,0.03972,1,0.4611646753246753,25
MF,GO:0000146,microfilament motor activity,32,1,0.04,0.04098,1,0.46374835443037976,25
MF,GO:0030515,snoRNA binding,32,1,0.04,0.04098,1,0.46374835443037976,25
MF,GO:0008200,ion channel inhibitor activity,33,1,0.04,0.04223,1,0.466094074074074,25
MF,GO:0050681,androgen receptor binding,33,1,0.04,0.04223,1,0.466094074074074,25
MF,GO:0016248,channel inhibitor activity,34,1,0.04,0.04349,1,0.47414707317073174,25
MF,GO:0004672,protein kinase activity,617,3,0.81,0.04548,1,0.4780820930232559,3.7
MF,GO:0016891,"endoribonuclease activity, producing 5'-...",36,1,0.05,0.04599,1,0.4780820930232559,20
MF,GO:0045505,dynein intermediate chain binding,36,1,0.05,0.04599,1,0.4780820930232559,20
MF,GO:0061631,ubiquitin conjugating enzyme activity,36,1,0.05,0.04599,1,0.4780820930232559,20
MF,GO:0008134,transcription factor binding,628,3,0.82,0.04751,1,0.4882062068965517,3.66
MF,GO:0042805,actinin binding,38,1,0.05,0.04848,1,0.4885562637362638,20
MF,GO:0003682,chromatin binding,637,3,0.83,0.04920,1,0.4885562637362638,3.61
MF,GO:0016776,"phosphotransferase activity, phosphate g...",39,1,0.05,0.04973,1,0.4885562637362638,20
MF,GO:0061650,ubiquitin-like protein conjugating enzym...,39,1,0.05,0.04973,1,0.4885562637362638,20
MF,GO:0035198,miRNA binding,40,1,0.05,0.05097,1,0.49529543478260873,20
MF,GO:0019205,nucleobase-containing compound kinase ac...,42,1,0.05,0.05345,1,0.5138096774193548,20
MF,GO:0005246,calcium channel regulator activity,44,1,0.06,0.05593,1,0.53193,16.67
MF,GO:0003723,RNA binding,2164,6,2.83,0.05654,1,0.5320711578947368,2.12
MF,GO:0005245,voltage-gated calcium channel activity,47,1,0.06,0.05963,1,0.546681,16.67
MF,GO:1904315,transmitter-gated ion channel activity i...,47,1,0.06,0.05963,1,0.546681,16.67
MF,GO:0005272,sodium channel activity,48,1,0.06,0.06086,1,0.546681,16.67
MF,GO:0016893,"endonuclease activity, active with eithe...",48,1,0.06,0.06086,1,0.546681,16.67
MF,GO:0016887,ATP hydrolysis activity,309,2,0.4,0.06115,1,0.546681,5
MF,GO:0018024,histone-lysine N-methyltransferase activ...,49,1,0.06,0.06209,1,0.5495887128712872,16.67
MF,GO:0000993,RNA polymerase II complex binding,50,1,0.07,0.06331,1,0.5548935294117648,14.29
MF,GO:0061980,regulatory RNA binding,52,1,0.07,0.06576,1,0.5646272222222223,14.29
MF,GO:0003743,translation initiation factor activity,53,1,0.07,0.06699,1,0.5646272222222223,14.29
MF,GO:0003824,catalytic activity,6046,12,7.89,0.06709,1,0.5646272222222223,1.52
MF,GO:0019899,enzyme binding,2266,6,2.96,0.06798,1,0.5646272222222223,2.03
MF,GO:0016706,2-oxoglutarate-dependent dioxygenase act...,54,1,0.07,0.06821,1,0.5646272222222223,14.29
MF,GO:0016773,"phosphotransferase activity, alcohol gro...",729,3,0.95,0.06821,1,0.5646272222222223,3.16
MF,GO:1901363,heterocyclic compound binding,6768,13,8.84,0.06921,1,0.567648990825688,1.47
MF,GO:0099529,neurotransmitter receptor activity invol...,56,1,0.07,0.07065,1,0.5735967857142856,14.29
MF,GO:0015459,potassium channel regulator activity,57,1,0.07,0.07186,1,0.5735967857142856,14.29
MF,GO:0043175,RNA polymerase core enzyme binding,57,1,0.07,0.07186,1,0.5735967857142856,14.29
MF,GO:0004869,cysteine-type endopeptidase inhibitor ac...,59,1,0.08,0.07429,1,0.5877456637168141,12.5
MF,GO:0097159,organic cyclic compound binding,6852,13,8.95,0.07563,1,0.5930984210526316,1.45
MF,GO:0042054,histone methyltransferase activity,63,1,0.08,0.07913,1,0.6113925619834711,12.5
MF,GO:0003690,double-stranded DNA binding,1797,5,2.35,0.07990,1,0.6113925619834711,2.13
MF,GO:0043621,protein self-association,64,1,0.08,0.08034,1,0.6113925619834711,12.5
MF,GO:0004888,transmembrane signaling receptor activit...,1807,5,2.36,0.08142,1,0.6113925619834711,2.12
MF,GO:0016279,protein-lysine N-methyltransferase activ...,65,1,0.08,0.08154,1,0.6113925619834711,12.5
MF,GO:0019904,protein domain specific binding,790,3,1.03,0.08243,1,0.6113925619834711,2.91
MF,GO:0016278,lysine N-methyltransferase activity,66,1,0.09,0.08275,1,0.6113925619834711,11.11
MF,GO:0106310,protein serine kinase activity,380,2,0.5,0.08751,1,0.6412618032786885,4
MF,GO:0001098,basal transcription machinery binding,73,1,0.1,0.09112,1,0.6516902400000001,10
MF,GO:0001099,basal RNA polymerase II transcription ma...,73,1,0.1,0.09112,1,0.6516902400000001,10
MF,GO:0098960,postsynaptic neurotransmitter receptor a...,73,1,0.1,0.09112,1,0.6516902400000001,10
MF,GO:0070063,RNA polymerase binding,74,1,0.1,0.09232,1,0.65310890625,10
MF,GO:0003777,microtubule motor activity,75,1,0.1,0.09351,1,0.65310890625,10
MF,GO:0030276,clathrin binding,75,1,0.1,0.09351,1,0.65310890625,10
MF,GO:0003725,double-stranded RNA binding,76,1,0.1,0.09469,1,0.6543261068702291,10
MF,GO:0035064,methylated histone binding,77,1,0.1,0.09588,1,0.6543261068702291,10
MF,GO:0140034,methylation-dependent protein binding,77,1,0.1,0.09588,1,0.6543261068702291,10
MF,GO:0004521,endoribonuclease activity,81,1,0.11,0.10061,1,0.6814040909090909,9.09
MF,GO:0004674,protein serine/threonine kinase activity,426,2,0.56,0.10612,1,0.7133178947368422,3.57
MF,GO:0003727,single-stranded RNA binding,91,1,0.12,0.11233,1,0.7494255223880597,8.33
MF,GO:0008270,zinc ion binding,920,3,1.2,0.11663,1,0.7689714705882352,2.5
MF,GO:0051213,dioxygenase activity,95,1,0.12,0.11698,1,0.7689714705882352,8.33
MF,GO:0051117,ATPase binding,96,1,0.13,0.11814,1,0.7709281751824818,7.69
MF,GO:0008135,"translation factor activity, RNA binding",97,1,0.13,0.11930,1,0.7728565217391304,7.69
MF,GO:0001540,amyloid-beta binding,102,1,0.13,0.12506,1,0.7985974285714287,7.69
MF,GO:0008170,N-methyltransferase activity,102,1,0.13,0.12506,1,0.7985974285714287,7.69
MF,GO:0038023,signaling receptor activity,2105,5,2.75,0.13367,1,0.8415561971830987,1.82
MF,GO:0060089,molecular transducer activity,2105,5,2.75,0.13367,1,0.8415561971830987,1.82
MF,GO:0090079,"translation regulator activity, nucleic ...",122,1,0.16,0.14775,1,0.9236958041958041,6.25
MF,GO:0005267,potassium channel activity,125,1,0.16,0.15110,1,0.9380791666666667,6.25
MF,GO:0042802,identical protein binding,2206,5,2.88,0.15434,1,0.9515859310344829,1.74
MF,GO:0004540,ribonuclease activity,129,1,0.17,0.15555,1,0.9524773972602739,5.88
MF,GO:0000976,transcription cis-regulatory region bind...,1631,4,2.13,0.15977,1,0.9681778378378378,1.88
MF,GO:0001067,transcription regulatory region nucleic ...,1633,4,2.13,0.16028,1,0.9681778378378378,1.88
MF,GO:0044325,transmembrane transporter binding,136,1,0.18,0.16329,1,0.9797399999999999,5.56
MF,GO:0004714,transmembrane receptor protein tyrosine ...,138,1,0.18,0.16549,1,0.9863204,5.56
MF,GO:0140678,molecular function inhibitor activity,140,1,0.18,0.16768,1,0.9927544370860926,5.56
MF,GO:0004519,endonuclease activity,143,1,0.19,0.17096,1,1,5.26
MF,GO:1990837,sequence-specific double-stranded DNA bi...,1688,4,2.2,0.17438,1,1,1.82
MF,GO:0050839,cell adhesion molecule binding,587,2,0.77,0.17791,1,1,2.6
MF,GO:0004713,protein tyrosine kinase activity,150,1,0.2,0.17856,1,1,5
MF,GO:0019838,growth factor binding,153,1,0.2,0.18180,1,1,5
MF,GO:0016922,nuclear receptor binding,154,1,0.2,0.18288,1,1,5
MF,GO:0005178,integrin binding,156,1,0.2,0.18502,1,1,5
MF,GO:0019199,transmembrane receptor protein kinase ac...,157,1,0.21,0.18610,1,1,4.76
MF,GO:0015081,sodium ion transmembrane transporter act...,159,1,0.21,0.18824,1,1,4.76
MF,GO:0015079,potassium ion transmembrane transporter ...,163,1,0.21,0.19250,1,1,4.76
MF,GO:0045182,translation regulator activity,165,1,0.22,0.19462,1,1,4.55
MF,GO:0046914,transition metal ion binding,1211,3,1.58,0.20833,1,1,1.9
MF,GO:0016705,"oxidoreductase activity, acting on paire...",180,1,0.24,0.21039,1,1,4.17
MF,GO:0017111,nucleoside-triphosphatase activity,666,2,0.87,0.21556,1,1,2.3
MF,GO:0140030,modification-dependent protein binding,188,1,0.25,0.21867,1,1,4
MF,GO:0004721,phosphoprotein phosphatase activity,191,1,0.25,0.22175,1,1,4
MF,GO:0003714,transcription corepressor activity,201,1,0.26,0.23195,1,1,3.85
MF,GO:0016787,hydrolase activity,2549,5,3.33,0.23381,1,1,1.5
MF,GO:0004866,endopeptidase inhibitor activity,205,1,0.27,0.23600,1,1,3.7
MF,GO:0030414,peptidase inhibitor activity,212,1,0.28,0.24302,1,1,3.57
MF,GO:0016462,pyrophosphatase activity,725,2,0.95,0.24421,1,1,2.11
MF,GO:0019901,protein kinase binding,727,2,0.95,0.24519,1,1,2.11
MF,GO:0016817,"hydrolase activity, acting on acid anhyd...",728,2,0.95,0.24568,1,1,2.11
MF,GO:0016818,"hydrolase activity, acting on acid anhyd...",728,2,0.95,0.24568,1,1,2.11
MF,GO:0042803,protein homodimerization activity,733,2,0.96,0.24812,1,1,2.08
MF,GO:0008236,serine-type peptidase activity,218,1,0.28,0.24899,1,1,3.57
MF,GO:0061135,endopeptidase regulator activity,221,1,0.29,0.25196,1,1,3.45
MF,GO:0017171,serine hydrolase activity,222,1,0.29,0.25295,1,1,3.45
MF,GO:0004518,nuclease activity,230,1,0.3,0.26080,1,1,3.33
MF,GO:0019902,phosphatase binding,230,1,0.3,0.26080,1,1,3.33
MF,GO:0051015,actin filament binding,234,1,0.31,0.26470,1,1,3.23
MF,GO:0005198,structural molecule activity,783,2,1.02,0.27259,1,1,1.96
MF,GO:0019900,kinase binding,814,2,1.06,0.28778,1,1,1.89
MF,GO:0061134,peptidase regulator activity,259,1,0.34,0.28861,1,1,2.94
MF,GO:0042393,histone binding,265,1,0.35,0.29424,1,1,2.86
MF,GO:0016788,"hydrolase activity, acting on ester bond...",832,2,1.09,0.29660,1,1,1.83
MF,GO:0035091,phosphatidylinositol binding,277,1,0.36,0.30536,1,1,2.78
MF,GO:0031267,small GTPase binding,283,1,0.37,0.31086,1,1,2.7
MF,GO:0008017,microtubule binding,285,1,0.37,0.31268,1,1,2.7
MF,GO:0098772,molecular function regulator,2185,4,2.85,0.31771,1,1,1.4
MF,GO:0016791,phosphatase activity,298,1,0.39,0.32442,1,1,2.56
MF,GO:0051020,GTPase binding,316,1,0.41,0.34036,1,1,2.44
MF,GO:0061629,RNA polymerase II-specific DNA-binding t...,316,1,0.41,0.34036,1,1,2.44
MF,GO:0005515,protein binding,15775,22,20.6,0.35463,1,1,1.07
MF,GO:0001227,DNA-binding transcription repressor acti...,339,1,0.44,0.36020,1,1,2.27
MF,GO:0001217,DNA-binding transcription repressor acti...,342,1,0.45,0.36274,1,1,2.22
MF,GO:0045296,cadherin binding,356,1,0.46,0.37449,1,1,2.17
MF,GO:0060090,molecular adaptor activity,389,1,0.51,0.40136,1,1,1.96
MF,GO:0015631,tubulin binding,393,1,0.51,0.40454,1,1,1.96
MF,GO:0042578,phosphoric ester hydrolase activity,397,1,0.52,0.40770,1,1,1.92
MF,GO:0140297,DNA-binding transcription factor binding,414,1,0.54,0.42097,1,1,1.85
MF,GO:0046983,protein dimerization activity,1117,2,1.46,0.43259,1,1,1.37
MF,GO:0140098,"catalytic activity, acting on RNA",452,1,0.59,0.44960,1,1,1.69
MF,GO:0042277,peptide binding,456,1,0.6,0.45254,1,1,1.67
MF,GO:0005543,phospholipid binding,483,1,0.63,0.47195,1,1,1.59
MF,GO:0005096,GTPase activator activity,509,1,0.66,0.49001,1,1,1.52
MF,GO:0004842,ubiquitin-protein transferase activity,524,1,0.68,0.50016,1,1,1.47
MF,GO:0000978,RNA polymerase II cis-regulatory region ...,1278,2,1.67,0.50382,1,1,1.2
MF,GO:0033218,amide binding,536,1,0.7,0.50814,1,1,1.43
MF,GO:0003712,transcription coregulator activity,537,1,0.7,0.50880,1,1,1.43
MF,GO:0000987,cis-regulatory region sequence-specific ...,1299,2,1.7,0.51272,1,1,1.18
MF,GO:0030695,GTPase regulator activity,544,1,0.71,0.51339,1,1,1.41
MF,GO:0060589,nucleoside-triphosphatase regulator acti...,544,1,0.71,0.51339,1,1,1.41
MF,GO:0019787,ubiquitin-like protein transferase activ...,550,1,0.72,0.51729,1,1,1.39
MF,GO:0003729,mRNA binding,588,1,0.77,0.54132,1,1,1.3
MF,GO:0030234,enzyme regulator activity,1378,2,1.8,0.54531,1,1,1.11
MF,GO:0008233,peptidase activity,683,1,0.89,0.59645,1,1,1.12
MF,GO:0000977,RNA polymerase II transcription regulato...,1523,2,1.99,0.60137,1,1,1.01
MF,GO:0044877,protein-containing complex binding,1572,2,2.05,0.61919,1,1,0.98
MF,GO:0016491,oxidoreductase activity,798,1,1.04,0.65468,1,1,0.96
MF,GO:0008289,lipid binding,840,1,1.1,0.67386,1,1,0.91
MF,GO:0005488,binding,18565,24,24.24,0.70429,1,1,0.99
MF,GO:0005102,signaling receptor binding,1891,2,2.47,0.72114,1,1,0.81
MF,GO:0004930,G protein-coupled receptor activity,1056,1,1.38,0.75737,1,1,0.72
MF,GO:0140110,transcription regulator activity,2055,2,2.68,0.76446,1,1,0.75
MF,GO:0000981,DNA-binding transcription factor activit...,1469,1,1.92,0.86344,1,1,0.52
MF,GO:0003700,DNA-binding transcription factor activit...,1521,1,1.99,0.87308,1,1,0.5
MF,GO:0003674,molecular_function,20678,27,27,1.00000,1,1,1
MF,GO:0000030,mannosyltransferase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0000049,tRNA binding,77,0,0.1,1.00000,1,1,0
MF,GO:0000062,fatty-acyl-CoA binding,22,0,0.03,1.00000,1,1,0
MF,GO:0000149,SNARE binding,120,0,0.16,1.00000,1,1,0
MF,GO:0000175,3'-5'-exoribonuclease activity,36,0,0.05,1.00000,1,1,0
MF,GO:0000217,DNA secondary structure binding,38,0,0.05,1.00000,1,1,0
MF,GO:0000287,magnesium ion binding,236,0,0.31,1.00000,1,1,0
MF,GO:0000979,RNA polymerase II core promoter sequence...,20,0,0.03,1.00000,1,1,0
MF,GO:0001091,RNA polymerase II general transcription ...,23,0,0.03,1.00000,1,1,0
MF,GO:0001216,DNA-binding transcription activator acti...,478,0,0.62,1.00000,1,1,0
MF,GO:0001221,transcription coregulator binding,86,0,0.11,1.00000,1,1,0
MF,GO:0001222,transcription corepressor binding,40,0,0.05,1.00000,1,1,0
MF,GO:0001223,transcription coactivator binding,32,0,0.04,1.00000,1,1,0
MF,GO:0001228,DNA-binding transcription activator acti...,472,0,0.62,1.00000,1,1,0
MF,GO:0001530,lipopolysaccharide binding,36,0,0.05,1.00000,1,1,0
MF,GO:0001614,purinergic nucleotide receptor activity,21,0,0.03,1.00000,1,1,0
MF,GO:0001618,virus receptor activity,93,0,0.12,1.00000,1,1,0
MF,GO:0001637,G protein-coupled chemoattractant recept...,26,0,0.03,1.00000,1,1,0
MF,GO:0001653,peptide receptor activity,163,0,0.21,1.00000,1,1,0
MF,GO:0001664,G protein-coupled receptor binding,341,0,0.45,1.00000,1,1,0
MF,GO:0001671,ATPase activator activity,33,0,0.04,1.00000,1,1,0
MF,GO:0001784,phosphotyrosine residue binding,44,0,0.06,1.00000,1,1,0
MF,GO:0001786,phosphatidylserine binding,63,0,0.08,1.00000,1,1,0
MF,GO:0001848,complement binding,34,0,0.04,1.00000,1,1,0
MF,GO:0001965,G-protein alpha-subunit binding,24,0,0.03,1.00000,1,1,0
MF,GO:0001968,fibronectin binding,29,0,0.04,1.00000,1,1,0
MF,GO:0001972,retinoic acid binding,20,0,0.03,1.00000,1,1,0
MF,GO:0002020,protease binding,171,0,0.22,1.00000,1,1,0
MF,GO:0002039,p53 binding,79,0,0.1,1.00000,1,1,0
MF,GO:0002161,aminoacyl-tRNA editing activity,24,0,0.03,1.00000,1,1,0
MF,GO:0003684,damaged DNA binding,68,0,0.09,1.00000,1,1,0
MF,GO:0003697,single-stranded DNA binding,131,0,0.17,1.00000,1,1,0
MF,GO:0003707,steroid hormone receptor activity,29,0,0.04,1.00000,1,1,0
MF,GO:0003713,transcription coactivator activity,298,0,0.39,1.00000,1,1,0
MF,GO:0003724,RNA helicase activity,98,0,0.13,1.00000,1,1,0
MF,GO:0003730,mRNA 3'-UTR binding,210,0,0.27,1.00000,1,1,0
MF,GO:0003735,structural constituent of ribosome,193,0,0.25,1.00000,1,1,0
MF,GO:0003746,translation elongation factor activity,22,0,0.03,1.00000,1,1,0
MF,GO:0003755,peptidyl-prolyl cis-trans isomerase acti...,39,0,0.05,1.00000,1,1,0
MF,GO:0003756,protein disulfide isomerase activity,20,0,0.03,1.00000,1,1,0
MF,GO:0003785,actin monomer binding,29,0,0.04,1.00000,1,1,0
MF,GO:0003823,antigen binding,298,0,0.39,1.00000,1,1,0
MF,GO:0003841,1-acylglycerol-3-phosphate O-acyltransfe...,38,0,0.05,1.00000,1,1,0
MF,GO:0003887,DNA-directed DNA polymerase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0003899,DNA-directed 5'-3' RNA polymerase activi...,49,0,0.06,1.00000,1,1,0
MF,GO:0003924,GTPase activity,357,0,0.47,1.00000,1,1,0
MF,GO:0003925,G protein activity,40,0,0.05,1.00000,1,1,0
MF,GO:0003950,"NAD+ ADP-ribosyltransferase activity",25,0,0.03,1.00000,1,1,0
MF,GO:0003953,"NAD+ nucleosidase activity",28,0,0.04,1.00000,1,1,0
MF,GO:0003954,"NADH dehydrogenase activity",60,0,0.08,1.00000,1,1,0
MF,GO:0003955,"NAD(P)H dehydrogenase (quinone) activity",60,0,0.08,1.00000,1,1,0
MF,GO:0004033,aldo-keto reductase (NADP) activity,39,0,0.05,1.00000,1,1,0
MF,GO:0004112,cyclic-nucleotide phosphodiesterase acti...,28,0,0.04,1.00000,1,1,0
MF,GO:0004114,"3',5'-cyclic-nucleotide phosphodiesteras...",26,0,0.03,1.00000,1,1,0
MF,GO:0004129,cytochrome-c oxidase activity,20,0,0.03,1.00000,1,1,0
MF,GO:0004175,endopeptidase activity,492,0,0.64,1.00000,1,1,0
MF,GO:0004177,aminopeptidase activity,40,0,0.05,1.00000,1,1,0
MF,GO:0004180,carboxypeptidase activity,45,0,0.06,1.00000,1,1,0
MF,GO:0004181,metallocarboxypeptidase activity,31,0,0.04,1.00000,1,1,0
MF,GO:0004190,aspartic-type endopeptidase activity,29,0,0.04,1.00000,1,1,0
MF,GO:0004197,cysteine-type endopeptidase activity,126,0,0.16,1.00000,1,1,0
MF,GO:0004222,metalloendopeptidase activity,124,0,0.16,1.00000,1,1,0
MF,GO:0004252,serine-type endopeptidase activity,200,0,0.26,1.00000,1,1,0
MF,GO:0004298,threonine-type endopeptidase activity,30,0,0.04,1.00000,1,1,0
MF,GO:0004303,estradiol 17-beta-dehydrogenase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0004364,glutathione transferase activity,30,0,0.04,1.00000,1,1,0
MF,GO:0004402,histone acetyltransferase activity,42,0,0.05,1.00000,1,1,0
MF,GO:0004407,histone deacetylase activity,22,0,0.03,1.00000,1,1,0
MF,GO:0004435,phosphatidylinositol phospholipase C act...,29,0,0.04,1.00000,1,1,0
MF,GO:0004438,phosphatidylinositol-3-phosphatase activ...,21,0,0.03,1.00000,1,1,0
MF,GO:0004497,monooxygenase activity,113,0,0.15,1.00000,1,1,0
MF,GO:0004520,endodeoxyribonuclease activity,39,0,0.05,1.00000,1,1,0
MF,GO:0004527,exonuclease activity,88,0,0.11,1.00000,1,1,0
MF,GO:0004529,exodeoxyribonuclease activity,24,0,0.03,1.00000,1,1,0
MF,GO:0004532,exoribonuclease activity,41,0,0.05,1.00000,1,1,0
MF,GO:0004536,deoxyribonuclease activity,59,0,0.08,1.00000,1,1,0
MF,GO:0004549,tRNA-specific ribonuclease activity,31,0,0.04,1.00000,1,1,0
MF,GO:0004551,nucleotide diphosphatase activity,20,0,0.03,1.00000,1,1,0
MF,GO:0004553,"hydrolase activity, hydrolyzing O-glycos...",104,0,0.14,1.00000,1,1,0
MF,GO:0004601,peroxidase activity,55,0,0.07,1.00000,1,1,0
MF,GO:0004602,glutathione peroxidase activity,25,0,0.03,1.00000,1,1,0
MF,GO:0004620,phospholipase activity,115,0,0.15,1.00000,1,1,0
MF,GO:0004622,lysophospholipase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0004623,phospholipase A2 activity,34,0,0.04,1.00000,1,1,0
MF,GO:0004629,phospholipase C activity,31,0,0.04,1.00000,1,1,0
MF,GO:0004653,polypeptide N-acetylgalactosaminyltransf...,20,0,0.03,1.00000,1,1,0
MF,GO:0004693,cyclin-dependent protein serine/threonin...,30,0,0.04,1.00000,1,1,0
MF,GO:0004709,MAP kinase kinase kinase activity,28,0,0.04,1.00000,1,1,0
MF,GO:0004712,protein serine/threonine/tyrosine kinase...,48,0,0.06,1.00000,1,1,0
MF,GO:0004715,non-membrane spanning protein tyrosine k...,48,0,0.06,1.00000,1,1,0
MF,GO:0004722,protein serine/threonine phosphatase act...,107,0,0.14,1.00000,1,1,0
MF,GO:0004725,protein tyrosine phosphatase activity,116,0,0.15,1.00000,1,1,0
MF,GO:0004806,triglyceride lipase activity,26,0,0.03,1.00000,1,1,0
MF,GO:0004812,aminoacyl-tRNA ligase activity,54,0,0.07,1.00000,1,1,0
MF,GO:0004843,thiol-dependent deubiquitinase,117,0,0.15,1.00000,1,1,0
MF,GO:0004857,enzyme inhibitor activity,76,0,0.1,1.00000,1,1,0
MF,GO:0004860,protein kinase inhibitor activity,78,0,0.1,1.00000,1,1,0
MF,GO:0004864,protein phosphatase inhibitor activity,62,0,0.08,1.00000,1,1,0
MF,GO:0004865,protein serine/threonine phosphatase inh...,20,0,0.03,1.00000,1,1,0
MF,GO:0004867,serine-type endopeptidase inhibitor acti...,104,0,0.14,1.00000,1,1,0
MF,GO:0004879,nuclear receptor activity,57,0,0.07,1.00000,1,1,0
MF,GO:0004896,cytokine receptor activity,100,0,0.13,1.00000,1,1,0
MF,GO:0004950,chemokine receptor activity,26,0,0.03,1.00000,1,1,0
MF,GO:0004984,olfactory receptor activity,562,0,0.73,1.00000,1,1,0
MF,GO:0004993,G protein-coupled serotonin receptor act...,36,0,0.05,1.00000,1,1,0
MF,GO:0005001,transmembrane receptor protein tyrosine ...,21,0,0.03,1.00000,1,1,0
MF,GO:0005003,ephrin receptor activity,21,0,0.03,1.00000,1,1,0
MF,GO:0005044,scavenger receptor activity,54,0,0.07,1.00000,1,1,0
MF,GO:0005048,signal sequence binding,54,0,0.07,1.00000,1,1,0
MF,GO:0005080,protein kinase C binding,58,0,0.08,1.00000,1,1,0
MF,GO:0005085,guanyl-nucleotide exchange factor activi...,244,0,0.32,1.00000,1,1,0
MF,GO:0005104,fibroblast growth factor receptor bindin...,25,0,0.03,1.00000,1,1,0
MF,GO:0005109,frizzled binding,42,0,0.05,1.00000,1,1,0
MF,GO:0005112,Notch binding,32,0,0.04,1.00000,1,1,0
MF,GO:0005123,death receptor binding,22,0,0.03,1.00000,1,1,0
MF,GO:0005125,cytokine activity,286,0,0.37,1.00000,1,1,0
MF,GO:0005126,cytokine receptor binding,324,0,0.42,1.00000,1,1,0
MF,GO:0005154,epidermal growth factor receptor binding,33,0,0.04,1.00000,1,1,0
MF,GO:0005158,insulin receptor binding,23,0,0.03,1.00000,1,1,0
MF,GO:0005160,transforming growth factor beta receptor...,25,0,0.03,1.00000,1,1,0
MF,GO:0005164,tumor necrosis factor receptor binding,51,0,0.07,1.00000,1,1,0
MF,GO:0005179,hormone activity,127,0,0.17,1.00000,1,1,0
MF,GO:0005184,neuropeptide hormone activity,29,0,0.04,1.00000,1,1,0
MF,GO:0005200,structural constituent of cytoskeleton,117,0,0.15,1.00000,1,1,0
MF,GO:0005201,extracellular matrix structural constitu...,198,0,0.26,1.00000,1,1,0
MF,GO:0005212,structural constituent of eye lens,25,0,0.03,1.00000,1,1,0
MF,GO:0005227,calcium activated cation channel activit...,25,0,0.03,1.00000,1,1,0
MF,GO:0005229,intracellular calcium activated chloride...,22,0,0.03,1.00000,1,1,0
MF,GO:0005231,excitatory extracellular ligand-gated io...,32,0,0.04,1.00000,1,1,0
MF,GO:0005242,inward rectifier potassium channel activ...,25,0,0.03,1.00000,1,1,0
MF,GO:0005243,gap junction channel activity,22,0,0.03,1.00000,1,1,0
MF,GO:0005248,voltage-gated sodium channel activity,24,0,0.03,1.00000,1,1,0
MF,GO:0005249,voltage-gated potassium channel activity,93,0,0.12,1.00000,1,1,0
MF,GO:0005251,delayed rectifier potassium channel acti...,35,0,0.05,1.00000,1,1,0
MF,GO:0005253,anion channel activity,98,0,0.13,1.00000,1,1,0
MF,GO:0005254,chloride channel activity,85,0,0.11,1.00000,1,1,0
MF,GO:0005310,dicarboxylic acid transmembrane transpor...,30,0,0.04,1.00000,1,1,0
MF,GO:0005319,lipid transporter activity,170,0,0.22,1.00000,1,1,0
MF,GO:0005326,neurotransmitter transmembrane transport...,20,0,0.03,1.00000,1,1,0
MF,GO:0005342,organic acid transmembrane transporter a...,170,0,0.22,1.00000,1,1,0
MF,GO:0005343,organic acid:sodium symporter activity,31,0,0.04,1.00000,1,1,0
MF,GO:0005355,glucose transmembrane transporter activi...,26,0,0.03,1.00000,1,1,0
MF,GO:0005385,zinc ion transmembrane transporter activ...,28,0,0.04,1.00000,1,1,0
MF,GO:0005416,amino acid:cation symporter activity,22,0,0.03,1.00000,1,1,0
MF,GO:0005484,SNAP receptor activity,36,0,0.05,1.00000,1,1,0
MF,GO:0005496,steroid binding,106,0,0.14,1.00000,1,1,0
MF,GO:0005501,retinoid binding,41,0,0.05,1.00000,1,1,0
MF,GO:0005504,fatty acid binding,39,0,0.05,1.00000,1,1,0
MF,GO:0005506,iron ion binding,162,0,0.21,1.00000,1,1,0
MF,GO:0005507,copper ion binding,63,0,0.08,1.00000,1,1,0
MF,GO:0005518,collagen binding,93,0,0.12,1.00000,1,1,0
MF,GO:0005520,insulin-like growth factor binding,30,0,0.04,1.00000,1,1,0
MF,GO:0005525,GTP binding,402,0,0.52,1.00000,1,1,0
MF,GO:0005537,mannose binding,24,0,0.03,1.00000,1,1,0
MF,GO:0005539,glycosaminoglycan binding,254,0,0.33,1.00000,1,1,0
MF,GO:0005540,hyaluronic acid binding,22,0,0.03,1.00000,1,1,0
MF,GO:0005544,calcium-dependent phospholipid binding,56,0,0.07,1.00000,1,1,0
MF,GO:0005546,"phosphatidylinositol-4,5-bisphosphate bi...",85,0,0.11,1.00000,1,1,0
MF,GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate...",39,0,0.05,1.00000,1,1,0
MF,GO:0005548,phospholipid transporter activity,59,0,0.08,1.00000,1,1,0
MF,GO:0005549,odorant binding,151,0,0.2,1.00000,1,1,0
MF,GO:0008009,chemokine activity,63,0,0.08,1.00000,1,1,0
MF,GO:0008013,beta-catenin binding,88,0,0.11,1.00000,1,1,0
MF,GO:0008028,monocarboxylic acid transmembrane transp...,62,0,0.08,1.00000,1,1,0
MF,GO:0008047,enzyme activator activity,115,0,0.15,1.00000,1,1,0
MF,GO:0008080,N-acetyltransferase activity,77,0,0.1,1.00000,1,1,0
MF,GO:0008081,phosphoric diester hydrolase activity,97,0,0.13,1.00000,1,1,0
MF,GO:0008083,growth factor activity,164,0,0.21,1.00000,1,1,0
MF,GO:0008093,cytoskeletal anchor activity,22,0,0.03,1.00000,1,1,0
MF,GO:0008106,alcohol dehydrogenase (NADP+) activity,32,0,0.04,1.00000,1,1,0
MF,GO:0008137,"NADH dehydrogenase (ubiquinone) activity",57,0,0.07,1.00000,1,1,0
MF,GO:0008138,protein tyrosine/serine/threonine phosph...,56,0,0.07,1.00000,1,1,0
MF,GO:0008139,nuclear localization sequence binding,28,0,0.04,1.00000,1,1,0
MF,GO:0008143,poly(A) binding,23,0,0.03,1.00000,1,1,0
MF,GO:0008146,sulfotransferase activity,56,0,0.07,1.00000,1,1,0
MF,GO:0008157,protein phosphatase 1 binding,48,0,0.06,1.00000,1,1,0
MF,GO:0008171,O-methyltransferase activity,27,0,0.04,1.00000,1,1,0
MF,GO:0008173,RNA methyltransferase activity,67,0,0.09,1.00000,1,1,0
MF,GO:0008175,tRNA methyltransferase activity,33,0,0.04,1.00000,1,1,0
MF,GO:0008186,"ATP-dependent activity, acting on RNA",100,0,0.13,1.00000,1,1,0
MF,GO:0008187,poly-pyrimidine tract binding,29,0,0.04,1.00000,1,1,0
MF,GO:0008188,neuropeptide receptor activity,47,0,0.06,1.00000,1,1,0
MF,GO:0008194,UDP-glycosyltransferase activity,158,0,0.21,1.00000,1,1,0
MF,GO:0008198,ferrous iron binding,25,0,0.03,1.00000,1,1,0
MF,GO:0008201,heparin binding,190,0,0.25,1.00000,1,1,0
MF,GO:0008227,G protein-coupled amine receptor activit...,53,0,0.07,1.00000,1,1,0
MF,GO:0008234,cysteine-type peptidase activity,197,0,0.26,1.00000,1,1,0
MF,GO:0008235,metalloexopeptidase activity,74,0,0.1,1.00000,1,1,0
MF,GO:0008237,metallopeptidase activity,205,0,0.27,1.00000,1,1,0
MF,GO:0008238,exopeptidase activity,105,0,0.14,1.00000,1,1,0
MF,GO:0008242,omega peptidase activity,131,0,0.17,1.00000,1,1,0
MF,GO:0008266,poly(U) RNA binding,26,0,0.03,1.00000,1,1,0
MF,GO:0008307,structural constituent of muscle,44,0,0.06,1.00000,1,1,0
MF,GO:0008320,protein transmembrane transporter activi...,24,0,0.03,1.00000,1,1,0
MF,GO:0008373,sialyltransferase activity,22,0,0.03,1.00000,1,1,0
MF,GO:0008374,O-acyltransferase activity,74,0,0.1,1.00000,1,1,0
MF,GO:0008375,acetylglucosaminyltransferase activity,48,0,0.06,1.00000,1,1,0
MF,GO:0008376,acetylgalactosaminyltransferase activity,37,0,0.05,1.00000,1,1,0
MF,GO:0008378,galactosyltransferase activity,38,0,0.05,1.00000,1,1,0
MF,GO:0008381,mechanosensitive ion channel activity,26,0,0.03,1.00000,1,1,0
MF,GO:0008391,arachidonic acid monooxygenase activity,21,0,0.03,1.00000,1,1,0
MF,GO:0008395,steroid hydroxylase activity,48,0,0.06,1.00000,1,1,0
MF,GO:0008408,3'-5' exonuclease activity,57,0,0.07,1.00000,1,1,0
MF,GO:0008409,5'-3' exonuclease activity,24,0,0.03,1.00000,1,1,0
MF,GO:0008474,palmitoyl-(protein) hydrolase activity,27,0,0.04,1.00000,1,1,0
MF,GO:0008483,transaminase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0008509,anion transmembrane transporter activity,347,0,0.45,1.00000,1,1,0
MF,GO:0008514,organic anion transmembrane transporter ...,201,0,0.26,1.00000,1,1,0
MF,GO:0008527,taste receptor activity,50,0,0.07,1.00000,1,1,0
MF,GO:0008528,G protein-coupled peptide receptor activ...,157,0,0.21,1.00000,1,1,0
MF,GO:0008649,rRNA methyltransferase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0009055,electron transfer activity,141,0,0.18,1.00000,1,1,0
MF,GO:0009678,pyrophosphate hydrolysis-driven proton t...,28,0,0.04,1.00000,1,1,0
MF,GO:0009931,calcium-dependent protein serine/threoni...,25,0,0.03,1.00000,1,1,0
MF,GO:0009975,cyclase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0010857,calcium-dependent protein kinase activit...,26,0,0.03,1.00000,1,1,0
MF,GO:0015020,glucuronosyltransferase activity,36,0,0.05,1.00000,1,1,0
MF,GO:0015026,coreceptor activity,52,0,0.07,1.00000,1,1,0
MF,GO:0015035,protein-disulfide reductase activity,39,0,0.05,1.00000,1,1,0
MF,GO:0015036,disulfide oxidoreductase activity,44,0,0.06,1.00000,1,1,0
MF,GO:0015078,proton transmembrane transporter activit...,142,0,0.19,1.00000,1,1,0
MF,GO:0015101,organic cation transmembrane transporter...,36,0,0.05,1.00000,1,1,0
MF,GO:0015103,inorganic anion transmembrane transporte...,168,0,0.22,1.00000,1,1,0
MF,GO:0015106,bicarbonate transmembrane transporter ac...,22,0,0.03,1.00000,1,1,0
MF,GO:0015125,bile acid transmembrane transporter acti...,23,0,0.03,1.00000,1,1,0
MF,GO:0015144,carbohydrate transmembrane transporter a...,44,0,0.06,1.00000,1,1,0
MF,GO:0015145,monosaccharide transmembrane transporter...,28,0,0.04,1.00000,1,1,0
MF,GO:0015149,hexose transmembrane transporter activit...,26,0,0.03,1.00000,1,1,0
MF,GO:0015171,amino acid transmembrane transporter act...,85,0,0.11,1.00000,1,1,0
MF,GO:0015175,neutral amino acid transmembrane transpo...,39,0,0.05,1.00000,1,1,0
MF,GO:0015179,L-amino acid transmembrane transporter a...,62,0,0.08,1.00000,1,1,0
MF,GO:0015215,nucleotide transmembrane transporter act...,28,0,0.04,1.00000,1,1,0
MF,GO:0015216,purine nucleotide transmembrane transpor...,22,0,0.03,1.00000,1,1,0
MF,GO:0015248,sterol transporter activity,36,0,0.05,1.00000,1,1,0
MF,GO:0015252,proton channel activity,24,0,0.03,1.00000,1,1,0
MF,GO:0015291,secondary active transmembrane transport...,252,0,0.33,1.00000,1,1,0
MF,GO:0015293,symporter activity,151,0,0.2,1.00000,1,1,0
MF,GO:0015294,solute:cation symporter activity,109,0,0.14,1.00000,1,1,0
MF,GO:0015295,solute:proton symporter activity,25,0,0.03,1.00000,1,1,0
MF,GO:0015296,anion:cation symporter activity,24,0,0.03,1.00000,1,1,0
MF,GO:0015297,antiporter activity,94,0,0.12,1.00000,1,1,0
MF,GO:0015298,solute:cation antiporter activity,38,0,0.05,1.00000,1,1,0
MF,GO:0015299,solute:proton antiporter activity,26,0,0.03,1.00000,1,1,0
MF,GO:0015301,anion:anion antiporter activity,29,0,0.04,1.00000,1,1,0
MF,GO:0015370,solute:sodium symporter activity,76,0,0.1,1.00000,1,1,0
MF,GO:0015399,primary active transmembrane transporter...,226,0,0.3,1.00000,1,1,0
MF,GO:0015433,ABC-type peptide antigen transporter act...,22,0,0.03,1.00000,1,1,0
MF,GO:0015440,ABC-type peptide transporter activity,22,0,0.03,1.00000,1,1,0
MF,GO:0015453,oxidoreduction-driven active transmembra...,88,0,0.11,1.00000,1,1,0
MF,GO:0015464,acetylcholine receptor activity,26,0,0.03,1.00000,1,1,0
MF,GO:0015485,cholesterol binding,50,0,0.07,1.00000,1,1,0
MF,GO:0015491,cation:cation antiporter activity,29,0,0.04,1.00000,1,1,0
MF,GO:0015605,organophosphate ester transmembrane tran...,41,0,0.05,1.00000,1,1,0
MF,GO:0015645,fatty acid ligase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0015662,P-type ion transporter activity,22,0,0.03,1.00000,1,1,0
MF,GO:0015932,nucleobase-containing compound transmemb...,52,0,0.07,1.00000,1,1,0
MF,GO:0016018,cyclosporin A binding,21,0,0.03,1.00000,1,1,0
MF,GO:0016209,antioxidant activity,100,0,0.13,1.00000,1,1,0
MF,GO:0016229,steroid dehydrogenase activity,40,0,0.05,1.00000,1,1,0
MF,GO:0016251,RNA polymerase II general transcription ...,47,0,0.06,1.00000,1,1,0
MF,GO:0016289,CoA hydrolase activity,26,0,0.03,1.00000,1,1,0
MF,GO:0016298,lipase activity,141,0,0.18,1.00000,1,1,0
MF,GO:0016405,CoA-ligase activity,28,0,0.04,1.00000,1,1,0
MF,GO:0016407,acetyltransferase activity,101,0,0.13,1.00000,1,1,0
MF,GO:0016408,C-acyltransferase activity,20,0,0.03,1.00000,1,1,0
MF,GO:0016409,palmitoyltransferase activity,38,0,0.05,1.00000,1,1,0
MF,GO:0016410,N-acyltransferase activity,104,0,0.14,1.00000,1,1,0
MF,GO:0016411,acylglycerol O-acyltransferase activity,49,0,0.06,1.00000,1,1,0
MF,GO:0016417,S-acyltransferase activity,30,0,0.04,1.00000,1,1,0
MF,GO:0016493,C-C chemokine receptor activity,23,0,0.03,1.00000,1,1,0
MF,GO:0016500,protein-hormone receptor activity,22,0,0.03,1.00000,1,1,0
MF,GO:0016502,nucleotide receptor activity,21,0,0.03,1.00000,1,1,0
MF,GO:0016504,peptidase activator activity,47,0,0.06,1.00000,1,1,0
MF,GO:0016505,peptidase activator activity involved in...,21,0,0.03,1.00000,1,1,0
MF,GO:0016538,cyclin-dependent protein serine/threonin...,50,0,0.07,1.00000,1,1,0
MF,GO:0016597,amino acid binding,61,0,0.08,1.00000,1,1,0
MF,GO:0016614,"oxidoreductase activity, acting on CH-OH...",158,0,0.21,1.00000,1,1,0
MF,GO:0016616,"oxidoreductase activity, acting on the C...",146,0,0.19,1.00000,1,1,0
MF,GO:0016620,"oxidoreductase activity, acting on the a...",37,0,0.05,1.00000,1,1,0
MF,GO:0016627,"oxidoreductase activity, acting on the C...",63,0,0.08,1.00000,1,1,0
MF,GO:0016628,"oxidoreductase activity, acting on the C...",31,0,0.04,1.00000,1,1,0
MF,GO:0016638,"oxidoreductase activity, acting on the C...",21,0,0.03,1.00000,1,1,0
MF,GO:0016645,"oxidoreductase activity, acting on the C...",29,0,0.04,1.00000,1,1,0
MF,GO:0016651,"oxidoreductase activity, acting on NAD(P...",105,0,0.14,1.00000,1,1,0
MF,GO:0016655,"oxidoreductase activity, acting on NAD(P...",73,0,0.1,1.00000,1,1,0
MF,GO:0016667,"oxidoreductase activity, acting on a sul...",61,0,0.08,1.00000,1,1,0
MF,GO:0016675,"oxidoreductase activity, acting on a hem...",21,0,0.03,1.00000,1,1,0
MF,GO:0016684,"oxidoreductase activity, acting on perox...",60,0,0.08,1.00000,1,1,0
MF,GO:0016701,"oxidoreductase activity, acting on singl...",27,0,0.04,1.00000,1,1,0
MF,GO:0016702,"oxidoreductase activity, acting on singl...",26,0,0.03,1.00000,1,1,0
MF,GO:0016709,"oxidoreductase activity, acting on paire...",48,0,0.06,1.00000,1,1,0
MF,GO:0016712,"oxidoreductase activity, acting on paire...",45,0,0.06,1.00000,1,1,0
MF,GO:0016746,acyltransferase activity,282,0,0.37,1.00000,1,1,0
MF,GO:0016747,"acyltransferase activity, transferring g...",252,0,0.33,1.00000,1,1,0
MF,GO:0016755,aminoacyltransferase activity,21,0,0.03,1.00000,1,1,0
MF,GO:0016757,glycosyltransferase activity,292,0,0.38,1.00000,1,1,0
MF,GO:0016758,hexosyltransferase activity,212,0,0.28,1.00000,1,1,0
MF,GO:0016763,pentosyltransferase activity,53,0,0.07,1.00000,1,1,0
MF,GO:0016765,"transferase activity, transferring alkyl...",64,0,0.08,1.00000,1,1,0
MF,GO:0016769,"transferase activity, transferring nitro...",25,0,0.03,1.00000,1,1,0
MF,GO:0016779,nucleotidyltransferase activity,139,0,0.18,1.00000,1,1,0
MF,GO:0016780,"phosphotransferase activity, for other s...",21,0,0.03,1.00000,1,1,0
MF,GO:0016782,"transferase activity, transferring sulph...",72,0,0.09,1.00000,1,1,0
MF,GO:0016790,thiolester hydrolase activity,57,0,0.07,1.00000,1,1,0
MF,GO:0016796,"exonuclease activity, active with either...",61,0,0.08,1.00000,1,1,0
MF,GO:0016798,"hydrolase activity, acting on glycosyl b...",154,0,0.2,1.00000,1,1,0
MF,GO:0016799,"hydrolase activity, hydrolyzing N-glycos...",50,0,0.07,1.00000,1,1,0
MF,GO:0016810,"hydrolase activity, acting on carbon-nit...",140,0,0.18,1.00000,1,1,0
MF,GO:0016811,"hydrolase activity, acting on carbon-nit...",75,0,0.1,1.00000,1,1,0
MF,GO:0016813,"hydrolase activity, acting on carbon-nit...",21,0,0.03,1.00000,1,1,0
MF,GO:0016814,"hydrolase activity, acting on carbon-nit...",37,0,0.05,1.00000,1,1,0
MF,GO:0016829,lyase activity,214,0,0.28,1.00000,1,1,0
MF,GO:0016830,carbon-carbon lyase activity,56,0,0.07,1.00000,1,1,0
MF,GO:0016831,carboxy-lyase activity,37,0,0.05,1.00000,1,1,0
MF,GO:0016835,carbon-oxygen lyase activity,79,0,0.1,1.00000,1,1,0
MF,GO:0016836,hydro-lyase activity,64,0,0.08,1.00000,1,1,0
MF,GO:0016849,phosphorus-oxygen lyase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0016853,isomerase activity,168,0,0.22,1.00000,1,1,0
MF,GO:0016859,cis-trans isomerase activity,42,0,0.05,1.00000,1,1,0
MF,GO:0016860,intramolecular oxidoreductase activity,55,0,0.07,1.00000,1,1,0
MF,GO:0016864,"intramolecular oxidoreductase activity, ...",20,0,0.03,1.00000,1,1,0
MF,GO:0016866,intramolecular transferase activity,28,0,0.04,1.00000,1,1,0
MF,GO:0016874,ligase activity,184,0,0.24,1.00000,1,1,0
MF,GO:0016875,"ligase activity, forming carbon-oxygen b...",54,0,0.07,1.00000,1,1,0
MF,GO:0016877,"ligase activity, forming carbon-sulfur b...",42,0,0.05,1.00000,1,1,0
MF,GO:0016878,acid-thiol ligase activity,32,0,0.04,1.00000,1,1,0
MF,GO:0016879,"ligase activity, forming carbon-nitrogen...",51,0,0.07,1.00000,1,1,0
MF,GO:0016881,acid-amino acid ligase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0016894,"endonuclease activity, active with eithe...",25,0,0.03,1.00000,1,1,0
MF,GO:0016895,"exodeoxyribonuclease activity, producing...",24,0,0.03,1.00000,1,1,0
MF,GO:0016896,"exoribonuclease activity, producing 5'-p...",39,0,0.05,1.00000,1,1,0
MF,GO:0016903,"oxidoreductase activity, acting on the a...",44,0,0.06,1.00000,1,1,0
MF,GO:0016917,GABA receptor activity,28,0,0.04,1.00000,1,1,0
MF,GO:0016918,retinal binding,22,0,0.03,1.00000,1,1,0
MF,GO:0017022,myosin binding,78,0,0.1,1.00000,1,1,0
MF,GO:0017025,TBP-class protein binding,24,0,0.03,1.00000,1,1,0
MF,GO:0017046,peptide hormone binding,59,0,0.08,1.00000,1,1,0
MF,GO:0017056,structural constituent of nuclear pore,27,0,0.04,1.00000,1,1,0
MF,GO:0017069,snRNA binding,77,0,0.1,1.00000,1,1,0
MF,GO:0017070,U6 snRNA binding,31,0,0.04,1.00000,1,1,0
MF,GO:0017075,syntaxin-1 binding,24,0,0.03,1.00000,1,1,0
MF,GO:0017080,sodium channel regulator activity,41,0,0.05,1.00000,1,1,0
MF,GO:0017116,single-stranded DNA helicase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0017124,SH3 domain binding,144,0,0.19,1.00000,1,1,0
MF,GO:0017134,fibroblast growth factor binding,23,0,0.03,1.00000,1,1,0
MF,GO:0017147,Wnt-protein binding,31,0,0.04,1.00000,1,1,0
MF,GO:0019001,guanyl nucleotide binding,425,0,0.55,1.00000,1,1,0
MF,GO:0019003,GDP binding,76,0,0.1,1.00000,1,1,0
MF,GO:0019198,transmembrane receptor protein phosphata...,21,0,0.03,1.00000,1,1,0
MF,GO:0019200,carbohydrate kinase activity,21,0,0.03,1.00000,1,1,0
MF,GO:0019207,kinase regulator activity,257,0,0.34,1.00000,1,1,0
MF,GO:0019208,phosphatase regulator activity,126,0,0.16,1.00000,1,1,0
MF,GO:0019209,kinase activator activity,114,0,0.15,1.00000,1,1,0
MF,GO:0019210,kinase inhibitor activity,83,0,0.11,1.00000,1,1,0
MF,GO:0019211,phosphatase activator activity,20,0,0.03,1.00000,1,1,0
MF,GO:0019212,phosphatase inhibitor activity,65,0,0.08,1.00000,1,1,0
MF,GO:0019213,deacetylase activity,41,0,0.05,1.00000,1,1,0
MF,GO:0019239,deaminase activity,34,0,0.04,1.00000,1,1,0
MF,GO:0019706,protein-cysteine S-palmitoyltransferase ...,26,0,0.03,1.00000,1,1,0
MF,GO:0019707,protein-cysteine S-acyltransferase activ...,26,0,0.03,1.00000,1,1,0
MF,GO:0019783,ubiquitin-like protein-specific protease...,129,0,0.17,1.00000,1,1,0
MF,GO:0019789,SUMO transferase activity,30,0,0.04,1.00000,1,1,0
MF,GO:0019825,oxygen binding,40,0,0.05,1.00000,1,1,0
MF,GO:0019829,ATPase-coupled cation transmembrane tran...,55,0,0.07,1.00000,1,1,0
MF,GO:0019840,isoprenoid binding,41,0,0.05,1.00000,1,1,0
MF,GO:0019842,vitamin binding,154,0,0.2,1.00000,1,1,0
MF,GO:0019843,rRNA binding,82,0,0.11,1.00000,1,1,0
MF,GO:0019865,immunoglobulin binding,39,0,0.05,1.00000,1,1,0
MF,GO:0019887,protein kinase regulator activity,225,0,0.29,1.00000,1,1,0
MF,GO:0019888,protein phosphatase regulator activity,108,0,0.14,1.00000,1,1,0
MF,GO:0019894,kinesin binding,43,0,0.06,1.00000,1,1,0
MF,GO:0019903,protein phosphatase binding,176,0,0.23,1.00000,1,1,0
MF,GO:0019905,syntaxin binding,84,0,0.11,1.00000,1,1,0
MF,GO:0019955,cytokine binding,153,0,0.2,1.00000,1,1,0
MF,GO:0019956,chemokine binding,33,0,0.04,1.00000,1,1,0
MF,GO:0019957,C-C chemokine binding,24,0,0.03,1.00000,1,1,0
MF,GO:0020037,heme binding,153,0,0.2,1.00000,1,1,0
MF,GO:0022804,active transmembrane transporter activit...,463,0,0.6,1.00000,1,1,0
MF,GO:0022829,wide pore channel activity,31,0,0.04,1.00000,1,1,0
MF,GO:0022839,ion gated channel activity,48,0,0.06,1.00000,1,1,0
MF,GO:0022853,active ion transmembrane transporter act...,287,0,0.37,1.00000,1,1,0
MF,GO:0022884,macromolecule transmembrane transporter ...,29,0,0.04,1.00000,1,1,0
MF,GO:0023023,MHC protein complex binding,126,0,0.16,1.00000,1,1,0
MF,GO:0023026,MHC class II protein complex binding,109,0,0.14,1.00000,1,1,0
MF,GO:0023029,MHC class Ib protein binding,104,0,0.14,1.00000,1,1,0
MF,GO:0030020,extracellular matrix structural constitu...,47,0,0.06,1.00000,1,1,0
MF,GO:0030021,extracellular matrix structural constitu...,23,0,0.03,1.00000,1,1,0
MF,GO:0030109,HLA-B specific inhibitory MHC class I re...,37,0,0.05,1.00000,1,1,0
MF,GO:0030145,manganese ion binding,71,0,0.09,1.00000,1,1,0
MF,GO:0030159,signaling receptor complex adaptor activ...,51,0,0.07,1.00000,1,1,0
MF,GO:0030165,PDZ domain binding,91,0,0.12,1.00000,1,1,0
MF,GO:0030170,pyridoxal phosphate binding,58,0,0.08,1.00000,1,1,0
MF,GO:0030215,semaphorin receptor binding,24,0,0.03,1.00000,1,1,0
MF,GO:0030246,carbohydrate binding,302,0,0.39,1.00000,1,1,0
MF,GO:0030247,polysaccharide binding,38,0,0.05,1.00000,1,1,0
MF,GO:0030291,protein serine/threonine kinase inhibito...,36,0,0.05,1.00000,1,1,0
MF,GO:0030295,protein kinase activator activity,108,0,0.14,1.00000,1,1,0
MF,GO:0030296,protein tyrosine kinase activator activi...,23,0,0.03,1.00000,1,1,0
MF,GO:0030331,estrogen receptor binding,41,0,0.05,1.00000,1,1,0
MF,GO:0030332,cyclin binding,33,0,0.04,1.00000,1,1,0
MF,GO:0030371,translation repressor activity,27,0,0.04,1.00000,1,1,0
MF,GO:0030374,nuclear receptor coactivator activity,57,0,0.07,1.00000,1,1,0
MF,GO:0030506,ankyrin binding,22,0,0.03,1.00000,1,1,0
MF,GO:0030507,spectrin binding,28,0,0.04,1.00000,1,1,0
MF,GO:0030544,Hsp70 protein binding,52,0,0.07,1.00000,1,1,0
MF,GO:0030545,signaling receptor regulator activity,630,0,0.82,1.00000,1,1,0
MF,GO:0030546,signaling receptor activator activity,564,0,0.74,1.00000,1,1,0
MF,GO:0030547,signaling receptor inhibitor activity,55,0,0.07,1.00000,1,1,0
MF,GO:0030548,acetylcholine receptor regulator activit...,23,0,0.03,1.00000,1,1,0
MF,GO:0030551,cyclic nucleotide binding,41,0,0.05,1.00000,1,1,0
MF,GO:0030552,cAMP binding,25,0,0.03,1.00000,1,1,0
MF,GO:0030621,U4 snRNA binding,25,0,0.03,1.00000,1,1,0
MF,GO:0030627,pre-mRNA 5'-splice site binding,20,0,0.03,1.00000,1,1,0
MF,GO:0030674,protein-macromolecule adaptor activity,312,0,0.41,1.00000,1,1,0
MF,GO:0030742,GTP-dependent protein binding,22,0,0.03,1.00000,1,1,0
MF,GO:0030881,beta-2-microglobulin binding,26,0,0.03,1.00000,1,1,0
MF,GO:0030971,receptor tyrosine kinase binding,79,0,0.1,1.00000,1,1,0
MF,GO:0030983,mismatched DNA binding,21,0,0.03,1.00000,1,1,0
MF,GO:0031072,heat shock protein binding,156,0,0.2,1.00000,1,1,0
MF,GO:0031210,phosphatidylcholine binding,31,0,0.04,1.00000,1,1,0
MF,GO:0031369,translation initiation factor binding,33,0,0.04,1.00000,1,1,0
MF,GO:0031406,carboxylic acid binding,181,0,0.24,1.00000,1,1,0
MF,GO:0031418,L-ascorbic acid binding,20,0,0.03,1.00000,1,1,0
MF,GO:0031490,chromatin DNA binding,107,0,0.14,1.00000,1,1,0
MF,GO:0031491,nucleosome binding,76,0,0.1,1.00000,1,1,0
MF,GO:0031492,nucleosomal DNA binding,41,0,0.05,1.00000,1,1,0
MF,GO:0031593,polyubiquitin modification-dependent pro...,64,0,0.08,1.00000,1,1,0
MF,GO:0031624,ubiquitin conjugating enzyme binding,32,0,0.04,1.00000,1,1,0
MF,GO:0031625,ubiquitin protein ligase binding,350,0,0.46,1.00000,1,1,0
MF,GO:0031681,G-protein beta-subunit binding,21,0,0.03,1.00000,1,1,0
MF,GO:0031683,G-protein beta/gamma-subunit complex bin...,20,0,0.03,1.00000,1,1,0
MF,GO:0031690,adrenergic receptor binding,20,0,0.03,1.00000,1,1,0
MF,GO:0032182,ubiquitin-like protein binding,120,0,0.16,1.00000,1,1,0
MF,GO:0032266,phosphatidylinositol-3-phosphate binding,44,0,0.06,1.00000,1,1,0
MF,GO:0032393,MHC class I receptor activity,97,0,0.13,1.00000,1,1,0
MF,GO:0032394,MHC class Ib receptor activity,50,0,0.07,1.00000,1,1,0
MF,GO:0032395,MHC class II receptor activity,67,0,0.09,1.00000,1,1,0
MF,GO:0032396,inhibitory MHC class I receptor activity,83,0,0.11,1.00000,1,1,0
MF,GO:0032451,demethylase activity,39,0,0.05,1.00000,1,1,0
MF,GO:0032452,histone demethylase activity,29,0,0.04,1.00000,1,1,0
MF,GO:0032561,guanyl ribonucleotide binding,425,0,0.55,1.00000,1,1,0
MF,GO:0032794,GTPase activating protein binding,22,0,0.03,1.00000,1,1,0
MF,GO:0032813,tumor necrosis factor receptor superfami...,70,0,0.09,1.00000,1,1,0
MF,GO:0032934,sterol binding,60,0,0.08,1.00000,1,1,0
MF,GO:0033038,bitter taste receptor activity,44,0,0.06,1.00000,1,1,0
MF,GO:0033293,monocarboxylic acid binding,74,0,0.1,1.00000,1,1,0
MF,GO:0033549,MAP kinase phosphatase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0033558,protein deacetylase activity,23,0,0.03,1.00000,1,1,0
MF,GO:0033612,receptor serine/threonine kinase binding,29,0,0.04,1.00000,1,1,0
MF,GO:0033691,sialic acid binding,22,0,0.03,1.00000,1,1,0
MF,GO:0033764,"steroid dehydrogenase activity, acting o...",36,0,0.05,1.00000,1,1,0
MF,GO:0034061,DNA polymerase activity,31,0,0.04,1.00000,1,1,0
MF,GO:0034062,5'-3' RNA polymerase activity,53,0,0.07,1.00000,1,1,0
MF,GO:0034185,apolipoprotein binding,20,0,0.03,1.00000,1,1,0
MF,GO:0034212,peptide N-acetyltransferase activity,58,0,0.08,1.00000,1,1,0
MF,GO:0034237,protein kinase A regulatory subunit bind...,28,0,0.04,1.00000,1,1,0
MF,GO:0034593,phosphatidylinositol bisphosphate phosph...,30,0,0.04,1.00000,1,1,0
MF,GO:0034987,immunoglobulin receptor binding,77,0,0.1,1.00000,1,1,0
MF,GO:0035014,phosphatidylinositol 3-kinase regulator ...,22,0,0.03,1.00000,1,1,0
MF,GO:0035035,histone acetyltransferase binding,28,0,0.04,1.00000,1,1,0
MF,GO:0035250,UDP-galactosyltransferase activity,34,0,0.04,1.00000,1,1,0
MF,GO:0035254,glutamate receptor binding,59,0,0.08,1.00000,1,1,0
MF,GO:0035255,ionotropic glutamate receptor binding,39,0,0.05,1.00000,1,1,0
MF,GO:0035591,signaling adaptor activity,82,0,0.11,1.00000,1,1,0
MF,GO:0035615,clathrin adaptor activity,21,0,0.03,1.00000,1,1,0
MF,GO:0035925,mRNA 3'-UTR AU-rich region binding,28,0,0.04,1.00000,1,1,0
MF,GO:0036002,pre-mRNA binding,61,0,0.08,1.00000,1,1,0
MF,GO:0038024,cargo receptor activity,85,0,0.11,1.00000,1,1,0
MF,GO:0038064,collagen receptor activity,21,0,0.03,1.00000,1,1,0
MF,GO:0038187,pattern recognition receptor activity,26,0,0.03,1.00000,1,1,0
MF,GO:0042056,chemoattractant activity,55,0,0.07,1.00000,1,1,0
MF,GO:0042162,telomeric DNA binding,37,0,0.05,1.00000,1,1,0
MF,GO:0042165,neurotransmitter binding,21,0,0.03,1.00000,1,1,0
MF,GO:0042169,SH2 domain binding,47,0,0.06,1.00000,1,1,0
MF,GO:0042171,lysophosphatidic acid acyltransferase ac...,40,0,0.05,1.00000,1,1,0
MF,GO:0042287,MHC protein binding,154,0,0.2,1.00000,1,1,0
MF,GO:0042288,MHC class I protein binding,59,0,0.08,1.00000,1,1,0
MF,GO:0042379,chemokine receptor binding,99,0,0.13,1.00000,1,1,0
MF,GO:0042562,hormone binding,94,0,0.12,1.00000,1,1,0
MF,GO:0042605,peptide antigen binding,138,0,0.18,1.00000,1,1,0
MF,GO:0042608,T cell receptor binding,36,0,0.05,1.00000,1,1,0
MF,GO:0042625,ATPase-coupled ion transmembrane transpo...,24,0,0.03,1.00000,1,1,0
MF,GO:0042626,ATPase-coupled transmembrane transporter...,138,0,0.18,1.00000,1,1,0
MF,GO:0042826,histone deacetylase binding,136,0,0.18,1.00000,1,1,0
MF,GO:0042887,amide transmembrane transporter activity,53,0,0.07,1.00000,1,1,0
MF,GO:0042910,xenobiotic transmembrane transporter act...,34,0,0.04,1.00000,1,1,0
MF,GO:0042923,neuropeptide binding,29,0,0.04,1.00000,1,1,0
MF,GO:0042974,retinoic acid receptor binding,28,0,0.04,1.00000,1,1,0
MF,GO:0043014,alpha-tubulin binding,41,0,0.05,1.00000,1,1,0
MF,GO:0043015,gamma-tubulin binding,35,0,0.05,1.00000,1,1,0
MF,GO:0043021,ribonucleoprotein complex binding,179,0,0.23,1.00000,1,1,0
MF,GO:0043022,ribosome binding,77,0,0.1,1.00000,1,1,0
MF,GO:0043027,cysteine-type endopeptidase inhibitor ac...,25,0,0.03,1.00000,1,1,0
MF,GO:0043028,cysteine-type endopeptidase regulator ac...,44,0,0.06,1.00000,1,1,0
MF,GO:0043130,ubiquitin binding,98,0,0.13,1.00000,1,1,0
MF,GO:0043177,organic acid binding,145,0,0.19,1.00000,1,1,0
MF,GO:0043225,ATPase-coupled inorganic anion transmemb...,28,0,0.04,1.00000,1,1,0
MF,GO:0043236,laminin binding,29,0,0.04,1.00000,1,1,0
MF,GO:0043274,phospholipase binding,24,0,0.03,1.00000,1,1,0
MF,GO:0043325,"phosphatidylinositol-3,4-bisphosphate bi...",29,0,0.04,1.00000,1,1,0
MF,GO:0043394,proteoglycan binding,39,0,0.05,1.00000,1,1,0
MF,GO:0043425,bHLH transcription factor binding,27,0,0.04,1.00000,1,1,0
MF,GO:0043495,protein-membrane adaptor activity,23,0,0.03,1.00000,1,1,0
MF,GO:0043531,ADP binding,47,0,0.06,1.00000,1,1,0
MF,GO:0043539,protein serine/threonine kinase activato...,48,0,0.06,1.00000,1,1,0
MF,GO:0043548,phosphatidylinositol 3-kinase binding,34,0,0.04,1.00000,1,1,0
MF,GO:0044183,protein folding chaperone,51,0,0.07,1.00000,1,1,0
MF,GO:0044389,ubiquitin-like protein ligase binding,368,0,0.48,1.00000,1,1,0
MF,GO:0044390,ubiquitin-like protein conjugating enzym...,44,0,0.06,1.00000,1,1,0
MF,GO:0044548,S100 protein binding,20,0,0.03,1.00000,1,1,0
MF,GO:0044594,17-beta-hydroxysteroid dehydrogenase (NA...,20,0,0.03,1.00000,1,1,0
MF,GO:0044769,"ATPase activity, coupled to transmembran...",24,0,0.03,1.00000,1,1,0
MF,GO:0045309,protein phosphorylated amino acid bindin...,57,0,0.07,1.00000,1,1,0
MF,GO:0045499,chemorepellent activity,28,0,0.04,1.00000,1,1,0
MF,GO:0046332,SMAD binding,82,0,0.11,1.00000,1,1,0
MF,GO:0046625,sphingolipid binding,30,0,0.04,1.00000,1,1,0
MF,GO:0046703,natural killer cell lectin-like receptor...,27,0,0.04,1.00000,1,1,0
MF,GO:0046875,ephrin receptor binding,28,0,0.04,1.00000,1,1,0
MF,GO:0046906,tetrapyrrole binding,163,0,0.21,1.00000,1,1,0
MF,GO:0046915,transition metal ion transmembrane trans...,47,0,0.06,1.00000,1,1,0
MF,GO:0046943,carboxylic acid transmembrane transporte...,169,0,0.22,1.00000,1,1,0
MF,GO:0046961,"proton-transporting ATPase activity, rot...",24,0,0.03,1.00000,1,1,0
MF,GO:0046966,thyroid hormone receptor binding,33,0,0.04,1.00000,1,1,0
MF,GO:0046977,TAP binding,50,0,0.07,1.00000,1,1,0
MF,GO:0046978,TAP1 binding,29,0,0.04,1.00000,1,1,0
MF,GO:0046979,TAP2 binding,20,0,0.03,1.00000,1,1,0
MF,GO:0046982,protein heterodimerization activity,337,0,0.44,1.00000,1,1,0
MF,GO:0047372,acylglycerol lipase activity,21,0,0.03,1.00000,1,1,0
MF,GO:0047485,protein N-terminus binding,129,0,0.17,1.00000,1,1,0
MF,GO:0047617,acyl-CoA hydrolase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0048018,receptor ligand activity,556,0,0.73,1.00000,1,1,0
MF,GO:0048019,receptor antagonist activity,32,0,0.04,1.00000,1,1,0
MF,GO:0048020,CCR chemokine receptor binding,75,0,0.1,1.00000,1,1,0
MF,GO:0048027,mRNA 5'-UTR binding,29,0,0.04,1.00000,1,1,0
MF,GO:0048029,monosaccharide binding,74,0,0.1,1.00000,1,1,0
MF,GO:0048038,quinone binding,23,0,0.03,1.00000,1,1,0
MF,GO:0048156,tau protein binding,46,0,0.06,1.00000,1,1,0
MF,GO:0048306,calcium-dependent protein binding,87,0,0.11,1.00000,1,1,0
MF,GO:0048487,beta-tubulin binding,42,0,0.05,1.00000,1,1,0
MF,GO:0048531,"beta-1,3-galactosyltransferase activity",22,0,0.03,1.00000,1,1,0
MF,GO:0050136,"NADH dehydrogenase (quinone) activity",58,0,0.08,1.00000,1,1,0
MF,GO:0050321,tau-protein kinase activity,22,0,0.03,1.00000,1,1,0
MF,GO:0050431,transforming growth factor beta binding,25,0,0.03,1.00000,1,1,0
MF,GO:0050660,flavin adenine dinucleotide binding,86,0,0.11,1.00000,1,1,0
MF,GO:0050661,"NADP binding",52,0,0.07,1.00000,1,1,0
MF,GO:0050699,WW domain binding,33,0,0.04,1.00000,1,1,0
MF,GO:0050750,low-density lipoprotein particle recepto...,23,0,0.03,1.00000,1,1,0
MF,GO:0050840,extracellular matrix binding,57,0,0.07,1.00000,1,1,0
MF,GO:0050997,quaternary ammonium group binding,39,0,0.05,1.00000,1,1,0
MF,GO:0051018,protein kinase A binding,55,0,0.07,1.00000,1,1,0
MF,GO:0051019,mitogen-activated protein kinase binding,25,0,0.03,1.00000,1,1,0
MF,GO:0051059,NF-kappaB binding,30,0,0.04,1.00000,1,1,0
MF,GO:0051082,unfolded protein binding,142,0,0.19,1.00000,1,1,0
MF,GO:0051087,chaperone binding,122,0,0.16,1.00000,1,1,0
MF,GO:0051119,sugar transmembrane transporter activity,31,0,0.04,1.00000,1,1,0
MF,GO:0051219,phosphoprotein binding,90,0,0.12,1.00000,1,1,0
MF,GO:0051287,"NAD binding",63,0,0.08,1.00000,1,1,0
MF,GO:0051393,alpha-actinin binding,29,0,0.04,1.00000,1,1,0
MF,GO:0051427,hormone receptor binding,33,0,0.04,1.00000,1,1,0
MF,GO:0051428,peptide hormone receptor binding,21,0,0.03,1.00000,1,1,0
MF,GO:0051536,iron-sulfur cluster binding,69,0,0.09,1.00000,1,1,0
MF,GO:0051537,"2 iron, 2 sulfur cluster binding",25,0,0.03,1.00000,1,1,0
MF,GO:0051539,"4 iron, 4 sulfur cluster binding",43,0,0.06,1.00000,1,1,0
MF,GO:0051540,metal cluster binding,69,0,0.09,1.00000,1,1,0
MF,GO:0051721,protein phosphatase 2A binding,36,0,0.05,1.00000,1,1,0
MF,GO:0051787,misfolded protein binding,47,0,0.06,1.00000,1,1,0
MF,GO:0051861,glycolipid binding,29,0,0.04,1.00000,1,1,0
MF,GO:0051879,Hsp90 protein binding,48,0,0.06,1.00000,1,1,0
MF,GO:0052650,"NADP-retinol dehydrogenase activity",23,0,0.03,1.00000,1,1,0
MF,GO:0052689,carboxylic ester hydrolase activity,169,0,0.22,1.00000,1,1,0
MF,GO:0052744,phosphatidylinositol monophosphate phosp...,22,0,0.03,1.00000,1,1,0
MF,GO:0052866,phosphatidylinositol phosphate phosphata...,39,0,0.05,1.00000,1,1,0
MF,GO:0055106,ubiquitin-protein transferase regulator ...,27,0,0.04,1.00000,1,1,0
MF,GO:0060229,lipase activator activity,21,0,0.03,1.00000,1,1,0
MF,GO:0061608,nuclear import signal receptor activity,22,0,0.03,1.00000,1,1,0
MF,GO:0061630,ubiquitin protein ligase activity,392,0,0.51,1.00000,1,1,0
MF,GO:0061659,ubiquitin-like protein ligase activity,404,0,0.53,1.00000,1,1,0
MF,GO:0061733,peptide-lysine-N-acetyltransferase activ...,50,0,0.07,1.00000,1,1,0
MF,GO:0061778,intracellular chloride channel activity,22,0,0.03,1.00000,1,1,0
MF,GO:0070001,aspartic-type peptidase activity,30,0,0.04,1.00000,1,1,0
MF,GO:0070003,threonine-type peptidase activity,41,0,0.05,1.00000,1,1,0
MF,GO:0070006,metalloaminopeptidase activity,27,0,0.04,1.00000,1,1,0
MF,GO:0070034,telomerase RNA binding,26,0,0.03,1.00000,1,1,0
MF,GO:0070122,isopeptidase activity,20,0,0.03,1.00000,1,1,0
MF,GO:0070182,DNA polymerase binding,22,0,0.03,1.00000,1,1,0
MF,GO:0070273,phosphatidylinositol-4-phosphate binding,31,0,0.04,1.00000,1,1,0
MF,GO:0070279,vitamin B6 binding,59,0,0.08,1.00000,1,1,0
MF,GO:0070300,phosphatidic acid binding,21,0,0.03,1.00000,1,1,0
MF,GO:0070330,aromatase activity,24,0,0.03,1.00000,1,1,0
MF,GO:0070412,R-SMAD binding,25,0,0.03,1.00000,1,1,0
MF,GO:0070530,K63-linked polyubiquitin modification-de...,28,0,0.04,1.00000,1,1,0
MF,GO:0070566,adenylyltransferase activity,31,0,0.04,1.00000,1,1,0
MF,GO:0070577,lysine-acetylated histone binding,27,0,0.04,1.00000,1,1,0
MF,GO:0070628,proteasome binding,29,0,0.04,1.00000,1,1,0
MF,GO:0070696,transmembrane receptor protein serine/th...,24,0,0.03,1.00000,1,1,0
MF,GO:0070717,poly-purine tract binding,29,0,0.04,1.00000,1,1,0
MF,GO:0070742,C2H2 zinc finger domain binding,22,0,0.03,1.00000,1,1,0
MF,GO:0070840,dynein complex binding,24,0,0.03,1.00000,1,1,0
MF,GO:0070851,growth factor receptor binding,145,0,0.19,1.00000,1,1,0
MF,GO:0070888,E-box binding,48,0,0.06,1.00000,1,1,0
MF,GO:0071617,lysophospholipid acyltransferase activit...,40,0,0.05,1.00000,1,1,0
MF,GO:0071813,lipoprotein particle binding,35,0,0.05,1.00000,1,1,0
MF,GO:0071814,protein-lipid complex binding,35,0,0.05,1.00000,1,1,0
MF,GO:0071855,neuropeptide receptor binding,38,0,0.05,1.00000,1,1,0
MF,GO:0071889,14-3-3 protein binding,38,0,0.05,1.00000,1,1,0
MF,GO:0071949,FAD binding,37,0,0.05,1.00000,1,1,0
MF,GO:0072341,modified amino acid binding,96,0,0.13,1.00000,1,1,0
MF,GO:0072349,modified amino acid transmembrane transp...,23,0,0.03,1.00000,1,1,0
MF,GO:0080025,"phosphatidylinositol-3,5-bisphosphate bi...",28,0,0.04,1.00000,1,1,0
MF,GO:0089720,caspase binding,22,0,0.03,1.00000,1,1,0
MF,GO:0090482,vitamin transmembrane transporter activi...,42,0,0.05,1.00000,1,1,0
MF,GO:0097001,ceramide binding,21,0,0.03,1.00000,1,1,0
MF,GO:0097110,scaffold protein binding,70,0,0.09,1.00000,1,1,0
MF,GO:0097472,cyclin-dependent protein kinase activity,30,0,0.04,1.00000,1,1,0
MF,GO:0097602,cullin family protein binding,27,0,0.04,1.00000,1,1,0
MF,GO:0097718,disordered domain specific binding,39,0,0.05,1.00000,1,1,0
MF,GO:0097747,RNA polymerase activity,53,0,0.07,1.00000,1,1,0
MF,GO:0098531,ligand-activated transcription factor ac...,57,0,0.07,1.00000,1,1,0
MF,GO:0098599,palmitoyl hydrolase activity,27,0,0.04,1.00000,1,1,0
MF,GO:0098631,cell adhesion mediator activity,59,0,0.08,1.00000,1,1,0
MF,GO:0098632,cell-cell adhesion mediator activity,49,0,0.06,1.00000,1,1,0
MF,GO:0099589,serotonin receptor activity,36,0,0.05,1.00000,1,1,0
MF,GO:0099602,neurotransmitter receptor regulator acti...,23,0,0.03,1.00000,1,1,0
MF,GO:0101005,deubiquitinase activity,118,0,0.15,1.00000,1,1,0
MF,GO:0106306,protein serine phosphatase activity,82,0,0.11,1.00000,1,1,0
MF,GO:0106307,protein threonine phosphatase activity,82,0,0.11,1.00000,1,1,0
MF,GO:0120013,lipid transfer activity,48,0,0.06,1.00000,1,1,0
MF,GO:0120014,phospholipid transfer activity,24,0,0.03,1.00000,1,1,0
MF,GO:0120015,sterol transfer activity,23,0,0.03,1.00000,1,1,0
MF,GO:0120020,cholesterol transfer activity,22,0,0.03,1.00000,1,1,0
MF,GO:0120227,acyl-CoA binding,25,0,0.03,1.00000,1,1,0
MF,GO:0140033,acetylation-dependent protein binding,27,0,0.04,1.00000,1,1,0
MF,GO:0140101,"catalytic activity, acting on a tRNA",155,0,0.2,1.00000,1,1,0
MF,GO:0140102,"catalytic activity, acting on a rRNA",23,0,0.03,1.00000,1,1,0
MF,GO:0140103,"catalytic activity, acting on a glycopro...",28,0,0.04,1.00000,1,1,0
MF,GO:0140104,molecular carrier activity,76,0,0.1,1.00000,1,1,0
MF,GO:0140142,nucleocytoplasmic carrier activity,33,0,0.04,1.00000,1,1,0
MF,GO:0140223,general transcription initiation factor ...,54,0,0.07,1.00000,1,1,0
MF,GO:0140272,exogenous protein binding,94,0,0.12,1.00000,1,1,0
MF,GO:0140296,general transcription initiation factor ...,51,0,0.07,1.00000,1,1,0
MF,GO:0140303,intramembrane lipid transporter activity,42,0,0.05,1.00000,1,1,0
MF,GO:0140312,cargo adaptor activity,22,0,0.03,1.00000,1,1,0
MF,GO:0140318,protein transporter activity,34,0,0.04,1.00000,1,1,0
MF,GO:0140323,solute:anion antiporter activity,34,0,0.04,1.00000,1,1,0
MF,GO:0140326,ATPase-coupled intramembrane lipid trans...,29,0,0.04,1.00000,1,1,0
MF,GO:0140358,P-type transmembrane transporter activit...,22,0,0.03,1.00000,1,1,0
MF,GO:0140359,ABC-type transporter activity,71,0,0.09,1.00000,1,1,0
MF,GO:0140375,immune receptor activity,323,0,0.42,1.00000,1,1,0
MF,GO:0140416,transcription regulator inhibitor activi...,27,0,0.04,1.00000,1,1,0
MF,GO:0140457,protein demethylase activity,29,0,0.04,1.00000,1,1,0
MF,GO:0140677,molecular function activator activity,161,0,0.21,1.00000,1,1,0
MF,GO:0150100,RNA binding involved in posttranscriptio...,261,0,0.34,1.00000,1,1,0
MF,GO:1901505,carbohydrate derivative transmembrane tr...,56,0,0.07,1.00000,1,1,0
MF,GO:1901567,fatty acid derivative binding,23,0,0.03,1.00000,1,1,0
MF,GO:1901618,organic hydroxy compound transmembrane t...,59,0,0.08,1.00000,1,1,0
MF,GO:1901681,sulfur compound binding,289,0,0.38,1.00000,1,1,0
MF,GO:1901682,sulfur compound transmembrane transporte...,62,0,0.08,1.00000,1,1,0
MF,GO:1901981,phosphatidylinositol phosphate binding,180,0,0.24,1.00000,1,1,0
MF,GO:1902936,phosphatidylinositol bisphosphate bindin...,112,0,0.15,1.00000,1,1,0
MF,GO:1903231,mRNA binding involved in posttranscripti...,261,0,0.34,1.00000,1,1,0
MF,GO:1904680,peptide transmembrane transporter activi...,34,0,0.04,1.00000,1,1,0
MF,GO:1990381,ubiquitin-specific protease binding,29,0,0.04,1.00000,1,1,0
MF,GO:1990756,ubiquitin ligase-substrate adaptor activ...,31,0,0.04,1.00000,1,1,0
MF,GO:1990782,protein tyrosine kinase binding,116,0,0.15,1.00000,1,1,0
MF,GO:1990841,promoter-specific chromatin binding,73,0,0.1,1.00000,1,1,0
CC,GO:0043005,neuron projection,1472,12,2.01,2.2e-07,1.397e-4,1.397e-4,5.97
CC,GO:0120025,plasma membrane bounded cell projection,2398,13,3.28,6.2e-06,0.0039369999999999995,0.0019684999999999998,3.96
CC,GO:0042995,cell projection,2511,13,3.44,1.0e-05,0.006350000000000001,0.002116666666666667,3.78
CC,GO:0030054,cell junction,2282,11,3.12,0.00013,0.08255,0.0206375,3.53
CC,GO:0034703,cation channel complex,222,4,0.3,0.00023,0.14605,0.02778125,13.33
CC,GO:0030424,axon,696,6,0.95,0.00031,0.19685,0.02778125,6.32
CC,GO:0120111,neuron projection cytoplasm,97,3,0.13,0.00031,0.19685,0.02778125,23.08
CC,GO:0098858,actin-based cell projection,249,4,0.34,0.00035,0.22225,0.02778125,11.76
CC,GO:0045202,synapse,1456,8,1.99,0.00058,0.3683,0.04092222222222222,4.02
CC,GO:0034702,ion channel complex,307,4,0.42,0.00078,0.4953,0.04953,9.52
CC,GO:0008328,ionotropic glutamate receptor complex,40,2,0.05,0.00137,0.8699499999999999,0.0790575,40
CC,GO:0098878,neurotransmitter receptor complex,42,2,0.06,0.00151,0.9588500000000001,0.0790575,33.33
CC,GO:1902495,transmembrane transporter complex,406,4,0.56,0.00217,1,0.0790575,7.14
CC,GO:0030425,dendrite,685,5,0.94,0.00219,1,0.0790575,5.32
CC,GO:0097447,dendritic tree,687,5,0.94,0.00222,1,0.0790575,5.32
CC,GO:0098794,postsynapse,695,5,0.95,0.00233,1,0.0790575,5.26
CC,GO:0043228,non-membrane-bounded organelle,6024,16,8.25,0.00243,1,0.0790575,1.94
CC,GO:0043232,intracellular non-membrane-bounded organ...,6024,16,8.25,0.00243,1,0.0790575,1.94
CC,GO:1990351,transporter complex,421,4,0.58,0.00248,1,0.0790575,6.9
CC,GO:0015630,microtubule cytoskeleton,1412,7,1.93,0.00249,1,0.0790575,3.63
CC,GO:1904115,axon cytoplasm,66,2,0.09,0.00368,1,0.11127619047619047,22.22
CC,GO:0032838,plasma membrane bounded cell projection ...,235,3,0.32,0.00399,1,0.11516590909090908,9.38
CC,GO:0016529,sarcoplasmic reticulum,71,2,0.1,0.00424,1,0.11706086956521738,20
CC,GO:0016528,sarcoplasm,80,2,0.11,0.00536,1,0.13530384615384616,18.18
CC,GO:0000792,heterochromatin,81,2,0.11,0.00549,1,0.13530384615384616,18.18
CC,GO:0099513,polymeric cytoskeletal fiber,851,5,1.16,0.00554,1,0.13530384615384616,4.31
CC,GO:0043235,receptor complex,543,4,0.74,0.00613,1,0.14012333333333335,5.41
CC,GO:0099568,cytoplasmic region,280,3,0.38,0.00649,1,0.14012333333333335,7.89
CC,GO:0009925,basal plasma membrane,282,3,0.39,0.00662,1,0.14012333333333335,7.69
CC,GO:0005815,microtubule organizing center,888,5,1.22,0.00662,1,0.14012333333333335,4.1
CC,GO:0031984,organelle subcompartment,1709,7,2.34,0.00715,1,0.14269861111111112,2.99
CC,GO:0005604,basement membrane,96,2,0.13,0.00763,1,0.14269861111111112,15.38
CC,GO:0036477,somatodendritic compartment,921,5,1.26,0.00770,1,0.14269861111111112,3.97
CC,GO:0045178,basal part of cell,301,3,0.41,0.00792,1,0.14269861111111112,7.32
CC,GO:0045211,postsynaptic membrane,303,3,0.41,0.00806,1,0.14269861111111112,7.32
CC,GO:0098839,postsynaptic density membrane,99,2,0.14,0.00809,1,0.14269861111111112,14.29
CC,GO:0016605,PML body,119,2,0.16,0.01152,1,0.19233444444444445,12.5
CC,GO:0005884,actin filament,120,2,0.16,0.01170,1,0.19233444444444445,12.5
CC,GO:0030175,filopodium,124,2,0.17,0.01246,1,0.19233444444444445,11.76
CC,GO:0014069,postsynaptic density,359,3,0.49,0.01276,1,0.19233444444444445,6.12
CC,GO:0034451,centriolar satellite,127,2,0.17,0.01303,1,0.19233444444444445,11.76
CC,GO:0099080,supramolecular complex,1468,6,2.01,0.01322,1,0.19233444444444445,2.99
CC,GO:0032279,asymmetric synapse,364,3,0.5,0.01324,1,0.19233444444444445,6
CC,GO:0099634,postsynaptic specialization membrane,129,2,0.18,0.01343,1,0.19233444444444445,11.11
CC,GO:0098978,glutamatergic synapse,368,3,0.5,0.01363,1,0.19233444444444445,6
CC,GO:0005694,chromosome,1965,7,2.69,0.01489,1,0.20456960784313727,2.6
CC,GO:0098687,chromosomal region,386,3,0.53,0.01548,1,0.20456960784313727,5.66
CC,GO:0099572,postsynaptic specialization,387,3,0.53,0.01558,1,0.20456960784313727,5.66
CC,GO:0099512,supramolecular fiber,1103,5,1.51,0.01597,1,0.20456960784313727,3.31
CC,GO:0098984,neuron to neuron synapse,392,3,0.54,0.01612,1,0.20456960784313727,5.56
CC,GO:0099081,supramolecular polymer,1111,5,1.52,0.01643,1,0.20456960784313727,3.29
CC,GO:0005856,cytoskeleton,2522,8,3.45,0.01741,1,0.2126028846153846,2.32
CC,GO:0097060,synaptic membrane,414,3,0.57,0.01862,1,0.22308867924528306,5.26
CC,GO:0042734,presynaptic membrane,159,2,0.22,0.01992,1,0.2304472727272727,9.09
CC,GO:0032991,protein-containing complex,6053,14,8.29,0.01996,1,0.2304472727272727,1.69
CC,GO:0140535,intracellular protein-containing complex,818,4,1.12,0.02442,1,0.27690535714285713,3.57
CC,GO:0005874,microtubule,466,3,0.64,0.02535,1,0.28240789473684214,4.69
CC,GO:0098797,plasma membrane protein complex,840,4,1.15,0.02660,1,0.28704152542372885,3.48
CC,GO:0000781,"chromosome, telomeric region",186,2,0.25,0.02667,1,0.28704152542372885,8
CC,GO:0042827,platelet dense granule,21,1,0.03,0.02837,1,0.2923930769230769,33.33
CC,GO:0043197,dendritic spine,197,2,0.27,0.02965,1,0.2923930769230769,7.41
CC,GO:0005721,pericentric heterochromatin,22,1,0.03,0.02970,1,0.2923930769230769,33.33
CC,GO:0016442,RISC complex,22,1,0.03,0.02970,1,0.2923930769230769,33.33
CC,GO:0031332,RNAi effector complex,22,1,0.03,0.02970,1,0.2923930769230769,33.33
CC,GO:0044309,neuron spine,198,2,0.27,0.02993,1,0.2923930769230769,7.41
CC,GO:0035371,microtubule plus-end,23,1,0.03,0.03103,1,0.29854621212121213,33.33
CC,GO:0005868,cytoplasmic dynein complex,24,1,0.03,0.03236,1,0.2996353333333333,33.33
CC,GO:0005654,nucleoplasm,4545,11,6.22,0.03272,1,0.2996353333333333,1.77
CC,GO:0000785,chromatin,1339,5,1.83,0.03364,1,0.2996353333333333,2.73
CC,GO:0000775,"chromosome, centromeric region",214,2,0.29,0.03451,1,0.2996353333333333,6.9
CC,GO:0005911,cell-cell junction,526,3,0.72,0.03454,1,0.2996353333333333,4.17
CC,GO:0005789,endoplasmic reticulum membrane,1352,5,1.85,0.03487,1,0.2996353333333333,2.7
CC,GO:0034706,sodium channel complex,26,1,0.04,0.03501,1,0.2996353333333333,25
CC,GO:0098827,endoplasmic reticulum subcompartment,1356,5,1.86,0.03525,1,0.2996353333333333,2.69
CC,GO:0070161,anchoring junction,919,4,1.26,0.03539,1,0.2996353333333333,3.17
CC,GO:0098590,plasma membrane region,1370,5,1.88,0.03662,1,0.3052123376623377,2.66
CC,GO:0042175,nuclear outer membrane-endoplasmic retic...,1374,5,1.88,0.03701,1,0.3052123376623377,2.66
CC,GO:0005963,magnesium-dependent protein serine/threo...,28,1,0.04,0.03765,1,0.3065096153846154,25
CC,GO:0031974,membrane-enclosed lumen,6611,14,9.05,0.04176,1,0.32737777777777777,1.55
CC,GO:0043233,organelle lumen,6611,14,9.05,0.04176,1,0.32737777777777777,1.55
CC,GO:0070013,intracellular organelle lumen,6611,14,9.05,0.04176,1,0.32737777777777777,1.55
CC,GO:0031981,nuclear lumen,5350,12,7.32,0.04281,1,0.33151646341463414,1.64
CC,GO:0000803,sex chromosome,33,1,0.05,0.04423,1,0.33435773809523806,20
CC,GO:1990752,microtubule end,33,1,0.05,0.04423,1,0.33435773809523806,20
CC,GO:0090543,Flemming body,35,1,0.05,0.04685,1,0.34999705882352944,20
CC,GO:0016323,basolateral plasma membrane,256,2,0.35,0.04772,1,0.35143965517241377,5.71
CC,GO:0032839,dendrite cytoplasm,36,1,0.05,0.04815,1,0.35143965517241377,20
CC,GO:1990391,DNA repair complex,37,1,0.05,0.04946,1,0.3568988636363636,20
CC,GO:0098796,membrane protein complex,1506,5,2.06,0.05163,1,0.360463829787234,2.43
CC,GO:0000791,euchromatin,39,1,0.05,0.05206,1,0.360463829787234,20
CC,GO:0031672,A band,39,1,0.05,0.05206,1,0.360463829787234,20
CC,GO:0031012,extracellular matrix,625,3,0.86,0.05302,1,0.360463829787234,3.49
CC,GO:0030312,external encapsulating structure,626,3,0.86,0.05322,1,0.360463829787234,3.49
CC,GO:0033017,sarcoplasmic reticulum membrane,40,1,0.05,0.05336,1,0.360463829787234,20
CC,GO:0071944,cell periphery,7498,15,10.26,0.05399,1,0.3608805263157895,1.46
CC,GO:0005891,voltage-gated calcium channel complex,44,1,0.06,0.05855,1,0.3872838541666666,16.67
CC,GO:0016020,membrane,11162,20,15.28,0.06056,1,0.39209646464646464,1.31
CC,GO:0032040,small-subunit processome,46,1,0.06,0.06113,1,0.39209646464646464,16.67
CC,GO:1902555,endoribonuclease complex,46,1,0.06,0.06113,1,0.39209646464646464,16.67
CC,GO:0005813,centrosome,667,3,0.91,0.06205,1,0.39401749999999996,3.3
CC,GO:0005886,plasma membrane,6972,14,9.54,0.06335,1,0.3982896039603961,1.47
CC,GO:0005887,integral component of plasma membrane,2123,6,2.91,0.06449,1,0.400666504854369,2.06
CC,GO:0099061,integral component of postsynaptic densi...,49,1,0.07,0.06499,1,0.400666504854369,14.29
CC,GO:0150034,distal axon,308,2,0.42,0.06618,1,0.40077571428571424,4.76
CC,GO:0014704,intercalated disc,50,1,0.07,0.06627,1,0.40077571428571424,14.29
CC,GO:0098802,plasma membrane signaling receptor compl...,310,2,0.42,0.06693,1,0.40094858490566043,4.76
CC,GO:0043209,myelin sheath,52,1,0.07,0.06883,1,0.40469490740740743,14.29
CC,GO:0099146,intrinsic component of postsynaptic dens...,52,1,0.07,0.06883,1,0.40469490740740743,14.29
CC,GO:0005938,cell cortex,322,2,0.44,0.07151,1,0.4148310924369748,4.55
CC,GO:0030286,dynein complex,56,1,0.08,0.07393,1,0.4148310924369748,12.5
CC,GO:0005802,trans-Golgi network,330,2,0.45,0.07461,1,0.4148310924369748,4.44
CC,GO:0001772,immunological synapse,57,1,0.08,0.07520,1,0.4148310924369748,12.5
CC,GO:0016459,myosin complex,57,1,0.08,0.07520,1,0.4148310924369748,12.5
CC,GO:0032420,stereocilium,57,1,0.08,0.07520,1,0.4148310924369748,12.5
CC,GO:0031226,intrinsic component of plasma membrane,2210,6,3.03,0.07546,1,0.4148310924369748,1.98
CC,GO:0099503,secretory vesicle,1189,4,1.63,0.07705,1,0.4148310924369748,2.45
CC,GO:0008287,protein serine/threonine phosphatase com...,59,1,0.08,0.07774,1,0.4148310924369748,12.5
CC,GO:0043195,terminal bouton,59,1,0.08,0.07774,1,0.4148310924369748,12.5
CC,GO:1903293,phosphatase complex,59,1,0.08,0.07774,1,0.4148310924369748,12.5
CC,GO:0005783,endoplasmic reticulum,2259,6,3.09,0.08210,1,0.43444583333333336,1.94
CC,GO:0032421,stereocilium bundle,64,1,0.09,0.08405,1,0.44108884297520656,11.11
CC,GO:0005844,polysome,67,1,0.09,0.08782,1,0.4502404,11.11
CC,GO:0016328,lateral plasma membrane,67,1,0.09,0.08782,1,0.4502404,11.11
CC,GO:0031410,cytoplasmic vesicle,2869,7,3.93,0.08824,1,0.4502404,1.78
CC,GO:0097708,intracellular vesicle,2872,7,3.93,0.08863,1,0.4502404,1.78
CC,GO:0005637,nuclear inner membrane,69,1,0.09,0.09032,1,0.45518412698412697,11.11
CC,GO:0031594,neuromuscular junction,73,1,0.1,0.09531,1,0.46097180451127817,10
CC,GO:0034704,calcium channel complex,73,1,0.1,0.09531,1,0.46097180451127817,10
CC,GO:0044304,main axon,73,1,0.1,0.09531,1,0.46097180451127817,10
CC,GO:0045121,membrane raft,382,2,0.52,0.09580,1,0.46097180451127817,3.85
CC,GO:0098857,membrane microdomain,382,2,0.52,0.09580,1,0.46097180451127817,3.85
CC,GO:0001725,stress fiber,74,1,0.1,0.09655,1,0.46097180451127817,10
CC,GO:0097517,contractile actin filament bundle,74,1,0.1,0.09655,1,0.46097180451127817,10
CC,GO:0000118,histone deacetylase complex,75,1,0.1,0.09779,1,0.4634078358208955,10
CC,GO:0005881,cytoplasmic microtubule,76,1,0.1,0.09903,1,0.46580777777777777,10
CC,GO:0099060,integral component of postsynaptic speci...,78,1,0.11,0.10150,1,0.4739154411764706,9.09
CC,GO:0044291,cell-cell contact zone,80,1,0.11,0.10397,1,0.48190474452554743,9.09
CC,GO:0098948,intrinsic component of postsynaptic spec...,81,1,0.11,0.10520,1,0.4840724637681159,9.09
CC,GO:0016324,apical plasma membrane,406,2,0.56,0.10611,1,0.4847471223021583,3.57
CC,GO:0032432,actin filament bundle,83,1,0.11,0.10766,1,0.4848517730496454,9.09
CC,GO:0042641,actomyosin,83,1,0.11,0.10766,1,0.4848517730496454,9.09
CC,GO:0030684,preribosome,88,1,0.12,0.11377,1,0.5052024475524476,8.33
CC,GO:0098685,Schaffer collateral - CA1 synapse,88,1,0.12,0.11377,1,0.5052024475524476,8.33
CC,GO:0034705,potassium channel complex,93,1,0.13,0.11985,1,0.5285052083333334,7.69
CC,GO:0001750,photoreceptor outer segment,96,1,0.13,0.12347,1,0.5407134482758621,7.69
CC,GO:0005667,transcription regulator complex,450,2,0.62,0.12575,1,0.5451928571428571,3.23
CC,GO:0031252,cell leading edge,451,2,0.62,0.12621,1,0.5451928571428571,3.23
CC,GO:0062023,collagen-containing extracellular matrix,455,2,0.62,0.12804,1,0.5466966442953021,3.23
CC,GO:0005902,microvillus,100,1,0.14,0.12828,1,0.5466966442953021,7.14
CC,GO:0070603,SWI/SNF superfamily-type complex,101,1,0.14,0.12948,1,0.5481320000000001,7.14
CC,GO:1904949,ATPase complex,102,1,0.14,0.13068,1,0.549548344370861,7.14
CC,GO:0035578,azurophil granule lumen,106,1,0.15,0.13545,1,0.565860197368421,6.67
CC,GO:0045177,apical part of cell,475,2,0.65,0.13728,1,0.5697568627450982,3.08
CC,GO:0005925,focal adhesion,479,2,0.66,0.13915,1,0.5737678571428572,3.03
CC,GO:0098791,Golgi apparatus subcompartment,481,2,0.66,0.14008,1,0.573876129032258,3.03
CC,GO:0030055,cell-substrate junction,486,2,0.67,0.14243,1,0.579763141025641,2.99
CC,GO:0016604,nuclear body,973,3,1.33,0.14654,1,0.5926936305732484,2.26
CC,GO:0000932,P-body,117,1,0.16,0.14845,1,0.5956619496855345,6.25
CC,GO:0005730,nucleolus,1512,4,2.07,0.14915,1,0.5956619496855345,1.93
CC,GO:1902494,catalytic complex,1523,4,2.08,0.15197,1,0.6031309375,1.92
CC,GO:0005635,nuclear envelope,513,2,0.7,0.15524,1,0.6122819875776397,2.86
CC,GO:0030141,secretory granule,1005,3,1.38,0.15695,1,0.6138711309523809,2.17
CC,GO:0097733,photoreceptor cell cilium,125,1,0.17,0.15778,1,0.6138711309523809,5.88
CC,GO:0016363,nuclear matrix,128,1,0.18,0.16125,1,0.6138711309523809,5.56
CC,GO:0042470,melanosome,128,1,0.18,0.16125,1,0.6138711309523809,5.56
CC,GO:0048770,pigment granule,128,1,0.18,0.16125,1,0.6138711309523809,5.56
CC,GO:0043679,axon terminus,129,1,0.18,0.16241,1,0.6138711309523809,5.56
CC,GO:0099055,integral component of postsynaptic membr...,129,1,0.18,0.16241,1,0.6138711309523809,5.56
CC,GO:0005923,bicellular tight junction,130,1,0.18,0.16356,1,0.6145597633136095,5.56
CC,GO:0015629,actin cytoskeleton,535,2,0.73,0.16585,1,0.6194985294117648,2.74
CC,GO:0030133,transport vesicle,539,2,0.74,0.16780,1,0.6208232558139535,2.7
CC,GO:0098936,intrinsic component of postsynaptic memb...,134,1,0.18,0.16816,1,0.6208232558139535,5.56
CC,GO:0097731,9+0 non-motile cilium,136,1,0.19,0.17045,1,0.6256401734104046,5.26
CC,GO:0070160,tight junction,137,1,0.19,0.17159,1,0.6262048850574712,5.26
CC,GO:0030018,Z disc,138,1,0.19,0.17273,1,0.6267631428571429,5.26
CC,GO:0098793,presynapse,552,2,0.76,0.17414,1,0.6282892045454544,2.63
CC,GO:0005634,nucleus,8809,15,12.06,0.18097,1,0.6467978142076504,1.24
CC,GO:0031982,vesicle,4734,9,6.48,0.18239,1,0.6467978142076504,1.39
CC,GO:0044306,neuron projection terminus,148,1,0.2,0.18406,1,0.6467978142076504,5
CC,GO:0031674,I band,149,1,0.2,0.18518,1,0.6467978142076504,5
CC,GO:0042383,sarcolemma,149,1,0.2,0.18518,1,0.6467978142076504,5
CC,GO:0034399,nuclear periphery,150,1,0.21,0.18631,1,0.6467978142076504,4.76
CC,GO:0009986,cell surface,1092,3,1.49,0.18640,1,0.6467978142076504,2.01
CC,GO:0043296,apical junction complex,153,1,0.21,0.18967,1,0.6478358288770053,4.76
CC,GO:0000779,"condensed chromosome, centromeric region",154,1,0.21,0.19078,1,0.6478358288770053,4.76
CC,GO:0005777,peroxisome,154,1,0.21,0.19078,1,0.6478358288770053,4.76
CC,GO:0042579,microbody,154,1,0.21,0.19078,1,0.6478358288770053,4.76
CC,GO:0099699,integral component of synaptic membrane,163,1,0.22,0.20077,1,0.6781327127659574,4.55
CC,GO:0005875,microtubule associated complex,170,1,0.23,0.20846,1,0.6930337628865979,4.35
CC,GO:0005766,primary lysosome,172,1,0.24,0.21064,1,0.6930337628865979,4.17
CC,GO:0042582,azurophil granule,172,1,0.24,0.21064,1,0.6930337628865979,4.17
CC,GO:0043204,perikaryon,172,1,0.24,0.21064,1,0.6930337628865979,4.17
CC,GO:0097730,non-motile cilium,172,1,0.24,0.21064,1,0.6930337628865979,4.17
CC,GO:0098862,cluster of actin-based cell projections,173,1,0.24,0.21173,1,0.6930337628865979,4.17
CC,GO:0099240,intrinsic component of synaptic membrane,176,1,0.24,0.21499,1,0.7000956410256409,4.17
CC,GO:0000922,spindle pole,178,1,0.24,0.21715,1,0.7035216836734695,4.17
CC,GO:0009898,cytoplasmic side of plasma membrane,184,1,0.25,0.22361,1,0.7205646464646465,4
CC,GO:0005912,adherens junction,185,1,0.25,0.22468,1,0.7205646464646465,4
CC,GO:0030426,growth cone,187,1,0.26,0.22682,1,0.7237723618090453,3.85
CC,GO:0031225,anchored component of membrane,189,1,0.26,0.22896,1,0.7269479999999999,3.85
CC,GO:0030427,site of polarized growth,193,1,0.26,0.23321,1,0.7364428217821782,3.85
CC,GO:0001726,ruffle,194,1,0.27,0.23427,1,0.7364428217821782,3.7
CC,GO:0030496,midbody,203,1,0.28,0.24373,1,0.7624066502463055,3.57
CC,GO:0005775,vacuolar lumen,207,1,0.28,0.24790,1,0.7678853658536586,3.57
CC,GO:0032993,protein-DNA complex,207,1,0.28,0.24790,1,0.7678853658536586,3.57
CC,GO:0098562,cytoplasmic side of membrane,213,1,0.29,0.25412,1,0.7833310679611651,3.45
CC,GO:0030017,sarcomere,223,1,0.31,0.26437,1,0.8109900966183574,3.23
CC,GO:0008021,synaptic vesicle,226,1,0.31,0.26742,1,0.8164024038461538,3.23
CC,GO:0005576,extracellular region,5248,9,7.18,0.27821,1,0.8452791866028709,1.25
CC,GO:0030016,myofibril,243,1,0.33,0.28446,1,0.860152857142857,3.03
CC,GO:0070382,exocytic vesicle,245,1,0.34,0.28644,1,0.8620350710900473,2.94
CC,GO:0012505,endomembrane system,5310,9,7.27,0.29087,1,0.8638048387096774,1.24
CC,GO:0000228,nuclear chromosome,250,1,0.34,0.29136,1,0.8638048387096774,2.94
CC,GO:0055037,recycling endosome,251,1,0.34,0.29234,1,0.8638048387096774,2.94
CC,GO:0043292,contractile fiber,252,1,0.34,0.29332,1,0.8638048387096774,2.94
CC,GO:0000793,condensed chromosome,253,1,0.35,0.29430,1,0.8638048387096774,2.86
CC,GO:0048471,perinuclear region of cytoplasm,791,2,1.08,0.29519,1,0.8638048387096774,1.85
CC,GO:0031224,intrinsic component of membrane,6739,11,9.22,0.30050,1,0.8753096330275228,1.19
CC,GO:0005882,intermediate filament,268,1,0.37,0.30883,1,0.8954659817351598,2.7
CC,GO:1990904,ribonucleoprotein complex,823,2,1.13,0.31156,1,0.8992754545454545,1.77
CC,GO:0005737,cytoplasm,13276,20,18.17,0.31390,1,0.8997263513513513,1.1
CC,GO:0036464,cytoplasmic ribonucleoprotein granule,274,1,0.38,0.31455,1,0.8997263513513513,2.63
CC,GO:0030659,cytoplasmic vesicle membrane,1460,3,2,0.32279,1,0.9191553811659193,1.5
CC,GO:0012506,vesicle membrane,1480,3,2.03,0.33047,1,0.9368234374999999,1.48
CC,GO:0035770,ribonucleoprotein granule,294,1,0.4,0.33332,1,0.9407031111111112,2.5
CC,GO:0000323,lytic vacuole,875,2,1.2,0.33803,1,0.9455905286343613,1.67
CC,GO:0005764,lysosome,875,2,1.2,0.33803,1,0.9455905286343613,1.67
CC,GO:0030666,endocytic vesicle membrane,311,1,0.43,0.34887,1,0.9673906113537118,2.33
CC,GO:0045111,intermediate filament cytoskeleton,311,1,0.43,0.34887,1,0.9673906113537118,2.33
CC,GO:0030658,transport vesicle membrane,324,1,0.44,0.36053,1,0.9916674568965519,2.27
CC,GO:0005770,late endosome,326,1,0.45,0.36231,1,0.9916674568965519,2.22
CC,GO:0031965,nuclear membrane,326,1,0.45,0.36231,1,0.9916674568965519,2.22
CC,GO:0005773,vacuole,980,2,1.34,0.39060,1,1,1.49
CC,GO:0034774,secretory granule lumen,375,1,0.51,0.40436,1,1,1.96
CC,GO:0016021,integral component of membrane,6550,10,8.97,0.40582,1,1,1.11
CC,GO:0060205,cytoplasmic vesicle lumen,378,1,0.52,0.40684,1,1,1.92
CC,GO:0030667,secretory granule membrane,380,1,0.52,0.40849,1,1,1.92
CC,GO:0031983,vesicle lumen,380,1,0.52,0.40849,1,1,1.92
CC,GO:0031253,cell projection membrane,381,1,0.52,0.40932,1,1,1.92
CC,GO:0005829,cytosol,5896,9,8.07,0.41786,1,1,1.12
CC,GO:0043231,intracellular membrane-bounded organelle,13894,20,19.02,0.43437,1,1,1.05
CC,GO:0005819,spindle,422,1,0.58,0.44216,1,1,1.72
CC,GO:0070062,extracellular exosome,2523,4,3.45,0.45934,1,1,1.16
CC,GO:0005622,intracellular anatomical structure,16937,24,23.18,0.46124,1,1,1.04
CC,GO:0030139,endocytic vesicle,464,1,0.64,0.47397,1,1,1.56
CC,GO:0005794,Golgi apparatus,1862,3,2.55,0.47490,1,1,1.18
CC,GO:1903561,extracellular vesicle,2619,4,3.59,0.48959,1,1,1.11
CC,GO:0043230,extracellular organelle,2621,4,3.59,0.49021,1,1,1.11
CC,GO:0065010,extracellular membrane-bounded organelle,2621,4,3.59,0.49021,1,1,1.11
CC,GO:0005615,extracellular space,4065,6,5.56,0.49194,1,1,1.08
CC,GO:0005768,endosome,1225,2,1.68,0.50577,1,1,1.19
CC,GO:0005769,early endosome,511,1,0.7,0.50749,1,1,1.43
CC,GO:0005759,mitochondrial matrix,516,1,0.71,0.51094,1,1,1.41
CC,GO:0043025,neuronal cell body,536,1,0.73,0.52447,1,1,1.37
CC,GO:0043229,intracellular organelle,15069,21,20.63,0.52988,1,1,1.02
CC,GO:0140513,nuclear protein-containing complex,1302,2,1.78,0.53921,1,1,1.12
CC,GO:0031967,organelle envelope,1345,2,1.84,0.55723,1,1,1.09
CC,GO:0031975,envelope,1345,2,1.84,0.55723,1,1,1.09
CC,GO:0043227,membrane-bounded organelle,15204,21,20.81,0.55918,1,1,1.01
CC,GO:0019866,organelle inner membrane,615,1,0.84,0.57449,1,1,1.19
CC,GO:0044297,cell body,618,1,0.85,0.57628,1,1,1.18
CC,GO:0043226,organelle,16116,22,22.06,0.60356,1,1,1
CC,GO:0005929,cilium,720,1,0.99,0.63315,1,1,1.01
CC,GO:0098552,side of membrane,813,1,1.11,0.67852,1,1,0.9
CC,GO:0031090,organelle membrane,4170,5,5.71,0.70076,1,1,0.88
CC,GO:0110165,cellular anatomical entity,21736,30,29.75,0.78069,1,1,1.01
CC,GO:0098588,bounding membrane of organelle,2470,2,3.38,0.86705,1,1,0.59
CC,GO:0005739,mitochondrion,1811,1,2.48,0.92492,1,1,0.4
CC,GO:0005575,cellular_component,21916,30,30,1.00000,1,1,1
CC,GO:0000123,histone acetyltransferase complex,82,0,0.11,1.00000,1,1,0
CC,GO:0000124,SAGA complex,24,0,0.03,1.00000,1,1,0
CC,GO:0000137,Golgi cis cisterna,44,0,0.06,1.00000,1,1,0
CC,GO:0000139,Golgi membrane,767,0,1.05,1.00000,1,1,0
CC,GO:0000151,ubiquitin ligase complex,319,0,0.44,1.00000,1,1,0
CC,GO:0000152,nuclear ubiquitin ligase complex,48,0,0.07,1.00000,1,1,0
CC,GO:0000242,pericentriolar material,23,0,0.03,1.00000,1,1,0
CC,GO:0000307,cyclin-dependent protein kinase holoenzy...,43,0,0.06,1.00000,1,1,0
CC,GO:0000313,organellar ribosome,94,0,0.13,1.00000,1,1,0
CC,GO:0000314,organellar small ribosomal subunit,36,0,0.05,1.00000,1,1,0
CC,GO:0000315,organellar large ribosomal subunit,56,0,0.08,1.00000,1,1,0
CC,GO:0000407,phagophore assembly site,35,0,0.05,1.00000,1,1,0
CC,GO:0000421,autophagosome membrane,44,0,0.06,1.00000,1,1,0
CC,GO:0000428,DNA-directed RNA polymerase complex,123,0,0.17,1.00000,1,1,0
CC,GO:0000439,transcription factor TFIIH core complex,21,0,0.03,1.00000,1,1,0
CC,GO:0000502,proteasome complex,79,0,0.11,1.00000,1,1,0
CC,GO:0000776,kinetochore,144,0,0.2,1.00000,1,1,0
CC,GO:0000786,nucleosome,112,0,0.15,1.00000,1,1,0
CC,GO:0000794,condensed nuclear chromosome,75,0,0.1,1.00000,1,1,0
CC,GO:0000795,synaptonemal complex,43,0,0.06,1.00000,1,1,0
CC,GO:0001533,cornified envelope,52,0,0.07,1.00000,1,1,0
CC,GO:0001650,fibrillar center,168,0,0.23,1.00000,1,1,0
CC,GO:0001669,acrosomal vesicle,130,0,0.18,1.00000,1,1,0
CC,GO:0001891,phagocytic cup,40,0,0.05,1.00000,1,1,0
CC,GO:0001917,photoreceptor inner segment,64,0,0.09,1.00000,1,1,0
CC,GO:0001931,uropod,20,0,0.03,1.00000,1,1,0
CC,GO:0002080,acrosomal membrane,29,0,0.04,1.00000,1,1,0
CC,GO:0002102,podosome,33,0,0.05,1.00000,1,1,0
CC,GO:0005581,collagen trimer,93,0,0.13,1.00000,1,1,0
CC,GO:0005640,nuclear outer membrane,29,0,0.04,1.00000,1,1,0
CC,GO:0005643,nuclear pore,86,0,0.12,1.00000,1,1,0
CC,GO:0005657,replication fork,61,0,0.08,1.00000,1,1,0
CC,GO:0005669,transcription factor TFIID complex,42,0,0.06,1.00000,1,1,0
CC,GO:0005675,transcription factor TFIIH holo complex,22,0,0.03,1.00000,1,1,0
CC,GO:0005680,anaphase-promoting complex,21,0,0.03,1.00000,1,1,0
CC,GO:0005681,spliceosomal complex,226,0,0.31,1.00000,1,1,0
CC,GO:0005682,U5 snRNP,23,0,0.03,1.00000,1,1,0
CC,GO:0005684,U2-type spliceosomal complex,114,0,0.16,1.00000,1,1,0
CC,GO:0005685,U1 snRNP,33,0,0.05,1.00000,1,1,0
CC,GO:0005686,U2 snRNP,23,0,0.03,1.00000,1,1,0
CC,GO:0005687,U4 snRNP,28,0,0.04,1.00000,1,1,0
CC,GO:0005688,U6 snRNP,23,0,0.03,1.00000,1,1,0
CC,GO:0005689,U12-type spliceosomal complex,28,0,0.04,1.00000,1,1,0
CC,GO:0005697,telomerase holoenzyme complex,22,0,0.03,1.00000,1,1,0
CC,GO:0005732,sno(s)RNA-containing ribonucleoprotein c...,31,0,0.04,1.00000,1,1,0
CC,GO:0005736,RNA polymerase I complex,20,0,0.03,1.00000,1,1,0
CC,GO:0005740,mitochondrial envelope,859,0,1.18,1.00000,1,1,0
CC,GO:0005741,mitochondrial outer membrane,215,0,0.29,1.00000,1,1,0
CC,GO:0005742,mitochondrial outer membrane translocase...,22,0,0.03,1.00000,1,1,0
CC,GO:0005743,mitochondrial inner membrane,547,0,0.75,1.00000,1,1,0
CC,GO:0005746,mitochondrial respirasome,104,0,0.14,1.00000,1,1,0
CC,GO:0005747,mitochondrial respiratory chain complex ...,63,0,0.09,1.00000,1,1,0
CC,GO:0005751,mitochondrial respiratory chain complex ...,20,0,0.03,1.00000,1,1,0
CC,GO:0005753,mitochondrial proton-transporting ATP sy...,20,0,0.03,1.00000,1,1,0
CC,GO:0005758,mitochondrial intermembrane space,89,0,0.12,1.00000,1,1,0
CC,GO:0005761,mitochondrial ribosome,94,0,0.13,1.00000,1,1,0
CC,GO:0005762,mitochondrial large ribosomal subunit,56,0,0.08,1.00000,1,1,0
CC,GO:0005763,mitochondrial small ribosomal subunit,36,0,0.05,1.00000,1,1,0
CC,GO:0005765,lysosomal membrane,518,0,0.71,1.00000,1,1,0
CC,GO:0005767,secondary lysosome,22,0,0.03,1.00000,1,1,0
CC,GO:0005771,multivesicular body,66,0,0.09,1.00000,1,1,0
CC,GO:0005774,vacuolar membrane,576,0,0.79,1.00000,1,1,0
CC,GO:0005776,autophagosome,110,0,0.15,1.00000,1,1,0
CC,GO:0005778,peroxisomal membrane,72,0,0.1,1.00000,1,1,0
CC,GO:0005782,peroxisomal matrix,54,0,0.07,1.00000,1,1,0
CC,GO:0005788,endoplasmic reticulum lumen,334,0,0.46,1.00000,1,1,0
CC,GO:0005790,smooth endoplasmic reticulum,39,0,0.05,1.00000,1,1,0
CC,GO:0005791,rough endoplasmic reticulum,83,0,0.11,1.00000,1,1,0
CC,GO:0005793,endoplasmic reticulum-Golgi intermediate...,156,0,0.21,1.00000,1,1,0
CC,GO:0005795,Golgi stack,183,0,0.25,1.00000,1,1,0
CC,GO:0005796,Golgi lumen,146,0,0.2,1.00000,1,1,0
CC,GO:0005798,Golgi-associated vesicle,101,0,0.14,1.00000,1,1,0
CC,GO:0005801,cis-Golgi network,92,0,0.13,1.00000,1,1,0
CC,GO:0005811,lipid droplet,101,0,0.14,1.00000,1,1,0
CC,GO:0005814,centriole,170,0,0.23,1.00000,1,1,0
CC,GO:0005834,heterotrimeric G-protein complex,35,0,0.05,1.00000,1,1,0
CC,GO:0005838,proteasome regulatory particle,20,0,0.03,1.00000,1,1,0
CC,GO:0005839,proteasome core complex,36,0,0.05,1.00000,1,1,0
CC,GO:0005840,ribosome,258,0,0.35,1.00000,1,1,0
CC,GO:0005849,mRNA cleavage factor complex,21,0,0.03,1.00000,1,1,0
CC,GO:0005858,axonemal dynein complex,23,0,0.03,1.00000,1,1,0
CC,GO:0005865,striated muscle thin filament,24,0,0.03,1.00000,1,1,0
CC,GO:0005871,kinesin complex,57,0,0.08,1.00000,1,1,0
CC,GO:0005876,spindle microtubule,74,0,0.1,1.00000,1,1,0
CC,GO:0005892,acetylcholine-gated channel complex,20,0,0.03,1.00000,1,1,0
CC,GO:0005901,caveola,95,0,0.13,1.00000,1,1,0
CC,GO:0005903,brush border,116,0,0.16,1.00000,1,1,0
CC,GO:0005905,clathrin-coated pit,82,0,0.11,1.00000,1,1,0
CC,GO:0005921,gap junction,35,0,0.05,1.00000,1,1,0
CC,GO:0005922,connexin complex,22,0,0.03,1.00000,1,1,0
CC,GO:0005930,axoneme,136,0,0.19,1.00000,1,1,0
CC,GO:0005942,phosphatidylinositol 3-kinase complex,29,0,0.04,1.00000,1,1,0
CC,GO:0008023,transcription elongation factor complex,53,0,0.07,1.00000,1,1,0
CC,GO:0008076,voltage-gated potassium channel complex,83,0,0.11,1.00000,1,1,0
CC,GO:0008305,integrin complex,31,0,0.04,1.00000,1,1,0
CC,GO:0009295,nucleoid,45,0,0.06,1.00000,1,1,0
CC,GO:0009897,external side of plasma membrane,507,0,0.69,1.00000,1,1,0
CC,GO:0010008,endosome membrane,710,0,0.97,1.00000,1,1,0
CC,GO:0010494,cytoplasmic stress granule,80,0,0.11,1.00000,1,1,0
CC,GO:0012507,ER to Golgi transport vesicle membrane,154,0,0.21,1.00000,1,1,0
CC,GO:0015030,Cajal body,101,0,0.14,1.00000,1,1,0
CC,GO:0015934,large ribosomal subunit,115,0,0.16,1.00000,1,1,0
CC,GO:0015935,small ribosomal subunit,95,0,0.13,1.00000,1,1,0
CC,GO:0016010,dystrophin-associated glycoprotein compl...,22,0,0.03,1.00000,1,1,0
CC,GO:0016234,inclusion body,95,0,0.13,1.00000,1,1,0
CC,GO:0016235,aggresome,51,0,0.07,1.00000,1,1,0
CC,GO:0016327,apicolateral plasma membrane,22,0,0.03,1.00000,1,1,0
CC,GO:0016342,catenin complex,32,0,0.04,1.00000,1,1,0
CC,GO:0016460,myosin II complex,21,0,0.03,1.00000,1,1,0
CC,GO:0016469,proton-transporting two-sector ATPase co...,55,0,0.08,1.00000,1,1,0
CC,GO:0016471,vacuolar proton-transporting V-type ATPa...,27,0,0.04,1.00000,1,1,0
CC,GO:0016514,SWI/SNF complex,37,0,0.05,1.00000,1,1,0
CC,GO:0016591,"RNA polymerase II, holoenzyme",89,0,0.12,1.00000,1,1,0
CC,GO:0016592,mediator complex,43,0,0.06,1.00000,1,1,0
CC,GO:0016607,nuclear speck,493,0,0.67,1.00000,1,1,0
CC,GO:0017053,transcription repressor complex,64,0,0.09,1.00000,1,1,0
CC,GO:0019005,SCF ubiquitin ligase complex,62,0,0.08,1.00000,1,1,0
CC,GO:0019774,"proteasome core complex, beta-subunit co...",27,0,0.04,1.00000,1,1,0
CC,GO:0019814,immunoglobulin complex,150,0,0.21,1.00000,1,1,0
CC,GO:0019867,outer membrane,243,0,0.33,1.00000,1,1,0
CC,GO:0019897,extrinsic component of plasma membrane,182,0,0.25,1.00000,1,1,0
CC,GO:0019898,extrinsic component of membrane,328,0,0.45,1.00000,1,1,0
CC,GO:0022624,proteasome accessory complex,26,0,0.04,1.00000,1,1,0
CC,GO:0022625,cytosolic large ribosomal subunit,58,0,0.08,1.00000,1,1,0
CC,GO:0022626,cytosolic ribosome,118,0,0.16,1.00000,1,1,0
CC,GO:0022627,cytosolic small ribosomal subunit,58,0,0.08,1.00000,1,1,0
CC,GO:0030014,CCR4-NOT complex,23,0,0.03,1.00000,1,1,0
CC,GO:0030027,lamellipodium,221,0,0.3,1.00000,1,1,0
CC,GO:0030057,desmosome,30,0,0.04,1.00000,1,1,0
CC,GO:0030117,membrane coat,93,0,0.13,1.00000,1,1,0
CC,GO:0030118,clathrin coat,47,0,0.06,1.00000,1,1,0
CC,GO:0030119,AP-type membrane coat adaptor complex,38,0,0.05,1.00000,1,1,0
CC,GO:0030120,vesicle coat,57,0,0.08,1.00000,1,1,0
CC,GO:0030125,clathrin vesicle coat,30,0,0.04,1.00000,1,1,0
CC,GO:0030131,clathrin adaptor complex,26,0,0.04,1.00000,1,1,0
CC,GO:0030134,COPII-coated ER to Golgi transport vesic...,187,0,0.26,1.00000,1,1,0
CC,GO:0030135,coated vesicle,399,0,0.55,1.00000,1,1,0
CC,GO:0030136,clathrin-coated vesicle,258,0,0.35,1.00000,1,1,0
CC,GO:0030137,COPI-coated vesicle,28,0,0.04,1.00000,1,1,0
CC,GO:0030140,trans-Golgi network transport vesicle,36,0,0.05,1.00000,1,1,0
CC,GO:0030173,integral component of Golgi membrane,62,0,0.08,1.00000,1,1,0
CC,GO:0030176,integral component of endoplasmic reticu...,285,0,0.39,1.00000,1,1,0
CC,GO:0030285,integral component of synaptic vesicle m...,42,0,0.06,1.00000,1,1,0
CC,GO:0030315,T-tubule,53,0,0.07,1.00000,1,1,0
CC,GO:0030532,small nuclear ribonucleoprotein complex,122,0,0.17,1.00000,1,1,0
CC,GO:0030660,Golgi-associated vesicle membrane,57,0,0.08,1.00000,1,1,0
CC,GO:0030662,coated vesicle membrane,276,0,0.38,1.00000,1,1,0
CC,GO:0030665,clathrin-coated vesicle membrane,174,0,0.24,1.00000,1,1,0
CC,GO:0030669,clathrin-coated endocytic vesicle membra...,129,0,0.18,1.00000,1,1,0
CC,GO:0030670,phagocytic vesicle membrane,133,0,0.18,1.00000,1,1,0
CC,GO:0030672,synaptic vesicle membrane,125,0,0.17,1.00000,1,1,0
CC,GO:0030677,ribonuclease P complex,21,0,0.03,1.00000,1,1,0
CC,GO:0030686,90S preribosome,33,0,0.05,1.00000,1,1,0
CC,GO:0030687,"preribosome, large subunit precursor",25,0,0.03,1.00000,1,1,0
CC,GO:0030863,cortical cytoskeleton,121,0,0.17,1.00000,1,1,0
CC,GO:0030864,cortical actin cytoskeleton,92,0,0.13,1.00000,1,1,0
CC,GO:0030867,rough endoplasmic reticulum membrane,25,0,0.03,1.00000,1,1,0
CC,GO:0030880,RNA polymerase complex,127,0,0.17,1.00000,1,1,0
CC,GO:0030964,"NADH dehydrogenase complex",63,0,0.09,1.00000,1,1,0
CC,GO:0030990,intraciliary transport particle,24,0,0.03,1.00000,1,1,0
CC,GO:0031011,Ino80 complex,24,0,0.03,1.00000,1,1,0
CC,GO:0031045,dense core granule,29,0,0.04,1.00000,1,1,0
CC,GO:0031091,platelet alpha granule,102,0,0.14,1.00000,1,1,0
CC,GO:0031092,platelet alpha granule membrane,23,0,0.03,1.00000,1,1,0
CC,GO:0031093,platelet alpha granule lumen,72,0,0.1,1.00000,1,1,0
CC,GO:0031201,SNARE complex,48,0,0.07,1.00000,1,1,0
CC,GO:0031227,intrinsic component of endoplasmic retic...,293,0,0.4,1.00000,1,1,0
CC,GO:0031228,intrinsic component of Golgi membrane,67,0,0.09,1.00000,1,1,0
CC,GO:0031233,intrinsic component of external side of ...,25,0,0.03,1.00000,1,1,0
CC,GO:0031234,extrinsic component of cytoplasmic side ...,104,0,0.14,1.00000,1,1,0
CC,GO:0031248,protein acetyltransferase complex,92,0,0.13,1.00000,1,1,0
CC,GO:0031254,cell trailing edge,20,0,0.03,1.00000,1,1,0
CC,GO:0031256,leading edge membrane,193,0,0.26,1.00000,1,1,0
CC,GO:0031258,lamellipodium membrane,22,0,0.03,1.00000,1,1,0
CC,GO:0031300,intrinsic component of organelle membran...,552,0,0.76,1.00000,1,1,0
CC,GO:0031301,integral component of organelle membrane,522,0,0.71,1.00000,1,1,0
CC,GO:0031304,intrinsic component of mitochondrial inn...,61,0,0.08,1.00000,1,1,0
CC,GO:0031305,integral component of mitochondrial inne...,61,0,0.08,1.00000,1,1,0
CC,GO:0031306,intrinsic component of mitochondrial out...,24,0,0.03,1.00000,1,1,0
CC,GO:0031307,integral component of mitochondrial oute...,23,0,0.03,1.00000,1,1,0
CC,GO:0031312,extrinsic component of organelle membran...,56,0,0.08,1.00000,1,1,0
CC,GO:0031362,anchored component of external side of p...,20,0,0.03,1.00000,1,1,0
CC,GO:0031430,M band,26,0,0.04,1.00000,1,1,0
CC,GO:0031461,cullin-RING ubiquitin ligase complex,179,0,0.25,1.00000,1,1,0
CC,GO:0031462,Cul2-RING ubiquitin ligase complex,26,0,0.04,1.00000,1,1,0
CC,GO:0031463,Cul3-RING ubiquitin ligase complex,36,0,0.05,1.00000,1,1,0
CC,GO:0031514,motile cilium,224,0,0.31,1.00000,1,1,0
CC,GO:0031519,PcG protein complex,40,0,0.05,1.00000,1,1,0
CC,GO:0031526,brush border membrane,60,0,0.08,1.00000,1,1,0
CC,GO:0031527,filopodium membrane,24,0,0.03,1.00000,1,1,0
CC,GO:0031528,microvillus membrane,35,0,0.05,1.00000,1,1,0
CC,GO:0031901,early endosome membrane,266,0,0.36,1.00000,1,1,0
CC,GO:0031902,late endosome membrane,186,0,0.25,1.00000,1,1,0
CC,GO:0031903,microbody membrane,72,0,0.1,1.00000,1,1,0
CC,GO:0031904,endosome lumen,37,0,0.05,1.00000,1,1,0
CC,GO:0031907,microbody lumen,54,0,0.07,1.00000,1,1,0
CC,GO:0031941,filamentous actin,31,0,0.04,1.00000,1,1,0
CC,GO:0031966,mitochondrial membrane,804,0,1.1,1.00000,1,1,0
CC,GO:0031968,organelle outer membrane,241,0,0.33,1.00000,1,1,0
CC,GO:0031970,organelle envelope lumen,107,0,0.15,1.00000,1,1,0
CC,GO:0031985,Golgi cisterna,144,0,0.2,1.00000,1,1,0
CC,GO:0032039,integrator complex,27,0,0.04,1.00000,1,1,0
CC,GO:0032153,cell division site,77,0,0.11,1.00000,1,1,0
CC,GO:0032154,cleavage furrow,55,0,0.08,1.00000,1,1,0
CC,GO:0032281,AMPA glutamate receptor complex,26,0,0.04,1.00000,1,1,0
CC,GO:0032391,photoreceptor connecting cilium,41,0,0.06,1.00000,1,1,0
CC,GO:0032426,stereocilium tip,20,0,0.03,1.00000,1,1,0
CC,GO:0032580,Golgi cisterna membrane,109,0,0.15,1.00000,1,1,0
CC,GO:0032587,ruffle membrane,108,0,0.15,1.00000,1,1,0
CC,GO:0032588,trans-Golgi network membrane,165,0,0.23,1.00000,1,1,0
CC,GO:0032589,neuron projection membrane,65,0,0.09,1.00000,1,1,0
CC,GO:0032590,dendrite membrane,43,0,0.06,1.00000,1,1,0
CC,GO:0032592,integral component of mitochondrial memb...,92,0,0.13,1.00000,1,1,0
CC,GO:0032806,carboxy-terminal domain protein kinase c...,28,0,0.04,1.00000,1,1,0
CC,GO:0032809,neuronal cell body membrane,29,0,0.04,1.00000,1,1,0
CC,GO:0032982,myosin filament,24,0,0.03,1.00000,1,1,0
CC,GO:0032994,protein-lipid complex,46,0,0.06,1.00000,1,1,0
CC,GO:0033116,endoplasmic reticulum-Golgi intermediate...,98,0,0.13,1.00000,1,1,0
CC,GO:0033162,melanosome membrane,20,0,0.03,1.00000,1,1,0
CC,GO:0033176,proton-transporting V-type ATPase comple...,33,0,0.05,1.00000,1,1,0
CC,GO:0033177,proton-transporting two-sector ATPase co...,24,0,0.03,1.00000,1,1,0
CC,GO:0034358,plasma lipoprotein particle,43,0,0.06,1.00000,1,1,0
CC,GO:0034361,very-low-density lipoprotein particle,26,0,0.04,1.00000,1,1,0
CC,GO:0034364,high-density lipoprotein particle,34,0,0.05,1.00000,1,1,0
CC,GO:0034385,triglyceride-rich plasma lipoprotein par...,26,0,0.04,1.00000,1,1,0
CC,GO:0034707,chloride channel complex,59,0,0.08,1.00000,1,1,0
CC,GO:0034708,methyltransferase complex,102,0,0.14,1.00000,1,1,0
CC,GO:0034719,SMN-Sm protein complex,20,0,0.03,1.00000,1,1,0
CC,GO:0035097,histone methyltransferase complex,74,0,0.1,1.00000,1,1,0
CC,GO:0035102,PRC1 complex,21,0,0.03,1.00000,1,1,0
CC,GO:0035267,NuA4 histone acetyltransferase complex,22,0,0.03,1.00000,1,1,0
CC,GO:0035327,transcriptionally active chromatin,24,0,0.03,1.00000,1,1,0
CC,GO:0035577,azurophil granule membrane,60,0,0.08,1.00000,1,1,0
CC,GO:0035579,specific granule membrane,124,0,0.17,1.00000,1,1,0
CC,GO:0035580,specific granule lumen,84,0,0.11,1.00000,1,1,0
CC,GO:0035861,site of double-strand break,76,0,0.1,1.00000,1,1,0
CC,GO:0035869,ciliary transition zone,71,0,0.1,1.00000,1,1,0
CC,GO:0036019,endolysosome,30,0,0.04,1.00000,1,1,0
CC,GO:0036020,endolysosome membrane,20,0,0.03,1.00000,1,1,0
CC,GO:0036064,ciliary basal body,167,0,0.23,1.00000,1,1,0
CC,GO:0036126,sperm flagellum,128,0,0.18,1.00000,1,1,0
CC,GO:0036379,myofilament,28,0,0.04,1.00000,1,1,0
CC,GO:0036452,ESCRT complex,28,0,0.04,1.00000,1,1,0
CC,GO:0042101,T cell receptor complex,139,0,0.19,1.00000,1,1,0
CC,GO:0042571,"immunoglobulin complex, circulating",66,0,0.09,1.00000,1,1,0
CC,GO:0042575,DNA polymerase complex,20,0,0.03,1.00000,1,1,0
CC,GO:0042581,specific granule,215,0,0.29,1.00000,1,1,0
CC,GO:0042611,MHC protein complex,142,0,0.19,1.00000,1,1,0
CC,GO:0042612,MHC class I protein complex,46,0,0.06,1.00000,1,1,0
CC,GO:0042613,MHC class II protein complex,98,0,0.13,1.00000,1,1,0
CC,GO:0042645,mitochondrial nucleoid,45,0,0.06,1.00000,1,1,0
CC,GO:0042788,polysomal ribosome,33,0,0.05,1.00000,1,1,0
CC,GO:0042824,MHC class I peptide loading complex,34,0,0.05,1.00000,1,1,0
CC,GO:0043073,germ cell nucleus,20,0,0.03,1.00000,1,1,0
CC,GO:0043186,P granule,20,0,0.03,1.00000,1,1,0
CC,GO:0043189,H4/H2A histone acetyltransferase complex,22,0,0.03,1.00000,1,1,0
CC,GO:0043198,dendritic shaft,40,0,0.05,1.00000,1,1,0
CC,GO:0043202,lysosomal lumen,115,0,0.16,1.00000,1,1,0
CC,GO:0043596,nuclear replication fork,29,0,0.04,1.00000,1,1,0
CC,GO:0044232,organelle membrane contact site,51,0,0.07,1.00000,1,1,0
CC,GO:0044233,mitochondria-associated endoplasmic reti...,30,0,0.04,1.00000,1,1,0
CC,GO:0044295,axonal growth cone,31,0,0.04,1.00000,1,1,0
CC,GO:0044298,cell body membrane,32,0,0.04,1.00000,1,1,0
CC,GO:0044305,calyx of Held,20,0,0.03,1.00000,1,1,0
CC,GO:0044322,endoplasmic reticulum quality control co...,31,0,0.04,1.00000,1,1,0
CC,GO:0044391,ribosomal subunit,206,0,0.28,1.00000,1,1,0
CC,GO:0044665,MLL1/2 complex,42,0,0.06,1.00000,1,1,0
CC,GO:0044815,DNA packaging complex,120,0,0.16,1.00000,1,1,0
CC,GO:0044853,plasma membrane raft,131,0,0.18,1.00000,1,1,0
CC,GO:0045009,chitosome,20,0,0.03,1.00000,1,1,0
CC,GO:0045095,keratin filament,135,0,0.18,1.00000,1,1,0
CC,GO:0045171,intercellular bridge,80,0,0.11,1.00000,1,1,0
CC,GO:0045259,proton-transporting ATP synthase complex,21,0,0.03,1.00000,1,1,0
CC,GO:0045271,respiratory chain complex I,63,0,0.09,1.00000,1,1,0
CC,GO:0045277,respiratory chain complex IV,28,0,0.04,1.00000,1,1,0
CC,GO:0045334,clathrin-coated endocytic vesicle,150,0,0.21,1.00000,1,1,0
CC,GO:0045335,phagocytic vesicle,197,0,0.27,1.00000,1,1,0
CC,GO:0045495,pole plasm,21,0,0.03,1.00000,1,1,0
CC,GO:0046540,U4/U6 x U5 tri-snRNP complex,56,0,0.08,1.00000,1,1,0
CC,GO:0046658,anchored component of plasma membrane,63,0,0.09,1.00000,1,1,0
CC,GO:0046930,pore complex,26,0,0.04,1.00000,1,1,0
CC,GO:0048475,coated membrane,93,0,0.13,1.00000,1,1,0
CC,GO:0048786,presynaptic active zone,83,0,0.11,1.00000,1,1,0
CC,GO:0048787,presynaptic active zone membrane,30,0,0.04,1.00000,1,1,0
CC,GO:0051233,spindle midzone,39,0,0.05,1.00000,1,1,0
CC,GO:0055029,nuclear DNA-directed RNA polymerase comp...,122,0,0.17,1.00000,1,1,0
CC,GO:0055038,recycling endosome membrane,133,0,0.18,1.00000,1,1,0
CC,GO:0060076,excitatory synapse,52,0,0.07,1.00000,1,1,0
CC,GO:0060170,ciliary membrane,82,0,0.11,1.00000,1,1,0
CC,GO:0060293,germ plasm,20,0,0.03,1.00000,1,1,0
CC,GO:0061695,"transferase complex, transferring phosph...",271,0,0.37,1.00000,1,1,0
CC,GO:0070069,cytochrome complex,41,0,0.06,1.00000,1,1,0
CC,GO:0070461,SAGA-type complex,30,0,0.04,1.00000,1,1,0
CC,GO:0070469,respirasome,115,0,0.16,1.00000,1,1,0
CC,GO:0070820,tertiary granule,215,0,0.29,1.00000,1,1,0
CC,GO:0070821,tertiary granule membrane,108,0,0.15,1.00000,1,1,0
CC,GO:0070971,endoplasmic reticulum exit site,45,0,0.06,1.00000,1,1,0
CC,GO:0071005,U2-type precatalytic spliceosome,72,0,0.1,1.00000,1,1,0
CC,GO:0071007,U2-type catalytic step 2 spliceosome,31,0,0.04,1.00000,1,1,0
CC,GO:0071011,precatalytic spliceosome,74,0,0.1,1.00000,1,1,0
CC,GO:0071013,catalytic step 2 spliceosome,97,0,0.13,1.00000,1,1,0
CC,GO:0071339,MLL1 complex,42,0,0.06,1.00000,1,1,0
CC,GO:0071556,integral component of lumenal side of en...,127,0,0.17,1.00000,1,1,0
CC,GO:0071682,endocytic vesicle lumen,25,0,0.03,1.00000,1,1,0
CC,GO:0071782,endoplasmic reticulum tubular network,23,0,0.03,1.00000,1,1,0
CC,GO:0072562,blood microparticle,180,0,0.25,1.00000,1,1,0
CC,GO:0072686,mitotic spindle,179,0,0.25,1.00000,1,1,0
CC,GO:0080008,Cul4-RING E3 ubiquitin ligase complex,37,0,0.05,1.00000,1,1,0
CC,GO:0089717,spanning component of membrane,22,0,0.03,1.00000,1,1,0
CC,GO:0090575,RNA polymerase II transcription regulato...,190,0,0.26,1.00000,1,1,0
CC,GO:0090665,glycoprotein complex,22,0,0.03,1.00000,1,1,0
CC,GO:0090734,site of DNA damage,100,0,0.14,1.00000,1,1,0
CC,GO:0090741,pigment granule membrane,20,0,0.03,1.00000,1,1,0
CC,GO:0097014,ciliary plasm,138,0,0.19,1.00000,1,1,0
CC,GO:0097038,perinuclear endoplasmic reticulum,21,0,0.03,1.00000,1,1,0
CC,GO:0097225,sperm midpiece,35,0,0.05,1.00000,1,1,0
CC,GO:0097228,sperm principal piece,26,0,0.04,1.00000,1,1,0
CC,GO:0097346,INO80-type complex,34,0,0.05,1.00000,1,1,0
CC,GO:0097381,photoreceptor disc membrane,24,0,0.03,1.00000,1,1,0
CC,GO:0097386,glial cell projection,36,0,0.05,1.00000,1,1,0
CC,GO:0097431,mitotic spindle pole,38,0,0.05,1.00000,1,1,0
CC,GO:0097525,spliceosomal snRNP complex,111,0,0.15,1.00000,1,1,0
CC,GO:0097526,spliceosomal tri-snRNP complex,56,0,0.08,1.00000,1,1,0
CC,GO:0097542,ciliary tip,47,0,0.06,1.00000,1,1,0
CC,GO:0097546,ciliary base,42,0,0.06,1.00000,1,1,0
CC,GO:0097729,9+2 motile cilium,141,0,0.19,1.00000,1,1,0
CC,GO:0098533,ATPase dependent transmembrane transport...,25,0,0.03,1.00000,1,1,0
CC,GO:0098553,lumenal side of endoplasmic reticulum me...,127,0,0.17,1.00000,1,1,0
CC,GO:0098563,intrinsic component of synaptic vesicle ...,54,0,0.07,1.00000,1,1,0
CC,GO:0098573,intrinsic component of mitochondrial mem...,93,0,0.13,1.00000,1,1,0
CC,GO:0098576,lumenal side of membrane,135,0,0.18,1.00000,1,1,0
CC,GO:0098636,protein complex involved in cell adhesio...,36,0,0.05,1.00000,1,1,0
CC,GO:0098644,complex of collagen trimers,27,0,0.04,1.00000,1,1,0
CC,GO:0098686,hippocampal mossy fiber to CA3 synapse,34,0,0.05,1.00000,1,1,0
CC,GO:0098798,mitochondrial protein-containing complex,302,0,0.41,1.00000,1,1,0
CC,GO:0098799,outer mitochondrial membrane protein com...,23,0,0.03,1.00000,1,1,0
CC,GO:0098800,inner mitochondrial membrane protein com...,168,0,0.23,1.00000,1,1,0
CC,GO:0098803,respiratory chain complex,104,0,0.14,1.00000,1,1,0
CC,GO:0098852,lytic vacuole membrane,518,0,0.71,1.00000,1,1,0
CC,GO:0098889,intrinsic component of presynaptic membr...,78,0,0.11,1.00000,1,1,0
CC,GO:0098982,GABA-ergic synapse,84,0,0.11,1.00000,1,1,0
CC,GO:0099023,vesicle tethering complex,74,0,0.1,1.00000,1,1,0
CC,GO:0099056,integral component of presynaptic membra...,69,0,0.09,1.00000,1,1,0
CC,GO:0099086,synaptonemal structure,43,0,0.06,1.00000,1,1,0
CC,GO:0099501,exocytic vesicle membrane,125,0,0.17,1.00000,1,1,0
CC,GO:0099522,cytosolic region,22,0,0.03,1.00000,1,1,0
CC,GO:0099738,cell cortex region,44,0,0.06,1.00000,1,1,0
CC,GO:0101002,ficolin-1-rich granule,232,0,0.32,1.00000,1,1,0
CC,GO:0101003,ficolin-1-rich granule membrane,86,0,0.12,1.00000,1,1,0
CC,GO:0101031,chaperone complex,30,0,0.04,1.00000,1,1,0
CC,GO:0120114,Sm-like protein family complex,136,0,0.19,1.00000,1,1,0
CC,GO:0140534,endoplasmic reticulum protein-containing...,153,0,0.21,1.00000,1,1,0
CC,GO:1902493,acetyltransferase complex,92,0,0.13,1.00000,1,1,0
CC,GO:1902554,serine/threonine protein kinase complex,99,0,0.14,1.00000,1,1,0
CC,GO:1902562,H4 histone acetyltransferase complex,35,0,0.05,1.00000,1,1,0
CC,GO:1902710,GABA receptor complex,20,0,0.03,1.00000,1,1,0
CC,GO:1902911,protein kinase complex,114,0,0.16,1.00000,1,1,0
CC,GO:1904724,tertiary granule lumen,68,0,0.09,1.00000,1,1,0
CC,GO:1904813,ficolin-1-rich granule lumen,146,0,0.2,1.00000,1,1,0
CC,GO:1905354,exoribonuclease complex,20,0,0.03,1.00000,1,1,0
CC,GO:1905360,GTPase complex,35,0,0.05,1.00000,1,1,0
CC,GO:1905368,peptidase complex,119,0,0.16,1.00000,1,1,0
CC,GO:1905369,endopeptidase complex,85,0,0.12,1.00000,1,1,0
CC,GO:1990204,oxidoreductase complex,134,0,0.18,1.00000,1,1,0
CC,GO:1990234,transferase complex,818,0,1.12,1.00000,1,1,0
CC,GO:1990777,lipoprotein particle,43,0,0.06,1.00000,1,1,0
